FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Tagliaferri, TL
   Jansen, M
   Horz, HP
AF Tagliaferri, Thaysa Leite
   Jansen, Mathias
   Horz, Hans-Peter
TI Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as
   Combined Strategy
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE antibiotics; phages; phage therapy; phage and antibiotic combination;
   antimicrobial resistance; phage-antibiotic synergy (PAS); resistance
   evolution; ESKAPE
ID BURKHOLDERIA-CEPACIA COMPLEX; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI;
   ACINETOBACTER-BAUMANNII; PSEUDOMONAS; RESISTANCE; THERAPY; BIOFILM;
   INFECTIONS; BACTERIOPHAGES
AB With the emerging threat of infections caused by multidrug resistant bacteria, phages have been reconsidered as an alternative for treating infections caused by tenacious pathogens. However, instead of replacing antibiotics, the combination of both types of antimicrobials can be superior over the use of single agents. Enhanced bacterial suppression, more efficient penetration into biofilms, and lowered chances for the emergence of phage resistance are the likely advantages of the combined strategy. While a number of studies have provided experimental evidence in support of this concept, negative interference between phages and antibiotics have been reported as well. Neutral effects have also been observed, but in those cases, combined approaches may still be important for at least hampering the development of resistance. In any case, the choice of phage type and antibiotic as well as their mixing ratios must be given careful consideration when deciding for a dual antibacterial approach. The most frequently tested bacterium for a combined antibacterial treatment has been Pseudomonas aeruginosa, but encouraging results have also been reported for Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Enterococcus faecalis, and Burkholderia cepacia. Given the immense play area of conceivable phage-antibiotic combinations and their potential excess value, it is time to recapitulate of what has been achieved so far. This review therefore gathers and compares the results from most relevant studies in order to help researchers and clinicians in their strategies to combat multidrug resistant bacteria. Special attention is given to the selected bacterial model organisms, the phage families and genera employed, and the experimental design and evaluation (e.g., in vitro vs. in vivo models, bio film vs. planktonic culture experiments, order and frequency of administrationetc.). The presented data may serve as a framework for directed further experimental approaches to ultimately achieve a resolute challenge of multidrug resistant bacteria based on traditional antibiotics and phages.
C1 [Tagliaferri, Thaysa Leite; Jansen, Mathias; Horz, Hans-Peter] RWTH Aachen Univ Hosp, Inst Med Microbiol, Aachen, Germany.
   [Tagliaferri, Thaysa Leite] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Belo Horizonte, MG, Brazil.
RP Horz, HP (reprint author), RWTH Aachen Univ Hosp, Inst Med Microbiol, Aachen, Germany.
EM hhorz@ukaachen.de
FU CNPq Scholarship-Brazil
FX TT was supported by CNPq Scholarship-Brazil.
CR Alshalchi SA, 2015, ARCH MICROBIOL, V197, P135, DOI 10.1007/s00203-014-1030-y
   Barbu EM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023879
   Bawa AS, 2013, J FOOD SCI TECH MYS, V50, P1035, DOI 10.1007/s13197-012-0899-1
   Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8
   Blount ZD, 2015, ELIFE, V4, DOI 10.7554/eLife.05826
   Cairns J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0040
   Chan BK, 2018, EVOL MED PUBLIC HLTH, P60, DOI 10.1093/emph/eoy005
   Chan BK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26717
   Chanishvili N, 2012, ADV VIRUS RES, V83, P3, DOI 10.1016/B978-0-12-394438-2.00001-3
   Chaudhry WN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168615
   Chhibber S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056022
   Chhibber S, 2008, J MED MICROBIOL, V57, P1508, DOI 10.1099/jmm.0.2008/002873-0
   Choo EJ, 2016, INFECT CHEMOTHER, V48, P267, DOI 10.3947/ic.2016.48.4.267
   Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799
   Coulter LB, 2014, VIRUSES-BASEL, V6, P3778, DOI 10.3390/v6103778
   Danis-Wlodarczyk K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28115
   De Soyza A, 2013, MICROBIOLOGYOPEN, V2, P1010, DOI 10.1002/mbo3.141
   Decre D, 2011, J CLIN MICROBIOL, V49, P3012, DOI 10.1128/JCM.00676-11
   Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789
   Escobar-Paramo P, 2012, EVOL APPL, V5, P583, DOI 10.1111/j.1752-4571.2012.00248.x
   Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0
   Garcia BA, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0594-8
   Gelman D, 2018, RES MICROBIOL, V169, P531, DOI 10.1016/j.resmic.2018.04.008
   Hagens S, 2006, MICROB DRUG RESIST, V12, P164, DOI 10.1089/mdr.2006.12.164
   Hassoun A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1801-3
   Holland SJ, 2006, VIROLOGY, V345, P540, DOI 10.1016/j.virol.2005.10.020
   Horsley A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009529.pub3
   Huff WE, 2004, POULTRY SCI, V83, P1944, DOI 10.1093/ps/83.12.1944
   Jansen M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32344-y
   Jneid J, 2018, FRONT CELL INFECT MI, V8, DOI [10.3389/fcimb.2018.00282, 10.3389/fcimb.2013.00282]
   Kamal F, 2015, APPL ENVIRON MICROB, V81, P1132, DOI 10.1128/AEM.02850-14
   Khawaldeh A, 2011, J MED MICROBIOL, V60, P1697, DOI 10.1099/jmm.0.029744-0
   Kirby AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051017
   Knezevic P, 2013, RES MICROBIOL, V164, P55, DOI 10.1016/j.resmic.2012.08.008
   Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10
   Lee AS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.33
   Levin L, 2014, QUINTESSENCE INT, V45, P635, DOI 10.3290/j.qi.a32445
   Lin Derek M, 2017, World J Gastrointest Pharmacol Ther, V8, P162, DOI 10.4292/wjgpt.v8.i3.162
   Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106
   Madsen Kristian T, 2017, Open Microbiol J, V11, P1, DOI 10.2174/1874285801711010001
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x
   Mihara T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030066
   Miller WR, 2014, EXPERT REV ANTI-INFE, V12, P1221, DOI 10.1586/14787210.2014.956092
   Muller C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126143
   Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006
   Oechslin F, 2017, J INFECT DIS, V215, P703, DOI 10.1093/infdis/jiw632
   Ojala V, 2013, EVOL APPL, V6, P925, DOI 10.1111/eva.12076
   Oliveira D, 2018, TOXINS, V10, DOI 10.3390/toxins10060252
   ONeil J., 2016, TACKLING DRUG RESIST
   Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07
   Pelfrene E, 2016, J ANTIMICROB CHEMOTH, V71, P2071, DOI 10.1093/jac/dkw083
   Rahman M, 2011, BIOFOULING, V27, P1087, DOI 10.1080/08927014.2011.631169
   Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452
   Ryan EM, 2012, FEMS IMMUNOL MED MIC, V65, P395, DOI 10.1111/j.1574-695X.2012.00977.x
   Shen MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34067
   Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680
   Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14
   Torres-Barcelo C, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy107
   Torres-Barcelo C, 2016, TRENDS MICROBIOL, V24, P249, DOI 10.1016/j.tim.2015.12.011
   Torres-Barcelo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106628
   Uchiyama J, 2018, ARCH VIROL, V163, P1941, DOI 10.1007/s00705-018-3811-0
   Valerio N, 2017, VIRUS RES, V240, P8, DOI 10.1016/j.virusres.2017.07.015
   Verma V, 2010, BIOFOULING, V26, P729, DOI 10.1080/08927014.2010.511196
   Verma V, 2009, J ANTIMICROB CHEMOTH, V64, P1212, DOI 10.1093/jac/dkp360
   Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y
   Vila J, 2016, FEMS MICROBIOL REV, V40, P437, DOI 10.1093/femsre/fuw005
   Villarroel J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110328
   Wendt C, 1997, J CLIN MICROBIOL, V35, P1394
   Wisplinghoff H, 2007, J HOSP INFECT, V66, P174, DOI 10.1016/j.jhin.2007.02.016
   Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895
   Yilmaz C, 2013, J BONE JOINT SURG AM, V95A, P117, DOI 10.2106/JBJS.K.01135
   Zhang QG, 2012, EVOL APPL, V5, P575, DOI 10.1111/j.1752-4571.2011.00236.x
NR 73
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD FEB 18
PY 2019
VL 9
AR 22
DI 10.3389/fcimb.2019.00022
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HL9QP
UT WOS:000459077900001
OA DOAJ Gold
DA 2019-02-28
ER

PT J
AU Jamal, M
   Andleeb, S
   Jalil, F
   Imran, M
   Nawaz, MA
   Hussain, T
   Ali, M
   Rahman, SU
   Das, CR
AF Jamal, Muhsin
   Andleeb, Saadia
   Jalil, Fazal
   Imran, Muhammad
   Nawaz, Muhammad Asif
   Hussain, Tahir
   Ali, Muhammad
   Rahman, Sadeeq Ur
   Das, Chythanya Rajanna
TI Isolation, characterization and efficacy of phage MJ2 against biofilm
   forming multi-drug resistant Enterobacter cloacae
SO FOLIA MICROBIOLOGICA
LA English
DT Article
ID ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; PLANKTONIC CELLS;
   BACTERIOPHAGE; HOST; SUSCEPTIBILITY; DIVERSITY; SURFACES; GROWTH
AB Biofilm is involved in a variety of infections, playing a critical role in the chronicity of infections. Enterobacter cloacae is a biofilm-forming and multi-drug-resistant (MDR) nosocomial pathogen leading to significant morbidity and mortality. This study aimed at isolation of a bacteriophage against MDR clinical strain of E. cloacae and its efficacy against bacterial planktonic cells and biofilm. A bacteriophage MJ2 was successfully isolated from wastewater and was characterized. The phage exhibited a wide range of thermal and pH stability and demonstrated considerable adsorption to host bacteria in the presence of CaCl2 or MgCl2. Transmission electron microscopy (TEM) showed MJ2 head as approximately 62 and 54nm width and length, respectively. It had a short non-contractile tail and was characterized as a member of the family Podoviridae [order Caudovirales]. The phage MJ2 was found to possess 11 structural proteins (12-150kDa) and a double-stranded DNA genome with an approximate size of 40kb. The log-phase growth of E. cloacae both in biofilm and suspension was significantly reduced by the phage. The E. cloacae biofilm was formed under different conditions to evaluate the efficacy of MJ2 phage. Variable reduction pattern of E. cloacae biofilm was observed while treating it for 4h with MJ2, i.e., biofilm under static conditions. The renewed media with intervals of 24, 72, and 120h showed biomass decline of 2.8-, 3-, and 3.5-log, respectively. Whereas, the bacterial biofilm formed with dynamic conditions with refreshing media after 24, 72, and 120h demonstrated decline in growth at 2.5-, 2.6-, and 3.3-log, respectively. It was, therefore, concluded that phage MJ2 possessed considerable inhibitory effects on MDR E. cloacae both in planktonic and biofilm forms.
C1 [Jamal, Muhsin; Hussain, Tahir] Abdul Wali Khan Univ, Dept Microbiol, Garden Campus, Mardan 23200, Pakistan.
   [Jamal, Muhsin; Andleeb, Saadia; Das, Chythanya Rajanna] Univ Florida, EPI, Gainesville, FL USA.
   [Jamal, Muhsin; Rahman, Sadeeq Ur; Das, Chythanya Rajanna] Abdul Wali Khan Univ, Coll Vet Sci & Anim Husb, Mardan, Pakistan.
   [Andleeb, Saadia; Jalil, Fazal] Natl Univ Sci & Technol, Atta Ur Rahman Sch Appl Biosci, Islamabad, Pakistan.
   [Jalil, Fazal; Imran, Muhammad] Abdul Wali Khan Univ, Dept Biotechnol, Mardan 23200, Pakistan.
   [Imran, Muhammad; Nawaz, Muhammad Asif] Univ Hlth Sci, Dept Microbiol, Lahore, Pakistan.
   [Nawaz, Muhammad Asif; Ali, Muhammad] Shaheed Benazir Bhutto Univ, Dept Biotechnol, Sheringal, Dir Upper, Pakistan.
   [Ali, Muhammad; Rahman, Sadeeq Ur] Univ Management & Technol, Dept Life Sci, Sch Sci, C 2 Johar Town, Lahore 54770, Pakistan.
RP Jamal, M (reprint author), Abdul Wali Khan Univ, Dept Microbiol, Garden Campus, Mardan 23200, Pakistan.; Jamal, M (reprint author), Univ Florida, EPI, Gainesville, FL USA.; Jamal, M (reprint author), Abdul Wali Khan Univ, Coll Vet Sci & Anim Husb, Mardan, Pakistan.
EM muhsinjamal@awkum.edu.pk
OI ur Rahman, Sadeeq/0000-0002-9314-6257
FU Higher Education Commission, Pakistan
FX The study was sponsored by Higher Education Commission, Pakistan.
CR Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13
   Ali T, 2017, ONCOTARGET, V8, P90144, DOI 10.18632/oncotarget.21496
   Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211
   Ashelford KE, 2000, APPL ENVIRON MICROB, V66, P4193, DOI 10.1128/AEM.66.10.4193-4199.2000
   Barrow P, 1998, CLIN DIAGN LAB IMMUN, V5, P294
   Capra ML, 2006, J APPL MICROBIOL, V100, P334, DOI 10.1111/j.1365-2672.2005.02767.x
   Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005
   Cerca N, 2007, LETT APPL MICROBIOL, V45, P313, DOI 10.1111/j.1472-765X.2007.02190.x
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chhibber S, 2014, J BASIC MICROB, V54, P775, DOI 10.1002/jobm.201300051
   CLSI, 2008, PLAT FUNCT TEST AGGR, P1
   Donlan RM, 2005, CLIN ORTHOP RELAT R, P12, DOI 10.1097/01.blo.0000175120.66051.29
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   EIGHMY TT, 1983, APPL ENVIRON MICROB, V45, P1921
   Fernandez-Baca V, 2001, J HOSP INFECT, V49, P173, DOI 10.1053/jhin.2001.1053
   Gilbert P, 1997, Adv Dent Res, V11, P160
   Hadas H, 1997, MICROBIOL-UK, V143, P179, DOI 10.1099/00221287-143-1-179
   Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001
   Harbarth S, 1999, INFECT CONT HOSP EP, V20, P598, DOI 10.1086/501677
   Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039
   Jalaluddin S, 1998, J CLIN MICROBIOL, V36, P1846
   Jamal M, 2015, J MED MICROBIOL, V64, P454, DOI 10.1099/jmm.0.000040
   Jamal M, 2015, J BASIC MICROB, V55, P420, DOI 10.1002/jobm.201400688
   Jamalludeen N, 2007, VET MICROBIOL, V124, P47, DOI 10.1016/j.vetmic.2007.03.028
   Kim SM, 2012, J MICROBIOL, V50, P175, DOI 10.1007/s12275-012-2044-2
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liu CP, 2004, J HOSP INFECT, V58, P63, DOI 10.1016/j.jhin.2004.04.019
   Ma L, 2005, MICROB DRUG RESIST, V11, P31, DOI 10.1089/mdr.2005.11.31
   Marr KA, 1997, ANN INTERN MED, V127, P275, DOI 10.7326/0003-4819-127-4-199708150-00003
   Payne RJH, 2001, J THEOR BIOL, V208, P37, DOI 10.1006/jtbi.2000.2198
   Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Piracha ZZ, 2014, GLOBAL J MED RES, V14, P1
   REESE JF, 1974, J VIROL, V13, P22
   RICHARDS SR, 1984, WATER RES, V18, P767, DOI 10.1016/0043-1354(84)90173-8
   Sambrook J., 1989, MOL CLONING
   Sieradzki K, 2003, J CLIN MICROBIOL, V41, P1687, DOI 10.1128/JCM.41.4.1687-1693.2003
   Sillankorva S, 2004, BIOFOULING, V20, P133, DOI 10.1080/08927010410001723834
   Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-79
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001
   Sutherland IW, 2004, FEMS MICROBIOL LETT, V232, P1, DOI 10.1016/S0378-1097(04)00041-2
   Tait K, 2002, BIOFOULING, V18, P305, DOI 10.1080/0892701021000034418
   Tenover FC, 2001, CLIN INFECT DIS, V33, pS108, DOI 10.1086/321834
   Vinh Donald C, 2005, J Long Term Eff Med Implants, V15, P467, DOI 10.1615/JLongTermEffMedImplants.v15.i5.20
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Weld RJ, 2004, J THEOR BIOL, V227, P1, DOI 10.1016/S0022-5193(03)00262-5
   Zimmer M, 2002, J BACTERIOL, V184, P4359, DOI 10.1128/JB.184.16.4359-4368.2002
NR 47
TC 0
Z9 0
U1 2
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0015-5632
EI 1874-9356
J9 FOLIA MICROBIOL
JI Folia Microbiol.
PD JAN
PY 2019
VL 64
IS 1
BP 101
EP 111
DI 10.1007/s12223-018-0636-x
PG 11
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA HH7MW
UT WOS:000455916000013
PM 30090964
DA 2019-02-28
ER

PT J
AU Mendoza, MLZ
   Roggenbuck, M
   Vargas, KM
   Hansen, LH
   Brunak, S
   Gilbert, MTP
   Sicheritz-Ponten, T
AF Mendoza, Marie Lisandra Zepeda
   Roggenbuck, Michael
   Manzano Vargas, Karla
   Hansen, Lars Hestbjerg
   Brunak, Soren
   Gilbert, M. Thomas P.
   Sicheritz-Ponten, Thomas
TI Protective role of the vulture facial skin and gut microbiomes aid
   adaptation to scavenging
SO ACTA VETERINARIA SCANDINAVICA
LA English
DT Article
DE Colonization resistance; Diet specialization; Metagenomics; Microbiome;
   Pathogens; Scavenging; Vulture
ID RNA GENE DATABASE; SALMONELLA-TYPHIMURIUM; COLONIZATION RESISTANCE;
   ESCHERICHIA-COLI; FATTY-ACIDS; BACTERIOPHAGE; PATHOGEN; PROJECT;
   IDENTIFICATION; CARNOBACTERIUM
AB Background: Vultures have adapted the remarkable ability to feed on carcasses that may contain microorganisms that would be pathogenic to most other animals. The holobiont concept suggests that the genetic basis of such adaptation may not only lie within their genomes, but additionally in their associated microbes. To explore this, we generated shotgun DNA sequencing datasets of the facial skin and large intestine microbiomes of the black vulture (Coragyps atratus) and the turkey vulture (Cathartes aura). We characterized the functional potential and taxonomic diversity of their microbiomes, the potential pathogenic challenges confronted by vultures, and the microbial taxa and genes that could play a protective role on the facial skin and in the gut.
   Results: We found microbial taxa and genes involved in diseases, such as dermatitis and pneumonia (more abundant on the facial skin), and gas gangrene and food poisoning (more abundant in the gut). Interestingly, we found taxa and functions with potential for playing beneficial roles, such as antilisterial bacteria in the gut, and genes for the production of antiparasitics and insecticides on the facial skin. Based on the identified phages, we suggest that phages aid in the control and possibly elimination, as in phage therapy, of microbes reported as pathogenic to a variety of species. Interestingly, we identified Adineta vaga in the gut, an invertebrate that feeds on dead bacteria and protozoans, suggesting a defensive predatory mechanism. Finally, we suggest a colonization resistance role through biofilm formation played by Fusobacteria and Clostridia in the gut.
   Conclusions: Our results highlight the importance of complementing genomic analyses with metagenomics in order to obtain a clearer understanding of the host-microbial alliance and show the importance of microbiome-mediated health protection for adaptation to extreme diets, such as scavenging.
C1 [Mendoza, Marie Lisandra Zepeda; Manzano Vargas, Karla; Gilbert, M. Thomas P.; Sicheritz-Ponten, Thomas] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.
   [Roggenbuck, Michael] Novozymes AS, Dept Bioinformat & Microbe Technol, DK-2880 Bagsvaerd, Denmark.
   [Manzano Vargas, Karla] Univ Nacl Autonoma Mexico, Ctr Genom Sci, Undergrad Program Genom Sci, Ave Univ S-N, Cuernavaca 62210, Morelos, Mexico.
   [Hansen, Lars Hestbjerg] Aarhus Univ, Dept Environm Sci, Sect Microbiol & Biotechnol, Frederiksborgvej 399, DK-4000 Roskilde, Denmark.
   [Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Dept Bio & Hlth Informat, Ctr Biol Sequence Anal, Anker Engelunds Vej 1 Bygning 101A, DK-2800 Lyngby, Denmark.
   [Brunak, Soren] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.
   [Gilbert, M. Thomas P.] Norwegian Univ Sci & Technol, Univ Museum, N-7491 Trondheim, Norway.
   [Sicheritz-Ponten, Thomas] AIMST Univ, Fac Appl Sci, Ctr Excellence Om Driven Computat Biodiscovery CO, Bedong 08100, Malaysia.
RP Sicheritz-Ponten, T (reprint author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.
EM lisandracady@gmail.com; thomassp@snm.ku.dk
OI Zepeda Mendoza, Marie Lisandra/0000-0002-1126-8219; Gilbert,
   Marcus/0000-0002-5805-7195
FU Lundbeck Foundation [R52-A5062]
FX MLZM and MTPG thank Lundbeck Foundation Grant R52-A5062 for funding
   their research.
CR Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895
   Birdlife International, 2017, IUCN RED LIST THREAT
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bredholt S, 2001, INT J FOOD MICROBIOL, V66, P191, DOI 10.1016/S0168-1605(00)00519-5
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535
   Chain PSG, 2011, J BACTERIOL, V193, P4274, DOI 10.1128/JB.05335-11
   Chassard C, 2008, INT J SYST EVOL MICR, V58, P1008, DOI 10.1099/ijs.0.65504-0
   Chen SJ, 2003, SCI TOTAL ENVIRON, V313, P61, DOI 10.1016/S0048-9697(03)00256-0
   Chung O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0780-4
   Creuzburg K, 2005, J BACTERIOL, V187, P8494, DOI 10.1128/JB.187.24.8494-8498.2005
   de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Dhananjayan V, 2013, BIOMED RES INT, DOI 10.1155/2013/190353
   DZINK JL, 1990, ORAL MICROBIOL IMMUN, V5, P172, DOI 10.1111/j.1399-302X.1990.tb00418.x
   EAST IJ, 1993, IMMUNOL CELL BIOL, V71, P453, DOI 10.1038/icb.1993.51
   Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Foca A, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/326032
   Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597
   Frodyma ME, 1998, J BACTERIOL, V180, P4757
   GEORGE HA, 1983, APPL ENVIRON MICROB, V45, P1160
   Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106
   Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11
   Graves GR, 2017, J RAPTOR RES, V51, P465
   Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107
   Grigg NP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17794-0
   Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046
   HE YL, 1991, INT J SYST BACTERIOL, V41, P306
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   HOUSTON D C, 1975, Journal of Wildlife Diseases, V11, P306
   HOUSTON DC, 1974, J ZOOL, V172, P35
   Houston DC, 1972, ECOLOGY SERENGETI VU
   Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Jakhetia R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-677
   JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687
   Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451
   JUNG RC, 1951, PEDIATRICS, V8, P548
   KAGAWA H, 1984, J BACTERIOL, V157, P649
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Keenan SW, 2013, SCI REP-UK, V3, DOI 10.1038/srep02877
   Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2
   Koenig R, 2006, SCIENCE, V312, P1591, DOI 10.1126/science.312.5780.1591
   Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656
   Leisner JJ, 2007, FEMS MICROBIOL REV, V31, P592, DOI 10.1111/j.1574-6976.2007.00080.x
   Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978
   Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/nature4441022a
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467
   Loeffler AG, 2014, INTRO HUMAN DIS PATH, P396
   Louca S, 2016, ENVIRON MICROBIOL, V18, P1863, DOI 10.1111/1462-2920.13058
   Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18
   Madihah MS, 2001, FOLIA MICROBIOL, V46, P197, DOI 10.1007/BF02818533
   Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753
   Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104
   Mateos-Hernndez L, 2013, INTEGRATED VIEW MOL
   McKean Steven, 2013, Vulture News, V65, P15
   Metcalf JL, 2016, SCIENCE, V351, P158, DOI 10.1126/science.aad2646
   MURRAY WD, 1982, INT J SYST BACTERIOL, V32, P132, DOI 10.1099/00207713-32-1-132
   Namkung H, 2011, POULTRY SCI, V90, P2217, DOI 10.3382/ps.2011-01498
   Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451
   Phan NT, 2012, ENVIRON MONIT ASSESS, V184, P1683, DOI 10.1007/s10661-011-2070-2
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   PALLER G, 1995, J BASIC MICROB, V35, P325, DOI 10.1002/jobm.3620350508
   PAOCHANG H, 1955, J PATHOL BACTERIOL, V70, P53, DOI 10.1002/path.1700700106
   Pawlowski DR, 2011, J BIOTERROR BIODEF, DOI [10.4172/2157-2526.s3-004, DOI 10.4172/2157-2526.S3-004]
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Petersen TN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176469
   Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109
   Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993
   Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   R Foundation for Statistical Computing, 2013, R LANG ENV STAT COMP
   Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713
   Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498
   Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003
   Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X
   Snyder NFR, 2000, CALIFORNIA CONDOR SA, P410
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001
   Suzuki M, 2005, J APPL MICROBIOL, V98, P1146, DOI 10.1111/j.1365-2672.2005.02546.x
   USHIJIMA T, 1986, J MED MICROBIOL, V22, P157, DOI 10.1099/00222615-22-2-157
   Van Belkum A, 2011, COGEM RES REP CGM, V201107, P1
   Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858
   Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102
   VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409
   Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
   Zhang GJ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-26
   Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634
NR 94
TC 0
Z9 0
U1 7
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0044-605X
EI 1751-0147
J9 ACTA VET SCAND
JI Acta Vet. Scand.
PD OCT 11
PY 2018
VL 60
AR 61
DI 10.1186/s13028-018-0415-3
PG 19
WC Veterinary Sciences
SC Veterinary Sciences
GA GW7DU
UT WOS:000447127500002
PM 30309375
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Moulton-Brown, CE
   Friman, VP
AF Moulton-Brown, Claire E.
   Friman, Ville-Petri
TI Rapid evolution of generalized resistance mechanisms can constrain the
   efficacy of phage-antibiotic treatments
SO EVOLUTIONARY APPLICATIONS
LA English
DT Article
DE biofilms; coevolution; phage-antibiotic synergy; phages; Pseudomonas
   aeruginosa; resistance
ID PSEUDOMONAS-AERUGINOSA BIOFILMS; HOST-PARASITE COEXISTENCE; ANTAGONISTIC
   COEVOLUTION; BACTERIAL BIOFILMS; IN-VITRO; ESCHERICHIA-COLI;
   BACTERIOPHAGE; INFECTIONS; THERAPY; MUTATIONS
AB Antimicrobial resistance has been estimated to be responsible for over 700,000 deaths per year; therefore, new antimicrobial therapies are urgently needed. One way to increase the efficiency of antibiotics is to use them in combination with bacteria-specific parasitic viruses, phages, which have been shown to exert additive or synergistic effects in controlling bacteria. However, it is still unclear to what extent these combinatory effects are limited by rapid evolution of resistance, especially when the pathogen grows as biofilm on surfaces typical for many persistent and chronic infections. To study this, we used a microcosm system, where genetically isogenic populations of Pseudomonas aeruginosa PAO1 bacterial pathogen were exposed to a phage 14/1, gentamycin or a combination of them both in a spatially structured environment. We found that even though antibiotic and phage-antibiotic treatments were equally effective at controlling bacteria in the beginning of the experiment, combination treatment rapidly lost its efficacy in both planktonic and biofilm populations. In a mechanistic manner, this was due to rapid resistance evolution: While both antibiotic and phage selected for increased resistance on their own, phage selection correlated positively with increase in antibiotic resistance, while biofilm growth, which provided generalized resistance mechanism, was favoured most in the combination treatment. Only relatively small cost of resistance and weak evidence for coevolutionary dynamics were observed. Together, these results suggest that spatial heterogeneity can promote rapid evolution of generalized resistance mechanisms without corresponding increase in phage infectivity, which could potentially limit the effectiveness of phage-antibiotic treatments in the evolutionary timescale.
C1 [Moulton-Brown, Claire E.; Friman, Ville-Petri] Univ York, Wentworth Way, York YO10 5DD, N Yorkshire, England.
RP Friman, VP (reprint author), Univ York, Wentworth Way, York YO10 5DD, N Yorkshire, England.
EM ville.friman@york.ac.uk
FU Wellcome Trust [105624]; Department of Biology
FX Wellcome Trust, Grant/Award Number: 105624; Department of Biology
CR Abedon ST, 2017, AIMS MICROBIOL, V3, P186, DOI 10.3934/microbiol.2017.2.186
   Abedon ST, 2010, CURR PHARM BIOTECHNO, V11, P28, DOI 10.2174/138920110790725410
   Adams MH., 1959, BACTERIOPHAGES, P450
   Addy HS, 2012, PHYTOPATHOLOGY, V102, P469, DOI 10.1094/PHYTO-11-11-0319-R
   Allen RC, 2017, MBIO, V8, DOI [10.1128/mBio.01341-17, 10.1128/mbio.01341-17]
   Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319
   Barbosa C, 2017, MOL BIOL EVOL, V34, P2229, DOI 10.1093/molbev/msx158
   Betts A, 2013, EVOL APPL, V6, P1054, DOI 10.1111/eva.12085
   Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x
   Brockhurst MA, 2006, J EVOLUTION BIOL, V19, P374, DOI 10.1111/j.1420-9101.2005.01026.x
   Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x
   Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279
   Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945
   Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267
   Chan BK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26717
   Chaturongakul S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00442
   Chaudhry WN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168615
   Cochran WL, 2000, J APPL MICROBIOL, V88, P22, DOI 10.1046/j.1365-2672.2000.00825.x
   Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Davies Jane C, 2002, Paediatr Respir Rev, V3, P128, DOI 10.1016/S1526-0550(02)00003-3
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10
   deBeer D, 1997, BIOTECHNOL BIOENG, V53, P151, DOI 10.1002/(SICI)1097-0290(19970120)53:2<151::AID-BIT4>3.0.CO;2-N
   DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Doolittle MM, 1996, J IND MICROBIOL, V16, P331, DOI 10.1007/BF01570111
   Drenkard E, 2003, MICROBES INFECT, V5, P1213, DOI 10.1016/j.micinf.2003.08.009
   Forde SE, 2008, EVOLUTION, V62, P1830, DOI 10.1111/j.1558-5646.2008.00411.x
   Friman VP, 2016, J EVOLUTION BIOL, V29, P188, DOI 10.1111/jeb.12774
   Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767
   Hagens S, 2006, MICROB DRUG RESIST, V12, P164, DOI 10.1089/mdr.2006.12.164
   Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12
   Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001
   Huff WE, 2004, POULTRY SCI, V83, P1944, DOI 10.1093/ps/83.12.1944
   Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039
   Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609
   Jalasvuori M, 2011, BIOL LETTERS, V7, P902, DOI 10.1098/rsbl.2011.0384
   Kamal F, 2015, APPL ENVIRON MICROB, V81, P1132, DOI 10.1128/AEM.02850-14
   Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x
   Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Levin BR, 2000, GENETICS, V154, P985
   Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09
   MAYNARDSMITH J, 1974, MODELS ECOLOGY
   Melnyk AH, 2015, EVOL APPL, V8, P273, DOI 10.1111/eva.12196
   Merabishvili M, 2007, RES MICROBIOL, V158, P572, DOI 10.1016/j.resmic.2007.06.002
   Mumford R, 2017, EVOL APPL, V10, P161, DOI 10.1111/eva.12435
   NEE S, 1989, J THEOR BIOL, V140, P499, DOI 10.1016/S0022-5193(89)80111-0
   Nouraldin AAM, 2016, ALEX J MED, V52, P99, DOI 10.1016/j.ajme.2015.05.002
   O'Neill J., 2014, REV ANTIMICROBIAL RE
   Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032
   Perron GG, 2010, AM NAT, V176, P303, DOI 10.1086/655217
   Popat R, 2012, P ROY SOC B-BIOL SCI, V279, P4765, DOI 10.1098/rspb.2012.1976
   Ryan EM, 2012, FEMS IMMUNOL MED MIC, V65, P395, DOI 10.1111/j.1574-695X.2012.00977.x
   Scanlan P., 2015, BACTERIOPHAGE, V5, DOI [10.1080/21597081.2015.1050153, DOI 10.1080/21597081.2015.1050153]
   Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929
   Skurnik M, 2007, BIOTECHNOL LETT, V29, P995, DOI 10.1007/s10529-007-9346-1
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stover CK, 2000, NATURE, V406, P959
   Torres-Barcelo C, 2016, EVOL APPL, V9, P583, DOI 10.1111/eva.12364
   Torres-Barcelo C, 2016, TRENDS MICROBIOL, V24, P249, DOI 10.1016/j.tim.2015.12.011
   Trautner BW, 2004, AM J INFECT CONTROL, V32, P177, DOI 10.1016/j.ajilc.2003.08.005
   Traverse CC, 2013, P NATL ACAD SCI USA, V110, pE250, DOI 10.1073/pnas.1207025110
   TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297
   Verma V, 2009, J ANTIMICROB CHEMOTH, V64, P1212, DOI 10.1093/jac/dkp360
   Vidakovic L, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0050-1
   Wang XF, 2017, EVOLUTION, V71, P733, DOI [10.1111/evo.13184, 10.1111/evo.13143]
   Ward H, 2009, J EVOLUTION BIOL, V22, P997, DOI 10.1111/j.1420-9101.2009.01712.x
   Zhang QG, 2012, EVOL APPL, V5, P575, DOI 10.1111/j.1752-4571.2011.00236.x
NR 69
TC 0
Z9 0
U1 11
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1752-4571
J9 EVOL APPL
JI Evol. Appl.
PD OCT
PY 2018
VL 11
IS 9
BP 1630
EP 1641
DI 10.1111/eva.12653
PG 12
WC Evolutionary Biology
SC Evolutionary Biology
GA GW7FB
UT WOS:000447131200012
PM 30344632
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Maikova, A
   Peltier, J
   Boudry, P
   Hajnsdorf, E
   Kint, N
   Monot, M
   Poquet, I
   Martin-Verstraete, I
   Dupuy, B
   Soutourina, O
AF Maikova, Anna
   Peltier, Johann
   Boudry, Pierre
   Hajnsdorf, Eliane
   Kint, Nicolas
   Monot, Marc
   Poquet, Isabelle
   Martin-Verstraete, Isabelle
   Dupuy, Bruno
   Soutourina, Olga
TI Discovery of new type I toxin-antitoxin systems adjacent to CRISPR
   arrays in Clostridium difficile
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID BACTERIAL TYPE-I; PROVIDES ACQUIRED-RESISTANCE; PROGRAMMED CELL-DEATH;
   BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ANTISENSE RNA; MESSENGER-RNA;
   STAPHYLOCOCCUS-AUREUS; FUNCTIONAL-ANALYSIS; DEFENSE SYSTEMS
AB Clostridium difficile, a major human enteropathogen, must cope with foreign DNA invaders and multiple stress factors inside the host. We have recently provided an experimental evidence of defensive function of the C. difficile CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) system important for its survival within phage-rich gut communities. Here, we describe the identification of type I toxin-antitoxin (TA) systems with the first functional antisense RNAs in this pathogen. Through the analysis of deep-sequencing data, we demonstrate the general co-localization with CRISPR arrays for the majority of sequenced C. difficile strains. We provide a detailed characterization of the overlapping convergent transcripts for three selected TA pairs. The toxic nature of small membrane proteins is demonstrated by the growth arrest induced by their overexpression. The co-expression of antisense RNA acting as an antitoxin prevented this growth defect. Co-regulation of CRISPR-Cas and type I TA genes by the general stress response Sigma B and biofilm-related factors further suggests a possible link between these systems with a role in recurrent C. difficile infections. Our results provide the first description of genomic links between CRISPR and type I TA systems within defense islands in line with recently emerged concept of functional coupling of immunity and cell dormancy systems in prokaryotes.
C1 [Maikova, Anna; Peltier, Johann; Boudry, Pierre; Kint, Nicolas; Monot, Marc; Poquet, Isabelle; Martin-Verstraete, Isabelle; Dupuy, Bruno; Soutourina, Olga] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, F-75724 Paris 15, France.
   [Maikova, Anna; Peltier, Johann; Boudry, Pierre; Kint, Nicolas; Monot, Marc; Martin-Verstraete, Isabelle; Dupuy, Bruno; Soutourina, Olga] Univ Paris Diderot, Sorbonne Paris Cite, F-75724 Paris 15, France.
   [Maikova, Anna] Skolkovo Inst Sci & Technol, Ctr Data Intens Biomed & Biotechnol, Moscow 143028, Russia.
   [Maikova, Anna] Peter Great St Petersburg Polytech Univ, St Petersburg 195251, Russia.
   [Hajnsdorf, Eliane] Univ Paris Diderot, Inst Biol Physicochim, Sorbonne Paris Cite, CNRS,UMR8261, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.
   [Monot, Marc] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Sherbrooke, PQ J1E 4K8, Canada.
   [Poquet, Isabelle] INRA, Micalis Microbiol Alimentat Serv Sante UMR1319, F-78352 Jouy En Josas, France.
   [Soutourina, Olga] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, F-91198 Gif Sur Yvette, France.
RP Soutourina, O (reprint author), Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, F-75724 Paris 15, France.; Soutourina, O (reprint author), Univ Paris Diderot, Sorbonne Paris Cite, F-75724 Paris 15, France.; Soutourina, O (reprint author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, F-91198 Gif Sur Yvette, France.
EM olga.soutourina@i2bc.paris-saclay.fr
RI Soutourina, Olga/F-2042-2015
OI Monot, Marc/0000-0003-0738-7335; Hajnsdorf, Eliane/0000-0002-8249-2007;
   Poquet, Isabelle/0000-0003-3514-6520
FU Institut Pasteur; University Paris Diderot; Agence Nationale de la
   Recherche ['CloSTARn'] [ANR-13-JSV3-0005-01]; Institut Universitaire de
   France (IUF); Pasteur-Weizmann Council; University Paris-Sud; Institute
   for Integrative Biology of the Cell; Vernadski Fellowship; Skoltech
   Biomedical Initiative [SBI RF-0000000136]; Centre National de la
   Recherche Scientifique [UMR8261]; 'Initiative d'Excellence' Program from
   the French State [ANR-11-LABX-0011]; IUF; Skoltech
FX Institut Pasteur; University Paris Diderot; Agence Nationale de la
   Recherche ['CloSTARn', ANR-13-JSV3-0005-01 to O.S.]; Institut
   Universitaire de France (IUF to O.S.); Pasteur-Weizmann Council;
   University Paris-Sud; Institute for Integrative Biology of the Cell;
   Vernadski Fellowship (to A.M.); Skoltech Biomedical Initiative [SBI
   RF-0000000136]; Centre National de la Recherche Scientifique [UMR8261];
   'Initiative d'Excellence' Program from the French State [Grant 'DYNAMO',
   ANR-11-LABX-0011 to E.H.]. Funding for open access charge: IUF,
   Skoltech.
CR Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14
   Andersen JM, 2016, GENOME BIOL EVOL, V8, P2841, DOI 10.1093/gbe/evw203
   Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601
   Arnion H, 2017, NUCLEIC ACIDS RES, V45, P4782, DOI 10.1093/nar/gkw1343
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Berghoff BA, 2017, MOL MICROBIOL, V103, P1020, DOI 10.1111/mmi.13607
   BERTANI G, 1951, J BACTERIOL, V62, P293
   Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430
   Bloom-Ackermann Z, 2016, ENVIRON MICROBIOL, V18, P5032, DOI 10.1111/1462-2920.13471
   Boudry P, 2014, J BACTERIOL, V196, P3234, DOI 10.1128/JB.01923-14
   Boudry P, 2015, MBIO, V6
   Brantl S, 2015, FEMS MICROBIOL REV, V39, P413, DOI 10.1093/femsre/fuv003
   Brantl S, 2012, RNA BIOL, V9, P1488, DOI 10.4161/rna.23045
   Brielle R, 2016, CURR OPIN MICROBIOL, V30, P114, DOI 10.1016/j.mib.2016.01.009
   Cairns M. D., 2017, J CLIN
   Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Coray DS, 2017, RNA BIOL, V14, P275, DOI 10.1080/15476286.2016.1272747
   Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156
   Darfeuille F, 2007, MOL CELL, V26, P381, DOI 10.1016/j.molcel.2007.04.003
   Dembek M, 2015, MBIO, V6, DOI [10.1128/mBio.02383-14d, 10.1128/mBio.02383-14]
   Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x
   Donegan NP, 2009, J BACTERIOL, V191, P2795, DOI 10.1128/JB.01713-08
   Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x
   Durand S, 2012, RNA BIOL, V9, P1491, DOI 10.4161/rna.22358
   Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003181
   Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889
   Folichon M, 2005, FEBS J, V272, P454, DOI 10.1111/j.1742-4658.2004.04485.x
   Fozo EM, 2012, RNA BIOL, V9, P1504, DOI 10.4161/rna.22568
   Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054
   Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x
   Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017962
   Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147
   Gerdes K, 1997, ANNU REV GENET, V31, P1, DOI 10.1146/annurev.genet.31.1.1
   Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159
   Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581
   Gil F, 2015, FUTURE MICROBIOL, V10, P1649, DOI 10.2217/fmb.15.94
   Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172
   Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279
   Hajnsdorf E, 2000, P NATL ACAD SCI USA, V97, P1501, DOI 10.1073/pnas.040549897
   Han K, 2010, NUCLEIC ACIDS RES, V38, P5851, DOI 10.1093/nar/gkq292
   Hargreaves KR, 2014, MBIO, V5, DOI 10.1128/mBio.01045-13
   Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157
   Iqbal N, 2015, J BACTERIOL, V197, P2150, DOI 10.1128/JB.00108-15
   Jahn N, 2016, MICROBIOL-SGM, V162, P590, DOI 10.1099/mic.0.000247
   Jahn N, 2015, MOL MICROBIOL, V98, P651, DOI 10.1111/mmi.13146
   Jahn N, 2013, NUCLEIC ACIDS RES, V41, P9870, DOI 10.1093/nar/gkt735
   Jahn N, 2012, MOL MICROBIOL, V83, P579, DOI 10.1111/j.1365-2958.2011.07952.x
   JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0
   Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x
   Kawano M, 2012, RNA BIOL, V9, P1520, DOI 10.4161/rna.22757
   Kint N, 2017, ENVIRON MICROBIOL, V19, P1933, DOI 10.1111/1462-2920.13696
   Koonin EV, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600186
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124
   Lee KY, 2016, TOXINS, V8, DOI 10.3390/toxins8100305
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lobato-Marquez D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09374
   Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x
   Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048
   Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157
   Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11
   Maldarelli GA, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw061
   Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386
   Meissner C, 2016, J BIOL CHEM, V291, P560, DOI 10.1074/jbc.M115.697524
   Mick E, 2013, RNA BIOL, V10, P900, DOI 10.4161/rna.23929
   Monot M, 2014, OMICS, V18, P184, DOI 10.1089/omi.2013.0119
   Muller P, 2016, RNA BIOL, V13, P511, DOI 10.1080/15476286.2016.1156288
   Nogueira T, 2009, CURR BIOL, V19, P1683, DOI 10.1016/j.cub.2009.08.056
   O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x
   Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]
   Patel S, 2006, J BACTERIOL, V188, P5374, DOI 10.1128/JB.00513-06
   Peltier J, 2015, J BIOL CHEM, V290, P24453, DOI 10.1074/jbc.M115.665091
   Pinel-Marie ML, 2014, CELL REP, V7, P424, DOI 10.1016/j.celrep.2014.03.012
   Richter C, 2012, VIRUSES-BASEL, V4, P2291, DOI 10.3390/v4102291
   Rothenbacher FP, 2012, J BACTERIOL, V194, P3464, DOI 10.1128/JB.00217-12
   Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sampson TR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003621
   Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11
   Sayed N, 2012, J BIOL CHEM, V287, P43454, DOI 10.1074/jbc.M112.402693
   Sayed N, 2012, NAT STRUCT MOL BIOL, V19, P105, DOI 10.1038/nsmb.2193
   Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830
   Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153
   Serrano M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006312
   Shen ZQ, 2016, MOL MICROBIOL, V101, P909, DOI 10.1111/mmi.13431
   Shields K, 2015, ANAEROBE, V34, P59, DOI 10.1016/j.anaerobe.2015.04.012
   Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005
   Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.21, 10.1038/nrdp.2016.20]
   Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793
   Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493
   Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112
   Vedantam Gayatri, 2012, Gut Microbes, V3, P121, DOI 10.4161/gmic.19399
   Wagner EGH, 2015, ADV GENET, V90, P133, DOI 10.1016/bs.adgen.2015.05.001
   WAGNER EGH, 1992, EMBO J, V11, P1195, DOI 10.1002/j.1460-2075.1992.tb05160.x
   Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11
   Wen J, 2017, NUCLEIC ACIDS RES, V45, P4006, DOI 10.1093/nar/gkw1172
   Wen J, 2014, TOXINS, V6, P2310, DOI 10.3390/toxins6082310
   Wen J, 2014, NUCLEIC ACIDS RES, V42, P1930, DOI 10.1093/nar/gkt1018
   Wen YR, 2014, PATHOG DIS, V70, P240, DOI 10.1111/2049-632X.12145
   Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786
   Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651
NR 104
TC 2
Z9 2
U1 5
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAY 18
PY 2018
VL 46
IS 9
BP 4733
EP 4751
DI 10.1093/nar/gky124
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GG9YK
UT WOS:000433056900036
PM 29529286
OA DOAJ Gold
DA 2019-02-28
ER

PT J
AU Duarte, VD
   Dias, RS
   Kropinski, AM
   Xavier, AD
   Ferro, CG
   Vidigal, PMP
   da Silva, CC
   de Paula, SO
AF Duarte, Vinicius da Silva
   Dias, Roberto Sousa
   Kropinski, Andrew M.
   Xavier, Andre da Silva
   Ferro, Camila Geovana
   Vidigal, Pedro M. P.
   da Silva, Cynthia Canedo
   de Paula, Sergio Oliveira
TI A T4virus prevents biofilm formation by Trueperella pyogenes
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Trueperella pyogenes; Mastitis; Metritis; T4virus; Biofilm; VAPGHs;
   Virus depolymerase
ID ESCHERICHIA-COLI; BACTERIOPHAGE; ENZYMES; HYDROLASES; PREDICTION;
   INFECTION; PROTEINS; MASTITIS; DATABASE; PHAGES
AB Trueperella pyogenes is an opportunistic pathogen of many animal species. It causes economic losses worldwide, through mastitis, metritis and mainly endometritis in dairy cows. The ability of this bacterium to form biofilms is implicated in chronic infections through hampering immune system recognition and antibiotic penetration. Since it is difficult to eradicate T. pyogenes infections with antibiotics, phage therapy presents itself as a nontoxic, effective and economically viable alternative. The present study evaluated the use of the bacteriophage vB_EcoM-UFV13 (UFV13) in the prevention of T. pyogenes biofilm development. Based upon two different approaches (crystal violet and sessile cell counting) we observed that only a multiplicity of infection (MOI) of 10 showed a statistically significant reduction in biofilm formation. Although the exact mechanisms of biofilm disruption and cell-adhesion inhibition have not been determined, genome sequence analysis of the Escherichia phage UFV13 revealed a repertoire of virion-associated peptidoglycan hydrolases (VAPGHs). The present study presents new findings regarding the disruption of biofilm formation of a Gram-positive bacterium. Subsequent transcriptomic and proteomic research will help us to understand the exact interaction mechanisms between UFV13 and T. pyogenes.
C1 [Duarte, Vinicius da Silva; Dias, Roberto Sousa; da Silva, Cynthia Canedo] Univ Fed Vicosa, Dept Microbiol, Ave Peter Henry Rolfs S-N,Campus Univ, BR-36570900 Vicosa, MG, Brazil.
   [Kropinski, Andrew M.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada.
   [Kropinski, Andrew M.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.
   [Xavier, Andre da Silva] Embrapa Maize & Sorghum, Rodovia MG 424, Sete Lagoas, MG, Brazil.
   [Ferro, Camila Geovana] Univ Fed Vicosa, Dept Plant Pathol, Ave Peter Henry Rolfs S-N,Campus Univ, BR-36570900 Vicosa, MG, Brazil.
   [Vidigal, Pedro M. P.] Univ Fed Vicosa, Ctr Biol Sci, Nucleo Anal Biomol NuBioMol, Vicosa, MG, Brazil.
   [de Paula, Sergio Oliveira] Univ Fed Vicosa, Dept Gen Biol, Ave Peter Henry Rolfs S-N,Campus Univ, BR-36570900 Vicosa, MG, Brazil.
RP de Paula, SO (reprint author), Univ Fed Vicosa, Dept Gen Biol, Ave Peter Henry Rolfs S-N,Campus Univ, BR-36570900 Vicosa, MG, Brazil.
EM vinicius.duarte@ufv.br; rosousa318@yahoo.com.br; akropins@uoguelph.ca;
   andre.xavier@ufv.br; camila.ferro@ufv.br; pedro.vidigal@ufv.br;
   ccanedo@ufv.br; depaula@ufv.br
RI Duarte, Vinicius/P-2249-2018
OI Duarte, Vinicius/0000-0002-0356-3947; Vidigal, Pedro
   Marcus/0000-0002-5116-9856
FU Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (Fapemig); Brazilian agency: Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES); Brazilian agency: Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian agency:
   Financiadora de Estudos e Projetos (Finep); Brazilian agency: Sistema
   Nacional de Laboratorios em Nanotecnologias (SisNANO)/Ministerio da
   ciencia, tecnologia e Informacao (MCTI)
FX We are grateful to the Nude de Analise de Biomoleculas and Nucleo de
   Microscopia e Microanalise of the Universidade Federal de Vicosa for
   providing the facilities to conduct the experiments. We also acknowledge
   the financial support from the following Brazilian agencies: Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (Fapemig), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de
   Estudos e Projetos (Finep), Sistema Nacional de Laboratorios em
   Nanotecnologias (SisNANO)/Ministerio da ciencia, tecnologia e Informacao
   (MCTI). We are also grateful to the Empresa Brasileira de Pesquisa
   Agropecuaria (EMBRAPA), Gado de Leite Farm, Juiz de Fora, Minas Gerais,
   Brazil, that kindly provided us with Escherichia coli 30.
CR Abedon ST, 2011, BACTERIOPHAGE, V1, P1, DOI DOI 10.4161/BACT.1.1.13980
   Abouhmad A, 2016, J APPL MICROBIOL, V121, P115, DOI 10.1111/jam.13146
   Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y
   Assere A, 2008, J APPL MICROBIOL, V104, P1692, DOI 10.1111/j.1365-2672.2007.03711.x
   Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107
   Belle A, 2002, GENE DEV, V16, P351, DOI 10.1101/gad.960302
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Dias RS, 2013, J ANIM SCI, V91, P3930, DOI 10.2527/jas.2012-5884
   Ding H, 2016, VIROL SIN, V31, P350, DOI 10.1007/s12250-016-3740-6
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Duarte Vinicius S, 2016, Genome Announc, V4, DOI 10.1128/genomeA.01292-16
   Fallico V, 2011, J VIROL, V85, P12032, DOI 10.1128/JVI.00275-11
   Federman C, 2016, J DAIRY SCI, V99, P3667, DOI 10.3168/jds.2015-10538
   Fernandez L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02724-16
   Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344
   Golkar Z, 2014, J INFECT DEV COUNTR, V8, P129, DOI 10.3855/jidc.3573
   Jost BH, 2005, ANTON LEEUW INT J G, V88, P87, DOI 10.1007/s10482-005-2316-5
   Jurczak-Kurek A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34338
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Latka A, 2017, APPL MICROBIOL BIOT, V101, P3103, DOI 10.1007/s00253-017-8224-6
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243
   Olson ME, 2002, CAN J VET RES, V66, P86
   Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226
   Qin L, 2010, J MOL BIOL, V395, P728, DOI 10.1016/j.jmb.2009.10.007
   Rakhuba DV, 2010, POL J MICROBIOL, V59, P145
   Roach DR, 2015, BACTERIOPHAGE, V5, DOI [10.1080/21597081.2015.1062590, DOI 10.1080/21597081.2015.1062590]
   Romero P, 2004, J BACTERIOL, V186, P8229, DOI 10.1128/JB.186.24.8229-8239.2004
   Sambrook JS, 2001, MOL CLONING LAB MANU
   Schmelcher M, 2015, APPL MICROBIOL BIOT, V99, P8475, DOI 10.1007/s00253-015-6579-0
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706
   Sharma AK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2753-8
   Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874
   Wagener K, 2014, VET J, V202, P527, DOI 10.1016/j.tvjl.2014.08.023
   Weiss-Muszkat M, 2010, APPL ENVIRON MICROB, V76, P1545, DOI 10.1128/AEM.01395-09
   Zhao KL, 2013, ARCH MICROBIOL, V195, P203, DOI 10.1007/s00203-013-0869-7
NR 38
TC 0
Z9 0
U1 4
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD MAY
PY 2018
VL 218
BP 45
EP 51
DI 10.1016/j.vetmic.2018.03.025
PG 7
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA GG2EC
UT WOS:000432501800008
PM 29685220
DA 2019-02-28
ER

PT J
AU Cui, HY
   Bai, M
   Yuan, L
   Surendhiran, D
   Lin, L
AF Cui, Haiying
   Bai, Mei
   Yuan, Lu
   Surendhiran, Duraiarasan
   Lin, Lin
TI Sequential effect of phages and cold nitrogen plasma against Escherichia
   coli O157:H7 biofilms on different vegetables
SO INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
LA English
DT Article
DE Cold nitrogen plasma; E coli O157:H7 phages; E coil O157:H7; Sequential
   treatment; Vegetables
ID RESISTANT STAPHYLOCOCCUS-AUREUS; BARRIER DISCHARGE PLASMA; ANTIBACTERIAL
   ACTIVITY; SALMONELLA-ENTERICA; ESSENTIAL OIL; LISTERIA-MONOCYTOGENES;
   PATHOGEN INACTIVATION; FRESH PRODUCE; CLOVE-OIL; LETTUCE
AB Escherichia coli O157:H7 (E. coli O157:H7) is one of the most common pathogens in fresh vegetables and fruits, and most of the diseases produced by E. coli O157:H7 are associated with biofilms. Cold nitrogen plasma (CNP) is a cold sterilization technique which has no residue. However to completely eliminate the biofilm on the surface of vegetables the processing power and time of CNP have to be enhanced, which will impact on the quality of fruits and vegetables. Thus the sequential treatment of CNP and phage techniques was engineered in this study. Compared to treatment performed separately, sequential treatment not only had more mild treatment conditions as 400 W CNP treatment for 2 min and 5% phage treatment for 30 min, but also exhibited more remarkable effect on eradicating E. colt O157:H7 biofilms in vitro and on vegetables. The population of E. coil O157:H7 was approximately reduced by 2 log CFU/cm(2) after individual treatment of 5% phages for 30 min or 500 W CNP for 3 min. While the sequential treatment of CNP (400 W, 2 min) and phages (5%, 30 min) reduced the E. coli O157:H7 viable count in biofilm by 5.71 log CFU/cm(2). Therefore, the sequential treatment holds a great promise to improve the current treatment systems of bacterial contamination on different vegetable surfaces.
C1 [Cui, Haiying; Bai, Mei; Yuan, Lu; Surendhiran, Duraiarasan; Lin, Lin] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Peoples R China.
RP Lin, L (reprint author), Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Peoples R China.
EM linl@ujs.edu.cn
RI Lin, Lin/H-9423-2015
OI Lin, Lin/0000-0001-6374-2165
FU National Natural Science Foundation of China [31470594]; Natural Science
   Foundation of Jiangsu Province [BK20170070]; Jiangsu Province Foundation
   for talents of six key industries [NY-013]; Jiangsu University Research
   Fund [11JDG050]
FX The authors acknowledge the financial support from National Natural
   Science Foundation of China (grant no. 31470594), Natural Science
   Foundation of Jiangsu Province (grant no. BK20170070), Jiangsu Province
   Foundation for talents of six key industries (grant no. NY-013) and
   Jiangsu University Research Fund (grant no. 11JDG050).
CR Ai CQ, 2015, FOOD CONTROL, V50, P283, DOI 10.1016/j.foodcont.2014.08.040
   Bang J, 2014, INT J FOOD MICROBIOL, V191, P129, DOI 10.1016/j.ijfoodmicro.2014.09.014
   Basiak E, 2017, INT J BIOL MACROMOL, V98, P348, DOI 10.1016/j.ijbiomac.2017.01.122
   Bigwood T, 2008, FOOD MICROBIOL, V25, P400, DOI 10.1016/j.fm.2007.11.003
   Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899
   Cui HY, 2017, LWT-FOOD SCI TECHNOL, V81, P233, DOI 10.1016/j.lwt.2017.04.003
   Cui HY, 2017, INT J FOOD SCI TECH, V52, P687, DOI 10.1111/ijfs.13322
   Cui HY, 2016, FOOD CONTROL, V70, P183, DOI 10.1016/j.foodcont.2016.05.056
   Cui HY, 2016, FOOD CONTROL, V66, P8, DOI 10.1016/j.foodcont.2016.01.035
   Cui HY, 2016, BIOFOULING, V32, P215, DOI 10.1080/08927014.2015.1134516
   Cui HY, 2016, FOOD CONTROL, V61, P92, DOI 10.1016/j.foodcont.2015.09.034
   Cui HY, 2015, FOOD CONTROL, V56, P128, DOI 10.1016/j.foodcont.2015.03.026
   Dasan BG, 2016, INT J FOOD MICROBIOL, V216, P50, DOI 10.1016/j.ijfoodmicro.2015.09.006
   Velazquez LD, 2009, FOOD CONTROL, V20, P262, DOI 10.1016/j.foodcont.2008.05.012
   Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048
   Fernandez A, 2013, FOOD MICROBIOL, V33, P24, DOI 10.1016/j.fm.2012.08.007
   Finger S, 2012, INT J PHARMACEUT, V436, P851, DOI 10.1016/j.ijpharm.2012.07.009
   Gutierrez J, 2008, INT J FOOD MICROBIOL, V124, P91, DOI 10.1016/j.ijfoodmicro.2008.02.028
   Jadhav S, 2013, FOOD CONTROL, V29, P125, DOI 10.1016/j.foodcont.2012.05.071
   Jahid IK, 2015, FOOD MICROBIOL, V46, P383, DOI 10.1016/j.fm.2014.08.003
   Jayasena DD, 2015, FOOD MICROBIOL, V46, P51, DOI 10.1016/j.fm.2014.07.009
   Kim JS, 2014, INNOV FOOD SCI EMERG, V22, P124, DOI 10.1016/j.ifset.2013.12.012
   Korachi M, 2009, J ELECTROSTAT, V67, P678, DOI 10.1016/j.elstat.2009.03.002
   Kwiecinski J, 2009, INT J ANTIMICROB AG, V33, P343, DOI 10.1016/j.ijantimicag.2008.08.028
   Leverentz B, 2003, APPL ENVIRON MICROB, V69, P4519, DOI 10.1128/AEM.69.8.4519-4526.2003
   Ma RN, 2015, J HAZARD MATER, V300, P643, DOI 10.1016/j.jhazmat.2015.07.061
   Macarisin D, 2014, INT J FOOD MICROBIOL, V173, P48, DOI 10.1016/j.ijfoodmicro.2013.12.004
   Mahmoud BSM, 2015, FOOD CONTROL, V57, P110, DOI 10.1016/j.foodcont.2015.03.040
   Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451
   O'Beirne D, 2014, FOOD CONTROL, V40, P71, DOI 10.1016/j.foodcont.2013.11.026
   Park S, 2015, FOOD MICROBIOL, V48, P200, DOI 10.1016/j.fm.2015.01.003
   Poimenidou SV, 2016, INT J FOOD MICROBIOL, V220, P6, DOI 10.1016/j.ijfoodmicro.2015.12.013
   Rohani SMR, 2011, LWT-FOOD SCI TECHNOL, V44, P2260, DOI 10.1016/j.lwt.2011.07.020
   Sabaeifard P, 2014, J MICROBIOL METH, V105, P134, DOI 10.1016/j.mimet.2014.07.024
   Sagdic O, 2013, FOOD CONTROL, V30, P7, DOI 10.1016/j.foodcont.2012.07.010
   Seo KH, 1999, J FOOD PROTECT, V62, P3, DOI 10.4315/0362-028X-62.1.3
   Sharma M, 2005, J APPL MICROBIOL, V99, P449, DOI 10.1111/j.1365-2672.2005.02659.x
   Shenga E, 2010, J FOOD SCI TECH MYS, V47, P420, DOI 10.1007/s13197-010-0069-2
   Sun P, 2012, PLASMA PROCESS POLYM, V9, P157, DOI 10.1002/ppap.201100041
   Tortes A. G., 2005, APPL ENVIRON MICROB, V71, P8008
   Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006
   Wu WS, 2013, J MICROBIOL IMMUNOL, V46, P89, DOI 10.1016/j.jmii.2012.03.009
   Yong HI, 2015, FOOD MICROBIOL, V46, P46, DOI 10.1016/j.fm.2014.07.010
   Zhao L, 2014, INT J FOOD MICROBIOL, V174, P12, DOI 10.1016/j.ijfoodmicro.2013.12.023
   Ziuzina D, 2014, PLASMA MED, V4, P137
NR 45
TC 1
Z9 1
U1 5
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1605
EI 1879-3460
J9 INT J FOOD MICROBIOL
JI Int. J. Food Microbiol.
PD MAR 2
PY 2018
VL 268
BP 1
EP 9
DI 10.1016/j.ijfoodmicro.2018.01.004
PG 9
WC Food Science & Technology; Microbiology
SC Food Science & Technology; Microbiology
GA FX4GT
UT WOS:000426031400001
PM 29306732
DA 2019-02-28
ER

PT J
AU Cui, XW
   Wen, HMS
   Kinoshita, Y
   Koishi, S
   Isowaki, C
   Ou, LS
   Masuda, Y
   Honjoh, K
   Miyamoto, T
AF Cui, Xiaowen
   Wen, Hsu-Ming Sherman
   Kinoshita, Yoshimasa
   Koishi, Shota
   Isowaki, Chika
   Ou, Liushu
   Masuda, Yoshimitsu
   Honjoh, Ken-ichi
   Miyamoto, Takahisa
TI Role of Phage Shock Protein in Recovery of Heat-injured Salmonella
SO BIOCONTROL SCIENCE
LA English
DT Article
DE Phage shock protein; Heat injury; Salmonella; Recovery; Membrane
   potential
ID ESCHERICHIA-COLI; FOODBORNE PATHOGENS; BIOFILM FORMATION;
   STRESS-PROTEIN; TYPHIMURIUM; PSPA; OPERON; RPOE; IDENTIFICATION;
   ENTERITIDIS
AB Sublethally heat-injured cells of Salmonella in food can recover under favorable conditions, leading to foodborne illness. To elucidate the molecular mechanism of recovery from heat injury, the global changes in gene transcription of Salmonella Typhimurium were investigated in previous study. In this study, the functions of genes involved in phage shock response (viz., phage shock protein (psp) genes), the transcription levels of which were found in previous study to be increased during recovery from heat injury, were investigated in recovering cells. The increase in pspABCDEFG transcription levels during the recovery process was confirmed by qRT-PCR. To understand the role of psp genes in heat injury recovery, a pspA deletion mutant (Delta pspA) and a pspA-overexpressing strain (S. Typhimurium pBAD30/pspA(+)) were constructed. Delta pspA showed slightly lower viable counts and membrane potential than those of the wild-type strain during recovery. On the other hand, there was no significant difference in the viable counts between S. Typhimurium pBAD30/pspA(+) and the control strains S. Typhimurium pBAD30/pspA (-) and S. Typhimurium pBAD30(+) during recovery. It would seem that a lack of PspA protein alone somewhat affects the recovery of S. Typhimurium from heat injury, but overexpression of PspA alone is not sufficient to overcome this effect.
C1 [Cui, Xiaowen; Wen, Hsu-Ming Sherman; Kinoshita, Yoshimasa; Koishi, Shota; Isowaki, Chika; Ou, Liushu; Masuda, Yoshimitsu; Honjoh, Ken-ichi; Miyamoto, Takahisa] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch, Fac Agr,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.
RP Miyamoto, T (reprint author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch, Fac Agr,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.
EM tmiyamot@agr.kyushu-u.ac.jp
FU Ministry of Agriculture, Forestry and Fisheries, Japan; China
   Scholarship Council (CSC) [20150831 0093]
FX This work was supported by a grant of the research project for improving
   food safety and animal health (Ministry of Agriculture, Forestry and
   Fisheries, Japan; 2013-2017 FY). CUI is grateful for the financial
   support by the China Scholarship Council (CSC No. 20150831 0093).
CR Back KH, 2012, J FOOD PROTECT, V75, P1867, DOI 10.4315/0362-028X.JFP-11-512
   Becker LA, 2005, MOL MICROBIOL, V56, P1004, DOI 10.1111/j.1365-2958.2005.04604.x
   BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862
   Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x
   Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x
   Datta P, 2015, MOL MICROBIOL, V97, P408, DOI 10.1111/mmi.13037
   Flores-Kim J, 2016, ANNU REV MICROBIOL, V70, P83, DOI 10.1146/annurev-micro-102215-095359
   Gurtler JB, 2009, LETT APPL MICROBIOL, V49, P503, DOI 10.1111/j.1472-765X.2009.02695.x
   GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995
   Honjoh K, 2009, J FAC AGR KYUSHU U, V54, P421
   Hsu-Ming W, 2012, AMINO ACIDS, V42, P2059, DOI 10.1007/s00726-011-0934-y
   Huvet M, 2011, MOL BIOL EVOL, V28, P1141, DOI 10.1093/molbev/msq301
   Jay J. M., 2012, MODERN FOOD MICROBIO, P229
   Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x
   Karlinsey JE, 2010, MOL MICROBIOL, V78, P669, DOI 10.1111/j.1365-2958.2010.07357.x
   Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x
   Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x
   Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004
   McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614
   Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x
   Russell A., 1984, SOC APPL BACTERIOLOG
   Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x
   Southern SJ, 2015, MICROBIOL-SGM, V161, P2192, DOI 10.1099/mic.0.000175
   Taskila S, 2011, J FOOD SCI, V76, pM157, DOI 10.1111/j.1750-3841.2010.02050.x
   WEINER L, 1994, P NATL ACAD SCI USA, V91, P2191, DOI 10.1073/pnas.91.6.2191
   Wesche AM, 2009, J FOOD PROTECT, V72, P1121, DOI 10.4315/0362-028X-72.5.1121
   Wu VCH, 2008, FOOD MICROBIOL, V25, P735, DOI 10.1016/j.fm.2008.04.011
   Wu VCH, 2001, J FOOD PROTECT, V64, P1067, DOI 10.4315/0362-028X-64.7.1067
   Zheng QW, 2013, J FOOD PROTECT, V76, P1963, DOI 10.4315/0362-028X.JFP-13-041
NR 29
TC 0
Z9 0
U1 2
U2 4
PU SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN
PI OSAKA
PA NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA,
   550-0005, JAPAN
SN 1342-4815
EI 1884-0205
J9 BIOCONTROL SCI
JI Biocontrol Sci.
PD MAR
PY 2018
VL 23
IS 1
BP 17
EP 25
PG 9
WC Biology; Biotechnology & Applied Microbiology
SC Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied
   Microbiology
GA GC0RX
UT WOS:000429486600003
PM 29576591
OA Bronze
DA 2019-02-28
ER

PT J
AU Lai, JYH
   Zhang, H
   Chiang, MHY
   Lun, CHI
   Zhang, R
   Lau, SCK
AF Lai, Jennifer Yuet Ha
   Zhang, Hao
   Chiang, Miranda Hei Yin
   Lun, Clare Hau In
   Zhang, Rui
   Lau, Stanley Chun Kwan
TI The putative functions of lysogeny in mediating the survivorship of
   Escherichia coli in seawater and marine sediment
SO FEMS MICROBIOLOGY ECOLOGY
LA English
DT Article
DE lysogeny; Escherichia coli; fitness
ID COMPLETE NUCLEOTIDE-SEQUENCE; ENTERIC BACTERIA; MOUSE INTESTINE;
   SURVIVAL; PERSISTENCE; TEMPERATE; METABOLISM; EVOLUTION; STRAINS;
   GENOMES
AB Escherichia coli colonizes various body parts of animal hosts as a commensal and a pathogen. It can also persist in the external environment in the absence of fecal pollution. It remains unclear how this species has evolved to adapt to such contrasting habitats. Lysogeny plays pivotal roles in the diversification of the phenotypic and ecologic characters of E. coli as a symbiont. We hypothesized that lysogeny could also confer fitness to survival in the external environment. To test this hypothesis, we used the induced phages of an E. coli strain originating from marine sediment to infect a fecal E. coli strain to obtain an isogenic lysogen of the latter. The three strains were tested for survivorship in microcosms of seawater, marine sediment and sediment interstitial water as well as swimming motility, glycogen accumulation, biofilm formation, substrate utilization and stress resistance. The results indicate that lysogenic infection led to tractable changes in many of the ecophysiological attributes tested. Particularly, the lysogen had better survivorship in the microcosms and had a substrate utilization profile resembling the sediment strain more than the wild type fecal strain. Our findings provide new insights into the understanding of how E. coli survives in the natural environment.
C1 [Lai, Jennifer Yuet Ha; Zhang, Hao; Chiang, Miranda Hei Yin; Lun, Clare Hau In; Lau, Stanley Chun Kwan] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.
   [Zhang, Rui] Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen, Peoples R China.
   [Zhang, Rui] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.
RP Lau, SCK (reprint author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.
EM scklau@ust.hk
FU Hong Kong University of Science and Technology School of Science
   allocation [FSGRF16SC06];  [664012];  [661413]
FX This study was supported by the General Research Fund (664012 and
   661413), and Hong Kong University of Science and Technology School of
   Science allocation (FSGRF16SC06) to SCKL.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Badgley BD, 2011, WATER RES, V45, P721, DOI 10.1016/j.watres.2010.08.041
   Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004
   Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847
   Berney M, 2006, APPL ENVIRON MICROB, V72, P2586, DOI 10.1128/AEM.72.4.2586-2593.2006
   Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204
   Brennan FP, 2010, APPL ENVIRON MICROB, V76, P1449, DOI 10.1128/AEM.02335-09
   Burton E, 2007, J IND MICROBIOL BIOT, V34, P1, DOI 10.1007/s10295-006-0086-3
   Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x
   Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x
   Chen Y, 2005, PLOS BIOL, V3, P1276, DOI 10.1371/journal.pbio.0030229
   Craig DL, 2004, J APPL MICROBIOL, V96, P922, DOI 10.1111/j.1365-2672.2004.02243.x
   Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265
   Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704
   Denisov G, 2008, BIOINFORMATICS, V24, P1035, DOI 10.1093/bioinformatics/btn074
   Durso LM, 2004, APPL ENVIRON MICROB, V70, P6466, DOI 10.1128/AEM.70.11.6466-6472.2004
   EDLIN G, 1977, J VIROL, V21, P560
   Esposito D, 1996, NUCLEIC ACIDS RES, V24, P2360, DOI 10.1093/nar/24.12.2360
   Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07
   Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527
   Garzio-Hadzick A, 2010, WATER RES, V44, P2753, DOI 10.1016/j.watres.2010.02.011
   Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038
   GERBA CP, 1976, APPL ENVIRON MICROB, V32, P114
   Goosney DL, 2000, ANNU REV CELL DEV BI, V16, P173, DOI 10.1146/annurev.cellbio.16.1.173
   GOVONS S, 1969, J BACTERIOL, V97, P970
   HAGGARDLJUNGQUIST E, 1992, J BACTERIOL, V174, P1462, DOI 10.1128/jb.174.5.1462-1477.1992
   Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11
   Ihssen J, 2007, MICROBIOL-SGM, V153, P2052, DOI 10.1099/mic.0.2006/002006-0
   Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006
   Ishii S, 2008, MICROBES ENVIRON, V23, P101, DOI 10.1264/jsme2.23.101
   Ishii S, 2010, MICROBES ENVIRON, V25, P8, DOI 10.1264/jsme2.ME09172
   Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550
   Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08
   Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039
   Kwon HJ, 2013, VET MICROBIOL, V162, P785, DOI 10.1016/j.vetmic.2012.10.005
   Lai Jennifer Y H, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00955-14
   Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172
   Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043
   Liu RL, 2015, APPL MICROBIOL BIOT, V99, P5669, DOI 10.1007/s00253-015-6410-y
   LOPEZTORRES AJ, 1988, MICROBIAL ECOL, V15, P41, DOI 10.1007/BF02012951
   Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108
   Mirold S, 2001, J MOL BIOL, V312, P7, DOI 10.1006/jmbi.2001.4950
   Moreira S, 2012, FEMS MICROBIOL ECOL, V79, P608, DOI 10.1111/j.1574-6941.2011.01244.x
   Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x
   Nesper J, 1999, J BACTERIOL, V181, P2902
   Nilsson AS, 2004, MOL BIOL EVOL, V21, P1, DOI 10.1093/molbev/msg223
   Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4
   Orro A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139467
   POMMEPUY M, 1992, WATER SCI TECHNOL, V25, P93
   Rozen Y, 2001, FEMS MICROBIOL REV, V25, P513, DOI 10.1016/S0168-6445(01)00065-1
   SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168
   STEPHENSON GR, 1982, J RANGE MANAGE, V35, P119, DOI 10.2307/3898537
   Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x
   Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344
   Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291
   van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80
   Vehkala M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118392
   Veses-Garcia M, 2015, APPL ENVIRON MICROB, V81, P8118, DOI 10.1128/AEM.02034-15
   Vorwerk H, 2014, MOL MICROBIOL, V93, P1224, DOI 10.1111/mmi.12732
   Walk ST, 2009, APPL ENVIRON MICROB, V75, P6534, DOI 10.1128/AEM.01262-09
   Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146
   WHITTAM TS, 1989, A VAN LEEUW J MICROB, V55, P23, DOI 10.1007/BF02309616
   Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005
   Wiles TJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003175
   Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x
   Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003
   Yu ZC, 2015, ISME J, V9, P871, DOI 10.1038/ismej.2014.185
   Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485
NR 72
TC 0
Z9 0
U1 4
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0168-6496
EI 1574-6941
J9 FEMS MICROBIOL ECOL
JI FEMS Microbiol. Ecol.
PD FEB
PY 2018
VL 94
IS 2
AR fix187
DI 10.1093/femsec/fix187
PG 10
WC Microbiology
SC Microbiology
GA GA2BR
UT WOS:000428122100013
PM 29293955
DA 2019-02-28
ER

PT J
AU Lee, Y
   Song, S
   Sheng, LL
   Zhu, L
   Kim, JS
   Wood, TK
AF Lee, Yunho
   Song, Sooyeon
   Sheng, Lili
   Zhu, Lei
   Kim, Jun-Seob
   Wood, Thomas K.
TI Substrate Binding Protein DppA1 of ABC Transporter DppBCDF Increases
   Biofilm Formation in Pseudomonas aeruginosa by Inhibiting Pf5 Prophage
   Lysis
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE PA4496; biofilm formation; swarming motility; bacteriophage Pf5; ABC
   transporter
ID ESCHERICHIA-COLI; GENE-EXPRESSION; EXTRACELLULAR DNA; FILAMENTOUS PHAGE;
   MATRIX; BACTERIOPHAGE; SYSTEM; PA14; IDENTIFICATION; BIOSYNTHESIS
AB Filamentous phage impact biofilm development, stress tolerance, virulence, biofilm dispersal, and colony variants. Previously, we identified 137 Pseudomonas aeruginosa PA14 mutants with more than threefold enhanced and 88 mutants with more than 10-fold reduced biofilm formation by screening 5850 transposon mutants (PLoS Pathogens 5: e1000483, 2009). Here, we characterized the function of one of these 225 mutations, dppA1 (PA14_58350), in regard to biofilm formation. DppA1 is a substrate-binding protein (SBP) involved in peptide utilization via the DppBCDF ABC transporter system. We show that compared to the wild-type strain, inactivating dppA1 led to 68-fold less biofilm formation in a static model and abolished biofilm formation in flow cells. Moreover, the dppA1 mutant had a delay in swarming and produced 20-fold less small-colony variants, and both biofilm formation and swarming were complemented by producing DppA1. A whole-transcriptome analysis showed that only 10 bacteriophage Pf5 genes were significantly induced in the biofilm cells of the dppA1 mutant compared to the wild-type strain, and inactivation of dppA1 resulted in a 600-fold increase in Pf5 excision and a million-fold increase in phage production. As expected, inactivating Pf5 genes PA0720 and PA0723 increased biofilm formation substantially. Inactivation of DppA1 also reduced growth (due to cell lysis). Hence, DppA1 increases biofilm formation by repressing Pf5 prophage.
C1 [Lee, Yunho; Song, Sooyeon; Sheng, Lili; Zhu, Lei; Wood, Thomas K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.
   [Wood, Thomas K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
   [Lee, Yunho] Chung Ang Univ, Dept Life Sci, Seoul, South Korea.
RP Wood, TK (reprint author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.; Wood, TK (reprint author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
EM tuw14@psu.edu
OI Kim, Jun-Seob/0000-0003-0001-6646
FU NIH [R01 GM089999]; Biotechnology Endowed Professorship at the
   Pennsylvania State University
FX This research was supported by the NIH (R01 GM089999) and funds derived
   from the Biotechnology Endowed Professorship at the Pennsylvania State
   University.
CR Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508
   Balasubramanian Deepak, 2009, Human Genomics, V3, P349
   Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102
   Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006
   Bjarnsholt T, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001420
   Chung CW, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-11
   Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619
   Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x
   Dy RL, 2014, NUCLEIC ACIDS RES, V42, P4590, DOI 10.1093/nar/gkt1419
   Eisenstark A., 1967, BACTERIOPHAGE TECHNI
   ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167
   Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x
   Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Hui JGK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00654
   Iwai S, 2010, ISME J, V4, P809, DOI 10.1038/ismej.2010.12
   Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112
   Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000
   Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07
   Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103
   Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398
   Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x
   Mai-Prochnow A, 2015, FEMS MICROBIOL REV, V39, P465, DOI 10.1093/femsre/fuu007
   Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x
   Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001
   McElroy KE, 2014, P NATL ACAD SCI USA, V111, pE1419, DOI 10.1073/pnas.1314340111
   Mooij MJ, 2007, MICROBIOL-SGM, V153, P1790, DOI 10.1099/mic.0.2006/003533-0
   Moussatova A, 2008, BBA-BIOMEMBRANES, V1778, P1757, DOI 10.1016/j.bbamem.2008.06.009
   O'May GA, 2009, MICROBIOL-SGM, V155, P1523, DOI 10.1099/mic.0.026500-0
   Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07
   Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668
   Pletzer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111311
   Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y
   Ren DC, 2004, BIOTECHNOL BIOENG, V88, P630, DOI 10.1002/bit.20259
   Ren DC, 2005, APPL MICROBIOL BIOT, V66, P689, DOI 10.1007/s00253-004-1691-6
   Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109
   Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010
   Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07
   Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004
   Secor PR, 2015, CELL HOST MICROBE, V18, P549, DOI 10.1016/j.chom.2015.10.013
   Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06
   Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   TAM R, 1993, MICROBIOL REV, V57, P320
   Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220
   Ueda A, 2010, ENV MICROBIOL REP, V2, P449, DOI 10.1111/j.1758-2229.2010.00171.x
   Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483
   Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x
   Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004
   Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003
   Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627
   Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09
NR 54
TC 1
Z9 1
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 24
PY 2018
VL 9
AR 30
DI 10.3389/fmicb.2018.00030
PG 11
WC Microbiology
SC Microbiology
GA FT5BR
UT WOS:000423169500001
PM 29416528
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Harada, LK
   Silva, EC
   Campos, WF
   Del Fiol, FS
   Vila, M
   Dabrowska, K
   Krylov, VN
   Balcao, VM
AF Harada, Liliam K.
   Silva, Erica C.
   Campos, Welida F.
   Del Fiol, Fernando S.
   Vila, Marta
   Dabrowska, Krystyna
   Krylov, Victor N.
   Balcao, Victor M.
TI Biotechnological applications of bacteriophages: State of the art
SO MICROBIOLOGICAL RESEARCH
LA English
DT Article
DE Bacteriophages; Phage therapy; Phage display; Bacterial biosensing;
   Vaccine carriers; Gene delivery; Food biopreservation and safety;
   Biofilm control; Surface disinfection; Corrosion control; Structural and
   functional stabilization
ID CAMPYLOBACTER-JEJUNI BIOFILMS; PSEUDOMONAS-AERUGINOSA INFECTIONS;
   BURKHOLDERIA-CEPACIA COMPLEX; INFLAMMATORY-BOWEL-DISEASE;
   ESCHERICHIA-COLI DIARRHEA; RESISTANCE EFFLUX PUMPS; PHAGE THERAPY;
   ENTEROCOCCUS-FAECALIS; DRUG-DELIVERY; ANTIMICROBIAL RESISTANCE
AB Bacteriophage particles are the most abundant biological entities on our planet, infecting specific bacterial hosts in every known environment and being major drivers of bacterial adaptive evolution. The study of bacteriophage particles potentially sheds light on the development of new biotechnology products. Bacteriophage therapy, although not new, makes use of strictly lytic phage particles as an alternative in the antimicrobial treatment of resistant bacterial infections and is being rediscovered as a safe method due to the fact that these biological entities devoid of any metabolic machinery do not have affinity to eukaryotic cells. Furthermore, bacteriophage-based vaccination is emerging as one of the most promising preventive strategies. This review paper discusses the biological nature of bacteriophage particles, their mode(s) of action and potential exploitation in modern biotechnology. Topics covered in detail include the potential of bacteriophage particles in human infections (bacteriophage therapy), nanocages for gene delivery, food biopreservation and safety, biocontrol of plant pathogens, phage display, bacterial biosensing devices, vaccines and vaccine carriers, biofilm and bacterial growth control, surface disinfection, corrosion control, together with structural and functional stabilization issues.
C1 [Harada, Liliam K.; Silva, Erica C.; Campos, Welida F.; Del Fiol, Fernando S.; Vila, Marta; Balcao, Victor M.] Univ Sorocaba, Ibs 2 Intelligent Biosensing & Biomol Stabilizat, PhageLab Lab Biofilms & Bacteriophages, Sorocaba, SP, Brazil.
   [Dabrowska, Krystyna] Polish Acad Sci, Inst Immunol & Expt Therapy, Bacteriophage Lab, Wroclaw, Poland.
   [Krylov, Victor N.] Russian Acad Med Sci, Mechnikov Res Inst Vaccines & Sera, Lab Genet Bacteriophages, State Inst Genet & Select Ind Microorganisms, 1st Dorozhnii Proezd 1, Moscow 113545, Russia.
   [Balcao, Victor M.] Univ Minho, CEB Ctr Biol Engn, Braga, Portugal.
RP Balcao, VM (reprint author), Univ Sorocaba, PhageLab Lab Biofilms & Bacteriophages, Campus Cidade Univ Prof Aldo Vannucchi, BR-18023000 Sorocaba, SP, Brazil.
EM victor.balcao@prof.uniso.br
OI DEL FIOL, FERNANDO DE SA/0000-0002-7138-0376
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo,
   Brazil) [2016/08884-3, 2016/12234-4]; Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo(FAPESP) [2016/16641-3]; CNPq, National Council for
   Scientific and Technological Development Brazil [306113/2014-7,
   308208/2017-0]; National Science Centre in Poland
   [UMO-2012/05/E/NZ6/03314]
FX Project funding by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP, Sao Paulo, Brazil) (FAPESP Refs. No. 2016/08884-3 (Project
   PneumoPhageColor) and 2016/12234-4 (Project TransAppIL)), is hereby
   gratefully acknowledged. Funding by Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo(FAPESP Ref. No. 2016/16641-3) in the form of an
   M.Sc. fellowship granted to Liliam Harada is hereby gratefully
   acknowledged. This work also received support from CNPq, National
   Council for Scientific and Technological Development Brazil, in the form
   of Research Productivity (PQ) fellowships granted to Victor M. Balcao
   (Refs. No. 306113/2014-7 and 308208/2017-0). Financial support to
   Krystyna Dabrowska by the National Science Centre in Poland (Grant
   UMO-2012/05/E/NZ6/03314) is also gratefully acknowledged. The authors
   have no conflicts of interest whatsoever to declare.
CR Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9
   Aarestrup FM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0085
   Abedon S. T., 2015, BACTERIOPHAGE, V5
   Abedon ST, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00983
   Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1
   Adhya S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a012518
   Adriaenssens EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033227
   Ahmed A, 2014, CLIN MICROBIOL REV, V27, P631, DOI 10.1128/CMR.00120-13
   Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2
   [Anonymous], 2015, WORLDWIDE COUNTRY SI, P42
   Ashley CE, 2011, ACS NANO, V5, P5729, DOI 10.1021/nn201397z
   Babickova J, 2015, WORLD J GASTROENTERO, V21, P11321, DOI 10.3748/wjg.v21.i40.11321
   Bakhshinejad B, 2015, NEURAL REGEN RES, V10, P862, DOI 10.4103/1673-5374.158330
   Bakhshinejad B, 2014, NEURAL REGEN RES, V9, P1955, DOI 10.4103/1673-5374.145371
   Balcao VM, 2015, ADV DRUG DELIVER REV, V93, P25, DOI 10.1016/j.addr.2014.10.005
   Balcao VM, 2014, COLLOID SURFACE B, V123, P478, DOI 10.1016/j.colsurfb.2014.09.045
   Balcao VM, 2014, APPL BIOCHEM BIOTECH, V172, P1194, DOI 10.1007/s12010-013-0579-2
   Balcao VM, 2013, ENZYME MICROB TECH, V53, P55, DOI 10.1016/j.enzmictec.2013.03.001
   Baldwin D, 2012, Patent number, Patent No. [US8168419 B2, 8168419]
   Basu S, 2015, OSTOMY WOUND MANAG, V61, P16
   Bazaka K, 2011, ADV EXP MED BIOL, V715, P213, DOI 10.1007/978-94-007-0940-9_13
   Beghetto E, 2011, MOLECULES, V16, P3089, DOI 10.3390/molecules16043089
   Beheshti-Maal K, 2015, CURR RES BACTERIOL, V8, P90, DOI DOI 10.3923/crb.2015.90.100
   Benhar I, 2001, BIOTECHNOL ADV, V19, P1, DOI 10.1016/S0734-9750(00)00054-9
   BENNETT FW, 1966, J DAIRY SCI, V49, P1350, DOI 10.3168/jds.S0022-0302(66)88093-1
   BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0
   Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X
   Borie C, 2009, AVIAN DIS, V53, P250, DOI 10.1637/8406-071008-Reg.1
   Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005
   Briers Y, 2014, MBIO, V5, DOI 10.1128/mBio.01379-14
   Brussow H, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P129
   Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7
   Caims B.J., 2009, PLOS PATHOG, V5
   Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9
   Cao ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116571
   Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227
   Casey E, 2018, VIRUSES, V10, P1
   Catalao MJ, 2013, FEMS MICROBIOL REV, V37, P554, DOI 10.1111/1574-6976.12006
   Ceglarek I, 2013, SCI REP-UK, V3, DOI 10.1038/srep03220
   Chacko RT, 2012, ADV DRUG DELIVER REV, V64, P836, DOI 10.1016/j.addr.2012.02.002
   Chan BK, 2012, ADV APPL MICROBIOL, V78, P1, DOI 10.1016/B978-0-12-394805-2.00001-4
   Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004
   Clark Jason R, 2004, Expert Rev Vaccines, V3, P463, DOI 10.1586/14760584.3.4.463
   Clark JR, 2006, TRENDS BIOTECHNOL, V24, P212, DOI 10.1016/j.tibtech.2006.03.003
   Coller J, 2007, METHOD ENZYMOL, V429, P299, DOI 10.1016/S0076-6879(07)29014-7
   Cooper CJ, 2014, LETT APPL MICROBIOL, V58, P118, DOI 10.1111/lam.12161
   Corbitt AJ, 2000, LETT APPL MICROBIOL, V30, P443, DOI 10.1046/j.1472-765X.2000.00744.x
   Cornelissen A, 2012, VIROLOGY, V434, P251, DOI 10.1016/j.virol.2012.09.030
   Criscuolo E, 2017, J IMMUNOL RES, DOI 10.1155/2017/3780697
   Dabrowska K, 2006, ARCH VIROL, V151, P209, DOI 10.1007/s00705-005-0641-7
   Dabrowska K, 2005, J APPL MICROBIOL, V98, P7, DOI 10.1111/j.1365-2672.2004.02422.x
   Dabrowska K, 2014, J VIROL, V88, P12551, DOI 10.1128/JVI.02043-14
   Dalmasso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138651
   Dalmasso M, 2014, TRENDS MICROBIOL, V22, P399, DOI 10.1016/j.tim.2014.02.010
   Davidson AR, 2017, NATURE, V541, P466, DOI 10.1038/nature21118
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Debarbieux L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv225
   Delisle AL, 2012, APPL ENVIRON MICROB, V78, P2264, DOI 10.1128/AEM.07726-11
   Domenech M, 2011, ANTIMICROB AGENTS CH, V55, P4144, DOI 10.1128/AAC.00492-11
   Donabedian SM, 2003, J CLIN MICROBIOL, V41, P1109, DOI 10.1128/JCM.41.3.1109-1113.2003
   Donlan R.M, 2013, Patent number, Patent No. [WO2013048604A2, 2013048604]
   Drulis-Kawa Z, 2015, CURR MED CHEM, V22, P1757, DOI 10.2174/0929867322666150209152851
   Drulis-Kawa Z, 2012, CURR PROTEIN PEPT SC, V13, P699, DOI 10.2174/138920312804871193
   Edlund A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27423
   Endersen L, 2014, ANNU REV FOOD SCI T, V5, P327, DOI 10.1146/annurev-food-030713-092415
   Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049
   Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459
   Fan Xiang-yu, 2012, Yaoxue Xuebao, V47, P29
   Farr R, 2014, ACTA BIOMATER, V10, P1741, DOI 10.1016/j.actbio.2013.06.037
   Fujiwara A, 2011, APPL ENVIRON MICROB, V77, P4155, DOI 10.1128/AEM.02847-10
   Funatsu T, 2002, MICROBIOL IMMUNOL, V46, P365, DOI 10.1111/j.1348-0421.2002.tb02708.x
   Gerritsen V.B, 2017, PROTEIN SPOTLIGHT, V1424-4721, P2017
   Gervals L, 2007, SENSOR ACTUAT B-CHEM, V125, P615, DOI 10.1016/j.snb.2007.03.007
   Ghequire MGK, 2015, TRENDS MICROBIOL, V23, P587, DOI 10.1016/j.tim.2015.07.011
   Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x
   Golkar Z, 2014, J INFECT DEV COUNTR, V8, P129, DOI 10.3855/jidc.3573
   Golshahi L, 2011, J APPL MICROBIOL, V110, P106, DOI 10.1111/j.1365-2672.2010.04863.x
   Goodridge L, 1999, APPL ENVIRON MICROB, V65, P1397
   Gorski A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01515
   Gutierrez D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00825
   Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.02.006
   Hao CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4890
   Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9
   Hemminga MA, 2010, EUR BIOPHYS J BIOPHY, V39, P541, DOI 10.1007/s00249-009-0523-0
   Henry M, 2013, ANTIMICROB AGENTS CH, V57, P5961, DOI 10.1128/AAC.01596-13
   Henry M, 2012, VIROLOGY, V434, P151, DOI 10.1016/j.virol.2012.09.017
   Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002
   Hiremath N.P, 2013, THESIS, P103
   Hodyra K, 2015, ARCH IMMUNOL THER EX, V63, P117, DOI 10.1007/s00005-014-0305-y
   Hodyra-Stefaniak K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14802
   Holguin AV, 2015, VIRUSES-BASEL, V7, P4602, DOI 10.3390/v7082835
   Hosseinidoust Z, 2014, COLLOID SURFACE B, V124, P2, DOI 10.1016/j.colsurfb.2014.05.036
   Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12
   Huff WE, 2013, POULTRY SCI, V92, P930, DOI 10.3382/ps.2012-02916
   Huff WE, 2003, POULTRY SCI, V82, P1108, DOI 10.1093/ps/82.7.1108
   Huff WE, 2002, POULTRY SCI, V81, P1486, DOI 10.1093/ps/81.10.1486
   Hyman P, 2012, ADV APPL MICROBIOL, V78, P55, DOI 10.1016/B978-0-12-394805-2.00003-8
   Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1
   Ica T, 2012, APPL ENVIRON MICROB, V78, P1033, DOI 10.1128/AEM.07364-11
   Imai S, 2008, PHARMAZIE, V63, P760, DOI 10.1691/ph.2008.8132
   Inamdar MM, 2006, BIOPHYS J, V91, P411, DOI 10.1529/biophysj.105.070532
   Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8
   Jhajharia K, 2015, J INT SOC PREV COMMU, V5, P1, DOI 10.4103/2231-0762.151956
   Jhamb S, 2014, BOMBAY TECHNOL, V64, P9
   Jun JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22636
   Karimi M, 2016, ADV DRUG DELIVER REV, V106, P45, DOI 10.1016/j.addr.2016.03.003
   Kazmierczak Z, 2014, VIRUSES-BASEL, V6, P2551, DOI 10.3390/v6072551
   KELLER R, 1958, SCIENCE, V128, P718, DOI 10.1126/science.128.3326.718-a
   Keryer-Bibens C, 2008, BIOL CELL, V100, P125, DOI 10.1042/BC20070067
   Khalifa L, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.32157
   Khalifa L, 2015, APPL ENVIRON MICROB, V81, P2696, DOI 10.1128/AEM.00096-15
   Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104
   KODIKARA CP, 1991, FEMS MICROBIOL LETT, V83, P261, DOI 10.1016/0378-1097(91)90486-T
   KOKJOHN TA, 1991, J GEN MICROBIOL, V137, P661, DOI 10.1099/00221287-137-3-661
   Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975
   Kovacs EW, 2007, BIOCONJUGATE CHEM, V18, P1140, DOI 10.1021/bc070006e
   Krylov V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01631
   Krylov V, 2015, VIROL SIN, V30, P33, DOI 10.1007/s12250-014-3546-3
   Krylov V, 2013, VIRUSES-BASEL, V5, P15, DOI 10.3390/v5010015
   Kutateladze M, 2008, MED MALADIES INFECT, V38, P426, DOI 10.1016/j.medmal.2008.06.023
   Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401
   Kutter EM, 2015, FUTURE MICROBIOL, V10, P685, DOI [10.2217/FMB.15.28, 10.2217/fmb.15.28]
   Lee EJ, 2016, ADV DRUG DELIVER REV, V106, P157, DOI 10.1016/j.addr.2016.03.002
   Lee JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25543
   Lee JW, 2013, INT J NANOMED, V8, P3917, DOI 10.2147/IJN.S51894
   Lee TJ, 2009, ANN BIOMED ENG, V37, P2064, DOI 10.1007/s10439-009-9723-0
   Leiman P.G, 2012, VIRAL MOL MACHINES A, V726, P1
   Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022
   Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822
   Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7
   Lopez-Causape C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05621-5
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106
   Lu XN, 2012, J ANTIMICROB CHEMOTH, V67, P1915, DOI 10.1093/jac/dks138
   Lopez RL, 2017, APMIS, V125, P3, DOI 10.1111/apm.12609
   Maciejewska B, 2018, APPL MICROBIOL BIOT, V102, P2563, DOI 10.1007/s00253-018-8811-1
   Mahony J, 2011, CURR OPIN BIOTECH, V22, P157, DOI 10.1016/j.copbio.2010.10.008
   Majewska J, 2015, VIRUSES-BASEL, V7, P4783, DOI 10.3390/v7082845
   Matinkhoo S, 2011, J PHARM SCI-US, V100, P5197, DOI 10.1002/jps.22715
   Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1
   McCallin S, 2013, VIROLOGY, V443, P187, DOI 10.1016/j.virol.2013.05.022
   Mead GC, 2000, VET J, V159, P111, DOI 10.1053/tvjl.1999.0423
   Mendes JJ, 2013, WOUND REPAIR REGEN, V21, P595, DOI 10.1111/wrr.12056
   Meng Fan-Mei, 2011, Yichuan, V33, P1113, DOI 10.3724/SP.J.1005.2011.01113
   Meng XP, 2011, APPL ENVIRON MICROB, V77, P8272, DOI 10.1128/AEM.05151-11
   Merabishvili M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052709
   Merzlyak A, 2006, CURR OPIN CHEM BIOL, V10, P246, DOI 10.1016/j.cbpa.2006.04.008
   Miernikiewicz P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01112
   Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x
   Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963
   Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12
   Nitsch-Osuch A, 2016, ADV EXP MED BIOL, V905, P25, DOI 10.1007/5584_2015_198
   Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655
   O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x
   Ojala V, 2013, EVOL APPL, V6, P925, DOI 10.1111/eva.12076
   Oldfield E, 2014, TRENDS PHARMACOL SCI, V35, P664, DOI 10.1016/j.tips.2014.10.007
   Oliveira H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00180
   Onodera K, 2010, ADV BIOCHEM ENG BIOT, V119, P17, DOI 10.1007/10_2008_46
   Paisano AF, 2004, ORAL MICROBIOL IMMUN, V19, P327, DOI 10.1111/j.1399-302x.2004.00166.x
   Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004
   Parasion S, 2014, POL J MICROBIOL, V63, P137
   Patel KG, 2011, BIOCONJUGATE CHEM, V22, P376, DOI 10.1021/bc100367u
   Payne RJH, 2001, J THEOR BIOL, V208, P37, DOI 10.1006/jtbi.2000.2198
   Petrenko VA, 2003, J MICROBIOL METH, V53, P253, DOI 10.1016/S0167-7012(03)00029-0
   Petty NK, 2007, TRENDS BIOTECHNOL, V25, P7, DOI 10.1016/j.tibtech.2006.11.003
   Phee A, 2013, J ENDODONT, V39, P364, DOI 10.1016/j.joen.2012.10.023
   Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006
   Pires DP, 2016, APPL MICROBIOL BIOT, V100, P2141, DOI 10.1007/s00253-015-7247-0
   Pirnay JP, 2015, PHARM RES-DORDR, V32, P2173, DOI 10.1007/s11095-014-1617-7
   Pirnay JP, 2012, FUTURE VIROL, V7, P379, DOI 10.2217/FVL.12.24
   Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51
   Rees CED, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P267
   Rhoads D D, 2009, J Wound Care, V18, P237
   Rios AC, 2018, PROCESS BIOCHEM, V64, P177, DOI 10.1016/j.procbio.2017.09.022
   Rios AC, 2016, MICROBIOL RES, V191, P51, DOI 10.1016/j.micres.2016.04.008
   Ripp S, 2006, J APPL MICROBIOL, V100, P488, DOI 10.1111/j.1365-2672.2005.02828.x
   Roach DR, 2015, BACTERIOPHAGE, V5, DOI [10.1080/21597081.2015.1062590, DOI 10.1080/21597081.2015.1062590]
   Rodriguez-Rubio L, 2016, CRIT REV BIOTECHNOL, V36, P542, DOI 10.3109/07388551.2014.993587
   Rodriguez-Rubio L, 2013, CRIT REV MICROBIOL, V39, P427, DOI 10.3109/1040841X.2012.723675
   Ronca R, 2012, INT J MOL SCI, V13, P5254, DOI 10.3390/ijms13045254
   Rossmann MG, 2005, STRUCTURE, V13, P355, DOI 10.1016/j.str.2005.01.005
   Rouveix B, 2007, J ANTIMICROB CHEMOTH, V59, P1208, DOI 10.1093/jac/dkl564
   Ryan E, 2012, EUR J PHARM SCI, V47, P297, DOI 10.1016/j.ejps.2012.06.012
   Salli KM, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.26149
   Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI [10.1038/nrmicr03564, 10.1038/nrmicro3564]
   Santos SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102507
   Sarker SA, 2016, ANN NY ACAD SCI, V1372, P42, DOI 10.1111/nyas.13087
   Sarker SA, 2012, VIROLOGY, V434, P222, DOI 10.1016/j.virol.2012.09.002
   Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06
   Saussereau E, 2014, CLIN MICROBIOL INFEC, V20, pO983, DOI 10.1111/1469-0691.12712
   Schmelcher M., 2014, BACTERIOPHAGE, V4, DOI DOI 10.4161/BACT.28137
   Scholl D, 2009, ANTIMICROB AGENTS CH, V53, P3074, DOI 10.1128/AAC.01660-08
   Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107
   Scibilia S., 2016, SENS BIOSENSING RES, V7, P146, DOI DOI 10.1016/J.SBSR.2016.02.002
   Semler DD, 2014, ANTIMICROB AGENTS CH, V58, P4005, DOI 10.1128/AAC.02388-13
   Shao YP, 2008, GENETICS, V180, P471, DOI 10.1534/genetics.108.090100
   Shen Y, 2013, J ANTIMICROB CHEMOTH, V68, P1818, DOI 10.1093/jac/dkt104
   Shlezinger M, 2017, CURR TOP MED CHEM, V17, P1199, DOI 10.2174/1568026616666160930145649
   Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1
   Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414
   Sillankorva S.M., 2012, INT J FOOD MICROBIOL, V2012, P13
   Singh A, 2009, BIOSENS BIOELECTRON, V24, P3645, DOI 10.1016/j.bios.2009.05.028
   Singh A, 2013, SENSORS-BASEL, V13, P1763, DOI 10.3390/s130201763
   Singh A, 2012, ANALYST, V137, P3405, DOI 10.1039/c2an35371g
   Siringan P, 2011, APPL ENVIRON MICROB, V77, P3320, DOI 10.1128/AEM.02704-10
   Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002
   Smartt AE, 2012, ANAL BIOANAL CHEM, V402, P3127, DOI 10.1007/s00216-011-5555-5
   Smietana M, 2011, OPT EXPRESS, V19, P7971, DOI 10.1364/OE.19.007971
   Smith HL, 2009, MATH MODEL NAT PHENO, V4, P109, DOI 10.1051/mmnp/20094604
   SMITH HW, 1983, J GEN MICROBIOL, V129, P2659
   Son JS, 2010, APPL MICROBIOL BIOT, V86, P1439, DOI 10.1007/s00253-009-2386-9
   Sorokulova I, 2014, EXPERT REV MED DEVIC, V11, P175, DOI 10.1586/17434440.2014.882767
   Stanford K, 2010, J FOOD PROTECT, V73, P1304, DOI 10.4315/0362-028X-73.7.1304
   Stavri M, 2007, J ANTIMICROB CHEMOTH, V59, P1247, DOI 10.1093/jac/dkl460
   Stevens RH, 2009, ORAL MICROBIOL IMMUN, V24, P278, DOI 10.1111/j.1399-302X.2009.00506.x
   Stoesser N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06256-2
   Struzycka I, 2014, POL J MICROBIOL, V63, P127
   Summer N.S, 2012, Patent number, Patent No. [US20120258523 Al, 20120258523]
   Summers WC, 2012, BACTERIOPHAGE, V2, P130, DOI DOI 10.4161/BACT.20757
   Sun W, 2001, J IND MICROBIOL BIOT, V27, P126, DOI 10.1038/sj.jim.7000198
   Szermer-Olearnik B, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0266-5
   Teesalu T, 2012, METHOD ENZYMOL, V503, P35, DOI 10.1016/B978-0-12-396962-0.00002-1
   Tlili C, 2013, ANAL CHEM, V85, P4893, DOI 10.1021/ac302699x
   Tolba M, 2010, APPL ENVIRON MICROB, V76, P528, DOI 10.1128/AEM.02294-09
   TOLKACHEVA T V, 1981, Problemy Gematologii i Perelivaniya Krovi, V26, P29
   Trigo G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002183
   Uyanga T., 2015, THESIS
   van der Ploeg JR, 2007, FEMS MICROBIOL LETT, V275, P130, DOI 10.1111/j.1574-6968.2007.00873.x
   Vinay M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131466
   Viswanathan VK, 2014, GUT MICROBES, V5, P3, DOI 10.4161/gmic.28027
   Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790
   Wagenaar JA, 2013, CLIN INFECT DIS, V57, P1600, DOI 10.1093/cid/cit555
   Waltimo T, 2005, J ENDODONT, V31, P863, DOI 10.1097/01.don.0000164856.27920.85
   Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668
   Webster M, 2010, THESIS, P343
   Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009
   Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001
   Wittebole X., 2013, VIRULENCE, V4, P1
   Yan JL, 2014, BIODRUGS, V28, P265, DOI 10.1007/s40259-013-0081-y
   Zaczek M, 2015, J APPL MICROBIOL, V118, P537, DOI 10.1111/jam.12700
   Zarasvand KA, 2014, INT BIODETER BIODEGR, V87, P66, DOI 10.1016/j.ibiod.2013.10.023
   Zourob M, 2010, RECOGNITION RECEPTORS IN BIOSENSORS, P415, DOI 10.1007/978-1-4419-0919-0_11
NR 242
TC 3
Z9 3
U1 22
U2 32
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0944-5013
J9 MICROBIOL RES
JI Microbiol. Res.
PY 2018
VL 212
BP 38
EP 58
DI 10.1016/j.micres.2018.04.007
PG 21
WC Microbiology
SC Microbiology
GA GM6WQ
UT WOS:000438320100005
PM 29853167
OA Green Published
DA 2019-02-28
ER

PT J
AU Vidakovic, L
   Singh, PK
   Hartmann, R
   Nadell, CD
   Drescher, K
AF Vidakovic, Lucia
   Singh, Praveen K.
   Hartmann, Raimo
   Nadell, Carey D.
   Drescher, Knut
TI Dynamic biofilm architecture confers individual and collective
   mechanisms of viral protection
SO NATURE MICROBIOLOGY
LA English
DT Article
ID VIBRIO-CHOLERAE BIOFILMS; ESCHERICHIA-COLI; FIBRONECTIN-BINDING;
   BACTERIAL BIOFILMS; BACTERIOPHAGE; INFECTION; FLUORESCENT; MATRIX; GENES
AB In nature, bacteria primarily live in surface-attached, multicellular communities, termed biofilms(1-6). In medical settings, biofilms cause devastating damage during chronic and acute infections; indeed, bacteria are often viewed as agents of human disease(7). However, bacteria themselves suffer from diseases, most notably in the form of viral pathogens termed bacteriophages(8-12), which are the most abundant replicating entities on Earth. Phage-biofilm encounters are undoubtedly common in the environment, but the mechanisms that determine the outcome of these encounters are unknown. Using Escherichia coli biofilms and the lytic phage T7 as models, we discovered that an amyloid fibre network of CsgA (curli polymer) protects biofilms against phage attack via two separate mechanisms. First, collective cell protection results from inhibition of phage transport into the biofilm, which we demonstrate in vivo and in vitro. Second, CsgA fibres protect cells individually by coating their surface and binding phage particles, thereby preventing their attachment to the cell exterior. These insights into biofilm-phage interactions have broad-ranging implications for the design of phage applications in biotechnology, phage therapy and the evolutionary dynamics of phages with their bacterial hosts.
C1 [Vidakovic, Lucia; Singh, Praveen K.; Hartmann, Raimo; Nadell, Carey D.; Drescher, Knut] Max Planck Inst Terr Microbiol, Marburg, Germany.
   [Nadell, Carey D.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.
   [Drescher, Knut] Philipps Univ Marburg, Dept Phys, Marburg, Germany.
RP Nadell, CD; Drescher, K (reprint author), Max Planck Inst Terr Microbiol, Marburg, Germany.; Nadell, CD (reprint author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.; Drescher, K (reprint author), Philipps Univ Marburg, Dept Phys, Marburg, Germany.
EM carey.d.nadell@dartmouth.edu; k.drescher@mpi-marburg.mpg.de
RI Drescher, Knut/N-6730-2015
OI Drescher, Knut/0000-0002-7340-2444; Singh, Praveen
   Kumar/0000-0002-0254-7400
FU Max Planck Society; Human Frontier Science Program [CDA00084/2015-C];
   Deutsche Forschungsgemeinschaft [SFB987]; Alexander von Humboldt
   Foundation; Cystic Fibrosis Foundation [STANTO15RO]; European Research
   Council [StG-716734]; Behrens Weise Foundation
FX The authors thank M. Rakwalska-Bange, T. Heimerl and G. Malengo for
   experimental assistance, R. Hengge and V. Sourjik for strains and N.
   Rigel and members of the Drescher laboratory for discussions and
   suggestions. This work was supported by grants from the Max Planck
   Society, Behrens Weise Foundation, European Research Council
   (StG-716734), Human Frontier Science Program (CDA00084/2015-C) and
   Deutsche Forschungsgemeinschaft (SFB987) to K.D., and the Alexander von
   Humboldt Foundation and Cystic Fibrosis Foundation (STANTO15RO) to
   C.D.N.
CR ARNQVIST A, 1992, MOL MICROBIOL, V6, P2443
   Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981
   Besharova O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01568
   Boas DV, 2016, BIOFOULING, V32, P179, DOI 10.1080/08927014.2015.1131821
   Briandet R, 2008, APPL ENVIRON MICROB, V74, P2135, DOI 10.1128/AEM.02304-07
   Bull JJ, 2012, ANTIMICROB AGENTS CH, V56, P949, DOI 10.1128/AAC.05842-11
   Chan BK, 2015, CURR PHARM DESIGN, V21, P85
   DePas WH, 2013, P NATL ACAD SCI USA, V110, P2629, DOI [10.1073/pnas.1218703110, 10.1073/pnas.1218703110/-/DCSupplemental]
   Doolittle MM, 1996, J IND MICROBIOL, V16, P331, DOI 10.1007/BF01570111
   Drescher K, 2016, P NATL ACAD SCI USA, V113, pE2066, DOI 10.1073/pnas.1601702113
   Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94
   Forde SE, 2008, NATURE, V455, P220, DOI 10.1038/nature07152
   Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767
   Grantcharova N, 2010, J BACTERIOL, V192, P456, DOI 10.1128/JB.01826-08
   Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015
   Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887
   Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   May T, 2011, ISME J, V5, P771, DOI 10.1038/ismej.2010.158
   Nadell CD, 2015, ISME J, V9, P1700, DOI 10.1038/ismej.2014.246
   Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543
   OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0
   Persat A, 2015, CELL, V161, P988, DOI 10.1016/j.cell.2015.05.005
   Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808
   Pires DP, 2016, APPL MICROBIOL BIOT, V100, P2141, DOI 10.1007/s00253-015-7247-0
   Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853
   Rohwer F, 2015, NATURE, V528, P46, DOI 10.1038/528046a
   Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI [10.1038/nrmicr03564, 10.1038/nrmicro3564]
   Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096
   Serra DO, 2013, MBIO, V4, DOI 10.1128/mBio.00103-13
   Weitz J. S., P NATL ACAD SCI US, V102
   Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034
   Zhou Yizhou, 2013, Methods Mol Biol, V966, P53, DOI 10.1007/978-1-62703-245-2_4
NR 33
TC 14
Z9 14
U1 10
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JAN
PY 2018
VL 3
IS 1
DI 10.1038/s41564-017-0050-1
PG 6
WC Microbiology
SC Microbiology
GA FT2OF
UT WOS:000422983100007
PM 29085075
OA Green Accepted
DA 2019-02-28
ER

PT J
AU Jamal, M
   Andleeb, S
   Jalil, F
   Imran, M
   Nawaz, MA
   Hussain, T
   Ali, M
   Das, CR
AF Jamal, Muhsin
   Andleeb, Saadia
   Jalil, Fazal
   Imran, Muhammad
   Nawaz, Muhammad Asif
   Hussain, Tahir
   Ali, Muhammad
   Das, Chythanya Rajanna
TI Isolation and characterization of a bacteriophage and its utilization
   against multi-drug resistant Pseudomonas aeruginosa-2995
SO LIFE SCIENCES
LA English
DT Article
DE Bacteriophage; Biofilm; Cocktail; Pseudomonas aeruginosa; Suspension
ID ESCHERICHIA-COLI O157-H7; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS;
   BIOFILMS; INFECTION; COCKTAIL; THERAPY; PHAGES
AB Aims: To identify, isolate, and characterize a lytic bacteriophage against the multiple-drug resistant clinical strain of Pseudomonas aeruginosa-2995 and to determine the phage efficacy against the bacterial planktonic cells and the biofilm.
   Main methods: Wastewater was used to isolate a bacteriophage. The phage was characterized with Transmission electron microscopy (TEM). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) was used to identify the expressed proteins. Bacteria were cultured in both suspension and biofilm to check and compare their susceptibility to phage lytic action. The activity of the phage (determined as AZ1) was determined against P. aeruginosa-2995 in both planktonic cells and the biofilm.
   Key findings: A bacteriophage, designated as AZ1, was isolated from waste water showing a narrow host range. AZ1 was characterized by TEM and could be identified as an isolate in the family Siphoviridae [order Caudovirals]. Seventeen structural proteins ranging from about 12 to 110 kDa were found through SDS-PAGE analysis. Its genome was confirmed as dsDNA with a length of approx. 50 kb. The log-phase growth of P. aeruginosa-2995 was significantly reduced after treatment with AZ1 (4.50 x 10(8) to 2.1 x 10(3) CFU/ml) as compared to control. Furthermore, phage AZ1 significantly reduced 48 h old biofilm biomass about 3-fold as compared to control.
   Significance: Pseudomonas aeruginosa is a ubiquitous free-living opportunistic human pathogen characterized by high antibiotic tolerance and tendency for biofilm formation. The phage, identified in this study, AZ1, showed promising activity in the destruction of both planktonic cells and biofilm of P. aeruginosa-2995. However, complete eradication may require a combination of phages.
C1 [Jamal, Muhsin; Hussain, Tahir] Abdul Wali Khan Univ, Dept Microbiol, Garden Campus, Mardan 23000, Pakistan.
   [Jamal, Muhsin; Andleeb, Saadia] NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad 44000, Pakistan.
   [Jalil, Fazal] Abdul Wali Khan Univ, Dept Biotechnol, Mardan, Pakistan.
   [Imran, Muhammad] Univ Hlth Sci, Dept Microbiol, Lahore, Pakistan.
   [Nawaz, Muhammad Asif] Shaheed Benazir Bhutto Univ, Dept Biotechnol, Dir, Upper, Pakistan.
   [Ali, Muhammad] Univ Management & Technol, Sch Sci, Dept Life Sci, Lahore, Pakistan.
   [Jamal, Muhsin; Das, Chythanya Rajanna] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
RP Jamal, M (reprint author), Abdul Wali Khan Univ, Dept Microbiol, Garden Campus, Mardan 23000, Pakistan.
EM muhsinjamal@awkum.edu.pk
FU Higher Education Commission, Pakistan (HEC) [117-8525-BM7-040]
FX This study was funded by Higher Education Commission, Pakistan
   (117-8525-BM7-040) (HEC).
CR Ackermann H.W., 2009, PHAGE CLASSIFICATION, P127
   Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604
   Barrow PA, 2001, J CHEM TECHNOL BIOT, V76, P677, DOI 10.1002/jctb.436
   Capra ML, 2006, J APPL MICROBIOL, V100, P334, DOI 10.1111/j.1365-2672.2005.02767.x
   Carson L, 2010, FEMS IMMUNOL MED MIC, V59, P447, DOI 10.1111/j.1574-695X.2010.00696.x
   Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chan B.K., 2010, ADV APPL MICROBIOL, V78, P1
   Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/fmb.13.47, 10.2217/FMB.13.47]
   Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597
   Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Gilbert P, 1997, Adv Dent Res, V11, P160
   Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12
   Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909
   Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001
   Harper DR, 2014, ANTIBIOTICS-BASEL, V3, P270, DOI 10.3390/antibiotics3030270
   Hazem A, 2002, MICROBIOLOGICA, V25, P469
   Holder A.A., 1993, ANN NY ACAD SCI, V21, P707
   Jamal M, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.25917
   Jamal M, 2015, J BASIC MICROB, V55, P420, DOI 10.1002/jobm.201400688
   Jamalludeen N, 2007, VET MICROBIOL, V124, P47, DOI 10.1016/j.vetmic.2007.03.028
   Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001
   Kutter E, 2004, BACTERIOPHAGES BIOL
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Larson EL, 2003, AM J INFECT CONTROL, V31, P72, DOI 10.1067/mic.2003.33
   Lautenbach E, 2010, INFECT CONT HOSP EP, V31, P47, DOI 10.1086/649021
   Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022
   Lutz JK, 2011, INT J ENV RES PUB HE, V8, P554, DOI 10.3390/ijerph8020554
   Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002
   Nakai T, 2002, RES MICROBIOL, V153, P13, DOI 10.1016/S0923-2508(01)01280-3
   O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004
   Piracha Z., 2014, G J MED RES, P14
   Ranjan K Prabhat, 2010, J Lab Physicians, V2, P74, DOI 10.4103/0974-2727.72153
   Sambrook J., 1989, MOL CLONING
   Sharp R., 2006, U.S. Patent, Patent No. [20,060,140,911, 20060140911]
   Sillankorva S., 2008, BMC BIOTECHNOL, V8, P79
   Sillankorva S., 2011, USE BACTERIOPHAGES C
   Sklar IB, 2001, J FOOD SAFETY, V21, P15, DOI 10.1111/j.1745-4565.2001.tb00305.x
   Spencker FB, 2003, CLIN MICROBIOL INFEC, V9, P370, DOI 10.1046/j.1469-0691.2003.00534.x
   Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9
   Ullah A., 2012, J BIOL FOOD SCI RES, V1, P19
   Yan JL, 2014, BIODRUGS, V28, P265, DOI 10.1007/s40259-013-0081-y
NR 43
TC 0
Z9 0
U1 2
U2 57
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD DEC 1
PY 2017
VL 190
BP 21
EP 28
DI 10.1016/j.lfs.2017.09.034
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA FK3PJ
UT WOS:000413397800004
PM 28964812
DA 2019-02-28
ER

PT J
AU Srivastava, D
   Moumene, A
   Flores-Kim, J
   Darwin, AJ
AF Srivastava, Disha
   Moumene, Amal
   Flores-Kim, Josue
   Darwin, Andrew J.
TI Psp Stress Response Proteins Form a Complex with Mislocalized Secretins
   in the Yersinia enterocolitica Cytoplasmic Membrane
SO MBIO
LA English
DT Article
DE secretin; Yersinia; protein interactions; stress response
ID PHAGE-SHOCK-PROTEIN; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; IN-VIVO;
   ENVELOPE; SYSTEM; OPERON; IDENTIFICATION; EXPRESSION; MEMBER
AB The bacterial phage shock protein system (Psp) is a conserved extracytoplasmic stress response that is essential for the virulence of some pathogens, including Yersinia enterocolitica. It is induced by events that can compromise inner membrane (IM) integrity, including the mislocalization of outer membrane pore-forming proteins called secretins. In the absence of the Psp system, secretin mislocalization permeabilizes the IM and causes rapid cell death. The Psp proteins PspB and PspC form an integral IM complex with two independent roles. First, the PspBC complex is required to activate the Psp response in response to some inducing triggers, including a mislocalized secretin. Second, PspBC are sufficient to counteract mislocalized secretin toxicity. Remarkably, secretin mislocalization into the IM induces psp gene expression without significantly affecting the expression of any other genes. Furthermore, psp null strains are killed by mislocalized secretins, whereas no other null mutants have been found to share this specific secretin sensitivity. This suggests an exquisitely specific relationship between secretins and the Psp system, but there has been no mechanism described to explain this. In this study, we addressed this deficiency by using a coimmunoprecipitation approach to show that the Psp proteins form a specific complex with mislocalized secretins in the Y. enterocolitica IM. Importantly, analysis of different secretin mutant proteins also revealed that this interaction is absolutely dependent on a secretin adopting a multimeric state. Therefore, the Psp system has evolved with the ability to detect and detoxify dangerous secretin multimers while ignoring the presence of innocuous monomers.
   IMPORTANCE The phage shock protein (Psp) response has been linked to important phenotypes in diverse bacteria, including those related to antibiotic resistance, biofilm formation, and virulence. This has generated widespread interest in understanding various aspects of its function. Outer membrane secretin proteins are essential components of export systems required for the virulence of many bacterial pathogens. However, secretins can mislocalize into the inner membrane, and this induces the Psp response in a highly specific manner and kills Psp-defective strains with similar specificity. There has been no mechanism described to explain this exquisitely specific relationship between secretins and the Psp system. Therefore, this study provides a critical advance by discovering that Psp effector proteins form a complex with secretins in the Yersinia enterocolitica inner membrane. Remarkably, this interaction is absolutely dependent on a secretin adopting its multimeric state. Therefore, the Psp system detects and detoxifies dangerous secretin multimers, while ignoring the presence of innocuous secretin monomers.
C1 [Srivastava, Disha; Moumene, Amal; Flores-Kim, Josue; Darwin, Andrew J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
   [Moumene, Amal] Univ Reunion, UMR PVBMT, St Denis, Reunion, France.
   [Flores-Kim, Josue] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA.
RP Darwin, AJ (reprint author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
EM andrew.darwin@med.nyu.edu
OI Darwin, Andrew/0000-0002-7751-1293
FU National Institute of Allergy and Infectious Diseases (NIAID)
   [R01AI052148]
FX This study was supported by award R01AI052148 from the National
   Institute of Allergy and Infectious Diseases (NIAID) to A.J.D.
CR Adams H, 2003, J BACTERIOL, V185, P1174, DOI 10.1128/JB.185.4.1174-1180.2003
   Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004
   Becker LA, 2005, MOL MICROBIOL, V56, P1004, DOI 10.1111/j.1365-2958.2005.04604.x
   BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862
   Darwin AJ, 2001, MOL MICROBIOL, V39, P429, DOI 10.1046/j.1365-2958.2001.02235.x
   DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9
   Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84
   Dworkin J, 2000, J BACTERIOL, V182, P311, DOI 10.1128/JB.182.2.311-319.2000
   Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7
   Engl C, 2009, MOL MICROBIOL, V73, P382, DOI 10.1111/j.1365-2958.2009.06776.x
   Flores-Kim J, 2016, J BACTERIOL, V198, P3367, DOI 10.1128/JB.00655-16
   Flores-Kim J, 2016, ANNU REV MICROBIOL, V70, P83, DOI 10.1146/annurev-micro-102215-095359
   Flores-Kim J, 2015, J BIOL CHEM, V290, P11417, DOI 10.1074/jbc.M114.614107
   Flores-Kim J, 2012, J BACTERIOL, V194, P6548, DOI 10.1128/JB.01250-12
   Grabowicz M, 2017, TRENDS BIOCHEM SCI, V42, P232, DOI 10.1016/j.tibs.2016.10.002
   Green RC, 2004, J BACTERIOL, V186, P4910, DOI 10.1128/JB.186.15.4910-4920.2004
   Gueguen E, 2011, J BACTERIOL, V193, P5747, DOI 10.1128/JB.05080-11
   Gueguen E, 2009, MOL MICROBIOL, V74, P619, DOI 10.1111/j.1365-2958.2009.06885.x
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995
   Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132
   Hobbs EC, 2012, P NATL ACAD SCI USA, V109, P16696, DOI 10.1073/pnas.1210093109
   Horstman NK, 2012, MOL MICROBIOL, V85, P445, DOI 10.1111/j.1365-2958.2012.08120.x
   Hunke S, 2012, FEMS MICROBIOL LETT, V326, P12, DOI 10.1111/j.1574-6968.2011.02436.x
   Huvet M, 2011, MOL BIOL EVOL, V28, P1141, DOI 10.1093/molbev/msq301
   Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x
   Jovanovic G, 1996, J BACTERIOL, V178, P1936, DOI 10.1128/jb.178.7.1936-1945.1996
   Jovanovic G, 2006, J BIOL CHEM, V281, P21147, DOI 10.1074/jbc.M602323200
   KINDER SA, 1993, GENE, V136, P271, DOI 10.1016/0378-1119(93)90478-L
   KLEEREBEZEM M, 1993, MOL MICROBIOL, V7, P947, DOI 10.1111/j.1365-2958.1993.tb01186.x
   Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x
   Kobayashi H, 1998, MICROBIOL-UK, V144, P353, DOI 10.1099/00221287-144-2-353
   Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08
   Koo J, 2012, FEMS MICROBIOL LETT, V328, P1, DOI 10.1111/j.1574-6968.2011.02464.x
   Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002
   Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07
   Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200
   Maxson ME, 2006, MOL MICROBIOL, V59, P1610, DOI 10.1111/j.1365-2958.2006.05047.x
   Maxson ME, 2005, APPL ENVIRON MICROB, V71, P5614, DOI 10.1128/AEM.71.9.5614-5618.2005
   Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004
   McDonald C, 2015, MBIO, V6, DOI 10.1128/mBio.01188-15
   Nickerson NN, 2012, J BACTERIOL, V194, P4951, DOI 10.1128/JB.00798-12
   Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9
   Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394
   RUSSEL M, 1993, J BACTERIOL, V175, P3998
   Seo J, 2007, MOL MICROBIOL, V65, P714, DOI 10.1111/j.1365-2958.2007.05821.x
   Seo J, 2009, J BACTERIOL, V191, P898, DOI 10.1128/JB.01443-08
   Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414
   Singh S, 2011, J BACTERIOL, V193, P6436, DOI 10.1128/JB.05942-11
   WEINER L, 1994, P NATL ACAD SCI USA, V91, P2191, DOI 10.1073/pnas.91.6.2191
   Yamaguchi S, 2013, MOL MICROBIOL, V87, P656, DOI 10.1111/mmi.12122
   Yamaguchi S, 2010, MOL MICROBIOL, V78, P429, DOI 10.1111/j.1365-2958.2010.07344.x
   Zhang N, 2016, ADV EXP MED BIOL, V915, P207, DOI 10.1007/978-3-319-32189-9_13
NR 53
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2017
VL 8
IS 5
AR e01088-17
DI 10.1128/mBio.01088-17
PG 15
WC Microbiology
SC Microbiology
GA FN8JS
UT WOS:000416271100024
PM 28900025
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Sadekuzzaman, M
   Yang, S
   Mizan, MFR
   Ha, SD
AF Sadekuzzaman, Mohammad
   Yang, Sungdae
   Mizan, Md. Furkanur Rahaman
   Ha, Sang-Do
TI Reduction of Escherichia coli O157:H7 in Biofilms Using Bacteriophage
   BPECO 19
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE bacteriophage; biofilms; Escherichia coli O157:H7; Lettuce; stainless
   steel
ID HEMOLYTIC-UREMIC SYNDROME; MICROBIAL BIOFILMS; STAINLESS-STEEL; O157-H7;
   INACTIVATION; RESISTANCE; SURFACES; BEEF; SALMONELLA; BIOCONTROL
AB Biofilm formation is a growing concern in the food industry. Escherichia coli O157:H7 is one of the most important foodborne pathogens that can persists in food and food-related environments and subsequently produce biofilms. The efficacy of bacteriophage BPECO 19 was evaluated against three E. coli O157:H7 strains in biofilms. Biofilms of the three E. coli O157:H7 strains were grown on abiotic (stainless steel, rubber, and minimum biofilm eradication concentration [MBECTM] device) and biotic (lettuce) surfaces at different temperatures. The effectiveness of bacteriophage BPECO 19 in reducing preformed biofilms on these surfaces was further evaluated by treating the surfaces with a phage suspension (10(8) PFU/mL) for 2 h. The results indicated that the phage treatment significantly reduced (P <0.05) the number of adhered cells in all the surfaces. Following phage treatment, the viability of adhered cells was reduced by 3 log CFU/cm(2), 2.4 log CFU/cm(2), and 3.1 log CFU/peg in biofilms grown on stainless steel, rubber, and the MBECTM device, respectively. Likewise, the phage treatment reduced cell viability by 2 log CFU/cm(2) in biofilms grown on lettuce. Overall, these results suggested that bacteriophages such as BPECO 19 could be effective in reducing the viability of biofilm-adhered cells.
   Practical Application Our results suggested that bacteriophages such as BPECO 19 could be effective in reducing the viability of biofilm-adhered cells. Therefore, it could serve as a practical method to control the growth of E. coli O157:H7 in biofilms. In fact, bacteriophages could be part of an ideal, eco-friendly biocontrol intervention strategy to control pathogens in biofilms.
C1 [Sadekuzzaman, Mohammad; Yang, Sungdae; Mizan, Md. Furkanur Rahaman; Ha, Sang-Do] Chung Ang Univ, Sch Food Sci & Technol, 72-1 Nae Ri, Anseong 456756, Gyunggido, South Korea.
   [Sadekuzzaman, Mohammad] Dept Livestock Serv, Dhaka, Bangladesh.
RP Ha, SD (reprint author), Chung Ang Univ, Sch Food Sci & Technol, 72-1 Nae Ri, Anseong 456756, Gyunggido, South Korea.
EM sangdoha@cau.ac.kr
OI Mizan, Md. Furkanur Rahaman/0000-0003-1819-3827
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013005051]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF), funded by the
   Ministry of Science, ICT & Future Planning (2013005051).
CR Abuladze T, 2008, APPL ENVIRON MICROB, V74, P6230, DOI 10.1128/AEM.01465-08
   Al-Mola GA, 2010, J VET MED SCI, V9, P45
   Besser RE, 1999, ANNU REV MED, V50, P355
   BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608
   Carmichael I, 1999, J APPL MICROBIOL, V85, p45S, DOI 10.1111/j.1365-2672.1998.tb05282.x
   CDC, 2012, MULT OUTBR E COL O15
   Chmielewski R. A. N., 2003, Comprehensive Reviews in Food Science and Food Safety, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x
   Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002
   Else TA, 2003, APPL ENVIRON MICROB, V69, P5006, DOI 10.1128/AEM.69.8.5006-5010.2003
   Ferguson S., 2013, BACTERIOPHAGE, V3, DOI [10. 4161/bact. 24323, DOI 10.4161/BACT.24323]
   Fett WF, 2000, J FOOD PROTECT, V63, P625, DOI 10.4315/0362-028X-63.5.625
   Food and Drug Administration Center for Food Safety and Applied Nutrition, 2013, AG RESP LETT GRAS NO
   Food and Drug Administration Center for Food Safety and Applied Nutrition, 2006, AG RESP LETT GRAS NO
   Gallet R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-241
   Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6
   Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698
   Hudson JA, 2013, FOOD MICROBIOL, V36, P14, DOI 10.1016/j.fm.2013.03.006
   Hudson JA, 2005, J FOOD PROTECT, V68, P426, DOI 10.4315/0362-028X-68.2.426
   Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039
   Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x
   Jahid IK, 2013, J FOOD PROTECT, V76, P239, DOI 10.4315/0362-028X.JFP-12-321
   Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Lee YD, 2015, LWT-FOOD SCI TECHNOL, V60, P571, DOI 10.1016/j.lwt.2014.09.017
   Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7
   Moore-Neibel K, 2012, J APPL MICROBIOL, V112, P485, DOI 10.1111/j.1365-2672.2011.05222.x
   Morris CE, 1997, APPL ENVIRON MICROB, V63, P1570
   Murinda Shelton E, 2004, Foodborne Pathog Dis, V1, P178, DOI 10.1089/fpd.2004.1.178
   Niemira BA, 2010, J FOOD SCI, V75, pM270, DOI 10.1111/j.1750-3841.2010.01650.x
   O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004
   Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x
   Patel J, 2011, FOODBORNE PATHOG DIS, V8, P541, DOI 10.1089/fpd.2010.0734
   Patel J, 2010, INT J FOOD MICROBIOL, V139, P41, DOI 10.1016/j.ijfoodmicro.2010.02.005
   Pawar DM, 2005, J APPL MICROBIOL, V99, P418, DOI [10.1111/j.1365-2672.2005.02499.x, 10.1111/j.1365-2672.2004.02499.x]
   Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096
   Seo J, 2016, KOREAN J FOOD SCI AN, V36, P186, DOI 10.5851/kosfa.2016.36.2.186
   Sharma M, 2005, J APPL MICROBIOL, V99, P449, DOI 10.1111/j.1365-2672.2005.02659.x
   Sharma M, 2009, J FOOD PROTECT, V72, P1481, DOI 10.4315/0362-028X-72.7.1481
   Shen CL, 2012, APPL ENVIRON MICROB, V78, P6789, DOI 10.1128/AEM.01094-12
   Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-79
   Simoes M, 2009, WATER RES, V43, P229, DOI 10.1016/j.watres.2008.10.010
   Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008
   Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006
   Ukuku DO, 2002, J FOOD PROTECT, V65, P1093, DOI 10.4315/0362-028X-65.7.1093
   WHO, 2015, WHO EST GLOB BURD FO
NR 45
TC 1
Z9 1
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD JUN
PY 2017
VL 82
IS 6
BP 1433
EP 1442
DI 10.1111/1750-3841.13729
PG 10
WC Food Science & Technology
SC Food Science & Technology
GA EX1US
UT WOS:000403012800018
PM 28542913
DA 2019-02-28
ER

PT J
AU Shafique, M
   Alvi, IA
   Abbas, Z
   Rehman, SU
AF Shafique, Muafia
   Alvi, Iqbal Ahmad
   Abbas, Zaigham
   Rehman, Shafiq Ur
TI Assessment of biofilm removal capacity of a broad host range
   bacteriophage JHP against Pseudomonas aeruginosa
SO APMIS
LA English
DT Article
DE Pseudomonas aeruginosa; bacteriophage therapy; phage cocktail;
   microtiter plate; viable count; CV assay
ID ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; CLINICAL IMPACT; RESISTANCE;
   THERAPY; PHAGE; INFECTIONS; MECHANISMS
AB Pseudomonas aeruginosa is an efficient biofilm-dwelling microbial pathogen, associated with nosocomial infections. These biofilm-associated infections are resistant to antibiotics and immune defenses, therefore pose major problem against their treatment. This scenario demands alternative therapeutic regimens, and bacteriophage therapy is one among potential strategies for clinical management of multiple drug resistance. In this investigation, the efficacy of a bacteriophage, JHP, is evaluated to eradicate P. aeruginosa biofilms. Growth kinetics of P. aeruginosa biofilm revealed that the highest cell density biofilm (1.5 x 10(16) CFU/mL) was established within the polystyrene microtiter plate at 72 h post inoculation. Pseudomonas aeruginosa biofilms of different ages, treated with JHP (0.6 MOI) for different post-infection durations, reduced biomass from 2 to 4.5 logs (60-90%). JHP treatment before biofilm development reduced the bacterial load up to 9 logs (>95% bacterial load reduction) as compared with untreated control, which highlights its potential to prevent biofilm formation in indwelling medical devices. Combinations of JHP with other phages or antibiotics could be an efficient alternative for P. aeruginosa biofilm removal in clinical and industrial settings.
C1 [Shafique, Muafia; Alvi, Iqbal Ahmad; Abbas, Zaigham; Rehman, Shafiq Ur] Univ Punjab, Dept Microbiol & Mol Genet, Lahore 54590, Pakistan.
   [Shafique, Muafia] PCSIR Labs Complex, Food & Biotechnol Res Ctr, Lahore, Pakistan.
RP Rehman, SU (reprint author), Univ Punjab, Dept Microbiol & Mol Genet, Lahore 54590, Pakistan.
EM shafiq.mmg@pu.edu.pk
OI Rehman, Shafiq ur/0000-0002-1265-3442
CR Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006
   Bibi Z, 2016, BIOCONTROL SCI TECHN, V26, P181, DOI 10.1080/09583157.2015.1086311
   Chaudhary N, 2008, PAK J ZOOL, V40, P99
   Clark JR, 2006, TRENDS BIOTECHNOL, V24, P212, DOI 10.1016/j.tibtech.2006.03.003
   Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597
   Coulter LB, 2014, VIRUSES-BASEL, V6, P3778, DOI 10.3390/v6103778
   Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002
   Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803
   Gorski A, 2009, CURR OPIN INVEST DR, V10, P766
   Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152
   Khawaja KA, 2016, J BASIC MICROB, V56, P1090, DOI 10.1002/jobm.201500764
   Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09
   Pan Y, 2010, APPL ENVIRON MICROB, V76, P1433, DOI 10.1128/AEM.02185-09
   Rahman M, 2011, BIOFOULING, V27, P1087, DOI 10.1080/08927014.2011.631169
   Rhoads D D, 2009, J Wound Care, V18, P237
   Rhoads DD, 2009, J WOUND CARE, V238, P240, DOI DOI 10.12968/J0WC.2009.18.6.42801
   Schmitz N, 2009, J EXP MED, V206, P1941, DOI 10.1084/jem.20090199
   Sharma M, 2009, J FOOD PROTECT, V72, P1481, DOI 10.4315/0362-028X-72.7.1481
   Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-79
   Sutherland IW, 2004, FEMS MICROBIOL LETT, V232, P1, DOI 10.1016/S0378-1097(04)00041-2
   Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x
   Zimecki M, 2010, MED MICROBIOL IMMUN, V199, P71, DOI 10.1007/s00430-009-0135-4
NR 22
TC 0
Z9 1
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0903-4641
EI 1600-0463
J9 APMIS
JI APMIS
PD JUN
PY 2017
VL 125
IS 6
BP 579
EP 584
DI 10.1111/apm.12691
PG 6
WC Immunology; Microbiology; Pathology
SC Immunology; Microbiology; Pathology
GA EW1ZO
UT WOS:000402295800008
PM 28418081
DA 2019-02-28
ER

PT J
AU Yu, PF
   Mathieu, J
   Yang, Y
   Alvarez, PJJ
AF Yu, Pingfeng
   Mathieu, Jacques
   Yang, Yu
   Alvarez, Pedro J. J.
TI Suppression of Enteric Bacteria by Bacteriophages: Importance of Phage
   Polyvalence in the Presence of Soil Bacteria
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; POPULATION-DYNAMICS; BIOFILM
   FORMATION; PHIIPLA-RODI; HOST-RANGE; DIVERSITY; VIRUSES; COMMUNITIES;
   COMPETITION
AB Bacteriophages are widely recognized for their importance in microbial ecology and bacterial control. However, little is known about how phage polyvalence (i.e., broad host range) affects bacterial suppression and interspecies competition in environments harboring enteric pathogens and soil bacteria. Here we compare the efficacy of polyvalent phage PEf1 versus coliphage T4 in suppressing a model enteric bacterium (E. coli K-12) in mixtures with soil bacteria (Pseudomonas putida F1 and Bacillus subtilis 168). Although T4 was more effective than PEf1 in infecting E. coli K-12 in pure cultures, PEf1 was 20-fold more effective in suppressing E. coli under simulated multispecies biofilm conditions because polyvalence enhanced PEf1 propagation in P. putida. In contrast, soil bacteria do not propagate coliphages and hindered T4 diffusion through the biofilm. Similar tests were also conducted under planktonic conditions to discern how interspecies competition contributes to E. coli suppression without the confounding effects of restricted phage diffusion. Significant synergistic suppression was observed by the combined effects of phages plus competing bacteria. T4 was slightly more effective in suppressing E. coli in these planktonic mixed cultures, even though PEf1 reached higher concentrations by reproducing also in P. putida (7.2 +/- 0.4 vs 6.0 +/- 1.0 log10PFU/mL). Apparently, enhanced suppression by higher PEf1 propagation was offset by P. putida lysis, which decreased stress from interspecies competition relative to incubations with T4. In similar planktonic tests with more competing soil bacteria species, P. putida lysis was less critical in mitigating interspecies competition and PEf1 eliminated E. coli faster than T4 (36 vs 42 h). Overall, this study shows that polyvalent phages can propagate in soil bacteria and significantly enhance suppression of co-occurring enteric species.
C1 [Yu, Pingfeng; Mathieu, Jacques; Yang, Yu; Alvarez, Pedro J. J.] Rice Univ, Dept Civil & Environm Engn, Houston, TX 77005 USA.
RP Alvarez, PJJ (reprint author), Rice Univ, Dept Civil & Environm Engn, Houston, TX 77005 USA.
EM alvarez@rice.edu
FU NSF PIRE grant [OISE-1545756]
FX This work was supported by NSF PIRE grant (Fund number OISE-1545756). We
   thank Xifan Wang for his help on SEM imaging in this research.
CR Abedon Stephen T, 2011, Bacteriophage, V1, P66
   ACKERMANN HW, 1987, VIRUSES PROKARYOTES, V1, P49
   Beller HR, 2002, ENVIRON SCI TECHNOL, V36, P3977, DOI 10.1021/es025556w
   BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0
   Bhattacharjee AS, 2015, BIOTECHNOL BIOENG, V112, P1644, DOI 10.1002/bit.25574
   Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x
   Brockhurst Michael A., 2006, BMC Ecology, V6, P19, DOI 10.1186/1472-6785-6-19
   Bull JJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00618
   Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004
   Clokie M. R. J., 2011, BACTERIOPHAGE, V1, P31, DOI DOI 10.4161/BACT.1.1.14942
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199
   Denes T, 2015, APPL ENVIRON MICROB, V81, P4295, DOI 10.1128/AEM.00087-15
   Doron S, 2016, ISME J, V10, P1437, DOI 10.1038/ismej.2015.210
   Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498
   Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicrol163
   Fernandez L, 2017, SCI REP-UK, V7, DOI 10.1038/srep40965
   Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498
   Filee J, 2005, P NATL ACAD SCI USA, V102, P12471, DOI 10.1073/pnas.0503404102
   Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108
   Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149
   Gallet R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-241
   Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014
   Gomez P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123752
   Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767
   Gonzalez S, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02821-16
   Gutierrez D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00825
   Gutierrez D, 2015, APPL ENVIRON MICROB, V81, P3336, DOI 10.1128/AEM.03560-14
   Hammerl JA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00024
   Harcombe WR, 2005, APPL ENVIRON MICROB, V71, P5254, DOI 10.1128/AEM.71.9.5254-5259.2005
   Harms G, 2003, ENVIRON SCI TECHNOL, V37, P343, DOI 10.1021/es0257164
   Holmfeldt K, 2016, ENVIRON MICROBIOL, V18, P3949, DOI 10.1111/1462-2920.13392
   Holmfeldt K, 2014, ENVIRON MICROBIOL, V16, P2501, DOI 10.1111/1462-2920.12391
   Hyman P, 2009, BACTERIOPHAGES METHO, V1, P175
   Joo J, 2006, P R SOC B, V273, P1843, DOI 10.1098/rspb.2006.3512
   Kay MK, 2011, APPL ENVIRON MICROB, V77, P821, DOI 10.1128/AEM.01797-10
   Khan MA, 2002, WATER RES, V36, P3364, DOI 10.1016/S0043-1354(02)00029-5
   Kropinski Andrew M., 2009, V501, P151, DOI 10.1007/978-1-60327-164-6_15
   Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7
   Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14
   Lehman SM, 2015, ANTIMICROB AGENTS CH, V59, P1127, DOI 10.1128/AAC.03786-14
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   Malki K, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0395-0
   Monaci P, 2001, CURR OPIN MOL THER, V3, P159
   Mrozik A, 2010, MICROBIOL RES, V165, P363, DOI 10.1016/j.micres.2009.08.001
   O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437
   Osek J, 2001, J VET DIAGN INVEST, V13, P308, DOI 10.1177/104063870101300405
   Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094
   Ross A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01352
   Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096
   Sillankorva S, 2010, BIOFOULING, V26, P567, DOI 10.1080/08927014.2010.494251
   Sturgill G, 2004, J BACTERIOL, V186, P7610, DOI 10.1128/JB.186.22.7610-7617.2004
   Suttle C. A., 2010, MANUAL AQUATIC VIRAL, P145, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7
   Tetart F, 1996, J MOL BIOL, V258, P726, DOI 10.1006/jmbi.1996.0281
   Thingstad TF, 2014, P NATL ACAD SCI USA, V111, P7813, DOI 10.1073/pnas.1400909111
   Waite RD, 2009, J BACTERIOL, V191, P1349, DOI 10.1128/JB.01458-08
   Wang L, 2009, J APPL MICROBIOL, V107, P1719, DOI 10.1111/j.1365-2672.2009.04358.x
   WIGGINS BA, 1985, APPL ENVIRON MICROB, V49, P19
   Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456
   Yu PF, 2016, APPL ENVIRON MICROB, V82, P808, DOI 10.1128/AEM.02382-15
   ZYLSTRA GJ, 1989, J BIOL CHEM, V264, P14940
NR 61
TC 7
Z9 7
U1 7
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD MAY 2
PY 2017
VL 51
IS 9
BP 5270
EP 5278
DI 10.1021/acs.est.7b00529
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA EU0TC
UT WOS:000400723200058
PM 28414441
DA 2019-02-28
ER

PT J
AU Guo, MQ
   Feng, CY
   Ren, J
   Zhuang, XR
   Zhang, Y
   Zhu, YZ
   Dong, K
   He, P
   Guo, XK
   Qin, JH
AF Guo, Mingquan
   Feng, Chunyan
   Ren, Jie
   Zhuang, Xuran
   Zhang, Yan
   Zhu, Yongzhang
   Dong, Ke
   He, Ping
   Guo, Xiaokui
   Qin, Jinhong
TI A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Pseudomonas aeruginosa; bacteriophage; endolysin; LysPA26; antimicrobial
   agent
ID GRAM-NEGATIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; LYTIC ACTIVITY; PHAGE
   THERAPY; ACINETOBACTER-BAUMANNII; OUTER-MEMBRANE; PHI-KZ; BIOFILMS;
   RESISTANCE; CHALLENGE
AB The global increase in multidrug resistant (MDR) bacteria has led to phage therapy being refocused upon. A novel endolysin, LysPA26, containing a lysozyme-like domain, was screened against Pseudomonas aeruginosa in this study. It had activity against MDR P. aeruginosa without pretreatment with an outer-membrane permeabilizer. LysPA26 could kill up to 4 log units P. aeruginosa in 30 min. In addition, temperature and pH effect assays revealed that LysPA26 had good stability over a broad range of pH and temperatures. Moreover, LysPA26 could kill other Gram-negative bacteria, such as Klebsiella pneumonia, Acinetobacter baumannii and Escherichia coli, but not Gram-positive bacteria. Furthermore, LysPA26 could eliminate P. aeruginosa in biofilm formation. Our current results show that LysPA26 is a new and promising antimicrobial agent for the combat of Gram-negative pathogens.
C1 [Guo, Mingquan; Ren, Jie; Zhuang, Xuran; Zhang, Yan; Zhu, Yongzhang; Dong, Ke; He, Ping; Guo, Xiaokui; Qin, Jinhong] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Microbiol & Immunol, Shanghai, Peoples R China.
   [Feng, Chunyan] Hangzhou Med Coll, Dept Clin Med, Hangzhou, Zhejiang, Peoples R China.
RP Guo, XK; Qin, JH (reprint author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Microbiol & Immunol, Shanghai, Peoples R China.
EM xkguo@shsmu.edu.cn; jinhongqin@sjtu.edu.cn
FU Shanghai Three-Year Plan of the Key Subjects Construction in Public
   Health-Infectious Diseases and Pathogenic Microorganism [15GWZK0102];
   Natural Science Foundation of Shanghai [17ZR1415900]
FX This work was supported by the Shanghai Three-Year Plan of the Key
   Subjects Construction in Public Health-Infectious Diseases and
   Pathogenic Microorganism (15GWZK0102) and Natural Science Foundation of
   Shanghai (17ZR1415900).
CR Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12
   Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604
   Boss R, 2016, J FOOD PROTECT, V79, P1240, DOI 10.4315/0362-028X.JFP-15-463
   Briers Y, 2011, J APPL MICROBIOL, V110, P778, DOI 10.1111/j.1365-2672.2010.04931.x
   Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x
   Briers Y, 2014, ANTIMICROB AGENTS CH, V58, P3774, DOI 10.1128/AAC.02668-14
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.2007.6100247
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007
   Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x
   Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002
   Keen EC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00238
   Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006
   Lai MJ, 2011, APPL MICROBIOL BIOT, V90, P529, DOI 10.1007/s00253-011-3104-y
   Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243
   Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14
   Lim JA, 2014, J MICROBIOL BIOTECHN, V24, P803, DOI 10.4014/jmb.1403.03035
   Lin NT, 2010, RES MICROBIOL, V161, P308, DOI 10.1016/j.resmic.2010.03.007
   Lood R, 2015, ANTIMICROB AGENTS CH, V59, P1983, DOI 10.1128/AAC.04641-14
   Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4
   Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398
   Oliveira H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108376
   Paradis-Bleau C, 2007, FEMS MICROBIOL LETT, V266, P201, DOI 10.1111/j.1574-6968.2006.00523.x
   Pires D, 2011, RES MICROBIOL, V162, P798, DOI 10.1016/j.resmic.2011.06.010
   Pires DP, 2016, MICROBIOL MOL BIOL R, V80, P523, DOI 10.1128/MMBR.00069-15
   Rodriguez L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-138
   Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06
   Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026
   Twort FW, 1915, LANCET, V2, P1241
   VAARA M, 1992, MICROBIOL REV, V56, P395
   Walmagh M, 2013, APPL MICROBIOL BIOT, V97, P4369, DOI 10.1007/s00253-012-4294-7
   Walmagh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036991
   Xavier JB, 2005, MICROBIOL-SGM, V151, P3817, DOI 10.1099/mic.0.28165-0
   Young R, 2015, SCIENCE, V350, P1163, DOI 10.1126/science.aad6791
NR 37
TC 7
Z9 8
U1 2
U2 26
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 27
PY 2017
VL 8
AR 293
DI 10.3389/fmicb.2017.00293
PG 9
WC Microbiology
SC Microbiology
GA EL7ZA
UT WOS:000394838600001
PM 28289407
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Qadir, MI
   Sajjad, S
AF Qadir, Muhammad Imran
   Sajjad, Sahir
TI Phage Therapy against &ITStreptococcus pneumoniae&IT: Modern Tool to
   Control Pneumonia
SO CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
LA English
DT Article
DE antibiotic resistance; bacteriophages; biolllms; toxin and antitoxin
   genes; multidrug resistance
ID RESONANCE ENERGY-TRANSFER; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI;
   BIOFILM FORMATION; BACTERIAL-INFECTIONS; LYSOGENIC CONVERSION; IN-VITRO;
   BACTERIOPHAGE; TOXIN; PATHOGENS
AB Phage therapy is important for treatment of drug-resistant pathogens as compared to antibiotics in this modem era. Since 1966, bacteriophages have been used as antibacterial agents and played a very crucial role in the expansion of molecular biology. Bacteriophages have been used to treat infection in Western medicine along with antibiotics. Antibacterial agents against the antibiotic resistance strains have been discovered. The lytic bacteriophage used for treatment in conventional phage therapy have shown hopeful results in human clinical cases. In animal models and in vitro studies, phages are used as therapeutics. Bacterial pathogens decreased with use of dual therapy of antibiotics and phages. Variation in intracellular targets of the type II DNA topoisomerases acquired by recombination with the fluoroquinolones have shown resistance. This review summarizes the role of Streptococcus pneumoniae in phage therapy. The study condenses the biochemical and structural data described for Streptococcus, pneumoniae biofilms.
C1 [Qadir, Muhammad Imran; Sajjad, Sahir] Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Pakistan.
RP Qadir, MI (reprint author), Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Pakistan.
EM mrimranqadir@hotmail.com
CR Abuladze T, 2008, APPL ENVIRON MICROB, V74, P6230, DOI 10.1128/AEM.01465-08
   Adhya S, 2006, NATURE, V443, P754, DOI 10.1038/443754a
   Alonso JC, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P313
   Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604
   Barbosa LCB, 2012, EUR J MED CHEM, V54, P591, DOI 10.1016/j.ejmech.2012.06.008
   Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004
   Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191
   Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x
   Cerveny KE, 2002, INFECT IMMUN, V70, P6251, DOI 10.1128/IAI.70.11.6251-6262.2002
   Danhauer JL, 2010, INT J AUDIOL, V49, P754, DOI 10.3109/14992027.2010.493897
   del Prado G, 2010, DIAGN MICR INFEC DIS, V67, P311, DOI 10.1016/j.diagmicrobio.2010.03.016
   Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393
   Domenech M, 2012, MICROB BIOTECHNOL, V5, P455, DOI 10.1111/j.1751-7915.2011.00294.x
   DUCKWORTH DH, 1976, BACTERIOL REV, V40, P793
   Duerkop BA, 2012, P NATL ACAD SCI USA, V109, P17621, DOI 10.1073/pnas.1206136109
   Filice GA, 2010, INFECT CONT HOSP EP, V31, P365, DOI 10.1086/651094
   Flockhart AF, 2012, MOL MICROBIOL, V83, P208, DOI 10.1111/j.1365-2958.2011.07927.x
   Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311
   Hagens S, 2004, ANTIMICROB AGENTS CH, V48, P3817, DOI 10.1128/ACC.48.10.3817-3822.2004
   Ho K, 2001, PERSPECT BIOL MED, V44, P1, DOI 10.1353/pbm.2001.0006
   Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403
   Keen EC, 2012, FUTURE MICROBIOL, V7, P1337, DOI [10.2217/FMB.12.115, 10.2217/fmb.12.115]
   Kurola P, 2011, APMIS, V119, P135, DOI 10.1111/j.1600-0463.2010.02703.x
   Leprohon P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2134-8
   Lioy VS, 2010, PLASMID, V63, P31, DOI 10.1016/j.plasmid.2009.09.005
   Marinelli LJ, 2012, MBIO, V3, DOI 10.1128/mBio.00279-12
   Mutschler H, 2011, J MOL MED, V89, P1183, DOI 10.1007/s00109-011-0797-4
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142
   Nieto C, 2006, MOL MICROBIOL, V59, P1280, DOI 10.1111/j.1365-2958.2005.05027.x
   Paul D, 2005, BIOESSAYS, V27, P563, DOI 10.1002/bies.20220
   Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589
   Qadir MI, 2015, PAK J PHARM SCI, V28, P265
   RAMOS JL, 1994, BIO-TECHNOL, V12, P1349, DOI 10.1038/nbt1294-1349
   Ruiz V, 2011, PEDIATR RES, V69, P23, DOI 10.1203/PDR.0b013e3181fed2b0
   SETLOW JK, 1992, J BACTERIOL, V174, P2943
   Srinivasiah S, 2008, RES MICROBIOL, V159, P349, DOI 10.1016/j.resmic.2008.04.010
   Straub ME, 1933, J AMER MED ASSOC, V100, P110, DOI 10.1001/jama.1933.02740020028009
   Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910
   Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005
   Wingender J, 2011, INT J HYG ENVIR HEAL, V214, P417, DOI 10.1016/j.ijheh.2011.05.009
   Xu Y, 2003, METHOD ENZYMOL, V360, P289
NR 43
TC 2
Z9 2
U1 1
U2 1
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 1045-4403
EI 2162-6502
J9 CRIT REV EUKAR GENE
JI Crit. Rev. Eukaryot. Gene Expr.
PY 2017
VL 27
IS 4
BP 289
EP 295
PG 7
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FQ8XM
UT WOS:000418646500001
PM 29283323
DA 2019-02-28
ER

PT J
AU Shlezinger, M
   Khalifa, L
   Houri-Haddad, Y
   Coppenhagen-Glazer, S
   Resch, G
   Que, YA
   Beyth, S
   Dorfman, E
   Hazan, R
   Beyth, N
AF Shlezinger, Mor
   Khalifa, Leron
   Houri-Haddad, Yael
   Coppenhagen-Glazer, Shunit
   Resch, Gregory
   Que, Yok-Ai
   Beyth, Shaul
   Dorfman, Elisheva
   Hazan, Ronen
   Beyth, Nurit
TI A New Horizon in the Antibacterial Treatment of Oral Pathogens
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Bacteriophage; Phage; Biofilm; Caries; Dentistry; Oral; Periodontal
   disease; Phage therapy; Antibiotic resistance; Multi drug resistant
   bacteria
ID RESISTANT PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI O157-H7; PHAGE
   THERAPY; BACTERIOPHAGE THERAPY; IN-VIVO; STAPHYLOCOCCUS-AUREUS;
   KLEBSIELLA-PNEUMONIAE; DENTAL-CARIES;
   ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL-INFECTIONS
AB Dental diseases are perhaps the most prevalent infection-related diseases in humans. Biofilm is involved in almost every infectious disease compromising oral health, notably caries, periodontal disease, gingivitis, endodontic infections and peri-implantitis. Current therapies of biofilm-derived oral infections lack sensitivity; they are not species-specific and kill pathogenic species as well as commensal species, which are protective against the formation of pathogenic biofilms. Moreover, antibiotics have a limited effect on biofilm and are almost unused in oral diseases.
   A promising alternative approach is bacteriophage (phage) therapy. Phages play a key role in the natural balance in a predator-prey relationship with bacteria and thus have the potential to be efficient anti-bacterial agents. Phages are highly efficient against biofilm, strain specific and easy to isolate and manipulate. Thus, like in many other medicinal fields, phage therapy offers new horizons to dentistry, both therapeutics and research. The present review presents the etiology of common oral diseases, characterization of the infection and the treatment challenges of phage therapy in dentistry. Recent findings and development in the use of phages for prevention, control, and treatment of oral infections as well as possibilities of engineering the oral microbiome are discussed.
C1 [Shlezinger, Mor; Houri-Haddad, Yael; Beyth, Nurit] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Prosthodont, Jerusalem, Israel.
   [Shlezinger, Mor; Khalifa, Leron; Coppenhagen-Glazer, Shunit; Dorfman, Elisheva; Hazan, Ronen] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Fac Med Sci, Jerusalem, Israel.
   [Resch, Gregory] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.
   [Que, Yok-Ai] Univ Lausanne Hosp, Dept Intens Care Med, Lausanne, Switzerland.
   [Beyth, Shaul] Hadassah Univ Hosp, Orthoped Surg Complex, Jerusalem, Israel.
RP Beyth, N (reprint author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Prosthodont, Jerusalem, Israel.
EM nuritb@ekmd.huji.ac.il
FU Rosetrees Trust [M458]
CR Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07
   Abedon ST, 2015, PHARMACEUTICALS, V8, P559, DOI 10.3390/ph8030559
   Abedon Stephen T, 2011, Bacteriophage, V1, P66
   Albino LAA, 2014, FOODBORNE PATHOG DIS, V11, P602, DOI 10.1089/fpd.2013.1600
   Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014
   Armau E., 1988, J DENT, V67
   Augustine J, 2014, FEMS MICROBIOL LETT, V356, P113, DOI 10.1111/1574-6968.12493
   Bachrach G, 2003, LETT APPL MICROBIOL, V36, P50, DOI 10.1046/j.1472-765X.2003.01262.x
   Badet C, 2008, Open Microbiol J, V2, P38, DOI 10.2174/1874285800802010038
   Barr J.J., 2013, BACTERIOPHAGE, V5
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Basu S, 2015, OSTOMY WOUND MANAG, V61, P16
   Bhardwaj S. B., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P437
   Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002
   Bouzari M, 2010, AFR J MICROBIOL RES, V4, P2127
   Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005
   Bull JJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-35
   Capparelli R, 2006, CLIN MICROBIOL INFEC, V12, P248, DOI 10.1111/j.1469-0691.2005.01340.x
   Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06
   Capparelli R, 2010, J INFECT DIS, V201, P52, DOI 10.1086/648478
   CARMINATI D, 1992, J DAIRY RES, V59, P71, DOI 10.1017/S0022029900030260
   Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227
   Castillo-Ruiz M, 2011, APPL ENVIRON MICROB, V77, P3157, DOI 10.1128/AEM.02115-10
   Cerveny KE, 2002, INFECT IMMUN, V70, P6251, DOI 10.1128/IAI.70.11.6251-6262.2002
   Chanishvili N, 2001, J CHEM TECHNOL BIOT, V76, P689, DOI 10.1002/jctb.438
   Chanishvili N, 2012, ADV VIRUS RES, V83, P3, DOI 10.1016/B978-0-12-394438-2.00001-3
   Chhibber S, 2008, J MED MICROBIOL, V57, P1508, DOI 10.1099/jmm.0.2008/002873-0
   Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799
   Conly Jm, 2005, Can J Infect Dis Med Microbiol, V16, P159
   d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373
   Dalmasso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138651
   Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135
   Delisle A.L., 1995, MICROB ECOL HLTH DIS, V8
   Delisle A.L., 2012, APPL ENV MICROBIOL, V78
   DELISLE AL, 1978, INFECT IMMUN, V20, P303
   Donovan David M, 2007, Recent Pat Biotechnol, V1, P113, DOI 10.2174/187220807780809463
   Duerkop BA, 2012, P NATL ACAD SCI USA, V109, P17621, DOI 10.1073/pnas.1206136109
   Dufour N, 2015, CRIT CARE MED, V43, pE190, DOI 10.1097/CCM.0000000000000968
   Edlund A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27423
   Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459
   Fard R. Mazaheri Nezhad, 2010, CURR MICROBIOL
   Fernebro J, 2011, DRUG RESIST UPDATE, V14, P125, DOI 10.1016/j.drup.2011.02.001
   Fogelman I, 2000, J INFECT DIS, V182, P435, DOI 10.1086/315739
   Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311
   Goldberg GW, 2015, NAT REV IMMUNOL, V15, P717, DOI 10.1038/nri3910
   Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455
   Gorski A, 2015, FUTURE MICROBIOL, V10, P199, DOI [10.2217/FMB.14.126, 10.2217/fmb.14.126]
   Gorski A, 2012, ADV VIRUS RES, V83, P41, DOI 10.1016/B978-0-12-394438-2.00002-5
   Gorski A, 2009, OPHTHALMOLOGICA, V223, P162, DOI 10.1159/000193293
   Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698
   Gupta R, 2011, CURR MICROBIOL, V62, P255, DOI 10.1007/s00284-010-9699-x
   HALHOUL N, 1975, ARCH ORAL BIOL, V20, P833, DOI 10.1016/0003-9969(75)90062-X
   Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.02.006
   Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y
   Heo YJ, 2009, ANTIMICROB AGENTS CH, V53, P2469, DOI 10.1128/AAC.01646-08
   HIROKI H, 1976, ARCH ORAL BIOL, V21, P215, DOI 10.1016/0003-9969(76)90132-1
   Hodyra-Stefaniak K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14802
   Holguin AV, 2015, VIRUSES-BASEL, V7, P4602, DOI 10.3390/v7082835
   Hong SS, 2013, J MICROBIOL BIOTECHN, V23, P1478, DOI 10.4014/jmb.1304.04067
   Hoshiba H, 2010, ARCH VIROL, V155, P545, DOI 10.1007/s00705-010-0623-2
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Irie K, 2015, J PERIODONTOL, V86, P899, DOI 10.1902/jop.2015.150006
   Jakubovics NS, 2010, ORAL DIS, V16, P729, DOI 10.1111/j.1601-0825.2010.01701.x
   Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272
   Kazhal N., 1968, NAUCHNOE IZDATELSTVO
   Kesik-Szeloch A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-100
   Khalifa L, 2015, GENOME ANNOUNC, V3
   Khalifa L, 2015, APPL ENVIRON MICROB, V81, P2696, DOI 10.1128/AEM.00096-15
   Kim KP, 2008, MICROB BIOTECHNOL, V1, P247, DOI 10.1111/j.1751-7915.2008.00028.x
   Kleinheinz K. A., 2014, BACTERIOPHAGE, V4, DOI [10.4161/bact.27943, DOI 10.4161/BACT.27943]
   Kolenbrander PE, 2011, INT J ORAL SCI, V3, P49, DOI 10.4248/IJOS11025
   Kumari S, 2010, J MICROBIOL BIOTECHN, V20, P935, DOI 10.4014/jmb.0909.09010
   Kutateladze M, 2008, MED MALADIES INFECT, V38, P426, DOI 10.1016/j.medmal.2008.06.023
   Kutateladze M, 2015, VIROL SIN, V30, P80, DOI 10.1007/s12250-014-3557-0
   Kutsch VK, 2014, J PROSTHET DENT, V111, P280, DOI 10.1016/j.prosdent.2013.07.014
   Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Leon M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00343
   LIPSKA I, 1951, Pediatr Pol, V26, P449
   Loc-Carrillo C., 2011, Bacteriophage, V1, P111
   Machuca P, 2010, APPL ENVIRON MICROB, V76, P7243, DOI 10.1128/AEM.01135-10
   MARSH PD, 1995, J IND MICROBIOL, V15, P169, DOI 10.1007/BF01569822
   Matsuzaki S, 2003, J INFECT DIS, V187, P613, DOI 10.1086/374001
   Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551
   Mcvay CS, 2007, ANTIMICROB AGENTS CH, V51, P1934, DOI 10.1128/AAC.01028-06
   Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944
   MEYERS CHARLES E., 1958, JOUR DENTAL RES, V37, P175, DOI 10.1177/00220345580370011201
   Miedzybrodzki R, 2012, ADV VIRUS RES, V83, P73, DOI 10.1016/B978-0-12-394438-2.00003-7
   Nicolas GG, 2011, CAN J MICROBIOL, V57, P1, DOI 10.1139/w10-095
   Nishikawa H, 2008, ARCH VIROL, V153, P507, DOI 10.1007/s00705-007-0031-4
   O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x
   OLSEN I, 1993, ORAL MICROBIOL IMMUN, V8, P383, DOI 10.1111/j.1399-302X.1993.tb00615.x
   Olszak T, 2015, APPL MICROBIOL BIOT, V99, P6021, DOI 10.1007/s00253-015-6492-6
   Paisano AF, 2004, ORAL MICROBIOL IMMUN, V19, P327, DOI 10.1111/j.1399-302x.2004.00166.x
   Papaioannou W, 2009, ORAL MICROBIOL IMMUN, V24, P183, DOI 10.1111/j.1399-302X.2008.00493.x
   Parracho Helena Mrt, 2012, J Mol Genet Med, V6, P279
   Pirisi A, 2000, LANCET, V356, P1418, DOI 10.1016/S0140-6736(05)74059-9
   Piwat S, 2012, J INVESTIG CLIN DENT, V3, P56, DOI 10.1111/j.2041-1626.2011.00098.x
   Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169
   Rahmani R, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.17744
   Resch G, 2004, J BACTERIOL, V186, P5523, DOI 10.1128/JB.186.16.5523-5528.2004
   Resch Gregory, 2002, Schweiz Monatsschr Zahnmed, V112, P643
   Rhoads D D, 2009, J Wound Care, V18, P237
   Rose T, 2014, INT J BURNS TRAUMA, V4, P66
   Rugg-Gunn Andrew, 2013, Acta Med Acad, V42, P117, DOI 10.5644/ama2006-124.80
   Ryan EM, 2011, J PHARM PHARMACOL, V63, P1253, DOI 10.1111/j.2042-7158.2011.01324.x
   Salli KM, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.26149
   Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI [10.1038/nrmicr03564, 10.1038/nrmicro3564]
   Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842
   SANDMEIER H, 1995, J PERIODONTAL RES, V30, P418, DOI 10.1111/j.1600-0765.1995.tb01296.x
   SANDMEIER H, 1993, FEMS IMMUNOL MED MIC, V6, P193
   Santiago-Rodriguez TM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1781-0
   Sarhan WA, 2015, EXPERT REV ANTI-INFE, V13, P91, DOI 10.1586/14787210.2015.990383
   Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42
   Semler DD, 2014, ANTIMICROB AGENTS CH, V58, P4005, DOI 10.1128/AAC.02388-13
   SMITH HW, 1987, J GEN MICROBIOL, V133, P1127
   SMITH HW, 1983, J GEN MICROBIOL, V129, P2659
   Struzycka I, 2014, POL J MICROBIOL, V63, P127
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001
   Summers WC, 2012, BACTERIOPHAGE, V2, P130, DOI DOI 10.4161/BACT.20757
   Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280
   Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9
   Teughels W, 2011, J CLIN PERIODONTOL, V38, P159, DOI 10.1111/j.1600-051X.2010.01665.x
   Twort FW, 1936, J HYG-CAMBRIDGE, V36, P204, DOI 10.1017/S0022172400043606
   Twort FW, 1915, LANCET, V2, P1241
   TYLENDA CA, 1985, INFECT IMMUN, V49, P1
   Uchiyama J, 2008, APPL ENVIRON MICROB, V74, P4149, DOI 10.1128/AEM.02371-07
   Uchiyama J, 2008, FEMS MICROBIOL LETT, V278, P200, DOI 10.1111/j.1574-6968.2007.00996.x
   Vandenheuvel D., 2015, ANN REV VIROL, V2
   Verbeken G, 2007, FUTURE MICROBIOL, V2, P485, DOI 10.2217/17460913.2.5.485
   Vinodkumar CS, 2008, INDIAN J PATHOL MICR, V51, P360, DOI 10.4103/0377-4929.42511
   Vinodkumar C. S., 2005, Journal of Communicable Diseases, V37, P18
   Vitiello CL, 2005, VIRUS RES, V114, P101, DOI 10.1016/j.virusres.2005.05.014
   Wang J, 2006, INT J MOL MED, V17, P347
   Wang J, 2006, INT J MOL MED, V17, P309, DOI 10.1177/1045389X06054331
   Watanabe R, 2007, ANTIMICROB AGENTS CH, V51, P446, DOI 10.1128/AAC.00635-06
   Willi K, 1997, ORAL MICROBIOL IMMUN, V12, P40, DOI 10.1111/j.1399-302X.1997.tb00365.x
   Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107
   Wills QF, 2005, ANTIMICROB AGENTS CH, V49, P1220, DOI 10.1128/AAC.49.3.1120-1221.2005
   Wittebole X, 2014, VIRULENCE, V5, P226, DOI 10.4161/viru.25991
   Wong CL, 2014, INT J FOOD MICROBIOL, V172, P92, DOI 10.1016/j.ijfoodmicro.2013.11.034
   Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x
   Yosef I, 2015, P NATL ACAD SCI USA, V112, P7267, DOI 10.1073/pnas.1500107112
   Zahid MSH, 2008, INFECT IMMUN, V76, P5266, DOI 10.1128/IAI.00578-08
   Zhang X, 2015, FOOD ENVIRON VIROL, V7, P333, DOI 10.1007/s12560-015-9206-4
   Zimecki M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-169
NR 146
TC 2
Z9 2
U1 15
U2 50
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PY 2017
VL 17
IS 10
BP 1199
EP 1211
DI 10.2174/1568026616666160930145649
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA EL4DJ
UT WOS:000394571600005
PM 27770768
DA 2019-02-28
ER

PT J
AU Sasikala, D
   Srinivasan, P
AF Sasikala, Dakshinamurthy
   Srinivasan, Pappu
TI Characterization of potential lytic bacteriophage against Vibrio
   alginolyticus and its therapeutic implications on biofilm dispersal
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Bacteriophage; Anti-biofilm activity; TEM; V. alginolyticus; Vibriosis;
   Antibacterial
ID STAPHYLOCOCCUS-AUREUS; ACINETOBACTER-BAUMANNII; IN-VITRO;
   KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; PHAGE THERAPY; INFECTION;
   SYSTEM; AQUACULTURE; VIRULENCE
AB Vibrio alginolyticus is a leading cause of vibriosis, presenting opportunistic infections to humans associated with raw seafood contamination. At present, phage therapy that acts as an alternative sanitizing agent is explored for targeting V alginolyticus. The study outcome revealed that the phage VP01 with its extreme lytic effect showed a high potential impact on the growth of V. alginolyticus as well as biofilm formation. Electron microscopy revealed the phage resemblance to Myoviridae, based on its morphology. Further study clarified that the phage VP01 possesses a broad host spectrum and amazing phage sensitivity at different pH, high thermal stability, and high burst size of 415 PFU/cell. In addition, the investigation of phage co-culturing against this pathogen resulted in a significant growth reduction even at less MOIs 0.1 and 1. These results suggest that the phage could be a promising candidate for the control of V. alginolyticus infections. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Sasikala, Dakshinamurthy] Alagappa Univ, Dept Bioinformat, Sci Campus, Karaikkudi, Tamil Nadu, India.
   [Srinivasan, Pappu] Alagappa Univ, Dept Anim Hlth & Management, Sci Campus, Karaikkudi 630003, Tamil Nadu, India.
RP Srinivasan, P (reprint author), Alagappa Univ, Dept Anim Hlth & Management, Sci Campus, Karaikkudi 630003, Tamil Nadu, India.
EM sri.bioinformatics@gmail.com
FU UGC RGNF (RGNF), Government of India [F1-17.1/RGNF-2012-13-SC-TAM-28029]
FX The authors gratefully acknowledge the Department of Bioinformatics,
   Alagappa University, Karaikudi for providing infrastructure facilities
   to carry out this work. DS gratefully acknowledge UGC RGNF (RGNF Ref:
   F1-17.1/RGNF-2012-13-SC-TAM-28029), Government of India, for financial
   assistance.
CR Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13
   Ahiwale S, 2011, CURR MICROBIOL, V62, P335, DOI 10.1007/s00284-010-9710-6
   Alagappan KM, 2010, CURR MICROBIOL, V61, P235, DOI 10.1007/s00284-010-9599-0
   Barbosa C, 2013, MICROB ECOL, V66, P897, DOI 10.1007/s00248-013-0284-2
   Basdew I. H., 2014, African Journal of Microbiology Research, V8, P200
   BRADLEY DE, 1967, BACTERIOL REV, V31, P230
   Marco MB, 2010, INT J FOOD MICROBIOL, V138, P270, DOI 10.1016/j.ijfoodmicro.2010.01.007
   Carson L, 2010, FEMS IMMUNOL MED MIC, V59, P447, DOI 10.1111/j.1574-695X.2010.00696.x
   Chang HC, 2005, APPL ENVIRON MICROB, V71, P1387, DOI 10.1128/AEM.71.3.1387-1393.2005
   Chen LK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-154
   Chhibber S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-174
   Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597
   Endersen L, 2013, INT DAIRY J, V28, P8, DOI 10.1016/j.idairyj.2012.07.010
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Garbe J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-301
   Ghasemi SM, 2014, AQUACULT INT, V22, P1469, DOI 10.1007/s10499-014-9760-z
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x
   Hanumanthappa K. M., 2013, International Research Journal of Biological Sciences, V2, P78
   He HH, 2011, CURR MICROBIOL, V62, P1193, DOI 10.1007/s00284-010-9844-6
   Jikia D, 2005, CLIN EXP DERMATOL, V30, P23, DOI 10.1111/j.1365-2230.2004.01600.x
   Jin J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-156
   Jonczyk E, 2011, FOLIA MICROBIOL, V56, P191, DOI 10.1007/s12223-011-0039-8
   Karunasagar I, 2007, AQUACULTURE, V268, P288, DOI 10.1016/j.aquaculture.2007.04.049
   Kim S, 2012, APPL ENVIRON MICROB, V78, P6380, DOI 10.1128/AEM.00648-12
   Kokare CR, 2009, INDIAN J BIOTECHNOL, V8, P159
   Krasowska A, 2015, BIOMED RES INT, DOI 10.1155/2015/179597
   Kumari S, 2010, J MICROBIOL BIOTECHN, V20, P935, DOI 10.4014/jmb.0909.09010
   Kwiatek M, 2012, ARCH VIROL, V157, P225, DOI 10.1007/s00705-011-1160-3
   Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288
   Li LP, 2014, MOL BIOL REP, V41, P5829, DOI 10.1007/s11033-014-3457-2
   Lin YR, 2012, ARCH VIROL, V157, P917, DOI 10.1007/s00705-012-1244-8
   Liu H, 2012, ARCH MICROBIOL, V194, P439, DOI 10.1007/s00203-011-0774-x
   Liu H, 2011, APPL MICROBIOL BIOT, V91, P353, DOI 10.1007/s00253-011-3286-3
   Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028
   Nithya C, 2010, ARCH MICROBIOL, V192, P843, DOI 10.1007/s00203-010-0612-6
   Olszak T, 2015, APPL MICROBIOL BIOT, V99, P6021, DOI 10.1007/s00253-015-6492-6
   Parasion S, 2012, CURR MICROBIOL, V65, P284, DOI 10.1007/s00284-012-0158-8
   Pei RT, 2014, APPL ENVIRON MICROB, V80, P5340, DOI 10.1128/AEM.01434-14
   Phumkhachorn P, 2010, AFR J MICROBIOL RES, V4, P1794
   Pires D, 2011, RES MICROBIOL, V162, P798, DOI 10.1016/j.resmic.2011.06.010
   Rahman M, 2011, BIOFOULING, V27, P1087, DOI 10.1080/08927014.2011.631169
   Rui HP, 2009, J MICROBIOL BIOTECHN, V19, P431, DOI 10.4014/jmb.0807.404
   Ryan EM, 2012, FEMS IMMUNOL MED MIC, V65, P395, DOI 10.1111/j.1574-695X.2012.00977.x
   Sanmukh SG, 2012, REV FISH BIOL FISHER, V22, P567, DOI 10.1007/s11160-012-9257-7
   Sasikala D, 2017, J MOL STRUCT, V1127, P322, DOI 10.1016/j.molstruc.2016.07.118
   Selvaraj C, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2364-8
   Sheng LL, 2012, ARCH MICROBIOL, V194, P379, DOI 10.1007/s00203-011-0780-z
   Shivu MM, 2007, ENVIRON MICROBIOL, V9, P322, DOI 10.1111/j.1462-2920.2006.01140.x
   Sillankorva S, 2004, FEMS MICROBIOL LETT, V241, P13, DOI 10.1016/j.femsle.2004.06.058
   Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08
   Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Ul Haq I, 2012, MICROB ECOL, V63, P954, DOI 10.1007/s00248-011-9944-2
   Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x
   Wu SS, 2014, J ANTIMICROB CHEMOTH, V69, P3011, DOI 10.1093/jac/dku240
   Yang HJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-131
   Ye J, 2008, J FISH DIS, V31, P161, DOI 10.1111/j.1365-2761.2007.00882.x
   Yele AB, 2012, ARCH VIROL, V157, P1441, DOI 10.1007/s00705-012-1320-0
   Yu YP, 2013, FEMS MICROBIOL LETT, V348, P112, DOI 10.1111/1574-6968.12277
   Zhang YY, 2013, BIOTECHNOL BIOENG, V110, P286, DOI 10.1002/bit.24630
   Zhao Z, 2010, MICROBIOL-SGM, V156, P2864, DOI 10.1099/mic.0.040626-0
NR 61
TC 1
Z9 1
U1 3
U2 30
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD DEC
PY 2016
VL 101
BP 24
EP 35
DI 10.1016/j.micpath.2016.10.017
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EE5YO
UT WOS:000389685700003
PM 27793690
DA 2019-02-28
ER

PT J
AU Luo, ZH
   Yu, YP
   Jost, G
   Liu, WH
   Huang, XL
   Gu, L
AF Luo, Zhu-Hua
   Yu, Yan-Ping
   Jost, Guenter
   Liu, Wen-Hua
   Huang, Xiang-Ling
   Gu, Li
TI Characterization of two bacteriophages for specific treatment of biofilm
   formed by a Vibrio sp isolated from an abalone farm
SO AQUACULTURE RESEARCH
LA English
DT Article
DE bacteriophages; Siphoviridae; biological control; Vibrios; harveyi
   clade; biofilm
ID ESCHERICHIA-COLI; HARVEYI; HATCHERIES; PATHOGEN; INDIA; ENVIRONMENTS;
   BIOCONTROL; CAMPBELLII; RESISTANCE; INFECTION
AB Vibrio harveyi and related vibrios are potential pathogens causing luminous vibriosis in marine aquaculture systems. In this study, two lytic phages P4A and P4F isolated using Vibrio strains B4A and B4F as indicator bacteria, respectively, were isolated from seawater of an abalone farm. Vibrio strain B4F belongs to the Harveyi clade of the genus Vibrio and was found to cause mortality of abalones in laboratory microcosms. Both phages were able to lyse Vibrio strain B4F. Electron microscopy revealed that phage P4A had an icosahedral head while P4F possessed an elongated hexagonal head. Both phages belong to the family Siphoviridae with long non-contractile tails. Restriction endonuclease analysis indicated that both phages were double-stranded DNA viruses and the genome sizes of P4A and P4F were estimated to be about 49 and 44 kb respectively. One-step growth curves revealed that these two phages exhibited distinct latent periods, exponential periods and burst sizes by infecting the same Vibrio strain B4F. Both phages were able to significantly reduce Vibrio population density in biofilm formed by Vibrio strain B4F on the surface of polyethylene film. It is suggested that these two phages may be promising candidates as biocontrol agents of infections caused by Vibrio strains belonging to the Haveyi clade in marine aquaculture systems.
C1 [Luo, Zhu-Hua; Yu, Yan-Ping; Huang, Xiang-Ling; Gu, Li] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, 178 Daxue Rd, Xiamen 361005, Peoples R China.
   [Luo, Zhu-Hua; Huang, Xiang-Ling; Gu, Li] Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China.
   [Luo, Zhu-Hua; Huang, Xiang-Ling; Gu, Li] South China Sea Bioresource Exploitat & Utilizat, Xiamen, Peoples R China.
   [Yu, Yan-Ping; Liu, Wen-Hua] Shantou Univ, Inst Marine Biol, Shantou, Peoples R China.
   [Jost, Guenter] Leibniz Inst Balt Sea Res Warnemunde, Rostock, Germany.
RP Luo, ZH (reprint author), State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, 178 Daxue Rd, Xiamen 361005, Peoples R China.
EM luozhuhua@tio.org.cn
FU Sino-Germany Cooperative Projects in Marine and Polar Science [HC140303,
   HC150301]; Xiamen Science and Technology Planning Project [3502Z20112
   006]; Key Project of the Science and Technology Foundation of Fujian,
   China [2011N0018]; Scientific Research Foundation of Third Institute of
   Oceanography, SOA, China [2011003]; Federal Ministry of Education and
   Research, Germany [01D012039]
FX The study was financially supported by Sino-Germany Cooperative Projects
   in Marine and Polar Science (HC140303, HC150301), Xiamen Science and
   Technology Planning Project (3502Z20112 006), the Key Project of the
   Science and Technology Foundation of Fujian, China (2011N0018), the
   Scientific Research Foundation of Third Institute of Oceanography, SOA,
   China (No. 2011003) and the Federal Ministry of Education and Research,
   Germany (01D012039).
CR Almeida A, 2009, MAR DRUGS, V7, P268, DOI 10.3390/md7030268
   Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x
   Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000
   Carvalho CM, 2012, BACTERIOPHAGES, P179
   Crothers-Stomps C, 2010, J APPL MICROBIOL, V108, P1744, DOI 10.1111/j.1365-2672.2009.04578.x
   Durmaz E, 2000, APPL ENVIRON MICROB, V66, P895, DOI 10.1128/AEM.66.3.895-903.2000
   Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103
   Goodridge L, 2003, SIM NEWS, V53, P254
   Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698
   Hagens S, 2007, APPL MICROBIOL BIOT, V76, P513, DOI 10.1007/s00253-007-1031-8
   Haldar S, 2011, MICROBIOL-SGM, V157, P179, DOI 10.1099/mic.0.041475-0
   KARUNASAGAR I, 1994, AQUACULTURE, V128, P203, DOI 10.1016/0044-8486(94)90309-3
   Karunasagar I, 1996, AQUACULTURE, V140, P241, DOI 10.1016/0044-8486(95)01180-3
   Karunasagar I, 2007, AQUACULTURE, V268, P288, DOI 10.1016/j.aquaculture.2007.04.049
   Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0
   Liu PC, 2000, LETT APPL MICROBIOL, V31, P433, DOI 10.1046/j.1365-2672.2000.00843.x
   Lu Z, 2003, INT J FOOD MICROBIOL, V84, P225, DOI 10.1016/S0168-1605(03)00111-9
   Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293
   Noriega-Orozco L, 2007, REV LATINOAM MICROBI, V49, P60
   Pasharawipas T, 2005, VIRUS RES, V114, P63, DOI 10.1016/j.virusres.2005.05.012
   Peplies J, 2008, SYST APPL MICROBIOL, V31, P251, DOI 10.1016/j.syapm.2008.08.003
   Phumkhachorn P, 2010, AFR J MICROBIOL RES, V4, P1794
   Sainz-Hernandez JC, 2005, AQUAC RES, V36, P1611, DOI 10.1111/j.1365-2109.2005.01386.x
   Sharma SRK, 2012, AQUAC RES, V44, P86, DOI 10.1111/j.1365-2109.2011.03013.x
   Shivu MM, 2007, ENVIRON MICROBIOL, V9, P322, DOI 10.1111/j.1462-2920.2006.01140.x
   Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08
   Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9
   Thiyagarajan S, 2011, FEMS MICROBIOL LETT, V325, P85, DOI 10.1111/j.1574-6968.2011.02415.x
   Thompson FL, 2007, APPL ENVIRON MICROB, V73, P4279, DOI 10.1128/AEM.00020-07
   Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004
   Viazis S, 2011, J APPL MICROBIOL, V110, P1323, DOI 10.1111/j.1365-2672.2011.04989.x
   Vinod MG, 2006, AQUACULTURE, V255, P117, DOI 10.1016/j.aquaculture.2005.12.003
   Wang LP, 2015, AQUAC RES, V46, P395, DOI 10.1111/are.12191
   Wang SY, 2003, MICROBIOL-SGM, V149, P1061, DOI 10.1099/mic.0.26032-0
   Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004
   You JL, 2007, APPL MICROBIOL BIOT, V76, P1137, DOI 10.1007/s00253-007-1074-x
   Yu YP, 2013, FEMS MICROBIOL LETT, V348, P112, DOI 10.1111/1574-6968.12277
NR 37
TC 6
Z9 6
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1355-557X
EI 1365-2109
J9 AQUAC RES
JI Aquac. Res.
PD DEC
PY 2016
VL 47
IS 12
BP 3964
EP 3972
DI 10.1111/are.12846
PG 9
WC Fisheries
SC Fisheries
GA EB8TD
UT WOS:000387663000025
DA 2019-02-28
ER

PT J
AU Pulido, RP
   Burgos, MJG
   Galvez, A
   Lopez, RL
AF Perez Pulido, Ruben
   Grande Burgos, Maria Jose
   Galvez, Antonio
   Lucas Lopez, Rosario
TI Application of bacteriophages in post-harvest control of human
   pathogenic and food spoiling bacteria
SO CRITICAL REVIEWS IN BIOTECHNOLOGY
LA English
DT Review
DE Biofilm; biopreservation; foodborne pathogens; lytic bacteriophage;
   food; spoilage
ID REDUCING LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI O157-H7;
   STAPHYLOCOCCUS-AUREUS; PHAGE INACTIVATION; CONTROL SALMONELLA;
   PASTEURIZED MILK; STAINLESS-STEEL; CAMPYLOBACTER INFECTIONS; VIRULENT
   BACTERIOPHAGE; LYTIC BACTERIOPHAGES
AB Bacteriophages have attracted great attention for application in food biopreservation. Lytic bacteriophages specific for human pathogenic bacteria can be isolated from natural sources such as animal feces or industrial wastes where the target bacteria inhabit. Lytic bacteriophages have been tested in different food systems for inactivation of main food-borne pathogens including Listeria monocytogenes, Staphylococcus aureus, Escherichia coli O157:H7, Salmonella enterica, Shigella spp., Campylobacter jejuni and Cronobacter sakazkii, and also for control of spoilage bacteria. Application of lytic bacteriophages could selectively control host populations of concern without interfering with the remaining food microbiota. Bacteriophages could also be applied for inactivation of bacteria attached to food contact surfaces or grown as biofilms. Bacteriophages may receive a generally recognized as safe status based on their lack of toxicity and other detrimental effects to human health. Phage preparations specific for L. monocytogenes, E. coli O157:H7 and S. enterica serotypes have been commercialized and approved for application in foods or as part of surface decontamination protocols. Phage endolysins have a broader host specificity compared to lytic bacteriophages. Cloned endolysins could be used as natural preservatives, singly or in combination with other antimicrobials such as bacteriocins.
C1 [Perez Pulido, Ruben; Grande Burgos, Maria Jose; Galvez, Antonio; Lucas Lopez, Rosario] Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Edif B3,Campus Las Lagunillas S-N, Jaen 23071, Spain.
RP Galvez, A (reprint author), Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Edif B3,Campus Las Lagunillas S-N, Jaen 23071, Spain.
EM agalvez@ujaen.es
RI Galvez, Antonio/M-2359-2014; MARIA JOSE, GRANDE BURGOS/M-5225-2015;
   Perez-Pulido, Ruben/M-1140-2014; Lucas, Rosario/I-4855-2018
OI Galvez, Antonio/0000-0002-5894-5029; MARIA JOSE, GRANDE
   BURGOS/0000-0002-4803-0562; Perez-Pulido, Ruben/0000-0001-7257-7528;
   Lucas, Rosario/0000-0002-0180-9296
CR Abedon ST, 2011, BACTERIOPHAGE, V1, P1, DOI DOI 10.4161/BACT.1.1.13980
   Acheson D. W. K., 2001, Guide to foodborne pathogens, P193
   Ailes E, 2008, FOODBORNE PATHOG DIS, V5, P329, DOI 10.1089/fpd.2008.0090
   Akhtar S, 2014, CRIT REV MICROBIOL, V40, P348, DOI 10.3109/1040841X.2012.742036
   [Anonymous], 2012, EFSA J, V10, P2615, DOI DOI 10.2903/J.EFSA.2012.2615
   [Anonymous], 2008, OUTBREAK ALERT CLOSI
   Arachchi GJG, 2013, J IND MICROBIOL BIOT, V40, P1105, DOI 10.1007/s10295-013-1313-3
   Atterbury RJ, 2009, MICROB BIOTECHNOL, V2, P601, DOI 10.1111/j.1751-7915.2009.00089.x
   Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P6302, DOI 10.1128/AEM.69.10.6302-6306.2003
   Atterbury RJ, 2006, P 13 INT S SALM SALM, P579
   Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x
   Bigot B, 2011, FOOD MICROBIOL, V28, P1448, DOI 10.1016/j.fm.2011.07.001
   Bigwood T, 2008, FOOD MICROBIOL, V25, P400, DOI 10.1016/j.fm.2007.11.003
   Boyacioglu O, 2013, BACTERIOPHAGE, V3, DOI DOI 10.4161/BACT.24620
   Braden CR, 2013, INFECT DIS CLIN N AM, V27, P517, DOI 10.1016/j.idc.2013.06.001
   Bueno E, 2012, INT J FOOD MICROBIOL, V158, P23, DOI 10.1016/j.ijfoodmicro.2012.06.012
   Campagna C, 2014, INT J FOOD MICROBIOL, V171, P41, DOI 10.1016/j.ijfoodmicro.2013.11.012
   Carlton RM, 2005, REGUL TOXICOL PHARM, V43, P301, DOI 10.1016/j.yrtph.2005.08.005
   Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005
   Carter Chandi D, 2012, Bacteriophage, V2, P178
   Ceccarelli D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00256
   Celia LK, 2008, VET MICROBIOL, V130, P107, DOI 10.1016/j.vetmic.2007.12.004
   Chapot-Chartier Marie-Pierre, 2014, Front Microbiol, V5, P236, DOI 10.3389/fmicb.2014.00236
   Chibeu A, 2013, INT J FOOD MICROBIOL, V167, P208, DOI 10.1016/j.ijfoodmicro.2013.08.018
   Chighladze E, 2001, ASM GEN M
   Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328
   Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13
   Deasy T, 2011, J FOOD PROTECT, V74, P2157, DOI 10.4315/0362-028X.JFP-11-262
   Deutsch SM, 2004, APPL ENVIRON MICROB, V70, P96, DOI 10.1128/AEM.70.1.96-103.2004
   ELLIS DE, 1973, APPL MICROBIOL, V25, P24, DOI 10.1179/030801800679017
   Epps SVR, 2013, INT J ENV RES PUB HE, V10, P6292, DOI 10.3390/ijerph10126292
   European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3547, 10.2903/j.efsa.2014.3590]
   Ferguson S., 2013, BACTERIOPHAGE, V3, DOI [10. 4161/bact. 24323, DOI 10.4161/BACT.24323]
   Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002
   Galvez A, 2008, CRIT REV BIOTECHNOL, V28, P125, DOI [10.1080/07388550802107202, 10.1080/07388550802107202 ]
   Galvez A, 2010, CURR OPIN BIOTECH, V21, P142, DOI 10.1016/j.copbio.2010.01.005
   Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014
   Garcia P, 2010, INT J FOOD MICROBIOL, V141, P151, DOI 10.1016/j.ijfoodmicro.2010.04.029
   Gill JJ, 2006, J APPL MICROBIOL, V101, P377, DOI 10.1111/j.1365-2672.2006.02918.x
   Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283
   Goode D, 2003, APPL ENVIRON MICROB, V69, P5032, DOI 10.1128/AEM.69.8.5032-5036.2003
   Greer GG, 2007, INT J FOOD MICROBIOL, V114, P370, DOI 10.1016/j.ijfoodmicro.2006.09.021
   Greer GG, 2005, J FOOD PROTECT, V68, P1102, DOI 10.4315/0362-028X-68.5.1102
   GREER GG, 1988, J FOOD SCI, V53, P1226, DOI 10.1111/j.1365-2621.1988.tb13570.x
   Greer GG, 2002, J FOOD PROTECT, V65, P861, DOI 10.4315/0362-028X-65.5.861
   Guenther S., 2011, Bacteriophage, V1, P94
   Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08
   Hagens S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00159
   Hagens S, 2010, CURR PHARM BIOTECHNO, V11, P58, DOI 10.2174/138920110790725429
   Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379
   Hennekinne JA, 2012, FEMS MICROBIOL REV, V36, P815, DOI 10.1111/j.1574-6976.2011.00311.x
   Hibma AM, 1997, INT J FOOD MICROBIOL, V34, P197, DOI 10.1016/S0168-1605(96)01190-7
   Higgins JP, 2005, POULTRY SCI, V84, P1141, DOI 10.1093/ps/84.7.1141
   Holck A, 2009, APPL ENVIRON MICROB, V75, P6944, DOI 10.1128/AEM.00926-09
   Hooton SPT, 2011, INT J FOOD MICROBIOL, V151, P157, DOI 10.1016/j.ijfoodmicro.2011.08.015
   Jonczyk E, 2011, FOLIA MICROBIOL, V56, P191, DOI 10.1007/s12223-011-0039-8
   Jun JW, 2014, INT J FOOD MICROBIOL, V188, P31, DOI 10.1016/j.ijfoodmicro.2014.07.007
   Juneja VK, 2012, ANNU REV FOOD SCI T, V3, P381, DOI 10.1146/annurev-food-022811-101241
   Kang HW, 2013, APPL ENVIRON MICROB, V79, P1956, DOI 10.1128/AEM.02793-12
   Kim KP, 2007, INT J FOOD MICROBIOL, V115, P195, DOI 10.1016/j.ijfoodmicro.2006.10.029
   Kirk MD, 2008, CLIN INFECT DIS, V47, P392, DOI 10.1086/589861
   Klumpp J., 2013, BACTERIOPHAGE, V3, DOI DOI 10.4161/BACT.26861
   Kocharunchitt C, 2009, INT J FOOD MICROBIOL, V128, P453, DOI 10.1016/j.ijfoodmicro.2008.10.014
   Kudva IT, 1999, APPL ENVIRON MICROB, V65, P3767
   Leverentz B, 2004, J FOOD PROTECT, V67, P1682, DOI 10.4315/0362-028X-67.8.1682
   Leverentz B, 2003, APPL ENVIRON MICROB, V69, P4519, DOI 10.1128/AEM.69.8.4519-4526.2003
   Leverentz B, 2001, J FOOD PROTECT, V64, P1116, DOI 10.4315/0362-028X-64.8.1116
   Ly-Chatain MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00051
   Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969
   Mayer MJ, 2010, APPL ENVIRON MICROB, V76, P5415, DOI 10.1128/AEM.00989-10
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502
   Modi R, 2001, J FOOD PROTECT, V64, P927, DOI 10.4315/0362-028X-64.7.927
   Montanez-Izquierdo VY, 2012, FOOD CONTROL, V23, P470, DOI 10.1016/j.foodcont.2011.08.016
   MULLAN WMA, 1985, J DAIRY RES, V52, P123, DOI 10.1017/S0022029900023955
   Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021
   Norberg S, 2012, J FOOD PROTECT, V75, P607, DOI 10.4315/0362-028X.JFP-11-285
   O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P274, DOI 10.1111/j.1472-765X.2005.01762.x
   O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004
   Obeso JM, 2010, APPL ENVIRON MICROB, V76, P6038, DOI 10.1128/AEM.00613-10
   Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010
   Oliveira M, 2014, FOOD MICROBIOL, V38, P137, DOI 10.1016/j.fm.2013.08.018
   Organization WH, 2005, MAK EV MOTH CHILD CO
   Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866
   Pao S, 2004, J FOOD SCI, V69, pM127, DOI 10.1111/j.1365-2621.2004.tb10720.x
   Patel J, 2011, FOODBORNE PATHOG DIS, V8, P541, DOI 10.1089/fpd.2010.0734
   Pelon W, 2005, J FOOD PROTECT, V68, P1188, DOI 10.4315/0362-028X-68.6.1188
   Ribelles P, 2012, APPL MICROBIOL BIOT, V94, P101, DOI 10.1007/s00253-011-3588-5
   Roach DR, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-20
   ROY B, 1993, APPL ENVIRON MICROB, V59, P2914
   Schellekens MM, 2007, MILCHWISSENSCHAFT, V62, P284
   Sharma M, 2005, J APPL MICROBIOL, V99, P449, DOI 10.1111/j.1365-2672.2005.02659.x
   Sharma M, 2009, J FOOD PROTECT, V72, P1481, DOI 10.4315/0362-028X-72.7.1481
   Sillankorva S., 2008, BMC BIOTECHNOL, V8, P79
   Siringan P, 2011, APPL ENVIRON MICROB, V77, P3320, DOI 10.1128/AEM.02704-10
   Smith JL, 2014, ADV APPL MICROBIOL, V86, P145, DOI 10.1016/B978-0-12-800262-9.00003-2
   Soni KA, 2012, INT J FOOD MICROBIOL, V155, P82, DOI 10.1016/j.ijfoodmicro.2012.01.010
   Soni KA, 2010, J FOOD PROTECT, V73, P1519, DOI 10.4315/0362-028X-73.8.1519
   Soni KA, 2010, FOODBORNE PATHOG DIS, V7, P427, DOI 10.1089/fpd.2009.0432
   Soni KA, 2010, J FOOD PROTECT, V73, P32, DOI 10.4315/0362-028X-73.1.32
   Spricigo DA, 2013, INT J FOOD MICROBIOL, V165, P169, DOI 10.1016/j.ijfoodmicro.2013.05.009
   Stiles ME, 1996, ANTON LEEUW INT J G, V70, P331, DOI 10.1007/BF00395940
   Tabla R, 2012, INT J FOOD MICROBIOL, V156, P209, DOI 10.1016/j.ijfoodmicro.2012.03.023
   Tomat D, 2013, LETT APPL MICROBIOL, V57, P3, DOI 10.1111/lam.12074
   Tomat D., 2013, FRONTIERS CELLULAR I, V3, P1
   Tomat D, 2014, FOOD RES INT, V57, P123, DOI 10.1016/j.foodres.2014.01.013
   VASALA A, 1995, APPL ENVIRON MICROB, V61, P4004
   Viazis S, 2011, INT J FOOD MICROBIOL, V145, P37, DOI 10.1016/j.ijfoodmicro.2010.11.021
   Viazis S, 2011, FOOD MICROBIOL, V28, P149, DOI 10.1016/j.fm.2010.09.009
   Whichard JM, 2003, J FOOD PROTECT, V66, P220, DOI 10.4315/0362-028X-66.2.220
   Woolston J., 2013, Bacteriophage, V3, pe25697, DOI 10.4161/bact.25697
   Zhang H, 2013, POULTRY SCI, V92, P211, DOI 10.3382/ps.2011-02037
   Zhang H, 2012, FOOD MICROBIOL, V31, P133, DOI 10.1016/j.fm.2012.01.005
   ZINK R, 1995, MICROBIOL-SGM, V141, P2577, DOI 10.1099/13500872-141-10-2577
   Zuber S, 2008, MICROB BIOTECHNOL, V1, P532, DOI 10.1111/j.1751-7915.2008.00058.x
NR 114
TC 8
Z9 8
U1 4
U2 82
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0738-8551
EI 1549-7801
J9 CRIT REV BIOTECHNOL
JI Crit. Rev. Biotechnol.
PD OCT
PY 2016
VL 36
IS 5
BP 851
EP 861
DI 10.3109/07388551.2015.1049935
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DS8TA
UT WOS:000381054700007
PM 26042353
DA 2019-02-28
ER

PT J
AU Bardy, P
   Pantucek, R
   Benesik, M
   Doskar, J
AF Bardy, P.
   Pantucek, R.
   Benesik, M.
   Doskar, J.
TI Genetically modified bacteriophages in applied microbiology
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Review
DE bacteriophages; biopharmaceuticals; biotechnology; enzybiotics;
   genetically modified bacteriophages; pathogen detection; phage therapy
ID BIOLUMINESCENT REPORTER PHAGE; WALL-BINDING DOMAINS; RESISTANT
   STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI O157-H7; SALMONELLA-TYPHIMURIUM;
   ENGINEERED PHAGE; BACILLUS-ANTHRACIS; ANTIMICROBIAL ACTIVITY;
   ANTIBIOTIC-RESISTANCE; SENSITIVE DETECTION
AB Bacteriophages represent a simple viral model of basic research with many possibilities for practical application. Due to their ability to infect and kill bacteria, their potential in the treatment of bacterial infection has been examined since their discovery. With advances in molecular biology and gene engineering, the phage application spectrum has been expanded to various medical and biotechnological fields. The construction of bacteriophages with an extended host range or longer viability in the mammalian bloodstream enhances their potential as an alternative to conventional antibiotic treatment. Insertion of active depolymerase genes to their genomes can enforce the biofilm disposal. They can also be engineered to transfer various compounds to the eukaryotic organisms and the bacterial culture, applicable for the vaccine, drug or gene delivery. Phage recombinant lytic enzymes can be applied as enzybiotics in medicine as well as in biotechnology for pathogen detection or programmed cell death in bacterial expression strains. Besides, modified bacteriophages with high specificity can be applied as bioprobes in detection tools to estimate the presence of pathogens in food industry, or utilized in the control of food-borne pathogens as part of the constructed phage-based biosorbents.
C1 [Bardy, P.; Pantucek, R.; Benesik, M.; Doskar, J.] Masaryk Univ, Dept Expt Biol, Fac Sci, Brno, Czech Republic.
RP Pantucek, R (reprint author), Masaryk Univ, Fac Sci, Kotlarska 2, CZ-61137 Brno, Czech Republic.
EM pantucek@sci.muni.cz
RI Pantucek, Roman/P-6758-2014; Doskar, Jiri/O-1038-2017
OI Pantucek, Roman/0000-0002-3950-675X; Bardy, Pavol/0000-0002-1223-2584
FU Masaryk University [MUNI/C/1501/2014]; Masaryk University
   [MUNI/C/1501/2014]
FX This paper was supported by grant MUNI/C/1501/2014 from the Masaryk
   University.
CR Alcaine SD, 2015, ANALYST, V140, P7629, DOI 10.1039/c5an01181g
   Ali BH, 1995, GEN PHARMACOL, V26, P1477, DOI 10.1016/0306-3623(95)00049-6
   Anany H, 2011, APPL ENVIRON MICROB, V77, P6379, DOI 10.1128/AEM.05493-11
   Awais R, 2006, BIOTECHNOL PROGR, V22, P853, DOI 10.1021/bp060020q
   Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241
   Becker SC, 2009, GENE, V443, P32, DOI 10.1016/j.gene.2009.04.023
   Bhattarai SR, 2012, BIOMATERIALS, V33, P5166, DOI 10.1016/j.biomaterials.2012.03.054
   Briers Y, 2014, MBIO, V5, DOI 10.1128/mBio.01379-14
   Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7
   Burnham S, 2014, ANAL BIOANAL CHEM, V406, P5685, DOI 10.1007/s00216-014-7985-3
   Cai Z, 2008, PROTEIN ENG DES SEL, V21, P681, DOI 10.1093/protein/gzn049
   Cao J, 2000, BBA-GEN SUBJECTS, V1474, P107, DOI 10.1016/S0304-4165(00)00005-2
   Chai YT, 2013, BIOSENS BIOELECTRON, V50, P311, DOI 10.1016/j.bios.2013.06.056
   Chen JH, 2015, NANOSCALE, V7, P16230, DOI 10.1039/c5nr03779d
   Clark JR, 2004, FEMS IMMUNOL MED MIC, V40, P21, DOI 10.1016/S0928-8244(03)00344-4
   Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002
   Donovan DM, 2006, APPL ENVIRON MICROB, V72, P2988, DOI 10.1128/AEM.74.4.2988-2996.2006
   Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103
   Edgar R, 2012, APPL ENVIRON MICROB, V78, P744, DOI 10.1128/AEM.05741-11
   Eguchi A, 2005, J CONTROL RELEASE, V104, P507, DOI 10.1016/j.jconrel.2005.02.019
   Embleton ML, 2005, ANTIMICROB AGENTS CH, V49, P3690, DOI 10.1128/AAC.49.9.3690-3696.2005
   Fernandes S, 2012, MICROB DRUG RESIST, V18, P333, DOI 10.1089/mdr.2012.0025
   Gervals L, 2007, SENSOR ACTUAT B-CHEM, V125, P615, DOI 10.1016/j.snb.2007.03.007
   Gladstone EG, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-13
   Gorski A, 2015, FUTURE MICROBIOL, V10, P199, DOI [10.2217/FMB.14.126, 10.2217/fmb.14.126]
   Hagens S, 2003, LETT APPL MICROBIOL, V37, P318, DOI 10.1046/j.1472-765X.2003.01400.x
   Hashemi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045765
   Hashemi H, 2010, J VIROL METHODS, V163, P440, DOI 10.1016/j.jviromet.2009.11.008
   Huys I, 2013, RES MICROBIOL, V164, P806, DOI 10.1016/j.resmic.2013.03.020
   Javed MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069770
   Jikia D, 2005, CLIN EXP DERMATOL, V30, P23, DOI 10.1111/j.1365-2230.2004.01600.x
   Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4692.2003
   Karoonuthaisiri N, 2014, SENSOR ACTUAT B-CHEM, V190, P214, DOI 10.1016/j.snb.2013.08.068
   Kasparek P, 2007, FOLIA MICROBIOL, V52, P331, DOI 10.1007/BF02932087
   Keen EC, 2015, BIOESSAYS, V37, P6, DOI 10.1002/bies.201400152
   Kim KP, 2008, MICROB BIOTECHNOL, V1, P247, DOI 10.1111/j.1751-7915.2008.00028.x
   Kim S, 2014, ANAL CHEM, V86, P5858, DOI 10.1021/ac500645c
   Kong M, 2015, EUR BIOPHYS J BIOPHY, V44, P437, DOI 10.1007/s00249-015-1044-7
   Kretzer JW, 2007, APPL ENVIRON MICROB, V73, P1992, DOI 10.1128/AEM.02402-06
   Krom RJ, 2015, NANO LETT, V15, P4808, DOI 10.1021/acs.nanolett.5b01943
   Leon M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00343
   Li Z, 2010, COLLOID SURFACE B, V76, P529, DOI 10.1016/j.colsurfb.2009.12.014
   Libis VK, 2014, ACS SYNTH BIOL, V3, P1003, DOI 10.1021/sb500033d
   Liu JL, 2014, P NATL ACAD SCI USA, V111, P13319, DOI 10.1073/pnas.1321940111
   Liu XY, 2009, P NATL ACAD SCI USA, V106, P21550, DOI 10.1073/pnas.0911953106
   Loessner MJ, 1996, APPL ENVIRON MICROB, V62, P1133
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106
   Lukacik P, 2012, P NATL ACAD SCI USA, V109, P9857, DOI 10.1073/pnas.1203472109
   Lynch KH, 2010, J VIROL, V84, P1276, DOI 10.1128/JVI.01843-09
   Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x
   Manoharadas S, 2009, J BIOTECHNOL, V139, P118, DOI 10.1016/j.jbiotec.2008.09.003
   Matsuda T, 2005, SURGERY, V137, P639, DOI 10.1016/j.surg.2005.02.012
   Menendez T, 2011, INT J MED MICROBIOL, V301, P16, DOI 10.1016/j.ijmm.2010.04.020
   Merril C. R., 1997, US Patent, Patent No. [5660812 A, 5660812]
   Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188
   Minikh O, 2010, J MICROBIOL METH, V82, P177, DOI 10.1016/j.mimet.2010.05.013
   Miyake K, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-56
   Moradpour Z, 2009, FEMS MICROBIOL LETT, V296, P67, DOI 10.1111/j.1574-6968.2009.01620.x
   Morton J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074312
   Nanduri V, 2007, BIOSENS BIOELECTRON, V23, P248, DOI 10.1016/j.bios.2007.04.007
   Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006
   Ou CB, 2013, INT IMMUNOPHARMACOL, V16, P505, DOI 10.1016/j.intimp.2013.04.027
   Park MK, 2013, FOOD CONTROL, V33, P330, DOI 10.1016/j.foodcont.2013.02.026
   Park MK, 2013, SENSOR ACTUAT B-CHEM, V176, P1134, DOI 10.1016/j.snb.2012.10.084
   Park SY, 2011, J MICROBIOL METH, V86, P108, DOI 10.1016/j.mimet.2011.04.003
   Pastagia M, 2011, ANTIMICROB AGENTS CH, V55, P738, DOI 10.1128/AAC.00890-10
   Paul VD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-195
   Pei RT, 2014, APPL ENVIRON MICROB, V80, P5340, DOI 10.1128/AEM.01434-14
   Pires D, 2011, RES MICROBIOL, V162, P798, DOI 10.1016/j.resmic.2011.06.010
   Pirnay JP, 2015, PHARM RES-DORDR, V32, P2173, DOI 10.1007/s11095-014-1617-7
   Poshtiban S, 2013, ANALYST, V138, P5619, DOI 10.1039/c3an01100c
   Pouillot F, 2010, BIOSECUR BIOTERROR, V8, P155, DOI 10.1089/bsp.2009.0057
   PRINS JM, 1994, ANTIMICROB AGENTS CH, V38, P1211, DOI 10.1128/AAC.38.6.1211
   Resch S, 1998, J BIOTECHNOL, V65, P173, DOI 10.1016/S0168-1656(98)00127-8
   Robertson KL, 2011, BIOCONJUGATE CHEM, V22, P595, DOI 10.1021/bc100365j
   SANDERSON KE, 1972, BACTERIOL REV, V36, P608
   Sathaliyawala T, 2006, J VIROL, V80, P7688, DOI 10.1128/JVI.00235-06
   Sblattero D, 2000, NAT BIOTECHNOL, V18, P75
   Schmelcher M, 2012, APPL ENVIRON MICROB, V78, P2297, DOI 10.1128/AEM.07050-11
   Schmelcher M, 2010, APPL ENVIRON MICROB, V76, P5745, DOI 10.1128/AEM.00801-10
   Schmerer M, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-21
   Schofield DA, 2013, J MICROBIOL METH, V95, P156, DOI 10.1016/j.mimet.2013.08.013
   Schofield DA, 2012, J MICROBIOL METH, V90, P80, DOI 10.1016/j.mimet.2012.04.019
   Schofield DA, 2012, APPL ENVIRON MICROB, V78, P3592, DOI 10.1128/AEM.00252-12
   Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026
   Shu Y, 2013, RNA, V19, P767, DOI 10.1261/rna.037002.112
   Singh A, 2011, ANALYST, V136, P4780, DOI 10.1039/c1an15547d
   Singh A, 2010, BIOSENS BIOELECTRON, V26, P131, DOI 10.1016/j.bios.2010.05.024
   Singh PK, 2014, ANTIMICROB AGENTS CH, V58, P4621, DOI 10.1128/AAC.00126-14
   Skwarczynski M, 2016, CHEM SCI, V7, P842, DOI 10.1039/c5sc03892h
   SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944
   Sorokulova IB, 2005, J MICROBIOL METH, V63, P55, DOI 10.1016/j.mimet.2005.02.019
   Sun SP, 2011, BIOCHEM BIOPH RES CO, V407, P124, DOI 10.1016/j.bbrc.2011.02.122
   Sybesma W, 2016, BIOTECHNOL J, V11, P595, DOI 10.1002/biot.201600023
   Tao P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003495
   Ulitzur S, 1989, US patent, Patent No. [4,861,709, 4861709, 4:861,709]
   Vandenheuvel D, 2015, ANNU REV VIROL, V2, P599, DOI 10.1146/annurev-virology-100114-054915
   Verbeken G, 2014, ARCH IMMUNOL THER EX, V62, P117, DOI 10.1007/s00005-014-0269-y
   Vitiello CL, 2005, VIRUS RES, V114, P101, DOI 10.1016/j.virusres.2005.05.014
   Wan JH, 2007, SENSOR ACTUAT B-CHEM, V127, P559, DOI 10.1016/j.snb.2007.05.017
   Wang YC, 2014, HUM VACC IMMUNOTHER, V10, P1057, DOI 10.4161/hv.27714
   Westwater C, 2003, ANTIMICROB AGENTS CH, V47, P1301, DOI 10.1128/AAC.47.4.1301-1307.2003
   WITTE A, 1989, EUR J BIOCHEM, V180, P393, DOI 10.1111/j.1432-1033.1989.tb14661.x
   Yacoby I, 2007, ANTIMICROB AGENTS CH, V51, P2156, DOI 10.1128/AAC.00163-07
   Yata T, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.37
   Yim PB, 2009, BIOTECHNOL BIOENG, V104, P1059, DOI 10.1002/bit.22488
   Yoichi M, 2005, J BIOTECHNOL, V115, P101, DOI 10.1016/j.jbiotec.2004.08.003
   Yosef I, 2015, P NATL ACAD SCI USA, V112, P7267, DOI 10.1073/pnas.1500107112
   Yun J, 2007, J MICROBIOL BIOTECHN, V17, P1162
   Zhang XM, 2009, J MICROBIOL METH, V79, P199, DOI 10.1016/j.mimet.2009.09.001
NR 111
TC 14
Z9 15
U1 3
U2 92
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD SEP
PY 2016
VL 121
IS 3
BP 618
EP 633
DI 10.1111/jam.13207
PG 16
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA DW1LO
UT WOS:000383404900002
PM 27321680
DA 2019-02-28
ER

PT J
AU Yan, SQ
   Xu, MM
   Duan, XK
   Yu, ZX
   Li, QM
   Xie, LX
   Fan, XY
   Xie, JP
AF Yan, Shuangquan
   Xu, Mengmeng
   Duan, Xiangke
   Yu, Zhaoxiao
   Li, Qiming
   Xie, Longxiang
   Fan, Xiangyu
   Xie, Jianping
TI Mycobacteriophage putative GTPase-activating protein can potentiate
   antibiotics
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Mycobacteriophage; Antimicrobial resistance; Biofilm; GTPase-activating
   protein; Antibiotic potentiator
ID P-LOOP GTPASES; ESCHERICHIA-COLI; BACTERIAL BIOFILMS; G-DOMAINS; PHAGE;
   THERAPY; GENE; ENGA; RAS; INFECTIONS
AB The soaring incidences of infection by antimicrobial resistant (AR) pathogens and shortage of effective antibiotics with new mechanisms of action have renewed interest in phage therapy. This scenario is exemplified by resistant tuberculosis (TB), caused by resistant Mycobacterium tuberculosis. Mycobacteriophage SWU1 A321_gp67 encodes a putative GTPase-activating protein. Mycobacterium smegmatis with gp67 overexpression showed changed colony formation and biofilm morphology and supports the efficacy of streptomycin and capreomycin against Mycobacterium. gp67 down-regulated the transcription of genes involved in cell wall and biofilm development. To our knowledge, this is the first report to show that phage protein in addition to lysin or recombination components can synergize with existing antibiotics. Phage components might represent a promising new clue for better antibiotic potentiators.
C1 [Yan, Shuangquan; Xu, Mengmeng; Duan, Xiangke; Yu, Zhaoxiao; Li, Qiming; Xie, Longxiang; Xie, Jianping] Southwest Univ, Key Lab Ecoenvironm Three Gorges Reservoir Reg, State Key Lab Breeding Base Ecoenvironm & Bioreso, Inst Modern Biopharmaceut,Minist Educ,Sch Life Sc, Chongqing 400715, Peoples R China.
   [Fan, Xiangyu] Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Shandong, Peoples R China.
RP Xie, JP (reprint author), Southwest Univ, Key Lab Ecoenvironm Three Gorges Reservoir Reg, State Key Lab Breeding Base Ecoenvironm & Bioreso, Inst Modern Biopharmaceut,Minist Educ,Sch Life Sc, Chongqing 400715, Peoples R China.
EM georgex@swu.edu.cn
FU National Natural Science Foundation [81371851, 81511120001, 81071316,
   81271882, 81301394]; New Century Excellent Talents in Universities
   [NCET110703]; National Megaprojects for Key Infectious Diseases
   [2008ZX10003006]; Excellent Ph.D. Thesis Fellowship of Southwest
   University [kb2010017, ky2011003]; Fundamental Research Funds for the
   Central Universities [XDJK2011D006, XDJK2012D011, XDJK2012D007,
   XDJK2013D003, XD-JK2014D040, XDJK2016D025, XDJK2016E093]; Graduate
   Research and Innovation Project of Graduate in Chongqing [CYS14044];
   Chongqing chuying program for high school students [CY150202]
FX This work was supported by the National Natural Science Foundation
   [grant numbers 81371851, 81511120001, 81071316, 81271882, 81301394], the
   New Century Excellent Talents in Universities [grant number NCET110703],
   the National Megaprojects for Key Infectious Diseases [grant numbers
   2008ZX10003006], the Excellent Ph.D. Thesis Fellowship of Southwest
   University [grant numbers kb2010017, ky2011003], the Fundamental
   Research Funds for the Central Universities [grant numbers XDJK2011D006,
   XDJK2012D011, XDJK2012D007, XDJK2013D003, XD-JK2014D040, XDJK2016D025,
   XDJK2016E093], the Graduate Research and Innovation Project of Graduate
   in Chongqing (CYS14044), and the Chongqing chuying program for high
   school students (CY150202).
CR Flores-Valdez MA, 2009, FASEB J, V23, P4091, DOI 10.1096/fj.09-132407
   Alexander DC, 2004, J BIOL CHEM, V279, P18824, DOI 10.1074/jbc.M400791200
   Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06
   BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0
   Brown ED, 2005, BIOCHEM CELL BIOL, V83, P738, DOI 10.1139/O05-162
   Brussow H, 2005, MICROBIOL-SGM, V151, P2133, DOI 10.1099/mic.0.27849-0
   Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7
   Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x
   Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.2.633-641.2006
   Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004
   DIBB NJ, 1986, J BACTERIOL, V166, P83, DOI 10.1128/jb.166.1.83-87.1986
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Fan XY, 2015, GENE, V561, P45, DOI 10.1016/j.gene.2015.02.053
   Fan XY, 2012, J VIROL, V86, P10230, DOI 10.1128/JVI.01568-12
   Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016
   FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397
   Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x
   GUERRANT GO, 1981, J CLIN MICROBIOL, V13, P899
   Hagens S, 2004, ANTIMICROB AGENTS CH, V48, P3817, DOI 10.1128/ACC.48.10.3817-3822.2004
   Hagens S, 2003, LETT APPL MICROBIOL, V37, P318, DOI 10.1046/j.1472-765X.2003.01400.x
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233
   Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011
   HEITMAN J, 1989, GENE, V85, P193, DOI 10.1016/0378-1119(89)90480-0
   Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420
   Hwang J, 2010, J MOL BIOL, V399, P759, DOI 10.1016/j.jmb.2010.04.040
   Johnson DS, 2012, CURR OPIN PHARMACOL, V12, P458, DOI 10.1016/j.coph.2012.02.003
   KISER GL, 1995, YEAST, V11, P1311, DOI 10.1002/yea.320111312
   Lamb HK, 2007, PROTEIN SCI, V16, P2391, DOI 10.1110/ps.072900907
   Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378
   Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114
   Lewis K, 2008, CURR TOP MICROBIOL, V322, P107
   Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106
   Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111
   Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P21
   Molshanski-Mor S, 2014, P NATL ACAD SCI USA, V111, P18715, DOI 10.1073/pnas.1413271112
   Nguyen HT, 2010, MOL MICROBIOL, V76, P348, DOI 10.1111/j.1365-2958.2010.07110.x
   Organization WH, 2015, GLOB TUB REP 2015
   Pang JM, 2012, J BACTERIOL, V194, P715, DOI 10.1128/JB.06304-11
   Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720
   Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000
   Ribeiro ALDL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026675
   Sassi M, 2013, J VIROL, V87, P8099, DOI 10.1128/JVI.01209-13
   Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06
   Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002
   Tao J, 2013, NUCLEIC ACIDS RES, V41, P2370, DOI 10.1093/nar/gks1351
   Tomar SK, 2009, NUCLEIC ACIDS RES, V37, P2359, DOI 10.1093/nar/gkp107
   Westwater C, 2003, ANTIMICROB AGENTS CH, V47, P1301, DOI 10.1128/AAC.47.4.1301-1307.2003
   Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002
NR 49
TC 0
Z9 2
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD SEP
PY 2016
VL 100
IS 18
BP 8169
EP 8177
DI 10.1007/s00253-016-7681-7
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DU1YW
UT WOS:000382008000032
PM 27345061
DA 2019-02-28
ER

PT J
AU Melo, LDR
   Veiga, P
   Cerca, N
   Kropinski, AM
   Almeida, C
   Azeredo, J
   Sillankorva, S
AF Melo, Luis D. R.
   Veiga, Patricia
   Cerca, Nuno
   Kropinski, Andrew M.
   Almeida, Carina
   Azeredo, Joana
   Sillankorva, Sanna
TI Development of a Phage Cocktail to Control Proteus mirabilis
   Catheter-associated Urinary Tract Infections
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE bacteriophages; bacteriophage therapy; biofilms; urinary tract
   infection; Proteus mirabilis; phage cocktail
ID BACTERIAL BIOFILMS; URETHRAL CATHETERS; ESCHERICHIA-COLI; TRANSFER-RNAS;
   HEALTH-CARE; BACTERIOPHAGE; TOOL; PREDICTION; PATHOGENS; CLASSIFICATION
AB Proteus mirabilis is an enterobacterium that causes catheter-associated urinary tract infections (CAUTIs) due to its ability to colonize and form crystalline biofilms on the catheters surface. CAUTIs are very difficult to treat, since biofilm structures are highly tolerant to antibiotics. Phages have been used widely to control a diversity of bacterial species, however, a limited number of phages for P. mirabilis have been isolated and studied. Here we report the isolation of two novel virulent phages, the podovirus VB_PmiP_5460 and the myovirus VB_PmiM_5461, which are able to target, respectively, 16 of the 26 and all the Proteus strains tested in this study. Both phages have been characterized thoroughly and sequencing data revealed no traces of genes associated with lysogeny. To further evaluate the phages' ability to prevent catheter's colonization by Proteus, the phages adherence to silicone surfaces was assessed. Further tests in phage-coated catheters using a dynamic biofilm model simulating CAUTIs, have shown a significant reduction of P. mirabilis biofilm formation up to 168 h of catheterization. These results highlight the potential usefulness of the two isolated phages for the prevention of surface colonization by this bacterium.
C1 [Melo, Luis D. R.; Veiga, Patricia; Cerca, Nuno; Almeida, Carina; Azeredo, Joana; Sillankorva, Sanna] Univ Minho, Lab Invest Biofilmes Rosario Oliveira, Ctr Biol Engn, Braga, Portugal.
   [Kropinski, Andrew M.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada.
   [Kropinski, Andrew M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.
   [Kropinski, Andrew M.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.
RP Sillankorva, S (reprint author), Univ Minho, Lab Invest Biofilmes Rosario Oliveira, Ctr Biol Engn, Braga, Portugal.
EM s.sillankorva@deb.uminho.pt
OI Cerca, Nuno/0000-0003-3365-3537; Sillankorva, Sanna/0000-0002-8408-8550;
   Melo, Luis/0000-0002-6865-6044; Azeredo, Joana/0000-0002-5180-7133;
   Almeida, Carina/0000-0002-0175-1119
FU Portuguese Foundation for Science and Technology (FCT)
   [UID/BIO/04469/2013, POCI-01-0145-FEDER-006684, RECI/BBB-EBI/0179/2012
   (FCOMP-01-0124-FEDER-027462)]
FX This study was supported by the Portuguese Foundation for Science and
   Technology (FCT) under the scope of the strategic funding of
   UID/BIO/04469/2013 unit, COMPETE 2020 (POCI-01-0145-FEDER-006684) and by
   the Portuguese Foundation for Science and Technology (FCT) under the
   scope of the Project RECI/BBB-EBI/0179/2012
   (FCOMP-01-0124-FEDER-027462). NC and SS also thank FCT for the
   individual support through Investigador FCT contracts.
CR Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Armbruster CE, 2012, NAT REV MICROBIOL, V10, P743, DOI 10.1038/nrmicro2890
   Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807
   Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x
   Broomfield RJ, 2009, J MED MICROBIOL, V58, P1367, DOI 10.1099/jmm.0.012419-0
   Burton DC, 2011, INFECT CONT HOSP EP, V32, P748, DOI 10.1086/660872
   Cademartiri R, 2010, BIOMATERIALS, V31, P1904, DOI 10.1016/j.biomaterials.2009.11.029
   Carson L, 2010, FEMS IMMUNOL MED MIC, V59, P447, DOI 10.1111/j.1574-695X.2010.00696.x
   Chenoweth CE, 2014, INFECT DIS CLIN N AM, V28, P105, DOI 10.1016/j.idc.2013.09.002
   Coker C, 2000, MICROBES INFECT, V2, P1497, DOI 10.1016/S1286-4579(00)01304-6
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Doolittle MM, 1996, J IND MICROBIOL, V16, P331, DOI 10.1007/BF01570111
   Getliffe K, 2006, AGE AGEING, V35, P477, DOI 10.1093/ageing/afl052
   Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698
   Hadas H, 1997, MICROBIOL-UK, V143, P179, DOI 10.1099/00221287-143-1-179
   Harada K, 2014, J MED MICROBIOL, V63, P1561, DOI 10.1099/jmm.0.081539-0
   HOENIGER JF, 1965, J GEN MICROBIOL, V40, P29, DOI 10.1099/00221287-40-1-29
   Hosseinidoust Z, 2011, LANGMUIR, V27, P5472, DOI 10.1021/la200102z
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   Jonczyk E, 2011, FOLIA MICROBIOL, V56, P191, DOI 10.1007/s12223-011-0039-8
   Jones BV, 2005, J MED MICROBIOL, V54, P807, DOI 10.1099/JMM.0.46123-0
   Kaca W, 2011, BIOCHEMISTRY-MOSCOW+, V76, P851, DOI 10.1134/S0006297911070169
   Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016
   Kall L, 2002, FEBS LETT, V532, P415, DOI 10.1016/S0014-5793(02)03730-4
   Kropinski Andrew M., 2009, V501, P157, DOI 10.1007/978-1-60327-164-6_16
   Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152
   Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456
   Lehman SM, 2015, ANTIMICROB AGENTS CH, V59, P1127, DOI 10.1128/AAC.03786-14
   Levering V, 2014, ADV HEALTHC MATER, V3, P1588, DOI 10.1002/adhm.201400035
   Melo LDR, 2014, RES MICROBIOL, V165, P679, DOI 10.1016/j.resmic.2014.09.012
   Melo LDR, 2014, J GEN VIROL, V95, P506, DOI 10.1099/vir.0.060590-0
   Morris NS, 1999, WORLD J UROL, V17, P345, DOI 10.1007/s003450050159
   Moryl M, 2013, POL J MICROBIOL, V62, P377
   Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346
   O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000
   Pires D, 2011, RES MICROBIOL, V162, P798, DOI 10.1016/j.resmic.2011.06.010
   Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065
   Rahman M, 2011, BIOFOULING, V27, P1087, DOI 10.1080/08927014.2011.631169
   Reardon S, 2014, NATURE, V510, P15, DOI 10.1038/510015a
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2
   Saint S, 1999, ARCH INTERN MED, V159, P800, DOI 10.1001/archinte.159.8.800
   Saint S, 2008, CLIN INFECT DIS, V46, P243, DOI 10.1086/524662
   Sambrook JS, 2001, MOL CLONING LAB MANU
   Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096
   Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366
   Siddiq DM, 2012, NAT REV UROL, V9, P305, DOI 10.1038/nrurol.2012.68
   Silva S, 2010, J MED MICROBIOL, V59, P747, DOI 10.1099/jmm.0.017517-0
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6
   Stickler D, 1998, EUR J CLIN MICROBIOL, V17, P649, DOI 10.1007/s100960050150
   Stickler DJ, 2010, SPINAL CORD, V48, P784, DOI 10.1038/sc.2010.32
   Stickler DJ, 2006, J APPL MICROBIOL, V100, P1028, DOI 10.1111/j.1365-2672.2006.02840.x
   Stickler DJ, 2006, J MED MICROBIOL, V55, P489, DOI 10.1099/jmm.0.46404-0
   Viertel TM, 2014, J ANTIMICROB CHEMOTH, V69, P2326, DOI 10.1093/jac/dku173
   Vinogradov E, 2000, EUR J BIOCHEM, V267, P2439, DOI 10.1046/j.1432-1327.2000.01262.x
   Wang JT, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-486
   Weber DJ, 2011, INFECT CONT HOSP EP, V32, P822, DOI 10.1086/661107
   Wilkins MR, 1999, METH MOL B, V112, P531
   Zafar N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-12
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 65
TC 16
Z9 16
U1 0
U2 26
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 28
PY 2016
VL 7
AR 1024
DI 10.3389/fmicb.2016.01024
PG 12
WC Microbiology
SC Microbiology
GA DP7NR
UT WOS:000378686600001
PM 27446059
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Singh, R
   Nadhe, S
   Wadhwani, S
   Shedbalkar, U
   Chopade, BA
AF Singh, Richa
   Nadhe, Shradhda
   Wadhwani, Sweety
   Shedbalkar, Utkarsha
   Chopade, Balu Ananda
TI Nanoparticles for Control of Biofilms of Acinetobacter Species
SO MATERIALS
LA English
DT Review
DE Acinetobacter; biofilm; drug resistance; nanoparticles; phage;
   anti-biofilm agent
ID GRAM-NEGATIVE BACTERIA; D-AMINO ACIDS; IN-VITRO; SILVER NANOPARTICLES;
   GOLD NANOPARTICLES; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL ACTIVITY;
   ANTIMICROBIAL ACTIVITY; BAUMANNII BIOFILM; ESCHERICHIA-COLI
AB Biofilms are the cause of 80% of microbial infections. Acinetobacter species have emerged as multi-and pan-drug-resistant bacteria and pose a great threat to human health. These act as nosocomial pathogens and form excellent biofilms, both on biotic and abiotic surfaces, leading to severe infections and diseases. Various methods have been developed for treatment and control of Acinetobacter biofilm including photodynamic therapy, radioimmunotherapy, prophylactic vaccines and antimicrobial peptides. Nanotechnology, in the present scenario, offers a promising alternative. Nanomaterials possess unique properties, and multiple bactericidal mechanisms render them more effective than conventional drugs. This review intends to provide an overview of Acinetobacter biofilm and the significant role of various nanoparticles as anti-biofouling agents, surface-coating materials and drug-delivery vehicles for biofilm control and treatment of Acinetobacter infections.
C1 [Singh, Richa; Nadhe, Shradhda; Wadhwani, Sweety; Chopade, Balu Ananda] Savitribai Phule Pune Univ, Dept Microbiol, Pune 411007, Maharashtra, India.
   [Shedbalkar, Utkarsha] Inst Sci, Dept Biochem, Bombay 400032, Maharashtra, India.
   [Chopade, Balu Ananda] Dr Babasaheb Ambedkar Marathwada Univ, Aurangabad 431004, Maharashtra, India.
RP Chopade, BA (reprint author), Savitribai Phule Pune Univ, Dept Microbiol, Pune 411007, Maharashtra, India.; Chopade, BA (reprint author), Dr Babasaheb Ambedkar Marathwada Univ, Aurangabad 431004, Maharashtra, India.
EM richasngh316@gmail.com; nshraddha23@gmail.com;
   sweety.wadhwani123@gmail.com; utkarsha.shedbalkar@gmail.com;
   bachopade@gmail.com
OI Lekhak, Utkarsha/0000-0002-6748-5984
FU University Grants Commission, New Delhi, India
FX Richa Singh and Sweety Wadhwani thank the University Grants Commission,
   New Delhi, India for senior research fellowship.
CR Abdeen S, 2014, INT J NANO DIMENS, V5, P155, DOI 10.7508/ijnd.2014.02.008
   Alipour M, 2008, INT J PHARM, V355, P293, DOI 10.1016/j.ijpharm.2007.11.035
   Alipoura M, 2011, J PHARM PHARMACOL, V63, P999, DOI 10.1111/j.2042-7158.2011.01304.x
   Alzubaidi A.N.A., 2015, AM J BIOMED, V3, P59
   Aronson NE, 2006, CLIN INFECT DIS, V43, P1045, DOI 10.1086/507539
   Asok A, 2015, J MATER CHEM B, V3, P4597, DOI 10.1039/c5tb00407a
   Barraud N, 2015, CURR PHARM DESIGN, V21, P31, DOI 10.2174/1381612820666140905112822
   Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11
   Bentancor LV, 2012, INFECT IMMUN, V80, P651, DOI 10.1128/IAI.05653-11
   BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148
   Bindhu MR, 2014, MATER LETT, V120, P122, DOI 10.1016/j.matlet.2014.01.108
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Cady NC, 2011, ADV FUNCT MATER, V21, P2506, DOI 10.1002/adfm.201100123
   Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07
   Charnot-Katsikas A, 2009, J CLIN MICROBIOL, V47, P258, DOI 10.1128/JCM.01250-08
   Cheow WS, 2011, COLLOID SURFACE A, V389, P158, DOI 10.1016/j.colsurfa.2011.08.035
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Cochis A, 2016, BIOMATERIALS, V80, P80, DOI 10.1016/j.biomaterials.2015.11.042
   Conlon JM, 2012, J PEPT SCI, V18, P270, DOI 10.1002/psc.2397
   Conlon JM, 2012, INT J ANTIMICROB AG, V39, P317, DOI 10.1016/j.ijantimicag.2011.12.005
   Conlon JM, 2009, CHEM BIOL DRUG DES, V74, P488, DOI 10.1111/j.1747-0285.2009.00882.x
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cui Y, 2012, BIOMATERIALS, V33, P2327, DOI 10.1016/j.biomaterials.2011.11.057
   Dallo SF, 2010, ADV SKIN WOUND CARE, V23, P169, DOI 10.1097/01.ASW.0000363527.08501.a3
   Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08
   DESHPANDE LM, 1993, BIOMETALS, V6, P55
   Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100
   Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025
   Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009
   Falagas ME, 2007, EUR J CLIN MICROBIOL, V26, P857, DOI 10.1007/s10096-007-0365-6
   Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473
   Fattahian Y, 2011, MICROB PATHOGENESIS, V51, P402, DOI 10.1016/j.micpath.2011.09.004
   Feng K, 2010, J CONTROL RELEASE, V146, P363, DOI 10.1016/j.jconrel.2010.05.035
   Gaidhani S, 2013, MATER LETT, V108, P324, DOI 10.1016/j.matlet.2013.07.023
   Gaidhani SV, 2014, INDIAN J MED RES, V140, P665
   Garcia-Quintanilla M, 2013, TRENDS MICROBIOL, V21, P157, DOI 10.1016/j.tim.2012.12.002
   GHANNOUM M, 2004, MICROBIAL BIOFILMS
   Ghosh S, 2015, J NANOMED NANOTECHNO, VS6, P7
   Ghosh S, 2015, J NANOMATER, DOI 10.1155/2015/562938
   Ghosh S, 2012, INT J NANOMED, V7, P483, DOI 10.2147/IJN.S24793
   Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27
   Graves JL, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00042
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Halwani M, 2009, INT J PHARMACEUT, V373, P141, DOI 10.1016/j.ijpharm.2009.02.001
   Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a
   Hemmila MR, 2010, SURGERY, V148, P499, DOI 10.1016/j.surg.2010.01.001
   Hendiani S, 2015, NANOMED J, V2, P291, DOI 10.7508/nmj.2015.04.007
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Huang WC, 2007, NANOMEDICINE-UK, V2, P777, DOI 10.2217/17435889.2.6.777
   Huddedar SB, 2002, APPL BIOCHEM BIOTECH, V102, P21, DOI 10.1385/ABAB:102-103:1-6:021
   Hwang YY, 2013, ANTIMICROB AGENTS CH, V57, P3568, DOI 10.1128/AAC.02109-12
   Ip M, 2006, J MED MICROBIOL, V55, P59, DOI 10.1099/jmm.0.46124-0
   Jagtap S, 2010, INDIAN J EXP BIOL, V48, P936
   Jain P, 2005, BIOTECHNOL BIOENG, V90, P59, DOI 10.1002/bit.20368
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Johansson EMV, 2008, CHEM BIOL, V15, P1249, DOI 10.1016/j.chembiol.2008.10.009
   Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004
   Kitture R, 2015, J NANOSCI NANOTECHNO, V15, P4046, DOI 10.1166/jnn.2015.10323
   Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Kurkov SV, 2013, INT J PHARMACEUT, V453, P167, DOI 10.1016/j.ijpharm.2012.06.055
   Langsrud S, 2003, INT BIODETER BIODEGR, V51, P283, DOI 10.1016/S0964-8305(03)00039-8
   Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x
   Li WR, 2011, BIOMETALS, V24, P135, DOI 10.1007/s10534-010-9381-6
   Li Y, 2013, ANGEW CHEM INT EDIT, V52, P674, DOI 10.1002/anie.201206053
   Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023
   Lin NT, 2010, RES MICROBIOL, V161, P308, DOI 10.1016/j.resmic.2010.03.007
   Litzler PY, 2007, J THORAC CARDIOV SUR, V134, P1025, DOI 10.1016/j.jtcvs.2007.06.013
   Liu RH, 2015, J AM CHEM SOC, V137, P2183, DOI 10.1021/ja512567y
   Liu YC, 2013, BIOTECHNOL ADV, V31, P688, DOI 10.1016/j.biotechadv.2012.10.003
   Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07
   Lopez-Rojas R, 2011, EUR J CLIN MICROBIOL, V30, P1391, DOI 10.1007/s10096-011-1233-y
   Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446
   Mahmoudi M, 2012, ACS NANO, V6, P2656, DOI 10.1021/nn300042m
   Mallick A, 2015, ACS APPL MATER INTER, V7, P7584, DOI 10.1021/am5090226
   Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538
   Martinez-Gutierrez F, 2013, BIOFOULING, V29, P651, DOI 10.1080/08927014.2013.794225
   Mihu MR, 2010, VIRULENCE, V1, P62, DOI 10.4161/viru.1.2.10038
   Milenkovic J, 2014, BIOFOULING, V30, P965, DOI 10.1080/08927014.2014.959941
   Montagu A., 2014, J NANOMED NANOTECHNO, V5, P3
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007
   Pallavicini P, 2010, J COLLOID INTERF SCI, V350, P110, DOI 10.1016/j.jcis.2010.06.019
   Patel MR, 2011, PHARM DEV TECHNOL, V16, P250, DOI 10.3109/10837451003610845
   Patil JR, 2001, NATL MED J INDIA, V14, P204
   Patil JR, 2001, INDIAN J MED MICROBI, V19, P30
   Patwardhan RB, 2008, INDIAN J MED RES, V128, P178
   Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]
   Peng LL, 2011, CHEM COMMUN, V47, P4896, DOI 10.1039/c1cc10691k
   Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837
   Pour NK, 2011, FEMS IMMUNOL MED MIC, V62, P328, DOI 10.1111/j.1574-695X.2011.00818.x
   Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10
   Ragas X, 2010, LASER SURG MED, V42, P384, DOI 10.1002/lsm.20922
   Ramalingam K, 2012, ARCH ORAL BIOL, V57, P15, DOI 10.1016/j.archoralbio.2011.07.001
   Ramya S, 2015, J TRACE ELEM MED BIO, V32, P30, DOI 10.1016/j.jtemb.2015.05.005
   Rana S, 2012, ADV DRUG DELIVER REV, V64, P200, DOI 10.1016/j.addr.2011.08.006
   Rokhbakhsh-Zamin F, 2011, J MICROBIOL BIOTECHN, V21, P556, DOI 10.4014/jmb.1012.12006
   Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12
   Rukholm G, 2006, INT J ANTIMICROB AG, V27, P247, DOI 10.1016/j.ijantimicag.2005.10.021
   Russell AD, 2003, J ANTIMICROB CHEMOTH, V52, P750, DOI 10.1093/jac/dkg422
   Sachdev D, 2010, MICROBIOL RES, V165, P627, DOI 10.1016/j.micres.2009.12.002
   Saha SC, 2002, J FOOD SCI TECH MYS, V39, P26
   Saha SC, 2001, J FOOD SCI TECH MYS, V38, P17
   Sahu P. K., 2014, SCI WORLD J, V2014
   Sahu PK, 2012, INT J MICROBIOL, V2012
   Sahu PK, 2012, SCI WORLD J, P1, DOI 10.1100/2012/973436
   Salunke GR, 2014, INT J NANOMED, V9, P2635, DOI 10.2147/IJN.S59834
   Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513
   Shakibaie M. R., 2003, Iranian Journal of Biotechnology, V1, P41
   Sharma A, 1997, INT J PHARM, V154, P123, DOI 10.1016/S0378-5173(97)00135-X
   Shedbalkar U, 2014, ADV COLLOID INTERFAC, V209, P40, DOI 10.1016/j.cis.2013.12.011
   Si XR, 2014, WATER RES, V54, P247, DOI 10.1016/j.watres.2014.02.007
   Singh R, 2016, INT J NANOMED, V11, DOI 10.2147/IJN.S102488
   Singh R, 2015, INT J ANTIMICROB AG, V46, P183, DOI 10.1016/j.ijantimicag.2015.03.014
   Singh R, 2015, APPL MICROBIOL BIOT, V99, P4579, DOI 10.1007/s00253-015-6622-1
   Singh R, 2013, INT J NANOMED, V8, P4277, DOI 10.2147/IJN.S48913
   Terry J, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-1
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thawal ND, 2012, CURR MICROBIOL, V65, P66, DOI 10.1007/s00284-012-0127-2
   Tien HC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-95
   Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0
   Uppu DSSM, 2016, BIOMATERIALS, V74, P131, DOI 10.1016/j.biomaterials.2015.09.042
   Vigderman L, 2013, ADV DRUG DELIVER REV, V65, P663, DOI 10.1016/j.addr.2012.05.004
   Visca P, 2011, IUBMB LIFE, V63, P1048, DOI 10.1002/iub.534
   Wadhwani SA, 2016, APPL MICROBIOL BIOT, V100, P2555, DOI 10.1007/s00253-016-7300-7
   Wadhwani SA, 2014, WORLD J MICROB BIOT, V30, P2723, DOI 10.1007/s11274-014-1696-y
   Wang XF, 2012, VET J, V191, P115, DOI [10.1016/j.tvjl.2010.11.019, 10.1016/j.tvj1.2010.11.019]
   Wong HS, 2010, J APPL MICROBIOL, V108, P2222, DOI 10.1111/j.1365-2672.2009.04630.x
   Xu HJ, 2011, J MEMBRANE SCI, V376, P266, DOI 10.1016/j.memsci.2011.04.030
   Yavankar S P, 2007, Indian J Med Microbiol, V25, P336
   Yele AB, 2012, ARCH VIROL, V157, P1441, DOI 10.1007/s00705-012-1320-0
   Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19
NR 136
TC 3
Z9 3
U1 1
U2 50
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 383
DI 10.3390/ma9050383
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500078
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Latino, L
   Midoux, C
   Hauck, Y
   Vergnaud, G
   Pourcel, C
AF Latino, Libera
   Midoux, Cedric
   Hauck, Yolande
   Vergnaud, Gilles
   Pourcel, Christine
TI Pseudolysogeny and sequential mutations build multiresistance to
   virulent bacteriophages in Pseudomonas aeruginosa
SO MICROBIOLOGY-SGM
LA English
DT Article
ID CYSTIC-FIBROSIS PATIENTS; O-ANTIGEN BIOSYNTHESIS; ESCHERICHIA-COLI;
   POLYACRYLAMIDE-GELS; BIOFILM DEVELOPMENT; BACTERIAL PATHOGEN; GENOME
   SEQUENCE; TYPE-4 PILUS; GENE; LIPOPOLYSACCHARIDE
AB Coevolution between bacteriophages (phages) and their prey is the result of mutualistic interactions. Here, we show that pseudolysogeny is a frequent outcome of infection by virulent phages of Pseudomonas aeruginosa and that selection of resistant bacterial mutants is favoured by continuous production of phages. We investigated the frequency and characteristics of P. aeruginosa strain PAO1 variants resisting infection by different combinations of virulent phages belonging to four genera. The frequency of resistant bacteria was 10(-5) for single phage infection and 10(-6) for infections with combinations of two or four phages. The genome of 27 variants was sequenced and the comparison with the genome of the parental PAO1 strain allowed the identification of point mutations or small indels. Four additional variants were characterized by a candidate gene approach. In total, 27 independent mutations were observed affecting 14 genes and a regulatory region. The mutations affected genes involved in biosynthesis of type IV pilus, alginate, LPS and O-antigen. Half of the variants possessed changes in homopolymer tracts responsible for frameshift mutations and these phase variation mutants were shown to be unstable. Eleven double mutants were detected. The presence of free phage DNA was observed in association with exclusion of superinfection in half of the variants and no chromosomal mutation could be found in three of them. Upon further growth of these pseudolysogens, some variants with new chromosomal mutations were recovered, presumably due to continuous evolutionary pressure.
C1 [Latino, Libera; Midoux, Cedric; Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] Univ Paris 11, Univ Paris Saclay, Inst Integrat Biol Cell, CEA,CNRS, F-91198 Gif Sur Yvette, France.
RP Pourcel, C (reprint author), Univ Paris 11, Univ Paris Saclay, Inst Integrat Biol Cell, CEA,CNRS, F-91198 Gif Sur Yvette, France.
EM christine.pourcel@u-psud.fr
RI Vergnaud, Gilles/P-1304-2015; Pourcel, Christine/E-4949-2017
OI Vergnaud, Gilles/0000-0003-0913-194X; Pourcel,
   Christine/0000-0002-8951-466X
FU Direction Generale de l'Armement through Agence Nationale de la
   Recherche (France) [ANR-13-ASTRID-0011-01]; Direction Generale de
   l'Armement; IDEX; Paris-Saclay University
FX The research was funded by a grant from Direction Generale de l'Armement
   through Agence Nationale de la Recherche (France) 'Resisphage'
   ANR-13-ASTRID-0011-01. L. L. was the recipient of a doctoral fellowship
   from Direction Generale de l'Armement and IDEX, Paris-Saclay University.
   We are grateful to Michael DuBow for fruitful discussions and valuable
   criticism of the manuscript. We thank Hoang Vu-Thien for his advice as
   well as Marie-Agnes Petit for her helpful suggestions. We thank Simone
   Seror and Barry Holland for their expert advice in the study of
   swarming. We are very grateful to the anonymous reviewers for their
   comments which helped improve the manuscript. We thank the
   LPS-BioSciences staff for help in analysing LPS. This work has benefited
   from facilities and expertise of the high-throughput sequencing platform
   of I2BC.
CR Abedon ST, 2011, BACTERIOPHAGE, V1, P1, DOI DOI 10.4161/BACT.1.1.13980
   Augustin DK, 2007, J BACTERIOL, V189, P2203, DOI 10.1128/JB.01839-06
   BAESS I, 1971, ACTA PATHOLOG MICROB, VB 79, P428
   Betts A, 2014, P NATL ACAD SCI USA, V111, P11109, DOI 10.1073/pnas.1406763111
   BODE WERNER, 1967, J VIROL, V1, P948
   Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086
   Bucior I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002616
   Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945
   Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134
   Chaturongakul S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00442
   Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003
   Chibeu A, 2009, FEMS MICROBIOL LETT, V296, P210, DOI 10.1111/j.1574-6968.2009.01640.x
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   de Siqueira RS, 2006, INT J FOOD MICROBIOL, V111, P259, DOI 10.1016/j.ijfoodmicro.2006.04.047
   DEMEREC M, 1945, GENETICS, V30, P119
   Dennehy John J, 2012, Int J Evol Biol, V2012, P396165, DOI 10.1155/2012/396165
   Essoh C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130548
   Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575
   FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627
   Hahn HP, 1997, GENE, V192, P99, DOI 10.1016/S0378-1119(97)00116-9
   Hansen SK, 2007, J BACTERIOL, V189, P4932, DOI 10.1128/JB.00041-07
   HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269
   Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13
   Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P2862, DOI 10.1128/AEM.03817-12
   Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1
   Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595
   Islam ST, 2013, SCI REP-UK, V3, DOI 10.1038/srep03441
   Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108
   King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436
   Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x
   Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Lam JS, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00118
   Latino L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093777
   Le S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04738
   Leon M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00343
   Liebens V, 2014, PATHOG DIS, V71, P39, DOI 10.1111/2049-632X.12174
   Log M., 2003, RES MICROBIOL, V154, P547
   Los M, 2012, ADV VIRUS RES, V82, P339, DOI 10.1016/B978-0-12-394621-8.00019-4
   LU MJ, 1989, J VIROL, V63, P3472
   Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4
   MAILLOU J, 1990, VIROLOGY, V175, P500, DOI 10.1016/0042-6822(90)90434-S
   Maura D., 2012, BACTERIOPHAGE, V2, P229
   Maura D, 2012, ANTIMICROB AGENTS CH, V56, P6235, DOI 10.1128/AAC.00602-12
   Murphy K, 2014, J BACTERIOL, V196, P1306, DOI 10.1128/JB.01463-13
   O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x
   Olszak T, 2015, APPL MICROBIOL BIOT, V99, P6021, DOI 10.1007/s00253-015-6492-6
   Olvera C, 1999, FEMS MICROBIOL LETT, V179, P85, DOI 10.1016/S0378-1097(99)00381-X
   Poon KKH, 2008, J BACTERIOL, V190, P1857, DOI 10.1128/JB.01546-07
   Pulcrano G, 2012, NEW MICROBIOL, V35, P295
   Ripp S, 1997, MICROBIOL-UK, V143, P2065, DOI 10.1099/00221287-143-6-2065
   Ripp S, 1998, MICROBIOL-UK, V144, P2225, DOI 10.1099/00221287-144-8-2225
   Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523
   Scanlan PD, 2015, MOL BIOL EVOL, V32, P1425, DOI 10.1093/molbev/msv032
   Segura A, 2004, J BACTERIOL, V186, P1905, DOI 10.1128/JB.186.6.1905-1909.2004
   Siringan P, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130200
   Sistrom M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144514
   Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003
   Stover CK, 2000, NATURE, V406, P959
   Taylor VL, 2013, J BACTERIOL, V195, P4735, DOI 10.1128/JB.00903-13
   Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07
   WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2
   Williams HTP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-17
   Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000
   ZIERDT CH, 1964, J BACTERIOL, V87, P1003
NR 65
TC 9
Z9 9
U1 0
U2 10
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
EI 1465-2080
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD MAY
PY 2016
VL 162
BP 748
EP 763
DI 10.1099/mic.0.000263
PN 5
PG 16
WC Microbiology
SC Microbiology
GA DN5YX
UT WOS:000377148700004
PM 26921273
OA Green Published, Bronze
DA 2019-02-28
ER

PT J
AU Castillo, D
   Christiansen, RH
   Dalsgaard, I
   Madsen, L
   Espejo, R
   Middelboe, M
AF Castillo, Daniel
   Christiansen, Roi Hammershaimb
   Dalsgaard, Inger
   Madsen, Lone
   Espejo, Romilio
   Middelboe, Mathias
TI Comparative Genome Analysis Provides Insights into the Pathogenicity of
   Flavobacterium psychrophilum
SO PLOS ONE
LA English
DT Article
ID ANTIBIOTIC-RESISTANCE GENES; TROUT ONCORHYNCHUS-MYKISS; VIRULENCE
   FACTORS; RAINBOW-TROUT; POPULATION-STRUCTURE; ESCHERICHIA-COLI; GLIDING
   MOTILITY; PAN-GENOME; FISH; SEQUENCE
AB Flavobacterium psychrophilum is a fish pathogen in salmonid aquaculture worldwide that causes cold water disease (CWD) and rainbow trout fry syndrome (RTFS). Comparative genome analyses of 11 F. psychrophilum isolates representing temporally and geographically distant populations were used to describe the F. psychrophilum pan-genome and to examine virulence factors, prophages, CRISPR arrays, and genomic islands present in the genomes. Analysis of the genomic DNA sequences were complemented with selected phenotypic characteristics of the strains. The pan genome analysis showed that F. psychrophilum could hold at least 3373 genes, while the core genome contained 1743 genes. On average, 67 new genes were detected for every new genome added to the analysis, indicating that F. psychrophilum possesses an open pan genome. The putative virulence factors were equally distributed among isolates, independent of geographic location, year of isolation and source of isolates. Only one prophage-related sequence was found which corresponded to the previously described prophage 6H, and appeared in 5 out of 11 isolates. CRISPR array analysis revealed two different loci with dissimilar spacer content, which only matched one sequence in the database, the temperate bacteriophage 6H. Genomic Islands (GIs) were identified in F. psychrophilum isolates 950106-1/1 and CSF 259-93, associated with toxins and antibiotic resistance. Finally, phenotypic characterization revealed a high degree of similarity among the strains with respect to biofilm formation and secretion of extracellular enzymes. Global scale dispersion of virulence factors in the genomes and the abilities for biofilm formation, hemolytic activity and secretion of extracellular enzymes among the strains suggested that F. psychrophilum isolates have a similar mode of action on adhesion, colonization and destruction of fish tissues across large spatial and temporal scales of occurrence. Overall, the genomic characterization and phenotypic properties may provide new insights to the mechanisms of pathogenicity in F. psychrophilum.
C1 [Castillo, Daniel; Christiansen, Roi Hammershaimb; Middelboe, Mathias] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark.
   [Christiansen, Roi Hammershaimb; Dalsgaard, Inger; Madsen, Lone] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark.
   [Espejo, Romilio] Univ Chile, Ctr Nacl Genom & Bioinformat, Santiago, Chile.
   [Espejo, Romilio] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Chile.
RP Middelboe, M (reprint author), Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark.
EM mmiddelboe@bio.ku.dk
RI Middelboe, Mathias/B-9995-2009
OI Middelboe, Mathias/0000-0002-9587-9171
FU Danish Directorate for Food, Fisheries and Agri Business
   [3414-09-02613]; Danish Strategic Research Council (ProAqua)
   [09-072829]; EU-IRSES (AQUAPHAGE) [69175]; EU-IRSES
FX This work was supported by The Danish Directorate for Food, Fisheries
   and Agri Business, grant # 3414-09-02613; The Danish Strategic Research
   Council (ProAqua, grant # 09-072829); and EU-IRSES (AQUAPHAGE, grant #
   69175). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; This
   work was supported by a grant from The Danish Directorate for Food,
   Fisheries and Agri Business, The Danish Strategic Research Council
   (ProAqua, project # 09-072829) and by the EU-IRSES-funded project
   AQUAPHAGE.
CR Arai H, 2007, J FISH DIS, V30, P345, DOI 10.1111/j.1365-2761.2007.00809.x
   Avendano-Herrera R, 2014, VET MICROBIOL, V170, P298, DOI 10.1016/j.vetmic.2014.02.009
   Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0
   BERNARDET JF, 1989, APPL ENVIRON MICROB, V55, P1796
   Bertolini J. M., 1994, Journal of Aquatic Animal Health, V6, P224, DOI 10.1577/1548-8667(1994)006<0224:EDOPFS>2.3.CO;2
   Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154
   Bloomfield GA, 1997, MICROBIOL-UK, V143, P553, DOI 10.1099/00221287-143-2-553
   Bruno D. W., 1992, Bulletin of the European Association of Fish Pathologists, V12, P215
   Bruun MS, 2000, AQUACULTURE, V187, P201, DOI 10.1016/S0044-8486(00)00310-0
   Bustos P. A., 1995, Bulletin of the European Association of Fish Pathologists, V15, P162
   Castillo D, 2012, J FISH DIS, V35, P193, DOI 10.1111/j.1365-2761.2011.01336.x
   Castillo D, 2015, APPL ENVIRON MICROB, V81, P1157, DOI 10.1128/AEM.03699-14
   Castillo D, 2014, MICROB ECOL, V67, P748, DOI 10.1007/s00248-014-0375-8
   Castillo D, 2014, FEMS MICROBIOL LETT, V351, P51, DOI 10.1111/1574-6968.12342
   Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123
   Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704
   Drummond AJ, 2010, GENEIOUS V7 1 4
   Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313
   Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729
   Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732
   Fredriksen BN, 2013, VACCINE, V31, P1994, DOI 10.1016/j.vaccine.2013.01.016
   Fujiwara-Nagata E, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-34
   Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hesami S, 2011, APPL ENVIRON MICROB, V77, P1593, DOI 10.1128/AEM.01717-10
   Hogfors-Ronnholm E, 2010, MICROB PATHOGENESIS, V49, P369, DOI 10.1016/j.micpath.2010.08.002
   Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004
   Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13
   Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005
   Kondo M, 2002, MICROBES INFECT, V4, P279, DOI 10.1016/S1286-4579(02)01539-3
   Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024
   Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157
   Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x
   Lorenzen E., 1991, Bulletin of the European Association of Fish Pathologists, V11, P77
   Madsen L, 2000, J FISH DIS, V23, P211, DOI 10.1046/j.1365-2761.2000.00240.x
   Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869
   Mann RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055644
   McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12
   Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x
   Nicolas P, 2008, APPL ENVIRON MICROB, V74, P3702, DOI 10.1128/AEM.00244-08
   Nilsen H, 2014, APPL ENVIRON MICROB, V80, P2728, DOI 10.1128/AEM.04233-13
   Ostland VE, 2000, J FISH DIS, V23, P329, DOI 10.1046/j.1365-2761.2000.00251.x
   Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08
   Sampson TR, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00037
   Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107
   Soares SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030848
   Soule M, 2005, DIS AQUAT ORGAN, V65, P209, DOI 10.3354/dao065209
   Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08
   Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315
   Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529
   Tatusova T, 2013, PROKARYOTIC GENOME A
   Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102
   Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006
   Tomida S, 2008, MBIO, V4
   Toranzo A.E., 1993, Bulletin of the European Association of Fish Pathologists, V13, P30
   Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11
   Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93
   WAKABAYASHI H, 1991, Fish Pathology, V26, P211
   Whittle G, 2002, CELL MOL LIFE SCI, V59, P2044, DOI 10.1007/s000180200004
   Wiens Gregory D, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00889-14
   Wiklund T., 1994, Bulletin of the European Association of Fish Pathologists, V14, P44
   Wu AKK, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-3
   Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023
   Yoon SH, 2015, NUCLEIC ACIDS RES, V43, pD624, DOI 10.1093/nar/gku985
   Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08
   Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791
   Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485
NR 69
TC 12
Z9 12
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 12
PY 2016
VL 11
IS 4
AR e0152515
DI 10.1371/journal.pone.0152515
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ0NI
UT WOS:000373900700010
PM 27071075
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Motlagh, AM
   Bhattacharjee, AS
   Goel, R
AF Motlagh, Amir Mohaghegh
   Bhattacharjee, Ananda Shankar
   Goel, Ramesh
TI Biofilm control with natural and genetically-modified phages
SO WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
LA English
DT Review
DE Biofilm; Phage therapy; Genetically-modified phage; Membrane biofouling;
   Engineered phage; CRISPR
ID WASTE-WATER TREATMENT; EXTRACELLULAR POLYMERIC SUBSTANCES;
   ESCHERICHIA-COLI BIOFILMS; STREPTOMYCIN-TREATED MICE; BACTERIOPHAGE
   THERAPY; BACTERIAL BIOFILMS; LISTERIA-MONOCYTOGENES; ACTIVATED-SLUDGE;
   ULTRAFILTRATION MEMBRANES; PSEUDOMONAS-FLUORESCENS
AB Bacteriophages, as the most dominant and diverse entities in the universe, have the potential to be one of the most promising therapeutic agents. The emergence of multidrug-resistant bacteria and the antibiotic crisis in the last few decades have resulted in a renewed interest in phage therapy. Furthermore, bacteriophages, with the capacity to rapidly infect and overcome bacterial resistance, have demonstrated a sustainable approach against bacterial pathogens-particularly in biofilm. Biofilm, as complex microbial communities located at interphases embedded in a matrix of bacterial extracellular polysaccharide substances (EPS), is involved in health issues such as infections associated with the use of biomaterials and chronic infections by multidrug resistant bacteria, as well as industrial issues such as biofilm formation on stainless steel surfaces in food industry and membrane biofouling in water and wastewater treatment processes. In this paper, the most recent studies on the potential of phage therapy using natural and genetically-modified lytic phages and their associated enzymes in fighting biofilm development in various fields including engineering, industry, and medical applications are reviewed. Phage-mediated prevention approaches as an indirect phage therapy strategy are also explored in this review. In addition, the limitations of these approaches and suggestions to overcome these constraints are discussed to enhance the efficiency of phage therapy process. Finally, future perspectives and directions for further research towards a better understanding of phage therapy to control biofilm are recommended.
C1 [Motlagh, Amir Mohaghegh; Bhattacharjee, Ananda Shankar; Goel, Ramesh] Univ Utah, Dept Civil & Environm Engn, 110 S Cent Campus Dr, Salt Lake City, UT 84112 USA.
RP Goel, R (reprint author), Univ Utah, Dept Civil & Environm Engn, 110 S Cent Campus Dr, Salt Lake City, UT 84112 USA.
EM ram.goel@utah.edu
OI Bhattacharjee, Ananda/0000-0002-4326-1230
FU National Science Foundation [1055786]
FX We greatly appreciate the time reviewers have spent on this manuscript
   to provide their useful comments. This research was partially supported
   by National Science Foundation Grant #1055786. The views and rationale
   expressed in this manuscript are those of the authors and do not
   necessarily represent the funding agency.
CR Abedon Stephen T, 2011, Bacteriophage, V1, P66
   Abuladze T, 2008, APPL ENVIRON MICROB, V74, P6230, DOI 10.1128/AEM.01465-08
   Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2
   Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604
   Bales PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067950
   Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8
   Bender KO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9103
   Bhattacharjee AS, 2015, BIOTECHNOL BIOENG, V112, P1644, DOI 10.1002/bit.25574
   Born Y, 2014, ENVIRON MICROBIOL, V16, P2168, DOI 10.1111/1462-2920.12212
   Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402
   Brabban AD, 2005, FOODBORNE PATHOG DIS, V2, P287, DOI 10.1089/fpd.2005.2.287
   Briandet R, 2008, APPL ENVIRON MICROB, V74, P2135, DOI 10.1128/AEM.02304-07
   Brockhurst MA, 2006, J EVOLUTION BIOL, V19, P374, DOI 10.1111/j.1420-9101.2005.01026.x
   Bura R, 1998, WATER SCI TECHNOL, V37, P325, DOI 10.1016/S0273-1223(98)00125-5
   Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]
   Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x
   Chaitiemwong N, 2014, J FOOD PROTECT, V77, P2012, DOI 10.4315/0362-028X.JFP-14-151
   Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/fmb.13.47, 10.2217/FMB.13.47]
   Chan BK, 2012, ADV APPL MICROBIOL, V78, P1, DOI 10.1016/B978-0-12-394805-2.00001-4
   Chibani-Chennoufi S, 2004, ANTIMICROB AGENTS CH, V48, P2558, DOI 10.1128/AAC.48.7.2558-2569.2004
   Chibeu A, 2012, VIRUSES-BASEL, V4, P471, DOI 10.3390/v4040471
   Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799
   Corbin BD, 2001, CAN J MICROBIOL, V47, P680, DOI 10.1139/cjm-47-7-680
   Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Curtin JJ, 2006, ANTIMICROB AGENTS CH, V50, P1268, DOI 10.1128/AAC.50.4.1268-1275.2006
   Dabrowska K, 2005, J APPL MICROBIOL, V98, P7, DOI 10.1111/j.1365-2672.2004.02422.x
   Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002
   Doolittle MM, 1996, J IND MICROBIOL, V16, P331, DOI 10.1007/BF01570111
   Drulis-Kawa Z, 2012, CURR PROTEIN PEPT SC, V13, P699, DOI 10.2174/138920312804871193
   Edgar R, 2012, APPL ENVIRON MICROB, V78, P744, DOI 10.1128/AEM.05741-11
   Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014
   Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x
   Goldman G, 2009, J MEMBRANE SCI, V342, P145, DOI 10.1016/j.memsci.2009.06.036
   Goodridge LD, 2010, CURR PHARM BIOTECHNO, V11, P15, DOI 10.2174/138920110790725348
   Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698
   Guttman B, 2004, BACTERIOPHAGES BIOL, P30
   Hagens S, 2004, ANTIMICROB AGENTS CH, V48, P3817, DOI 10.1128/ACC.48.10.3817-3822.2004
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.02.006
   Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001
   Harper DR, 2014, ANTIBIOTICS-BASEL, V3, P270, DOI 10.3390/antibiotics3030270
   Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002
   Herzberg M, 2009, ENVIRON SCI TECHNOL, V43, P4393, DOI 10.1021/es900087j
   Hibma AM, 1997, INT J FOOD MICROBIOL, V34, P197, DOI 10.1016/S0168-1605(96)01190-7
   Kiro R, 2014, RNA BIOL, V11, P42, DOI 10.4161/rna.27766
   Kocharunchitt C, 2009, INT J FOOD MICROBIOL, V128, P453, DOI 10.1016/j.ijfoodmicro.2008.10.014
   Koskella B, 2013, VIRUSES-BASEL, V5, P806, DOI 10.3390/v5030806
   KROGFELT KA, 1993, INFECT IMMUN, V61, P5029
   Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Lajoie CA, 2000, WATER ENVIRON RES, V72, P56, DOI 10.2175/106143000X137112
   Le-Clech P, 2006, J MEMBRANE SCI, V284, P17, DOI 10.1016/j.memsci.2006.08.019
   Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022
   Letarov AV, 2010, ACTA NATURAE, V2, P60
   Lidmar J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.051910
   Lin TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030954
   Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467
   Lodish H., 2000, MOL CELL BIOL
   Loiselle M, 2003, BIOFOULING, V19, P77, DOI 10.1080/0892701021000030142
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106
   Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x
   Maiques E, 2007, J BACTERIOL, V189, P5608, DOI 10.1128/JB.00619-07
   Matsuda T, 2005, SURGERY, V137, P639, DOI 10.1016/j.surg.2005.02.012
   Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111
   Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188
   Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333
   Motlagh AM, 2014, WATER RECLAMATION SU, P391
   Motlagh AM, 2015, WATER RES, V81, P1, DOI 10.1016/j.watres.2015.04.023
   Motlagh AM, 2013, DESALINATION, V316, P85, DOI 10.1016/j.desal.2013.02.001
   Musk DJ, 2006, CURR MED CHEM, V13, P2163, DOI 10.2174/092986706777935212
   Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4
   Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006
   O'Shea YA, 2002, FEMS MICROBIOL LETT, V214, P153, DOI 10.1016/S0378-1097(02)00880-7
   Orlova E. V., 2012, BACTERIOPHAGES, DOI DOI 10.5772/34642
   Percival SL, 2012, WOUND REPAIR REGEN, V20, P647, DOI 10.1111/j.1524-475X.2012.00836.x
   POULSEN LK, 1995, J BACTERIOL, V177, P5840, DOI 10.1128/jb.177.20.5840-5845.1995
   Rapson ME, 2003, Patent, Patent No. [WO03080823, 03080823]
   Ryan EM, 2012, FEMS IMMUNOL MED MIC, V65, P395, DOI 10.1111/j.1574-695X.2012.00977.x
   SANIN FD, 1994, WATER SCI TECHNOL, V30, P117
   Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/FMB.12.97, 10.2217/fmb.12.97]
   Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005
   Sidhu SS, 2001, BIOMOL ENG, V18, P57, DOI 10.1016/S1389-0344(01)00087-9
   Sillankorva S, 2004, BIOFOULING, V20, P133, DOI 10.1080/08927010410001723834
   Sillankorva S, 2010, BIOFOULING, V26, P567, DOI 10.1080/08927014.2010.494251
   Soni KA, 2010, J FOOD PROTECT, V73, P1519, DOI 10.4315/0362-028X-73.8.1519
   Srey S, 2013, FOOD CONTROL, V31, P572, DOI 10.1016/j.foodcont.2012.12.001
   Sulakvelidze A, 2011, BACTERIOPHAGE, V1, P1, DOI [10.4161/bact.1.1.15030, DOI 10.4161/BACT.1.1.15030]
   Taylor EN, 2009, INT J NANOMED, V4, P145
   Vitiello CL, 2005, VIRUS RES, V114, P101, DOI 10.1016/j.virusres.2005.05.014
   Westwater C, 2003, ANTIMICROB AGENTS CH, V47, P1301, DOI 10.1128/AAC.47.4.1301-1307.2003
   Withey S, 2005, SCI TOTAL ENVIRON, V339, P1, DOI 10.1016/j.scitotenv.2004.09.021
   Wittebole X, 2014, VIRULENCE, V5, P226, DOI 10.4161/viru.25991
   Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65
   Xiong YH, 2010, APPL MICROBIOL BIOT, V86, P825, DOI 10.1007/s00253-010-2463-0
   Yan JL, 2014, BIODRUGS, V28, P265, DOI 10.1007/s40259-013-0081-y
   Yoichi M, 2005, J BIOTECHNOL, V115, P101, DOI 10.1016/j.jbiotec.2004.08.003
   Yosef I, 2015, P NATL ACAD SCI
   Zaky A, 2012, DESALINATION, V286, P296, DOI 10.1016/j.desal.2011.11.040
NR 102
TC 17
Z9 21
U1 4
U2 135
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0959-3993
EI 1573-0972
J9 WORLD J MICROB BIOT
JI World J. Microbiol. Biotechnol.
PD APR
PY 2016
VL 32
IS 4
AR 67
DI 10.1007/s11274-016-2009-4
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DI7QY
UT WOS:000373698000015
PM 26931607
DA 2019-02-28
ER

PT J
AU Khan, MSA
   Lee, J
AF Khan, Mohd S. A.
   Lee, Jintae
TI Novel Strategies for Combating Pathogenic Biofilms Using Plant Products
   and Microbial Antibiosis
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Article
DE Biofilms; natural products; pathogenicity; phage therapy; quorum
   sensing; small molecules
ID QUORUM-SENSING INHIBITORS; RESISTANT STAPHYLOCOCCUS-AUREUS;
   PSEUDOMONAS-AERUGINOSA BIOFILM; CANDIDA-ALBICANS BIOFILMS;
   ESCHERICHIA-COLI O157H7; ENTERICA SEROVAR TYPHIMURIUM; VIRULENCE FACTORS
   PRODUCTION; SMALL-MOLECULE INHIBITORS; MULTIDRUG EFFLUX PUMPS; IN-VITRO
   ACTIVITY
AB Microorganisms prefer to live in three-dimensional self-organized communities (biofilms), and this behavior provides microbial pathogens inhabiting various sites in the human body or on medical devices with survival advantages. In fact, pathogens in the biofilm stage exhibit up to a thousandfold more tolerance to conventional antimicrobial agents, and thus, they are difficult to eradicate and biofilms generated during acute infections become persistent, chronic, and recurrent. Consequently, novel strategies are being sought to control biofilm associated infections. The developmental strategies used include improved drug delivery and the penetration of biofilm matrices, and in particular, natural products that interfere with virulence and cross talk between microbial cells are being investigated as potential anti-biofilm agents. This article provides an overview of existing and promising biofilm control strategies based on plant and microbial products. Control strategies like quorum sensing inhibition, microbial antibiosis, and the uses of phages and probiotics are reviewed along with current developments in high throughput screening and in our understanding of structure activity relationships related to the regulation of biofilms by small molecules.
C1 [Khan, Mohd S. A.; Lee, Jintae] Yeungnam Univ, Sch Chem Engn, Gyongsan 712749, South Korea.
RP Lee, J (reprint author), Yeungnam Univ, Sch Chem Engn, Gyongsan 712749, South Korea.
EM jtlee@ynu.ac.kr
FU Priority Research Center Program through the Korean National Research
   Foundation (NRF) - Ministry of Education [2014R1A6A1031189]
FX This work was supported by the Priority Research Center Program through
   the Korean National Research Foundation (NRF) funded by the Ministry of
   Education (Grant no. 2014R1A6A1031189).
CR Abraham SVPI, 2011, ARCH MED RES, V42, P658, DOI 10.1016/j.arcmed.2011.12.002
   Adonizio A, 2008, ANTIMICROB AGENTS CH, V52, P198, DOI 10.1128/AAC.00612-07
   Agarwal V, 2008, MYCOPATHOLOGIA, V165, P13, DOI 10.1007/s11046-007-9077-9
   Al-Fattani MA, 2004, ANTIMICROB AGENTS CH, V48, P3291, DOI 10.1128/AAC.48.9.3291-3297.2004
   Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12
   Alvarez MV, 2012, J FOOD SAFETY, V32, P379, DOI 10.1111/j.1745-4565.2012.00390.x
   Ammons MC, 2013, BIOFOULING, V29, P443, DOI 10.1080/08927014.2013.773317
   Bandara HMHN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-125
   Bauer WD, 2002, CURR OPIN BIOTECH, V13, P234, DOI 10.1016/S0958-1669(02)00310-5
   Bjarnsholt T, 2007, PHILOS T R SOC B, V362, P1213, DOI 10.1098/rstb.2007.2046
   Bordi C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-19
   Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004
   Brackman G, 2009, MICROBIOL-SGM, V155, P4114, DOI 10.1099/mic.0.032474-0
   Brussow H, 2012, MBIO, V3, DOI 10.1128/mBio.00061-12
   Burt SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093414
   Cameotra SS, 2004, CURR OPIN MICROBIOL, V7, P262, DOI 10.1016/j.mib.2004.04.006
   Cerca N, 2006, INFECT IMMUN, V74, P4849, DOI 10.1128/IAI.00230-06
   Chen F, 2013, INT J MOL SCI, V14, P17477, DOI 10.3390/ijms140917477
   Cho HS, 2013, J AGR FOOD CHEM, V61, P7120, DOI 10.1021/jf4009313
   Chow J.Y., 2013, ANTI AGENTS CHEMOTHE, V58, P1802
   Chung PY, 2014, PATHOG DIS, V70, P231, DOI 10.1111/2049-632X.12141
   Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597
   Cuadra-Saenz G, 2012, MICROBIOL-SGM, V158, P1783, DOI 10.1099/mic.0.057182-0
   Dalleau S, 2008, INT J ANTIMICROB AG, V31, P572, DOI 10.1016/j.ijantimicag.2008.01.028
   Damte D., 2013, J MICROBBIOCHEM TECH, V5, P42
   Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003
   Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08
   De Kievit TR, 2001, ANTIMICROB AGENTS CH, V45, P1761, DOI 10.1128/AAC.45.6.1761-1770.2001
   deBeer D, 1997, BIOTECHNOL BIOENG, V53, P151, DOI 10.1002/(SICI)1097-0290(19970120)53:2<151::AID-BIT4>3.0.CO;2-N
   Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47
   Dheilly A, 2010, APPL ENVIRON MICROB, V76, P3452, DOI 10.1128/AEM.02632-09
   Ding X, 2011, J MED MICROBIOL, V60, P1827, DOI 10.1099/jmm.0.024166-0
   Dobrogosz WJ, 2010, ADV APPL MICROBIOL, V72, P1, DOI 10.1016/S0065-2164(10)72001-3
   Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897
   Dongari-Bagtzoglou A, 2008, EXPERT REV ANTI-INFE, V6, P201, DOI 10.1586/14787210.6.2.201
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   DOOLITTLE MM, 1995, CAN J MICROBIOL, V41, P12, DOI 10.1139/m95-002
   Douglas L. Julia, 2002, Revista Iberoamericana de Micologia, V19, P139
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Dusane Devendra H, 2012, Aquat Biosyst, V8, P17
   Dusane DH, 2010, COLLOID SURFACE B, V81, P242, DOI 10.1016/j.colsurfb.2010.07.013
   Dwidar M, 2012, BIOFOULING, V28, P671, DOI 10.1080/08927014.2012.701286
   Dworjanyn SA, 2006, MAR ECOL PROG SER, V318, P153, DOI 10.3354/meps318153
   Fatima Q, 2010, INDIAN J MICROBIOL, V50, P238, DOI 10.1007/s12088-010-0025-x
   Fenton M., 2013, INT J MICROBIOL, V2013, P8
   Fexby S, 2007, INFECT IMMUN, V75, P30, DOI 10.1128/IAI.01117-06
   Finch RG, 1998, J ANTIMICROB CHEMOTH, V42, P569, DOI 10.1093/jac/42.5.569
   Fracchia L, 2010, APPL MICROBIOL BIOT, V2, P827
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Fux CA, 2004, J BACTERIOL, V186, P4486, DOI 10.1128/JB.186.14.4486-4491.2004
   Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667
   Geske GD, 2005, J AM CHEM SOC, V127, P12762, DOI 10.1021/ja0530321
   Geske GD, 2008, CHEM SOC REV, V37, P1432, DOI 10.1039/b703021p
   Giacometti A, 2003, ANTIMICROB AGENTS CH, V47, P1979, DOI 10.1128/AAC.47.6.1979-1983.2003
   Givskov M, 1996, J BACTERIOL, V178, P6618, DOI 10.1128/jb.178.22.6618-6622.1996
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Harjai K, 2010, FEMS IMMUNOL MED MIC, V58, P161, DOI 10.1111/j.1574-695X.2009.00614.x
   Hendry ER, 2009, J ANTIMICROB CHEMOTH, V64, P1219, DOI 10.1093/jac/dkp362
   Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039
   Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074
   Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11
   Jakobsen TH, 2012, APPL ENVIRON MICROB, V78, P2410, DOI 10.1128/AEM.05992-11
   Janek T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-24
   Janek T, 2010, BIORESOURCE TECHNOL, V101, P6118, DOI 10.1016/j.biortech.2010.02.109
   Jaramillo-Colorado B, 2012, NAT PROD RES, V26, P1075, DOI 10.1080/14786419.2011.557376
   Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536
   Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514
   Junker LM, 2007, ANTIMICROB AGENTS CH, V51, P3582, DOI 10.1128/AAC.00506-07
   Kadouri DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063397
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   Keshavan ND, 2005, J BACTERIOL, V187, P8427, DOI 10.1128/JB.187.24.8427-8436.2005
   Khan MSA, 2012, J ETHNOPHARMACOL, V140, P416, DOI 10.1016/j.jep.2012.01.045
   Khan MSA, 2012, J ANTIMICROB CHEMOTH, V67, P618, DOI 10.1093/jac/dkr512
   Kim YG, 2012, APPL MICROBIOL BIOT, V96, P1607, DOI 10.1007/s00253-012-4225-7
   Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053
   Kiran GS, 2010, FEMS IMMUNOL MED MIC, V59, P432, DOI 10.1111/j.1574-695X.2010.00698.x
   Knowles JR, 2005, APPL ENVIRON MICROB, V71, P797, DOI 10.1128/AEM.71.2.797-803.2005
   Krishnan T, 2012, SENSORS-BASEL, V12, P4016, DOI 10.3390/s120404016
   Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x
   Kuzma L, 2007, PHYTOMEDICINE, V14, P31, DOI 10.1016/j.phymed.2005.10.008
   LaFleur MD, 2006, ANTIMICROB AGENTS CH, V50, P3839, DOI 10.1128/AAC.00684-06
   LAM J, 1980, INFECT IMMUN, V28, P546
   Lazar V, 2011, ANAEROBE, V17, P280, DOI 10.1016/j.anaerobe.2011.03.023
   Lee JH, 2014, PHYTOMEDICINE, V21, P1037, DOI 10.1016/j.phymed.2014.04.008
   Lee JH, 2014, INT J FOOD MICROBIOL, V174, P47, DOI 10.1016/j.ijfoodmicro.2013.12.030
   Lee JH, 2013, BIOFOULING, V29, P1189, DOI 10.1080/08927014.2013.832223
   Lee JH, 2012, APPL MICROBIOL BIOT, V96, P1071, DOI 10.1007/s00253-012-3881-y
   Lee JH, 2011, INFECT IMMUN, V79, P4819, DOI 10.1128/IAI.05580-11
   Lee JH, 2011, BIOFOULING, V27, P1095, DOI 10.1080/08927014.2011.633704
   Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x
   Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42
   Lee K, 2014, APPL MICROBIOL BIOT, V98, P9447, DOI 10.1007/s00253-014-5903-4
   Lee K, 2014, FOODBORNE PATHOG DIS, V11, P710, DOI 10.1089/fpd.2014.1758
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001
   Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3
   Monnappa AK, 2014, SCI REP-UK, V4, DOI 10.1038/srep03811
   Monteiro AS, 2011, COLLOID SURFACE B, V84, P467, DOI 10.1016/j.colsurfb.2011.02.001
   Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007
   Musthafa KS, 2011, J BIOSCIENCES, V36, P55, DOI 10.1007/s12038-011-9011-7
   Musthafa KS, 2010, CHEMOTHERAPY, V56, P333, DOI 10.1159/000320185
   Nett JE, 2014, EXPERT REV ANTI-INFE, V12, P375, DOI 10.1586/14787210.2014.885838
   Nikolaev YA, 2007, MICROBIOLOGY+, V76, P125, DOI 10.1134/S0026261707020014
   Nithyanand P, 2010, CURR MICROBIOL, V60, P454, DOI 10.1007/s00284-009-9564-y
   Niu C, 2006, LETT APPL MICROBIOL, V43, P489, DOI 10.1111/j.1472-765X.2006.02001.x
   Niu C, 2004, APPL ENVIRON MICROB, V70, P6951, DOI 10.1128/AEM.70.12.6951-6956.2004
   Norizan SNM, 2013, SENSORS-BASEL, V13, P5117, DOI 10.3390/s130405117
   Nostro A, 2007, J MED MICROBIOL, V56, P519, DOI 10.1099/jmm.0.46804-0
   Packiavathy I, 2013, APPL MICROBIOL BIOT, V97, P10177, DOI 10.1007/s00253-013-4704-5
   Padmapriya B., 2013, Middle East Journal of Scientific Research, V14, P1359
   Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x
   Park JH, 2012, FEMS MICROBIOL LETT, V335, P31, DOI 10.1111/j.1574-6968.2012.02635.x
   Park JH, 2012, BIOTECHNOL LETT, V34, P655, DOI 10.1007/s10529-011-0825-z
   Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005
   Raffa RB, 2005, J PHARMACOL EXP THER, V312, P417, DOI 10.1124/jpet.104.075150
   Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005
   Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac.dkf049
   Ramsey M.M., 2009, P NATL ACAD SCI US
   Rasmussen TB, 2006, MICROBIOL-SGM, V152, P895, DOI 10.1099/mic.0.28601-0
   Rasmussen TB, 2005, MICROBIOL-SGM, V151, P1325, DOI 10.1099/mic.0.27715-0
   Rautela R, 2014, ANTON LEEUW INT J G, V105, P809, DOI 10.1007/s10482-014-0135-2
   Ravichandiran V, 2012, EUR J MED CHEM, V48, P200, DOI 10.1016/j.ejmech.2011.12.015
   Ren DC, 2005, APPL ENVIRON MICROB, V71, P4022, DOI 10.1128/AEM.71.7.4022-4034.2005
   Ren DC, 2004, APPL ENVIRON MICROB, V70, P2038, DOI 10.1128/AEM.70.4.2038-2043.2004
   Rickard AH, 2008, J APPL MICROBIOL, V105, P2096, DOI 10.1111/j.1365-2672.2008.03910.x
   Rivardo F, 2009, APPL MICROBIOL BIOT, V83, P541, DOI 10.1007/s00253-009-1987-7
   Rodrigues L, 2004, APPL MICROBIOL BIOT, V66, P306, DOI 10.1007/s00253-004-1674-7
   Rodrigues LR, 2006, J APPL MICROBIOL, V100, P470, DOI 10.1111/j.1365-2672.2005.02826.x
   Rossland E, 2005, INT J FOOD MICROBIOL, V98, P193, DOI 10.1016/j.ijfoodmicro.2004.06.003
   Rufino RD, 2011, COLLOID SURFACE B, V84, P1, DOI 10.1016/j.colsurfb.2010.10.045
   Rukayadi Y, 2011, MED MYCOL, V49, P1, DOI 10.3109/13693786.2010.492482
   Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Sambanthamoorthy K, 2014, BIOFOULING, V30, P17, DOI 10.1080/08927014.2013.832224
   Sambanthamoorthy K, 2012, ANTIMICROB AGENTS CH, V56, P5202, DOI 10.1128/AAC.01396-12
   Sambanthamoorthy K, 2011, ANTIMICROB AGENTS CH, V55, P4369, DOI 10.1128/AAC.00583-11
   Sarabhai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053441
   Savage VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062513
   Sayem S M Abu, 2011, Microb Cell Fact, V10, P74, DOI 10.1186/1475-2859-10-74
   Schachter B, 2003, NAT BIOTECHNOL, V21, P361, DOI 10.1038/nbt0403-361
   Semmelhack MF, 2005, ORG LETT, V7, P569, DOI 10.1021/ol047695j
   Seth AK, 2013, PLAST RECONSTR SURG, V131, P225, DOI 10.1097/PRS.0b013e31827e47cd
   Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53
   Shen Y, 2013, J ANTIMICROB CHEMOTH, V68, P1818, DOI 10.1093/jac/dkt104
   Sillankorva S, 2004, BIOFOULING, V20, P133, DOI 10.1080/08927010410001723834
   Sillankorva S, 2010, BIOFOULING, V26, P567, DOI 10.1080/08927014.2010.494251
   Simoes M, 2007, BIOFOULING, V23, P249, DOI 10.1080/08927010701368476
   Simoes M, 2009, NAT PROD REP, V26, P746, DOI 10.1039/b821648g
   Singh N, 2013, APPL BIOCHEM BIOTECH, V169, P2374, DOI 10.1007/s12010-013-0149-7
   Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010
   Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257
   Singh R, 2010, J MED MICROBIOL, V59, P521, DOI 10.1099/jmm.0.017046-0
   Sintim HO, 2010, FUTURE MED CHEM, V2, P1005, DOI 10.4155/FMC.10.185
   Smith KM, 2003, CHEM BIOL, V10, P563, DOI 10.1016/S1074-5521(03)00107-8
   Smith KM, 2003, CHEM BIOL, V10, P81, DOI 10.1016/s1074-5521(03)00002-4
   Soderling EM, 2011, CURR MICROBIOL, V62, P618, DOI 10.1007/s00284-010-9752-9
   Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Suzuki N, 2011, INT J DENT, V2011
   Tahmourespour A, 2011, BOSNIAN J BASIC MED, V11, P37
   Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Thenmozhi R, 2009, FEMS IMMUNOL MED MIC, V57, P284, DOI 10.1111/j.1574-695X.2009.00613.x
   Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103
   Van Hamme JD, 2006, BIOTECHNOL ADV, V24, P604, DOI 10.1016/j.biotechadv.2006.08.001
   Vattem DA, 2007, FITOTERAPIA, V78, P302, DOI 10.1016/j.fitote.2007.03.009
   Vikram A, 2010, INT J FOOD MICROBIOL, V140, P109, DOI 10.1016/j.ijfoodmicro.2010.04.012
   Walencka E, 2008, FOLIA MICROBIOL, V53, P61, DOI 10.1007/s12223-008-0009-y
   Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003
   Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001
   Weiss EI, 1998, J AM DENT ASSOC, V129, P1719, DOI 10.14219/jada.archive.1998.0141
   Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4
   Wilson Michael, 2001, Science Progress, V84, P235, DOI 10.3184/003685001783238998
   Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h
   Yan HB, 2010, CHEM SOC REV, V39, P2914, DOI 10.1039/b914942m
   Yang L, 2009, ANTIMICROB AGENTS CH, V53, P2432, DOI 10.1128/AAC.01283-08
NR 181
TC 5
Z9 6
U1 6
U2 32
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
EI 1873-4316
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PY 2016
VL 17
IS 2
BP 126
EP 140
DI 10.2174/1389201016666150907113228
PG 15
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA DI5RQ
UT WOS:000373557300002
PM 26343132
DA 2019-02-28
ER

PT J
AU Keary, R
   Sanz-Gaitero, M
   van Raaij, MJ
   O'Mahony, J
   Fenton, M
   McAuliffe, O
   Hill, C
   Ross, RP
   Coffey, A
AF Keary, Ruth
   Sanz-Gaitero, Marta
   van Raaij, Mark J.
   O'Mahony, Jim
   Fenton, Mark
   McAuliffe, Olivia
   Hill, Colin
   Ross, R. Paul
   Coffey, Aidan
TI Characterization of a Bacteriophage-Derived Murein Peptidase for
   Elimination of Antibiotic-Resistant Staphylococcus aureus
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Article; Proceedings Paper
CT Katowice Conference on Chemistry Towards Biology
CY 2014
CL Katowice, POLAND
DE Bacteriophage; CHAP Domain; Endolysin; Murein/peptidoglycan hydrolase;
   Staphylococcus aureus
ID LYTIC ENZYME CPL-1; STREPTOCOCCUS-PNEUMONIAE; PHAGE ENDOLYSIN; IN-VIVO;
   ANTIMICROBIAL ACTIVITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI;
   BACILLUS-CEREUS; NASAL CARRIAGE; MRSA INFECTION
AB Staphylococcus aureus is a major cause of infection in humans and animals, causing a wide variety of diseases, from local inflammations to fatal sepsis. The bacterium is commonly multi-drug resistant and thus many front-line antibiotics have been rendered ineffective for treating such infections. Research on murein/peptidoglycan hydrolases, derived from bacterial viruses (bacteriophages), has demonstrated that such proteins are attractive candidates for development as novel antibacterial agents for combatting Gram-positive pathogens. Here we review the research produced to-date on the bacteriophage-derived CHAPK murein peptidase. Initially, we sequenced and annotated the genome of anti-staphylococcal bacteriophage K and cloned the gene for the bacteriophage endolysin, a murein hydrolase which plays a role in cell killing during the bacteriophage life cycle. An highly active domain of the enzyme, a cysteine, histidine-dependent amido hydrolase/peptidase (CHAPK), was cloned, over-expressed in E. coli and purified. This CHAPK enzyme was demonstrated to rapidly lyse several strains of methicillin resistant S. aureus and both disrupted and prevented the formation of a staphylococcal biofilm. The staphylolytic activity of the peptidase was demonstrated in vivo using a mouse model, without adverse effects on the animals. The crystal structure of the enzyme was elucidated, revealing a calcium ion close to the active site. Site-directed mutagenesis indicated that this calcium ion is involved in the catalytic mechanism of the enzyme. The crystal structure of this enzyme is a valuable source of information for efficient engineering of this and similar CHAP-domain-containing proteins. Overall, the data collected to date on CHAPK has demonstrated its strong potential as a novel therapeutic candidate for treatment of staphylococcal infections and has provided us with insight into the fundamental enzymatic mechanisms of CHAP domain-containing peptidoglycan hydrolases.
C1 [Keary, Ruth; O'Mahony, Jim; Fenton, Mark; Coffey, Aidan] Cork Inst Technol, Ctr Res Adv Therapeut Engn, Cork, Ireland.
   [Keary, Ruth; O'Mahony, Jim; Fenton, Mark; Coffey, Aidan] Cork Inst Technol, Dept Biol Sci, Cork, Ireland.
   [Sanz-Gaitero, Marta; van Raaij, Mark J.] CSIC, CNB, Dept Estruct Macromol, Calle Darwin 3, E-28049 Madrid, Spain.
   [McAuliffe, Olivia] TEAGASC, Moorepk Food Res Ctr, Biotechnol Dept, Fermoy, Cork, Ireland.
   [Hill, Colin] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.
   [Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Coll Sci Engn & Food Sci, Cork, Ireland.
RP Coffey, A (reprint author), Cork Inst Technol, Ctr Res Adv Therapeut Engn, Cork, Ireland.
EM aidan.coffey@cit.ie
RI Hill, Colin/A-5611-2012; Ross, Paul/A-7584-2015; van Raaij,
   Mark/B-3678-2009
OI Hill, Colin/0000-0002-8527-1445; Ross, Paul/0000-0003-4876-8839; van
   Raaij, Mark/0000-0002-4781-1375
CR Abad CL, 2013, CURR INFECT DIS REP, V15, P455, DOI 10.1007/s11908-013-0364-y
   Abaev I, 2013, APPL MICROBIOL BIOT, V97, P3449, DOI 10.1007/s00253-012-4252-4
   Becker S.C., 2015, FEMS MICROBIOL LETT, V2014
   Becker SC, 2008, FEMS MICROBIOL LETT, V287, P185, DOI 10.1111/j.1574-6968.2008.01308.x
   Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x
   Bromme D, 2001, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2102s21
   Cantante C.S.d.C., 2008, THESIS
   Cheng Q, 2005, ANTIMICROB AGENTS CH, V49, P111, DOI 10.1128/AAC.49.1.111-117.2005
   Chopra S, 2015, APPL MICROBIOL BIOT, V99, P3201, DOI 10.1007/s00253-015-6460-1
   Coates T, 2009, J ANTIMICROB CHEMOTH, V64, P9, DOI 10.1093/jac/dkp159
   Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09
   Donovan DM, 2006, FEMS MICROBIOL LETT, V265, P133, DOI 10.1111/j.1574-6968.2006.00483.x
   Entenza JM, 2005, ANTIMICROB AGENTS CH, V49, P4789, DOI 10.1128/AAC.49.11.4789-4792.2005
   Eseonu KC, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-25
   Fenton M, 2011, J APPL MICROBIOL, V111, P1025, DOI 10.1111/j.1365-2672.2011.05119.x
   Fenton M, 2011, BACTERIOPHAGE, V1, P198, DOI DOI 10.4161/BACT.1.4.18245
   Fenton Mark, 2013, Int J Microbiol, V2013, P625341, DOI 10.1155/2013/625341
   Fenton Mark, 2010, Bioeng Bugs, V1, P404, DOI 10.4161/bbug.1.6.13422
   Fernandes S, 2012, MICROB DRUG RESIST, V18, P333, DOI 10.1089/mdr.2012.0025
   Filatova LY, 2015, ENZYME MICROB TECH, V73-74, P51, DOI 10.1016/j.enzmictec.2015.03.005
   Garcia P, 2010, INT J FOOD MICROBIOL, V141, P151, DOI 10.1016/j.ijfoodmicro.2010.04.029
   Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066
   Grandgirard D, 2008, J INFECT DIS, V197, P1519, DOI 10.1086/587942
   Gu JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004109
   Gu JM, 2011, CURR MICROBIOL, V63, P538, DOI 10.1007/s00284-011-0018-y
   Gu Jingmin, 2011, Bioeng Bugs, V2, P96, DOI 10.4161/bbug.2.2.14883
   Gu JM, 2011, J CLIN MICROBIOL, V49, P111, DOI 10.1128/JCM.01144-10
   Gupta R, 2011, CURR MICROBIOL, V63, P39, DOI 10.1007/s00284-011-9939-8
   Gutierrez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107307
   Horgan M, 2009, APPL ENVIRON MICROB, V75, P872, DOI 10.1128/AEM.01831-08
   Jado I, 2003, J ANTIMICROB CHEMOTH, V52, P967, DOI 10.1093/jac/dkg485
   JAYASWAL RK, 1990, J BACTERIOL, V172, P5783, DOI 10.1128/jb.172.10.5783-5788.1990
   Jun SY, 2013, INT J ANTIMICROB AG, V41, P156, DOI 10.1016/j.ijantimicag.2012.10.011
   Jun SY, 2011, ANTIMICROB AGENTS CH, V55, P1764, DOI 10.1128/AAC.01097-10
   Kadurugamuwa JL, 2004, ANTIMICROB AGENTS CH, V48, P2283, DOI 10.1128/AAC.48.6.2283-2287.2004
   Linden SB, 2015, APPL MICROBIOL BIOT, V99, P741, DOI 10.1007/s00253-014-5930-1
   Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869
   Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI [10.1128/IAI.71.11.6199-6204.2003, 10.1128/IAI.71.6199-6204.2003]
   Loessner MJ, 1997, J BACTERIOL, V179, P2845, DOI 10.1128/jb.179.9.2845-2851.1997
   Loessner MJ, 1998, FEMS MICROBIOL LETT, V162, P265, DOI 10.1016/S0378-1097(98)00131-1
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Manoharadas S, 2009, J BIOTECHNOL, V139, P118, DOI 10.1016/j.jbiotec.2008.09.003
   McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028
   McGowan S, 2012, P NATL ACAD SCI USA, V109, P12752, DOI 10.1073/pnas.1208424109
   Meng XP, 2011, APPL ENVIRON MICROB, V77, P8272, DOI 10.1128/AEM.05151-11
   Mishra AK, 2013, J VET SCI, V14, P37, DOI 10.4142/jvs.2013.14.1.37
   Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847
   Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398
   Network E.A.R.S., 2014, ANN REPORT EUROPEAN
   O'Flaherty S, 2005, J BACTERIOL, V187, P7161, DOI 10.1128/JB.187.20.7161-7164.2005
   O'Flaherty S, 2004, J BACTERIOL, V186, P2862, DOI 10.1128/JB.186.9.2862-2871.2004
   Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010
   Olson ME, 2002, CAN J VET RES, V66, P86
   Pace J.L., 2005, BIOFILMS INFECT ANTI
   Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065
   Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305
   Sanz-Gaitero M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-133
   Sanz-Gaitero M, 2013, ACTA CRYSTALLOGR F, V69, P1393, DOI 10.1107/S1744309113030133
   Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06
   Schmelcher M, 2015, J ANTIMICROB CHEMOTH, V70, P1453, DOI 10.1093/jac/dku552
   Schmelcher M, 2012, J BIOTECHNOL, V162, P289, DOI 10.1016/j.jbiotec.2012.09.010
   Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/FMB.12.97, 10.2217/fmb.12.97]
   Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026
   Shen Y, 2013, J ANTIMICROB CHEMOTH, V68, P1818, DOI 10.1093/jac/dkt104
   Shokhen M, 2011, PROTEINS, V79, P975, DOI 10.1002/prot.22939
   Son JS, 2010, APPL MICROBIOL BIOT, V86, P1439, DOI 10.1007/s00253-009-2386-9
   Takac M, 2005, MICROBIOL-SGM, V151, P2331, DOI 10.1099/mic.0.27937-0
   von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102
   Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4
   Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005
   Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Yokoi KJ, 2005, GENE, V351, P97, DOI 10.1016/j.gene.2005.03.006
   Yu J, 2005, J ANTIMICROB CHEMOTH, V55, P528, DOI 10.1093/jac/dki053
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zimmer M, 2002, APPL ENVIRON MICROB, V68, P5311, DOI 10.1128/AEM.68.11.5311-5317.2002
NR 76
TC 7
Z9 7
U1 3
U2 24
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
EI 1875-5550
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PY 2016
VL 17
IS 2
BP 183
EP 190
DI 10.2174/1389203716666151102105515
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DH1MS
UT WOS:000372549200010
PM 26521950
DA 2019-02-28
ER

PT J
AU Alves, DR
   Perez-Esteban, P
   Kot, W
   Bean, JE
   Arnot, T
   Hansen, LH
   Enright, MC
   Jenkins, ATA
AF Alves, Diana R.
   Perez-Esteban, P.
   Kot, W.
   Bean, J. E.
   Arnot, T.
   Hansen, L. H.
   Enright, Mark C.
   Jenkins, A. Tobias A.
TI A novel bacteriophage cocktail reduces and disperses Pseudomonas
   aeruginosa biofilms under static and flow conditions
SO MICROBIAL BIOTECHNOLOGY
LA English
DT Article
ID STAPHYLOCOCCUS-AUREUS BIOFILM; ANTIMICROBIAL RESISTANCE;
   ESCHERICHIA-COLI; GENOME; PHAGES; IDENTIFICATION; INFECTIONS; VIRUSES;
   PAO1; MECHANISMS
AB Pseudomonas aeruginosa is an opportunistic human pathogen that forms highly stable communities biofilms, which contribute to the establishment and maintenance of infections. The biofilm state and intrinsic/acquired bacterial resistance mechanisms contribute to resistance/tolerance to antibiotics that is frequently observed in P. aeruginosa isolates. Here we describe the isolation and characterization of six novel lytic bacteriophages: viruses that infect bacteria, which together efficiently infect and kill a wide range of P. aeruginosa clinical isolates. The phages were used to formulate a cocktail with the potential to eliminate P. aeruginosa PAO1 planktonic cultures. Two biofilm models were studied, one static and one dynamic, and the phage cocktail was assessed for its ability to reduce and disperse the biofilm biomass. For the static model, after 4 h of contact with the phage suspension (MOI 10) more than 95% of biofilm biomass was eliminated. In the flow biofilm model, a slower rate of activity by the phage was observed, but 48 h after addition of the phage cocktail the biofilm was dispersed, with most cells eliminated (>4 logs) comparing with the control. This cocktail has the potential for development as a therapeutic to control P. aeruginosa infections, which are predominantly biofilm centred.
C1 [Alves, Diana R.; Bean, J. E.; Jenkins, A. Tobias A.] Univ Bath, Dept Chem, Claverton Down, Bath BA2 7AY, Avon, England.
   [Perez-Esteban, P.; Arnot, T.] Univ Bath, Dept Chem Engn, Claverton Down, Bath BA2 7AY, Avon, England.
   [Kot, W.; Hansen, L. H.] Aarhus Univ, Dept Environm Sci, Frederiksborgvej 399,Postboks,358, DK-4000 Roskilde, Denmark.
   [Enright, Mark C.] Manchester Metropolitan Univ, Sch Healthcare Sci, John Dalton Bldg,Chester St, Manchester M1 5GD, Lancs, England.
RP Alves, DR (reprint author), Univ Bath, Dept Chem, Claverton Down, Bath BA2 7AY, Avon, England.
EM dra26@bath.ac.uk
RI Kot, Witold/M-2170-2014; Jenkins, Toby/C-2124-2009; Kot,
   Witold/N-3747-2017
OI Kot, Witold/0000-0002-0188-4587; Jenkins, Toby/0000-0002-8981-3029; Kot,
   Witold/0000-0002-0188-4587; Arnot, Tom/0000-0002-7950-9429; Enright,
   Mark/0000-0001-5273-8750; Perez Esteban, Patricia/0000-0001-7084-1065
FU Engineering and Physical Sciences Research Council (EPSRC)
   [EP/I027602/1]; Engineering and Physical Sciences Research Council
   [EP/I027602/1]
FX This study was supported by the Engineering and Physical Sciences
   Research Council (EPSRC) (Grant number EP/I027602/1) healthcare
   partnership.
CR Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1
   Ackermann H. W., 2006, CLASSIFICATION BACTE
   ADAMS M, 1959, BACTERIOPHAGES
   Alves DR, 2014, APPL ENVIRON MICROB, V80, P6694, DOI 10.1128/AEM.01789-14
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   BARTELL PF, 1969, J VIROL, V3, P290
   Bean JE, 2014, CHEM MATER, V26, P7201, DOI 10.1021/cm503974g
   Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x
   Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038
   Ceyssens PJ, 2010, VIROLOGY, V405, P26, DOI 10.1016/j.virol.2010.06.011
   Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P2874, DOI 10.1111/j.1462-2920.2009.02030.x
   Chen P, 2012, J MICROBIOL METH, V90, P115, DOI 10.1016/j.mimet.2012.04.009
   Drenkard E, 2003, MICROBES INFECT, V5, P1213, DOI 10.1016/j.micinf.2003.08.009
   Drulis-Kawa Z, 2011, APPL MICROBIOL BIOT, V90, P1333, DOI 10.1007/s00253-011-3149-y
   Esteban PP, 2014, BIOTECHNOL PROGR, V30, P932, DOI 10.1002/btpr.1898
   Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Fukuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047742
   GILSDORF JR, 1989, SURGERY, V106, P37
   Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698
   Harper DR, 2014, ANTIBIOTICS-BASEL, V3, P270, DOI 10.3390/antibiotics3030270
   HEJKAL TW, 1981, APPL ENVIRON MICROB, V41, P628
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   JARRELL K, 1977, J VIROL, V23, P461
   JASS J, 1995, J IND MICROBIOL, V15, P283, DOI 10.1007/BF01569981
   Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13
   KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131
   Kos VN, 2015, ANTIMICROB AGENTS CH, V59, P427, DOI 10.1128/AAC.03954-14
   Kot W, 2014, J VIROL METHODS, V196, P152, DOI 10.1016/j.jviromet.2013.10.040
   Kushkina A. I., 2013, GENOME ANNOUNC, V1
   Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Lammens E, 2009, J MICROBIOL METH, V77, P207, DOI 10.1016/j.mimet.2009.02.006
   Lavigne R, 2003, VIROLOGY, V312, P49, DOI 10.1016/S0042-6822(03)00123-5
   Lima-Mendez G, 2011, RES MICROBIOL, V162, P737, DOI 10.1016/j.resmic.2011.06.006
   Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09
   Madden T, 2003, NCBI HDB
   Mann NH, 2008, RES MICROBIOL, V159, P400, DOI 10.1016/j.resmic.2008.04.003
   Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9
   MCELDOWNEY S, 1986, J GEN MICROBIOL, V132, P513
   McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538
   McNerney R, 1998, RES MICROBIOL, V149, P487, DOI 10.1016/S0923-2508(98)80003-X
   Miller A, 1997, SCIENCE, V275, P1655, DOI 10.1126/science.275.5306.1655
   NARANG HK, 1981, J CLIN MICROBIOL, V13, P982
   Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251
   Paddison P, 1998, GENETICS, V148, P1539
   Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120
   Pires D. P., 2014, GENOME ANNOUNC, V2, P798
   Pires D, 2011, RES MICROBIOL, V162, P798, DOI 10.1016/j.resmic.2011.06.010
   Stover CK, 2000, NATURE, V406, P959
   Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0
   STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292
   Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9
   TERRY JM, 1991, INFECT IMMUN, V59, P471
   TUCKER RG, 1961, J GEN MICROBIOL, V26, P313, DOI 10.1099/00221287-26-2-313
   Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799
   Wittmann J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-14
   YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
NR 61
TC 13
Z9 14
U1 0
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1751-7907
EI 1751-7915
J9 MICROB BIOTECHNOL
JI Microb. Biotechnol.
PD JAN
PY 2016
VL 9
IS 1
BP 61
EP 74
DI 10.1111/1751-7915.12316
PG 14
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA DF3HV
UT WOS:000371235700007
PM 26347362
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Jamal, M
   Hussain, T
   Das, CR
   Andleeb, S
AF Jamal, Muhsin
   Hussain, Tahir
   Das, Chythanya Rajanna
   Andleeb, Saadia
TI Isolation and Characterization of a Myoviridae MJ1 Bacteriophage Against
   Multi-Drug Resistant Escherichia coli 3
SO JUNDISHAPUR JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Bacteriophage; Nosocomial; Contractile; Planktonic; Escherichia coli;
   Myoviridae
ID THERAPY; PHAGE; ANTIBIOTICS; SALMONELLA; INFECTIONS; COLLECTION; BIOFILM
AB Background: Antibiotic resistance in Escherichia coli, a member of the Enterobacteriaceae, is of particular concern because it is the most common (Gram-negative) pathogen causing nosocomial and community infections. Researchers are now considering the use of phages for the control of various antibiotic-resistant bacterial infections.
   Objectives: The purpose of this study was to isolate and characterize a novel pathogenic/lytic phage that targets multi-drug resistant (MDR) E. coli 3, and to investigate its effectiveness at lysing this bacterium.
   Materials and Methods: A clinical strain of E. coli 3 was identified based on its 16S rRNA sequencing and its antibiotic resistance profile was determined by the disc diffusion method. A bacteriophage was isolated from wastewater and its various characteristics, such as host range, heat tolerance, pH stability, one step growth, total protein content, and genome size, were determined. The antibacterial property of the phage was determined against log-phase bacterial planktonic cells at 37 degrees C.
   Results: The bacteriophage, designated MJ1, was isolated by testing against a clinical MDR E. coli 3 strain. The MJ1 phage showed a wide range of heat and pH stability. The phage morphology, determined by transmission electron microscopy, revealed a structure comprised of a head (108 +/- 0.2 nm long by 128 +/- 0.5 nm wide) and a contractile tail (123 +/- 0.5 nm long by 15 - 26 nm wide). These features placed the MJ1 phage in the family Myoviridae and the order Caudovirales. Eleven structural proteins (17 to 200 kDa) for this phage were detected by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). A double stranded DNA, approximately 32 kb, in size was detected for this phage on agarose gels. The phage efficacy against E. coli 3 planktonic cells was also investigated. The MJ1 phage demonstrated a very good capability to reduce the numbers of E. coli 3 planktonic cells, as determined by a change in the bacterial growth (an optical density decrease at 600 nm from 0.40 to 0.12).
   Conclusions: MJ1 phage has much potential for use in phage therapy and other applications.
C1 [Jamal, Muhsin; Hussain, Tahir; Andleeb, Saadia] Natl Univ Sci & Technol, ASAB, Sect H-12, Islamabad, Pakistan.
   [Jamal, Muhsin; Das, Chythanya Rajanna] Univ Florida, EPI, Gainesville, FL 32611 USA.
RP Jamal, M (reprint author), Natl Univ Sci & Technol, ASAB, Sect H-12, Islamabad, Pakistan.
EM muhsinkhan08@gmail.com
FU higher education commission of Pakistan
FX This study was funded/supported by higher education commission of
   Pakistan.
CR Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13
   Ashelford KE, 2000, APPL ENVIRON MICROB, V66, P4193, DOI 10.1128/AEM.66.10.4193-4199.2000
   Capra ML, 2006, J APPL MICROBIOL, V100, P334, DOI 10.1111/j.1365-2672.2005.02767.x
   Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x
   Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005
   Hazem A, 2002, MICROBIOLOGICA, V25, P469
   Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x
   Hussain Tahir, 2014, Journal of Pure and Applied Microbiology, V8, P2667
   izade H, 2014, INT J ENTERIC PATHOG, V2, DOI 10.17705/ijep15195
   Jamal M., 2015, SCI LETT, V3, P122
   Jamal M, 2015, J MED MICROBIOL, V64, P454, DOI 10.1099/jmm.0.000040
   Jamal M, 2015, J BASIC MICROB, V55, P420, DOI 10.1002/jobm.201400688
   Jamalludeen N, 2007, VET MICROBIOL, V124, P47, DOI 10.1016/j.vetmic.2007.03.028
   Kutter E, 2004, BACTERIOPHAGES BIOL
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Maal KB, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.14945
   Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9
   Naves P, 2010, J HOSP INFECT, V76, P165, DOI 10.1016/j.jhin.2010.05.011
   Park SC, 2000, APPL ENVIRON MICROB, V66, P1416, DOI 10.1128/AEM.66.4.1416-1422.2000
   Payne RJH, 2001, J THEOR BIOL, V208, P37, DOI 10.1006/jtbi.2000.2198
   Pfaller MA, 2000, J ANTIMICROB CHEMOTH, V46, P25, DOI 10.1093/jac/46.suppl_2.25
   Piracha ZZ, 2014, GLOBAL J MED RES, V14, P1
   Rao V, 2005, APPL BIOSAFETY, V10, P83
   Sambrook J., 1989, MOL CLONING
   Sillankorva S, 2008, BMC BIOTECHNOL, V8, P79, DOI [10.1186/1472-6750-8-79, DOI 10.1186/1472-6750-8-79]
   SMITH HW, 1987, J GEN MICROBIOL, V133, P1127
   SMITH HW, 1982, J GEN MICROBIOL, V128, P307
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001
   Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639
   VANREGENMORTEL MHV, 2000, 7 INT COMM TAX VIR
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Wayne PA, 2007, IMPLEMENTATION GUIDE
   Weld RJ, 2004, J THEOR BIOL, V227, P1, DOI 10.1016/S0022-5193(03)00262-5
   Zimmer M, 2002, J BACTERIOL, V184, P4359, DOI 10.1128/JB.184.16.4359-4368.2002
NR 34
TC 8
Z9 9
U1 3
U2 17
PU AHVAZ JUNDISHAPUR UNIV MED SCI
PI AHVAZ
PA PO BOX 6357-33118, AHVAZ, 00000, IRAN
SN 2008-3645
EI 2008-4161
J9 JUNDISHAPUR J MICROB
JI Jundishapur J. Microbiol.
PD NOV
PY 2015
VL 8
IS 11
AR e25917
DI 10.5812/jjm.25917
PG 8
WC Microbiology
SC Microbiology
GA DB5DF
UT WOS:000368533400021
PM 26865936
OA Green Published
DA 2019-02-28
ER

PT J
AU Chhibber, S
   Bansal, S
   Kaur, S
AF Chhibber, Sanjay
   Bansal, Shruti
   Kaur, Sukhmandir
TI Disrupting the mixed-species biofilm of Klebsiella pneumoniae B5055 and
   Pseudomonas aeruginosa PAO using bacteriophages alone or in combination
   with xylitol
SO MICROBIOLOGY-SGM
LA English
DT Article
ID ESCHERICHIA-COLI; CANDIDA-ALBICANS; SUSCEPTIBILITY; CIPROFLOXACIN;
   DEPOLYMERASE; COEXISTENCE; POPULATION; GROWTH
AB We investigated the potential of bacteriophages alone as well as in combination with xylitol for tackling mixed-species biofilm of Pseudomonas aeruginosa and Klebsiella pneumoniae. When mixed-species biofilm was established on polycarbonate discs, P. aeruginosa formed the base layer which was physically shielded on the top by K. pneumoniae. Thereafter, mixed-species biofilm was treated with bacteriophages. K. pneumoniae-specific depolymerase-producing phage KPO1K2 caused significant reduction in the count of Klebsiella. In contrast, P. aeruginosa-specific non-depolymerase-producing phage Pa29 failed to cause any reduction in the count of Pseudomonas. However, application of both phages together resulted in significant reduction in the count of both organisms. This suggests that depolymerase produced by phage KPO1K2 hydrolysed the top layer of K pneumoniae and guided the entry of Pa29 to reach P. aeruginosa lying underneath. This phenomenon was confirmed when K pneumoniae-specific non-depolymerase-producing phage NDP was used along with Pa29. Pa29 could not penetrate and reach its host bacterium. Xylitol worked synergistically along with the phage, resulting in a significant decrease in counts of both organisms. Disruption of mixed species biofilm by phage and xylitol was confirmed on the basis of the amount of protein and DNA released. This phage-based approach to altering the structural pattern and disrupting the mixed species biofilm is the first of its kind. It can be used as a topical application, a coating for foreign bodies or for aerosol delivery to tackle infections where both pathogens coexist in a biofilm mode.
C1 [Chhibber, Sanjay; Bansal, Shruti; Kaur, Sukhmandir] Panjab Univ, Dept Microbiol, Chandigarh 160014, India.
RP Chhibber, S (reprint author), Panjab Univ, Dept Microbiol, Basic Med Sci BMS Block, Chandigarh 160014, India.
EM sanjaychhibber8@gmail.com
CR Abbas H. A., 2012, Asian Journal of Pharmaceutical Research, V2, P129
   ADAMS M, 1959, BACTERIOPHAGES
   Ammons MCB, 2009, INT J ANTIMICROB AG, V33, P230, DOI 10.1016/j.ijantimicag.2008.08.013
   An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103
   Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000
   Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Chandrasekar PH, 2008, FUTURE MICROBIOL, V3, P19, DOI 10.2217/17460913.3.1.19
   Childers BM, 2013, INFECT IMMUN, V81, P4112, DOI 10.1128/IAI.00521-13
   Cox SD, 2001, MOLECULES, V6, P87, DOI 10.3390/60100087
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Filoche SK, 2004, ORAL MICROBIOL IMMUN, V19, P322, DOI 10.1111/j.1399-302x.2004.00164.x
   FURUKAWA H, 1983, J BACTERIOL, V154, P938
   Ghezelbash GR, 2012, AFR J MICROBIOL RES, V6, P4404, DOI 10.5897/AJMR11.1122
   Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004
   Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039
   Ichikawa T, 2008, J DENT, V36, P965, DOI 10.1016/j.jdent.2008.07.013
   Kassa T, 2012, J VIROL METHODS, V179, P135, DOI 10.1016/j.jviromet.2011.10.011
   Kay MK, 2011, APPL ENVIRON MICROB, V77, P821, DOI 10.1128/AEM.01797-10
   Knoll BM, 2014, CLIN INFECT DIS, V58, P528, DOI 10.1093/cid/cit771
   Kumari S., 2009, AM J BIOMED SCI, V1, P91
   Luca M. D., 2014, PATHOG DIS, V70, P257
   Lynch Heather, 2003, J Calif Dent Assoc, V31, P205
   MAKINEN KK, 1980, J FOOD SCI, V45, P367, DOI 10.1111/j.1365-2621.1980.tb02616.x
   Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001
   Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11
   SIEBEL MA, 1991, BIOTECHNOL BIOENG, V37, P778, DOI 10.1002/bit.260370813
   Sillankorva S, 2010, BIOFOULING, V26, P567, DOI 10.1080/08927014.2010.494251
   Stewart PS, 1997, MICROBIAL ECOL, V33, P2, DOI 10.1007/s002489900002
   Thein ZM, 2007, APMIS, V115, P1241, DOI 10.1111/j.1600-0643.2007.00735.x
   Verma V, 2009, J ANTIMICROB CHEMOTH, V64, P1212, DOI 10.1093/jac/dkp360
   Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y
   Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966
   Yoshida S, 2009, J APPL MICROBIOL, V106, P790, DOI 10.1111/j.1365-2672.2008.04027.x
NR 34
TC 5
Z9 8
U1 2
U2 9
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD JUL
PY 2015
VL 161
BP 1369
EP 1377
DI 10.1099/mic.0.000104
PN 7
PG 9
WC Microbiology
SC Microbiology
GA CR5VG
UT WOS:000361411900008
PM 25922418
OA Bronze
DA 2019-02-28
ER

PT J
AU Tan, DM
   Dahl, A
   Middelboe, M
AF Tan, Demeng
   Dahl, Amalie
   Middelboe, Mathias
TI Vibriophages Differentially Influence Biofilm Formation by Vibrio
   anguillarum Strains
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID HOST-RANGE VIBRIOPHAGE; OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI;
   BACTERIOPHAGE; PHAGE; FISH; COEXISTENCE; BIOCONTROL; KVP40; PLEIOTROPY
AB Vibrio anguillarum is an important pathogen in marine aquaculture, responsible for vibriosis. Bacteriophages can potentially be used to control bacterial pathogens; however, successful application of phages requires a detailed understanding of phage-host interactions under both free-living and surface-associated growth conditions. In this study, we explored in vitro phage-host interactions in two different strains of V. anguillarum (BA35 and PF430-3) during growth in microcolonies, biofilms, and free-living cells. Two vibriophages, Phi H20 (Siphoviridae) and KVP40 (Myoviridae), had completely different effects on the biofilm development. Addition of phage Phi H20 to strain BA35 showed efficient control of biofilm formation and density of free-living cells. The interactions between BA35 and Phi H20 were thus characterized by a strong phage control of the phage-sensitive population and subsequent selection for phage-resistant mutants. Addition of phage KVP40 to strain PF430-3 resulted in increased biofilm development, especially during the early stage. Subsequent experiments in liquid cultures showed that addition of phage KVP40 stimulated the aggregation of host cells, which protected the cells against phage infection. By the formation of biofilms, strain PF430-3 created spatial refuges that protected the host from phage infection and allowed coexistence between phage-sensitive cells and lytic phage KVP40. Together, the results demonstrate highly variable phage protection mechanisms in two closely related V. anguillarum strains, thus emphasizing the challenges of using phages to control vibriosis in aquaculture and adding to the complex roles of phages as drivers of prokaryotic diversity and population dynamics.
C1 [Tan, Demeng; Dahl, Amalie; Middelboe, Mathias] Univ Copenhagen, Marine Biol Sect, Elsinore, Denmark.
RP Middelboe, M (reprint author), Univ Copenhagen, Marine Biol Sect, Elsinore, Denmark.
EM mmiddelboe@bio.ku.dk
RI Middelboe, Mathias/B-9995-2009
OI Middelboe, Mathias/0000-0002-9587-9171
FU Danish Strategic Research Council (ProAqua project) [12-132390]; Danish
   Council for Independent Research [FNU 09-072829]; EU-IRSES-funded
   project AQUAPHAGE [269175]
FX This study was supported by grants from the Danish Strategic Research
   Council (ProAqua project 12-132390), the Danish Council for Independent
   Research (FNU 09-072829), and EU-IRSES-funded project AQUAPHAGE
   (269175).
CR ADAMS M, 1959, BACTERIOPHAGES
   Brockhurst MA, 2006, J EVOLUTION BIOL, V19, P374, DOI 10.1111/j.1420-9101.2005.01026.x
   Croxatto A, 2004, MOL MICROBIOL, V52, P1677, DOI 10.1111/j.1365-2958.2004.04083.x
   Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002
   DOOLITTLE MM, 1995, CAN J MICROBIOL, V41, P12, DOI 10.1139/m95-002
   EVELYN TPT, 1971, J FISH RES BOARD CAN, V28, P517, DOI 10.1139/f71-073
   Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x
   FREESE E, 1959, J MOL BIOL, V1, P87, DOI 10.1016/S0022-2836(59)80038-3
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Harcombe WR, 2005, APPL ENVIRON MICROB, V71, P5254, DOI 10.1128/AEM.71.9.5254-5259.2005
   Heilmann S, 2012, P NATL ACAD SCI USA, V109, P12828, DOI 10.1073/pnas.1200771109
   Hojberg O, 1997, APPL ENVIRON MICROB, V63, P2920
   Hoyland-Kroghsbo NM, 2013, MBIO, V4, DOI 10.1128/mBio.00362-12
   Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039
   Imbeault S, 2006, J AQUAT ANIM HEALTH, V18, P203, DOI 10.1577/H06-019.1
   INOUE T, 1995, FEMS MICROBIOL LETT, V125, P101, DOI 10.1016/0378-1097(94)00480-F
   Karunasagar I, 2007, AQUACULTURE, V268, P288, DOI 10.1016/j.aquaculture.2007.04.049
   Kay MK, 2011, APPL ENVIRON MICROB, V77, P821, DOI 10.1128/AEM.01797-10
   Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10
   Kocharunchitt C, 2009, INT J FOOD MICROBIOL, V128, P453, DOI 10.1016/j.ijfoodmicro.2008.10.014
   Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072
   Kunisaki H, 2010, APPL MICROBIOL BIOT, V85, P1533, DOI 10.1007/s00253-009-2230-2
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   LARSEN JL, 1994, J FISH DIS, V17, P259, DOI 10.1111/j.1365-2761.1994.tb00221.x
   LENSKI RE, 1988, EVOLUTION, V42, P433, DOI 10.1111/j.1558-5646.1988.tb04150.x
   LENSKI RE, 1988, EVOLUTION, V42, P425, DOI 10.1111/j.1558-5646.1988.tb04149.x
   Lindell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037678
   LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167
   Martiny JBH, 2014, ANNU REV MAR SCI, V6, P393, DOI 10.1146/annurev-marine-010213-135108
   MATSUZAKI S, 1992, MICROBIOL IMMUNOL, V36, P93, DOI 10.1111/j.1348-0421.1992.tb01645.x
   Miller ES, 2003, J BACTERIOL, V185, P5220, DOI 10.1128/JB.185.17.5220-5233.2003
   Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044
   Nakai T, 1999, DIS AQUAT ORGAN, V37, P33, DOI 10.3354/dao037033
   O'Toole GA, 1999, METHOD ENZYMOL, V310, P91
   Pedersen K, 1997, J APPL MICROBIOL, V82, P365, DOI 10.1046/j.1365-2672.1997.00373.x
   Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096
   Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06
   Seed KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002917
   Sheng HQ, 2006, APPL ENVIRON MICROB, V72, P5359, DOI 10.1128/AEM.00099-06
   Silva-Rubio A, 2008, J FISH DIS, V31, P235, DOI 10.1111/j.1365-2761.2007.00878.x
   Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08
   Tan DM, 2014, APPL ENVIRON MICROB, V80, P3128, DOI 10.1128/AEM.03544-13
   Vinod MG, 2006, AQUACULTURE, V255, P117, DOI 10.1016/j.aquaculture.2005.12.003
NR 44
TC 12
Z9 12
U1 1
U2 35
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JUL
PY 2015
VL 81
IS 13
BP 4489
EP 4497
DI 10.1128/AEM.00518-15
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA CJ9TC
UT WOS:000355844800026
PM 25911474
OA Bronze, Green Published
DA 2019-02-28
ER

PT J
AU Heussler, GE
   Cady, KC
   Koeppen, K
   Bhuju, S
   Stanton, BA
   O'Toole, GA
AF Heussler, Gary E.
   Cady, Kyle C.
   Koeppen, Katja
   Bhuju, Sabin
   Stanton, Bruce A.
   O'Toole, George A.
TI Clustered Regularly Interspaced Short Palindromic Repeat-Dependent,
   Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased
   Expression of Phage-Related Genes
SO MBIO
LA English
DT Article
ID GUIDED SURVEILLANCE COMPLEX; BACTERIAL IMMUNE-SYSTEM; CRISPR RNA; PYOCIN
   PRODUCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SOS RESPONSE;
   BACTERIOPHAGE; CAS3; PROKARYOTES
AB The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (CRISPR/Cas) system is an adaptive immune system present in many archaea and bacteria. CRISPR/Cas systems are incredibly diverse, and there is increasing evidence of CRISPR/Cas systems playing a role in cellular functions distinct from phage immunity. Previously, our laboratory reported one such alternate function in which the type 1-F CRISPR/Cas system of the opportunistic pathogen Pseudomonas aeruginosa strain UCBPP-PA14 (abbreviated as P. aeruginosa PA14) inhibits both biofilm formation and swarming motility when the bacterium is lysogenized by the bacteriophage DMS3. In this study, we demonstrated that the presence of just the DMS3 protospacer and the protospacer-adjacent motif (PAM) on the P. aeruginosa genome is necessary and sufficient for this CRISPR-dependent loss of these group behaviors, with no requirement of additional DMS3 sequences. We also demonstrated that the interaction of the CRISPR system with the DMS3 protospacer induces expression of SOS-regulated phage-related genes, including the well-characterized pyocin operon, through the activity of the nuclease Cas3 and subsequent RecA activation. Furthermore, our data suggest that expression of the phage-related genes results in bacterial cell death on a surface due to the inability of the CRISPR-engaged strain to downregulate phage-related gene expression, while these phage-related genes have minimal impact on growth and viability under planktonic conditions. Deletion of the phage-related genes restores biofilm formation and swarming motility while still maintaining a functional CRISPR/Cas system, demonstrating that the loss of these group behaviors is an indirect effect of CRISPR self-targeting.
   IMPORTANCE The various CRISPR/Cas systems found in both archaea and bacteria are incredibly diverse, and advances in understanding the complex mechanisms of these varied systems has not only increased our knowledge of host-virus interplay but has also led to a major advancement in genetic engineering. Recently, increasing evidence suggested that bacteria can co-opt the CRISPR system for functions besides adaptive immunity to phage infection. This study examined one such alternative function, and this report describes the mechanism of type 1-F CRISPR-dependent loss of the biofilm and swarming in the medically relevant opportunistic pathogen Pseudomonas aeruginosa. Since both biofilm formation and swarming motility are important in the virulence of P. aeruginosa, a full understanding of how the CRISPR system can regulate such group behaviors is fundamental to developing new therapeutics.
C1 [Heussler, Gary E.; Cady, Kyle C.; Koeppen, Katja; Stanton, Bruce A.; O'Toole, George A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.
   [Bhuju, Sabin] Genome Anal Helmholtz Ctr Infect Res, Braunschweig, Germany.
RP O'Toole, GA (reprint author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.
EM georgeo@Dartmouth.edu
FU National Institutes of Health [R01 2 R37 AI83256-06, R01-HL074175,
   P20-RR018787/GM103413]; Cystic Fibrosis Foundation [STANTO14IO,
   STANTO11R0]; Dartmouth SYNERGY
FX This work was supported by National Institutes of Health grant R01 2 R37
   AI83256-06 (G.A.O.), National Institutes of Health grant R01-HL074175
   (B.A.S.), P20-RR018787/GM103413 (B.A.S.), the Cystic Fibrosis Foundation
   (STANTO14IO and STANTO11R0 to B.A.S.), and Dartmouth SYNERGY.
CR Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377
   Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723
   Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689
   Budzik JM, 2004, J BACTERIOL, V186, P3270, DOI 10.1128/JB.186.10.3270-3273.2004
   Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12
   Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10
   Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06
   Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115
   Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06
   FARMER JJ, 1969, APPL MICROBIOL, V18, P760
   Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111
   Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172
   Ha DG, 2014, APPL ENVIRON MICROB, V80, P3384, DOI 10.1128/AEM.00299-14
   Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040
   Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272
   Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328
   Kohler T, 2010, J BACTERIOL, V192, P1921, DOI 10.1128/JB.01459-09
   Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09
   Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x
   LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X
   Louwen R, 2013, EUR J CLIN MICROBIOL, V32, P207, DOI 10.1007/s10096-012-1733-4
   Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577
   MATSUI H, 1993, J BACTERIOL, V175, P1257
   Merritt J. H., 2005, CURR PROTOC MICROBIO, DOI DOI 10.1002/9780471729259.MC01B01S00
   Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10
   Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0
   Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996
   Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017
   Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x
   O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x
   Penterman J, 2014, J BACTERIOL, V196, P3351, DOI 10.1128/JB.01889-14
   Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527
   Sampson TR, 2014, P NATL ACAD SCI USA, V111, P11163, DOI 10.1073/pnas.1323025111
   Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048
   Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927
   Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108
   Taylor TB, 2013, J EVOLUTION BIOL, V26, P2154, DOI 10.1111/jeb.12214
   Toyofuku M, 2014, ENVIRON MICROBIOL, V16, P2927, DOI 10.1111/1462-2920.12260
   Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454
   Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07
   Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447
   Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018
   Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402
   Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08
NR 45
TC 16
Z9 16
U1 2
U2 21
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2015
VL 6
IS 3
AR e00129-15
DI 10.1128/mBio.00129-15
PG 13
WC Microbiology
SC Microbiology
GA CM7JH
UT WOS:000357867400006
PM 25968642
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Tan, DM
   Lo Svenningsen, S
   Middelboe, M
AF Tan, Demeng
   Lo Svenningsen, Sine
   Middelboe, Mathias
TI Quorum Sensing Determines the Choice of Antiphage Defense Strategy in
   Vibrio anguillarum
SO MBIO
LA English
DT Article
ID HOST-RANGE VIBRIOPHAGE; OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI K-12;
   REAL-TIME PCR; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA; HARVEYI-LUXR;
   OMPK GENE; BACTERIOPHAGE; RESISTANCE
AB Selection for phage resistance is a key driver of bacterial diversity and evolution, and phage-host interactions may therefore have strong influence on the genetic and functional dynamics of bacterial communities. In this study, we found that an important, but so far largely overlooked, determinant of the outcome of phage-bacterial encounters in the fish pathogen Vibrio anguillarum is bacterial cell-cell communication, known as quorum sensing. Specifically, V. anguillarum PF430-3 cells locked in the low-cell-density state (Delta vanT mutant) express high levels of the phage receptor OmpK, resulting in a high susceptibility to phage KVP40, but achieve protection from infection by enhanced biofilm formation. By contrast, cells locked in the high-cell-density state (Delta vanO mutant) are almost completely unsusceptible due to quorum-sensing-mediated downregulation of OmpK expression. The phenotypes of the two quorum-sensing mutant strains are accurately reflected in the behavior of wild-type V. anguillarum, which (i) displays increased OmpK expression in aggregated cells compared to free-living variants in the same culture, (ii) displays a clear inverse correlation between ompK mRNA levels and the concentration of N-acylhomoserine lactone quorum-sensing signals in the culture medium, and (iii) survives mainly by one of these two defense mechanisms, rather than by genetic mutation to phage resistance. Taken together, our results demonstrate that V. anguillarum employs quorum-sensing information to choose between two complementary antiphage defense strategies. Further, the prevalence of nonmutational defense mechanisms in strain PF430-3 suggests highly flexible adaptations to KVP40 phage infection pressure, possibly allowing the long-term coexistence of phage and host.
   IMPORTANCE Comprehensive knowledge on bacterial antiphage strategies and their regulation is essential for understanding the role of phages as drivers of bacterial evolution and diversity. In an applied context, development of successful phage-based control of bacterial pathogens also requires detailed understanding of the mechanisms of phage protection in pathogenic bacteria. Here, we demonstrate for the first time the presence of quorum-sensing-regulated phage defense mechanisms in the fish pathogen Vibrio anguillarum and provide evidence that quorum-sensing regulation allows V. anguillarum to alternate between different phage protection mechanisms depending on population cell density. Further, our results demonstrate the prevalence of nonmutational defense mechanisms in the investigated V. anguillarum strain, which allow flexible adaptations to a dynamic phage infection pressure.
C1 [Tan, Demeng; Middelboe, Mathias] Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark.
   [Lo Svenningsen, Sine] Univ Copenhagen, Dept Biol, Sect Biomol Sci, Copenhagen, Denmark.
RP Middelboe, M (reprint author), Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark.
EM mmiddelboe@bio.ku.dk
RI Svenningsen, Sine/M-7925-2014; Middelboe, Mathias/B-9995-2009
OI Svenningsen, Sine/0000-0001-7322-2681; Middelboe,
   Mathias/0000-0002-9587-9171
FU Danish Council for Strategic Research [12-132390]; EU-IRSES [269175]
FX The study was supported by the Danish Council for Strategic Research
   (ProAqua project 12-132390) and the EU-IRSES-funded project AQUAPHAGE
   (269175).
CR ADAMS M, 1959, BACTERIOPHAGES
   BASSFORD PJ, 1977, J BACTERIOL, V131, P608
   Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997
   Burmolle M, 2003, MICROBIAL ECOL, V45, P226, DOI 10.1007/s00248-002-2028-6
   Crisafi F, 2014, J FISH DIS, V37, P629, DOI 10.1111/jfd.12158
   Croxatto A, 2004, MOL MICROBIOL, V52, P1677, DOI 10.1111/j.1365-2958.2004.04083.x
   Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002
   Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x
   Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09
   Guglielmotti DM, 2006, INT J FOOD MICROBIOL, V111, P126, DOI 10.1016/j.ijfoodmicro.2006.04.035
   Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x
   Hamod MA, 2014, POL J MICROBIOL, V63, P27
   Heilmann S, 2012, P NATL ACAD SCI USA, V109, P12828, DOI 10.1073/pnas.1200771109
   Hosseinidoust Z, 2013, BIOFOULING, V29, P457, DOI 10.1080/08927014.2013.779370
   Hoyland-Kroghsbo NM, 2013, MBIO, V4, DOI 10.1128/mBio.00362-12
   INOUE T, 1995, FEMS MICROBIOL LETT, V125, P101, DOI 10.1016/0378-1097(94)00480-F
   INOUE T, 1995, FEMS MICROBIOL LETT, V134, P245, DOI 10.1016/0378-1097(95)00414-9
   Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x
   Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000
   LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364
   LENSKI RE, 1988, EVOLUTION, V42, P433, DOI 10.1111/j.1558-5646.1988.tb04150.x
   LENSKI RE, 1988, EVOLUTION, V42, P425, DOI 10.1111/j.1558-5646.1988.tb04149.x
   Luria SE, 1943, GENETICS, V28, P491
   Martiny JBH, 2014, ANNU REV MAR SCI, V6, P393, DOI 10.1146/annurev-marine-010213-135108
   MATSUZAKI S, 1992, MICROBIOL IMMUNOL, V36, P93, DOI 10.1111/j.1348-0421.1992.tb01645.x
   Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165
   Milton DL, 1997, J BACTERIOL, V179, P3004, DOI 10.1128/jb.179.9.3004-3012.1997
   Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996
   Milton DL, 2001, J BACTERIOL, V183, P3537, DOI 10.1128/JB.183.12.3537-3547.2001
   MORONA R, 1984, J BACTERIOL, V159, P570
   O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110
   O'Toole GA, 1999, METHOD ENZYMOL, V310, P91
   Pei RT, 2014, APPL ENVIRON MICROB, V80, P5340, DOI 10.1128/AEM.01434-14
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Silva-Rubio A, 2008, J FISH DIS, V31, P235, DOI 10.1111/j.1365-2761.2007.00878.x
   Svenningsen SL, 2008, GENE DEV, V22, P226, DOI 10.1101/gad.1629908
   SZMELCMAN S, 1975, J BACTERIOL, V124, P112
   Tan DM, 2015, APPL ENVIRON MICROB, V81, P4489, DOI 10.1128/AEM.00518-15
   Tan DM, 2014, APPL ENVIRON MICROB, V80, P3128, DOI 10.1128/AEM.03544-13
   Vinod MG, 2006, AQUACULTURE, V255, P117, DOI 10.1016/j.aquaculture.2005.12.003
   Wang SY, 2003, MICROBIOL-SGM, V149, P1061, DOI 10.1099/mic.0.26032-0
   Weber B, 2011, MICROBIOL-SGM, V157, P3324, DOI 10.1099/mic.0.051011-0
   Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002
NR 48
TC 13
Z9 16
U1 3
U2 37
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2015
VL 6
IS 3
AR e00627-15
DI 10.1128/mBio.00627-15
PG 10
WC Microbiology
SC Microbiology
GA CM7JH
UT WOS:000357867400063
PM 26081633
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Lehman, SM
   Donlan, RM
AF Lehman, Susan M.
   Donlan, Rodney M.
TI Bacteriophage-Mediated Control of a Two-Species Biofilm Formed by
   Microorganisms Causing Catheter-Associated Urinary Tract Infections in
   an In Vitro Urinary Catheter Model
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID CARE-ASSOCIATED INFECTIONS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA;
   BACTERIAL INTERFERENCE; ARTIFICIAL URINE; ANTIBIOTIC-RESISTANCE;
   ANTIMICROBIAL AGENTS; TERM CATHETERIZATION; URETHRAL CATHETER;
   PROTEUS-MIRABILIS
AB Microorganisms from a patient or their environment may colonize indwelling urinary catheters, forming biofilm communities on catheter surfaces and increasing patient morbidity and mortality. This study investigated the effect of pretreating hydrogelcoated silicone catheters with mixtures of Pseudomonas aeruginosa and Proteus mirabilis bacteriophages on the development of single-and two-species biofilms in a multiday continuous-flow in vitro model using artificial urine. Novel phages were purified from sewage, characterized, and screened for their abilities to reduce biofilm development by clinical isolates of their respective hosts. Our screening data showed that artificial urine medium (AUM) is a valid substitute for human urine for the purpose of evaluating uropathogen biofilm control by these bacteriophages. Defined phage cocktails targeting P. aeruginosa and P. mirabilis were designed based on the biofilm inhibition screens. Hydrogel-coated catheters were pretreated with one or both cocktails and challenged with approximately 1 x 10(3) CFU/ml of the corresponding pathogen(s). The biofilm growth on the catheter surfaces in AUM was monitored over 72 to 96 h. Phage pretreatment reduced P. aeruginosa biofilm counts by 4 log(10) CFU/cm(2) (P <= 0.01) and P. mirabilis biofilm counts by > 2 log(10) CFU/cm(2) (P <= 0.01) over 48 h. The presence of P. mirabilis was always associated with an increase in lumen pH from 7.5 to 9.5 and with eventual blockage of the reactor lines. The results of this study suggest that pretreatment of a hydrogel urinary catheter with a phage cocktail can significantly reduce mixed-species biofilm formation by clinically relevant bacteria.
C1 [Lehman, Susan M.; Donlan, Rodney M.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.
RP Donlan, RM (reprint author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.
EM rld8@cdc.gov
FU American Society for Microbiology/Coordinating Center for Infectious
   Disease International Postdoctoral Fellowship
FX S.M.L. was supported by an American Society for
   Microbiology/Coordinating Center for Infectious Disease International
   Postdoctoral Fellowship.
CR ADAMS M, 1959, BACTERIOPHAGES
   Appelmans R, 1921, CR SOC BIOL, V85, P1098
   Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002
   Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x
   Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05
   Chanishvili N, 2001, J CHEM TECHNOL BIOT, V76, P689, DOI 10.1002/jctb.438
   Cho YH, 2001, BJU INT, V87, P104, DOI 10.1046/j.1464-410x.2001.00978.x
   Chutipongtanate S, 2010, ANAL BIOCHEM, V402, P110, DOI 10.1016/j.ab.2010.03.031
   Clayton C L, 1982, J Hosp Infect, V3, P39, DOI 10.1016/0195-6701(82)90029-9
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cox A J, 1987, Eng Med, V16, P37
   Curtin JJ, 2006, ANTIMICROB AGENTS CH, V50, P1268, DOI 10.1128/AAC.50.4.1268-1275.2006
   DAIFUKU R, 1984, JAMA-J AM MED ASSOC, V252, P2028, DOI 10.1001/jama.252.15.2028
   Darouiche RO, 2008, J ANTIMICROB CHEMOTH, V61, P651, DOI 10.1093/jac/dkn006
   Darouiche RO, 2005, CLIN INFECT DIS, V41, P1531, DOI 10.1086/497272
   Desai DG, 2010, J UROLOGY, V184, P2565, DOI 10.1016/j.juro.2010.07.036
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Frank DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007811
   Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09
   GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877
   GARIBALDI RA, 1982, INFECT CONT HOSP EP, V3, P466, DOI 10.1017/S0195941700056599
   GAYNES RP, 1985, ARCH INTERN MED, V145, P1804, DOI 10.1001/archinte.145.10.1804
   GOULD CV, 2009, GUIDELINE FOR PREVEN
   GRIFFITH DP, 1976, INVEST UROL, V13, P346
   Hachem R, 2009, ANTIMICROB AGENTS CH, V53, P5145, DOI 10.1128/AAC.00718-09
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Hull RA, 2002, INFECT IMMUN, V70, P6481, DOI 10.1128/IAI.70.11.6481-6484.2002
   Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07
   JARVIS WR, 1992, J ANTIMICROB CHEMOTH, V29, P19, DOI 10.1093/jac/29.suppl_A.19
   Jones GL, 2006, J ANTIMICROB CHEMOTH, V57, P266, DOI 10.1093/jac/dki447
   Jones SM, 2007, FEMS MICROBIOL LETT, V268, P16, DOI 10.1111/j.1574-6968.2006.00587.x
   KAPPELL GM, 2009, ELECTRON J BIOTECHN, V12, pE8
   Kay MK, 2011, APPL ENVIRON MICROB, V77, P821, DOI 10.1128/AEM.01797-10
   Kowalczuk D, 2010, INT J PHARMACEUT, V402, P175, DOI 10.1016/j.ijpharm.2010.10.014
   KUNIN CM, 1997, URINARY TRACT INFECT, P226
   Lai KK, 2002, AM J INFECT CONTROL, V30, P221, DOI 10.1067/mic.2002.12018
   Liao KS, 2012, J APPL MICROBIOL, V113, P1530, DOI 10.1111/j.1365-2672.2012.05432.x
   LINDBERG RB, 1974, J INFECT DIS, V130, pS33, DOI 10.1093/infdis/130.Supplement.S33
   Macleod SM, 2007, J MED MICROBIOL, V56, P1549, DOI 10.1099/jmm.0.47395-0
   Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801
   MARTIN C, 1995, J CLIN MICROBIOL, V33, P1461
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x
   Park JH, 2003, J BIOMAT SCI-POLYM E, V14, P951, DOI 10.1163/156856203322381438
   Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4
   Prasad A, 2009, SPINAL CORD, V47, P565, DOI 10.1038/sc.2008.166
   Raz R, 2000, J UROLOGY, V164, P1254, DOI 10.1016/S0022-5347(05)67150-9
   Reddy ST, 2011, J ENDOUROL, V25, P1547, DOI 10.1089/end.2010.0611
   Regev-Shoshani G, 2010, ANTIMICROB AGENTS CH, V54, P273, DOI 10.1128/AAC.00511-09
   Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002
   Saint S, 2000, AM J INFECT CONTROL, V28, P68, DOI 10.1016/S0196-6553(00)90015-4
   Saint S, 1998, AM J MED, V105, P236, DOI 10.1016/S0002-9343(98)00240-X
   Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929
   Schumm K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004013.pub3
   Sillankorva S, 2010, BIOFOULING, V26, P567, DOI 10.1080/08927014.2010.494251
   SKILLMAN LC, 1999, J APPL MICROBIOL, V85, P13
   Smith K, 2008, J MED MICROBIOL, V57, P966, DOI 10.1099/jmm.0.47668-0
   Stensballe J, 2007, ANN INTERN MED, V147, P285, DOI 10.7326/0003-4819-147-5-200709040-00002
   Stickler DJ, 1999, METHOD ENZYMOL, V310, P494
   STICKLER DJ, 1994, J HOSP INFECT, V28, P177, DOI 10.1016/0195-6701(94)90101-5
   Tait K, 2002, BIOFOULING, V18, P305, DOI 10.1080/0892701021000034418
   Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964
   Tambyah PA, 1999, MAYO CLIN PROC, V74, P131, DOI 10.4065/74.2.131
   Tambyah PA, 2000, ARCH INTERN MED, V160, P673, DOI 10.1001/archinte.160.5.673
   Trautner BW, 2007, INFECT CONT HOSP EP, V28, P92, DOI 10.1086/510872
   Trautner BW, 2003, UROLOGY, V61, P1059, DOI 10.1016/S0090-4295(02)02555-4
   Trautner BW, 2002, J UROLOGY, V167, P375, DOI 10.1016/S0022-5347(05)65471-7
   Wagenlehner FME, 2005, J HOSP INFECT, V60, P191, DOI 10.1016/j.jhin.2004.12.017
   Warren John W., 1996, P3
   Williams GJ, 2007, J UROLOGY, V178, P697, DOI 10.1016/j.juro.2007.03.091
NR 70
TC 21
Z9 22
U1 2
U2 38
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD FEB
PY 2015
VL 59
IS 2
BP 1127
EP 1137
DI 10.1128/AAC.03786-14
PG 11
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA CA0LT
UT WOS:000348610000045
PM 25487795
OA Green Published, Bronze
DA 2019-02-28
ER

PT J
AU Munns, KD
   Selinger, LB
   Stanford, K
   Guan, LL
   Callaway, TR
   McAllister, TA
AF Munns, Krysty D.
   Selinger, L. Brent
   Stanford, Kim
   Guan, Leluo
   Callaway, Todd R.
   McAllister, Tim A.
TI Perspectives on Super-Shedding of Escherichia coli O157:H7 by Cattle
SO Foodborne Pathogens and Disease
LA English
DT Review
ID COMMERCIAL FEEDLOT CATTLE; SHIGA TOXIN; RECTOANAL-JUNCTION; BIOFILM
   FORMATION; BEEF-CATTLE; PREHARVEST INTERVENTIONS; SALMONELLA-ENTERICA;
   O157-H7 POPULATIONS; ANIMAL VARIATION; GENOME SEQUENCE
AB Escherichia coli O157:H7 is a foodborne pathogen that causes illness in humans worldwide. Cattle are the primary reservoir of this bacterium, with the concentration and frequency of E. coli O157:H7 shedding varying greatly among individuals. The term "super-shedder" has been applied to cattle that shed concentrations of E. coli O157:H7 >= 10(4) colony-forming units/g feces. Super-shedders have been reported to have a substantial impact on the prevalence and transmission of E. coli O157:H7 in the environment. The specific factors responsible for super-shedding are unknown, but are presumably mediated by characteristics of the bacterium, animal host, and environment. Super-shedding is sporadic and inconsistent, suggesting that biofilms of E. coli O157:H7 colonizing the intestinal epithelium in cattle are intermittently released into feces. Phenotypic and genotypic differences have been noted in E. coli O157:H7 recovered from super-shedders as compared to low-shedding cattle, including differences in phage type (PT21/28), carbon utilization, degree of clonal relatedness, tir polymorphisms, and differences in the presence of stx2a and stx2c, as well as antiterminator Q gene alleles. There is also some evidence to support that the native fecal microbiome is distinct between super-shedders and low-shedders and that low-shedders have higher levels of lytic phage within feces. Consequently, conditions within the host may determine whether E. coli O157:H7 can proliferate sufficiently for the host to obtain super-shedding status. Targeting super-shedders for mitigation of E. coli O157:H7 has been proposed as a means of reducing the incidence and spread of this pathogen to the environment. If super-shedders could be easily identified, strategies such as bacteriophage therapy, probiotics, vaccination, or dietary inclusion of plant secondary compounds could be specifically targeted at this subpopulation. Evidence that super-shedder isolates share a commonality with isolates linked to human illness makes it imperative that the etiology of this phenomenon be characterized.
C1 [Munns, Krysty D.; Selinger, L. Brent; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB T1J 4B1, Canada.
   [Munns, Krysty D.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.
   [Stanford, Kim] Alberta Agr & Rural Dev, Lethbridge, AB, Canada.
   [Guan, Leluo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Callaway, Todd R.] ARS, Food & Feed Safety Res Unit, USDA, College Stn, TX USA.
RP McAllister, TA (reprint author), Agr & Agri Food Canada, Lethbridge Res Ctr, 5403 1st Ave South, Lethbridge, AB T1J 4B1, Canada.
EM tim.mcallister@agr.gc.ca
OI Callaway, Todd/0000-0002-3310-4979; McAllister, Tim
   A./0000-0002-8266-6513
FU Genome Alberta; Alberta Livestock Meat Agency
FX The authors wish to express their appreciation to Genome Alberta and the
   Alberta Livestock Meat Agency for financial support for some of the
   research that was conducted in their laboratories and reported within
   this review article.
CR Ahmad A, 2006, CURR MICROBIOL, V53, P324, DOI 10.1007/s00284-006-0089-3
   Arthur TM, 2013, APPL ENVIRON MICROB, V79, P4294, DOI 10.1128/AEM.00846-13
   Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09
   Baines D, 2008, CAN J ANIM SCI, V88, P581, DOI 10.4141/CJAS08016
   Baker D, 2007, RARITAN, V27, P73
   Berg J, 2004, J FOOD PROTECT, V67, P666, DOI 10.4315/0362-028X-67.4.666
   Besser TE, 1997, J INFECT DIS, V175, P726, DOI 10.1093/infdis/175.3.726
   Besser TE, 2007, APPL ENVIRON MICROB, V73, P671, DOI 10.1128/AEM.01035-06
   Bono JL, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-98
   Bottemiller H., 2012, FOOD SAFETY NEWS
   Braden KW, 2004, J FOOD PROTECT, V67, P1824, DOI 10.4315/0362-028X-67.9.1824
   Brussow H, 2005, MICROBIOL-SGM, V151, P2133, DOI 10.1099/mic.0.27849-0
   Buchko SJ, 2000, J FOOD PROTECT, V63, P1467, DOI 10.4315/0362-028X-63.11.1467
   Callaway T., 2003, P 5 INT S SHIG TOX P, P25
   Callaway TR, 2008, FOODBORNE PATHOG DIS, V5, P183, DOI 10.1089/fpd.2007.0057
   Callaway TR, 2011, J FOOD PROTECT, V74, P1917, DOI 10.4315/0362-028X.JFP-11-234
   Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67
   Callaway TR, 2004, J FOOD PROTECT, V67, P2603, DOI 10.4315/0362-028X-67.11.2603
   Callaway TR, 2013, AGR FOOD ANAL BACTER, V3, P103
   Callaway TR, 2010, WHITE PAPER PREHARVE
   Carlson BA, 2009, APPL ENVIRON MICROB, V75, P5927, DOI 10.1128/AEM.00972-09
   Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06
   Cernicchiaro N, 2011, FOODBORNE PATHOG DIS, V8, P239, DOI 10.1089/fpd.2010.0666
   Cernicchiaro N, 2010, FOODBORNE PATHOG DIS, V7, P1071, DOI 10.1089/fpd.2009.0531
   CHAPMAN PA, 1993, EPIDEMIOL INFECT, V111, P439, DOI 10.1017/S0950268800057162
   Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029
   Chase-Topping ME, 2007, J CLIN MICROBIOL, V45, P1594, DOI 10.1128/JCM.01690-06
   Chmielewski R. A. N., 2003, Comprehensive Reviews in Food Science and Food Safety, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x
   Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06
   Cull CA, 2012, VACCINE, V30, P6210, DOI 10.1016/j.vaccine.2012.05.080
   Davis MA, 2006, APPL ENVIRON MICROB, V72, P3766, DOI 10.1128/AEM.72.5.3760--3770.2006
   DeanNystrom EA, 1997, ADV EXP MED BIOL, V412, P47
   Dodd CC, 2010, FOODBORNE PATHOG DIS, V7, P357, DOI 10.1089/fpd.2009.0415
   Dugat-Bony E, 2013, 12 S BACT GEN EC 201
   Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10
   Durso LM, 2004, APPL ENVIRON MICROB, V70, P6466, DOI 10.1128/AEM.70.11.6466-6472.2004
   Echeverry A, 2005, AM J VET RES, V66, P2023, DOI 10.2460/ajvr.2005.66.2023
   Edrington TS, 2006, CURR MICROBIOL, V53, P82, DOI 10.1007/s00284-006-0019-4
   ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x
   Fegan N, 2005, J FOOD PROTECT, V68, P451, DOI 10.4315/0362-028X-68.3.451
   Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673
   Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x
   Flint HJ, 2004, ADV APPL MICROBIOL, V56, P89, DOI 10.1016/S0065-2164(04)56003-3
   Fox JT, 2008, J FOOD PROTECT, V71, P1761, DOI 10.4315/0362-028X-71.9.1761
   Fox JT, 2007, J ANIM SCI, V85, P1207, DOI 10.2527/jas.2006-079
   Franz E, 2012, J CLIN MICROBIOL, V50, P772, DOI 10.1128/JCM.05964-11
   Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623
   Goering RV, 2010, INFECT GENET EVOL, V10, P866, DOI 10.1016/j.meegid.2010.07.023
   Greer GG, 2005, J FOOD PROTECT, V68, P1102, DOI 10.4315/0362-028X-68.5.1102
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   Gunn GJ, 2007, VET J, V174, P554, DOI 10.1016/j.tvjl.2007.08.024
   Hallewell J, 2014, APPL ENVIRON MICROB, V80, P3819, DOI 10.1128/AEM.00708-14
   HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335
   Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11
   Jeon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055728
   Jokinen C, 2011, WATER RES, V45, P1247, DOI 10.1016/j.watres.2010.10.001
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818
   Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011
   Kim J, 1999, P NATL ACAD SCI USA, V96, P13288, DOI 10.1073/pnas.96.23.13288
   Kim JY, 2001, J BACTERIOL, V183, P6885, DOI 10.1128/JB.183.23.6885-6897.2001
   Kim SH, 2007, J FOOD PROTECT, V70, P22, DOI 10.4315/0362-028X-70.1.22
   Kotewicz ML, 2008, MICROBIOL-SGM, V154, P3518, DOI 10.1099/mic.0.2008/019026-0
   LeJeune JT, 2007, J ANIM SCI, V85, pE73, DOI 10.2527/jas.2006-612
   LeJeune JT, 2004, APPL ENVIRON MICROB, V70, P377, DOI 10.1128/AEM.70.1.377-384.2004
   Lewis R.J., 2013, INDEPENDENT REV XL F
   Lim JY, 2007, APPL ENVIRON MICROB, V73, P1380, DOI 10.1128/AEM.02242-06
   Loneragan GH, 2005, MEAT SCI, V71, P72, DOI 10.1016/j.meatsci.2005.04.005
   Lorimor J, 2000, MANURE MANAGEMENT SY
   Low JC, 2005, APPL ENVIRON MICROB, V71, P93, DOI 10.1128/AEM.71.1.93-97.2005
   Matthews L, 2006, EPIDEMIOL INFECT, V134, P131, DOI 10.1017/S0950268805004590
   Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103
   Matthews L, 2013, P NATL ACAD SCI USA, V110, P16265, DOI 10.1073/pnas.1304978110
   McGee P, 2004, J FOOD PROTECT, V67, P2651, DOI 10.4315/0362-028X-67.12.2651
   Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502
   Melton-Celsa AR, 1998, JPN J MED SCI BIOL, V51, pS108, DOI 10.7883/yoken1952.51.Supplement1_S108
   Munns K, 2013, 2013 CAN SOC AN SCI
   Munns KD, 2014, FOODBORNE PATHOG DIS, V11, P329, DOI 10.1089/fpd.2013.1621
   Nart P, 2008, INFECT IMMUN, V76, P5366, DOI 10.1128/IAI.01223-07
   Naylor SW, 2007, APPL ENVIRON MICROB, V73, P3765, DOI 10.1128/AEM.02670-06
   Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003
   Niu YD, 2009, J APPL MICROBIOL, V107, P646, DOI 10.1111/j.1365-2672.2009.04231.x
   Niu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034585
   OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65
   Ogden ID, 2004, FEMS MICROBIOL LETT, V233, P297, DOI 10.1016/j.femsle.2004.02.021
   Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI [10.1128/AEM.69.5.2444-2447.2003, 10.1128/AEM.69.2444-2447.2003]
   Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089
   Pruimboom-Brees IM, 2000, P NATL ACAD SCI USA, V97, P10325, DOI 10.1073/pnas.190329997
   Public Health Agency of Canada, 2009, CAN INT SURV REP SAL
   Public Health Agency of Canada, 2013, FACT SHEET E COL
   Rashid RA, 2006, INFECT IMMUN, V74, P4142, DOI 10.1128/IAI.00299-06
   Raya RR, 2006, APPL ENVIRON MICROB, V72, P6405, DOI 10.1128/AEM.03011-05
   Reissbrodt R, 2009, FEMS MICROBIOL LETT, V290, P62, DOI 10.1111/j.1574-6968.2008.01405.x
   Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024
   Robinson SE, 2009, J R SOC INTERFACE, V6, P169, DOI 10.1098/rsif.2008.0183
   Sanderson MW, 2006, APPL ENVIRON MICROB, V72, P7614, DOI 10.1128/AEM.01412-06
   Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x
   Sawant AA, 2011, APPL ENVIRON MICROB, V77, P2345, DOI 10.1128/AEM.03150-09
   Schamberger GP, 2004, APPL ENVIRON MICROB, V70, P6053, DOI 10.1128/AEM.70.10.6053-6060.2004
   Scharff R, 2010, HLTH RELATED COSTS F
   Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003
   Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10
   Sharma R, 2009, J FOOD PROTECT, V72, P601, DOI 10.4315/0362-028X-72.3.601
   Smith HW, 1962, J APPL BACTERIOL, V24, P235
   Stanford K, 2005, J DAIRY SCI, V88, P4441, DOI 10.3168/jds.S0022-0302(05)73131-3
   Stanford K, 2011, J ANIM SCI, V89, P237, DOI 10.2527/jas.2010-3088
   Stanford K, 2014, FOODBORNE PATHOG DIS, V11, P379, DOI 10.1089/fpd.2013.1693
   Stanford K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-178
   Stephens TP, 2008, J FOOD PROTECT, V71, P648, DOI 10.4315/0362-028X-71.3.648
   Stephens TP, 2009, J ANIM SCI, V87, P4151, DOI 10.2527/jas.2009-1967
   Stevens MP, 2002, MICROBIOL-SGM, V148, P3767, DOI 10.1099/00221287-148-12-3767
   Stoffregen WC, 2004, J VET DIAGN INVEST, V16, P79, DOI 10.1177/104063870401600114
   Strauch E, 2008, INFECT IMMUN, V76, P5466, DOI 10.1128/IAI.00875-08
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001
   Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006
   Van Baale MJ, 2004, APPL ENVIRON MICROB, V70, P5336, DOI 10.1128/AEM.70.9.5336-5342.2004
   Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005
   Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001
   WELLS JG, 1991, J CLIN MICROBIOL, V29, P985
   Williams KJ, 2014, VET MICROBIOL, V173, P101, DOI 10.1016/j.vetmic.2014.07.001
   WOLIN MJ, 1969, APPL MICROBIOL, V17, P83
   Woodward MJ, 1999, VET REC, V144, P466, DOI 10.1136/vr.144.17.466
   Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098115
   Yang Z, 2004, APPL ENVIRON MICROB, V70, P6846, DOI 10.1128/AEM.70.11.6846-6854.2004
NR 123
TC 17
Z9 19
U1 1
U2 39
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1535-3141
EI 1556-7125
J9 FOODBORNE PATHOG DIS
JI Foodborne Pathog. Dis.
PD FEB 1
PY 2015
VL 12
IS 2
BP 89
EP 103
DI 10.1089/fpd.2014.1829
PG 15
WC Food Science & Technology
SC Food Science & Technology
GA CA6GI
UT WOS:000349008100001
PM 25514549
DA 2019-02-28
ER

PT J
AU Castillo, D
   Cristiansen, RH
   Dalsgaard, I
   Madsen, L
   Middelboe, M
AF Castillo, Daniel
   Cristiansen, Roi Hammershaimb
   Dalsgaard, Inger
   Madsen, Lone
   Middelboe, Mathias
TI Bacteriophage Resistance Mechanisms in the Fish Pathogen Flavobacterium
   psychrophilum: Linking Genomic Mutations to Changes in Bacterial
   Virulence Factors
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID ABC TRANSPORT-SYSTEMS; POR SECRETION SYSTEM; GLIDING MOTILITY;
   PSEUDOMONAS-AERUGINOSA; CRISPR/CAS SYSTEM; ESCHERICHIA-COLI; PHAGE
   RESISTANCE; RAINBOW-TROUT; PROKARYOTES; SEQUENCE
AB Flavobacterium psychrophilum is an important fish pathogen in salmonid aquaculture worldwide. Due to increased antibiotic resistance, pathogen control using bacteriophages has been explored as a possible alternative treatment. However, the effective use of bacteriophages in pathogen control requires overcoming the selection for phage resistance in the bacterial populations. Here, we analyzed resistance mechanisms in F. psychrophilum after phage exposure using whole-genome sequencing of the ancestral phage-sensitive strain 950106-1/1 and six phage-resistant isolates. The phage-resistant strains had all obtained unique insertions and/or deletions and point mutations distributed among intergenic and genic regions. Mutations in genes related to cell surface properties, gliding motility, and biosynthesis of lipopolysaccharides and cell wall were found. The observed links between phage resistance and the genetic modifications were supported by direct measurements of bacteriophage adsorption rates, biofilm formation, and secretion of extracellular enzymes, which were all impaired in the resistant strains, probably due to superficial structural changes. The clustered regularly interspaced short palindromic repeat (CRISPR) region was unaffected in the resistant isolates and thus did not play a role as a resistance mechanism for F. psychrophilum under the current conditions. All together, the results suggest that resistance in F. psychrophilum was driven by spontaneous mutations, which were associated with a number of derived effects on the physiological properties of the pathogen, including reduced virulence under in vitro conditions. Consequently, phage-driven physiological changes associated with resistance may have implications for the impact of the pathogen in aquaculture, and these effects of phage resistance on host properties are therefore important for the ongoing exploration of phage-based control of F. psychrophilum.
C1 [Castillo, Daniel; Cristiansen, Roi Hammershaimb; Middelboe, Mathias] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark.
   [Cristiansen, Roi Hammershaimb; Dalsgaard, Inger; Madsen, Lone] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark.
RP Middelboe, M (reprint author), Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark.
EM mmiddelboe@bio.ku.dk
RI Middelboe, Mathias/B-9995-2009
OI Middelboe, Mathias/0000-0002-9587-9171
FU Danish Council for Independent Research [FNU-09-072829]; Danish
   Directorate for Food, Fisheries and Agri Business; EU-IRSES-funded
   project AQUAPHAGE
FX This work was supported by a grant from The Danish Council for
   Independent Research (FNU-09-072829), The Danish Directorate for Food,
   Fisheries and Agri Business, and by the EU-IRSES-funded project
   AQUAPHAGE.
CR Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06
   Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172
   Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x
   Barnard AML, 2010, MICROBIOL-SGM, V156, P1030, DOI 10.1099/mic.0.034595-0
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0
   BERNARDET JF, 1989, APPL ENVIRON MICROB, V55, P1796
   Braun TF, 2005, J BACTERIOL, V187, P2628, DOI 10.1128/JB.187.7.2628-2637.2005
   Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689
   Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004
   Bruun MS, 2000, AQUACULTURE, V187, P201, DOI 10.1016/S0044-8486(00)00310-0
   Capparelli R, 2010, PLOS ONE, V22
   Castillo D, 2012, J FISH DIS, V35, P193, DOI 10.1111/j.1365-2761.2011.01336.x
   Castillo D, 2014, MICROB ECOL, V67, P748, DOI 10.1007/s00248-014-0375-8
   Castillo D, 2014, FEMS MICROBIOL LETT, V351, P51, DOI 10.1111/1574-6968.12342
   Chagnot C, 2013, FRONT MICROBIOL, V14, P303, DOI DOI 10.3389/FMICB.2013.00303
   Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704
   Davis BM, 2003, CURR OPIN MICROBIOL, V6, P35, DOI 10.1016/S1369-5274(02)00005-X
   Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123
   Drummond AJ, 2010, GENEIOUS V5 3
   Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313
   Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1
   Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131
   Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575
   Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x
   Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651
   Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004
   Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360
   Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060
   Hogfors-Ronnholm E, 2010, MICROB PATHOGENESIS, V49, P369, DOI 10.1016/j.micpath.2010.08.002
   Holt R. A., 1993, P3
   Honma K, 2001, INFECT IMMUN, V69, P4686, DOI 10.1128/IAI.69.7.4686-4690.2001
   Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13
   Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18
   Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004
   Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   LEDERBERG J, 1952, J BACTERIOL, V63, P399
   LENSKI RE, 1988, EVOLUTION, V42, P425, DOI 10.1111/j.1558-5646.1988.tb04149.x
   Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818
   MADSEN L, 1998, METHODOLOGY FISH DIS, P45
   Madsen L, 2013, APPL ENVIRON MICROB, V79, P4853, DOI 10.1128/AEM.00509-13
   Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7
   Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771
   Matthysse AG, 1996, J BACTERIOL, V178, P5302, DOI 10.1128/jb.178.17.5302-5308.1996
   McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12
   McBride MJ, 2004, J BACTERIOL, V186, P2295, DOI 10.1128/JB.186.8.2295-2302.2004
   Middelboe M, 2000, MICROBIAL ECOL, V40, P114
   Middelboe M, 2001, MICROBIAL ECOL, V42, P395, DOI 10.1007/s00248-001-0012-1
   Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x
   Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x
   Nicolas P, 2008, APPL ENVIRON MICROB, V74, P3702, DOI 10.1128/AEM.00244-08
   Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226
   Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048
   Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028
   Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107
   Schneider E, 1998, FEMS MICROBIOL REV, V22, P1
   Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08
   Tran HL, 1999, APPL ENVIRON MICROB, V65, P4793
   Valdebenito S, 2009, J FISH DIS, V32, P321, DOI 10.1111/j.1365-2761.2008.00996.x
   Yeom DH, 2013, GENES CELLS, V18, P682, DOI 10.1111/gtc.12076
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
NR 67
TC 17
Z9 18
U1 5
U2 35
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD FEB
PY 2015
VL 81
IS 3
BP 1157
EP 1167
DI 10.1128/AEM.03699-14
PG 11
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA AZ0CU
UT WOS:000347914800038
PM 25480749
OA Bronze, Green Published
DA 2019-02-28
ER

PT J
AU Alves, DR
   Gaudion, A
   Bean, JE
   Esteban, PP
   Arnot, TC
   Harper, DR
   Kot, W
   Hansen, LH
   Enright, MC
   Jenkins, ATA
AF Alves, D. R.
   Gaudion, A.
   Bean, J. E.
   Esteban, P. Perez
   Arnot, T. C.
   Harper, D. R.
   Kot, W.
   Hansen, L. H.
   Enright, M. C.
   Jenkins, A. Tobias A.
TI Combined Use of Bacteriophage K and a Novel Bacteriophage To Reduce
   Staphylococcus aureus Biofilm Formation
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID COMPLETE GENOME SEQUENCE; METHICILLIN-RESISTANT; PHAGE THERAPY;
   INFECTIONS; DNA; HOST; COLI; ADSORPTION; PARTICLES; PLAQUE
AB Biofilms are major causes of impairment of wound healing and patient morbidity. One of the most common and aggressive wound pathogens is Staphylococcus aureus, displaying a large repertoire of virulence factors and commonly reduced susceptibility to antibiotics, such as the spread of methicillin-resistant S. aureus (MRSA). Bacteriophages are obligate parasites of bacteria. They multiply intracellularly and lyse their bacterial host, releasing their progeny. We isolated a novel phage, DRA88, which has a broad host range among S. aureus bacteria. Morphologically, the phage belongs to the Myoviridae family and comprises a large double-stranded DNA (dsDNA) genome of 141,907 bp. DRA88 was mixed with phage K to produce a high-titer mixture that showed strong lytic activity against a wide range of S. aureus isolates, including representatives of the major international MRSA clones and coagulase-negative Staphylococcus. Its efficacy was assessed both in planktonic cultures and when treating established biofilms produced by three different biofilm-producing S. aureus isolates. A significant reduction of biofilm biomass over 48 h of treatment was recorded in all cases. The phage mixture may form the basis of an effective treatment for infections caused by S. aureus biofilms.
C1 [Alves, D. R.; Gaudion, A.; Bean, J. E.; Enright, M. C.; Jenkins, A. Tobias A.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England.
   [Esteban, P. Perez; Arnot, T. C.] Univ Bath, Dept Chem Engn, Bath BA2 7AY, Avon, England.
   [Harper, D. R.] AmpliPhi Biosci Corp, Sharnbrook, Beds, England.
   [Kot, W.; Hansen, L. H.] Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark.
   [Hansen, L. H.] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark.
RP Jenkins, ATA (reprint author), Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England.
EM a.t.a.jenkins@bath.ac.uk
RI Kot, Witold/N-3747-2017; Jenkins, Toby/C-2124-2009; Arnot,
   Tom/I-2904-2015; Kot, Witold/M-2170-2014
OI Kot, Witold/0000-0002-0188-4587; Jenkins, Toby/0000-0002-8981-3029;
   Arnot, Tom/0000-0002-7950-9429; Kot, Witold/0000-0002-0188-4587; Perez
   Esteban, Patricia/0000-0001-7084-1065; Enright, Mark/0000-0001-5273-8750
FU Danish Research Council for Technology and Production [11-106991];
   Engineering and Physical Sciences Research Council (EPSRC) Healthcare
   Partnership fund; MetaPhageLAB project; Biotechnology and Biological
   Sciences Research Council [1096378]; Engineering and Physical Sciences
   Research Council [EP/I027602/1]
FX This work was partly supported by the MetaPhageLAB project financed by
   The Danish Research Council for Technology and Production (project
   11-106991, document 2105568). We also thank the Engineering and Physical
   Sciences Research Council (EPSRC) Healthcare Partnership fund for their
   funding and support.
CR Abedon S., 2011, BACTERIOPHAGES BIOFI
   Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1
   Ackermann HW, 2011, MICROBIOL AUST, V32, P90
   ADAMS M, 1959, BACTERIOPHAGES
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Boulanger Pascale, 2009, V502, P227, DOI 10.1007/978-1-60327-565-1_13
   Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]
   Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06
   Cerca N, 2007, LETT APPL MICROBIOL, V45, P313, DOI 10.1111/j.1472-765X.2007.02190.x
   Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025
   Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799
   Cui ZL, 2012, J VIROL, V86, P13880, DOI 10.1128/JVI.02728-12
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Davies CE, 2004, J CLIN MICROBIOL, V42, P3549, DOI 10.1128/JCM.42.8.3549-3557.2004
   deBeer D, 1997, BIOTECHNOL BIOENG, V53, P151, DOI 10.1002/(SICI)1097-0290(19970120)53:2<151::AID-BIT4>3.0.CO;2-N
   Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316
   Donlan RM, 2008, CURR TOP MICROBIOL, V322, P133
   Enright MC, 2000, J CLIN MICROBIOL, V38, P1008
   Erol S, 2004, BURNS, V30, P357, DOI 10.1016/j.burns.2003.12.013
   Esteban PP, 2014, BIOTECHNOL PROGR, V30, P932, DOI 10.1002/btpr.1898
   Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289
   Gorski A, 2009, CURR OPIN INVEST DR, V10, P766
   Gu JM, 2012, J VIROL, V86, P8914, DOI 10.1128/JVI.01313-12
   Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698
   Gupta R, 2011, CURR MICROBIOL, V62, P255, DOI 10.1007/s00284-010-9699-x
   Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004
   HEJKAL TW, 1981, APPL ENVIRON MICROB, V41, P628
   HENEIN A, 2013, BACTERIOPHAGE, V3, DOI DOI 10.4161/BACT.24872
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Hsieh SE, 2011, APPL ENVIRON MICROB, V77, P756, DOI 10.1128/AEM.01848-10
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Keen EF, 2010, BURNS, V36, P819, DOI 10.1016/j.burns.2009.10.013
   Kelly D, 2012, LETT APPL MICROBIOL, V54, P286, DOI 10.1111/j.1472-765X.2012.03205.x
   Kirby AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051017
   Kot W, 2014, J VIROL METHODS, V196, P152, DOI 10.1016/j.jviromet.2013.10.040
   Kraushaar B, 2013, ARCH VIROL, V158, P2341, DOI 10.1007/s00705-013-1707-6
   Kumar GPN, 2012, VIRUS RES, V169, P182, DOI 10.1016/j.virusres.2012.07.026
   Kurlenda J, 2012, ACTA BIOCHIM POL, V59, P171
   Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102
   Kwiatek M, 2012, ARCH VIROL, V157, P225, DOI 10.1007/s00705-011-1160-3
   LAM J, 1980, INFECT IMMUN, V28, P546
   Langlet J, 2007, J APPL MICROBIOL, V103, P1632, DOI 10.1111/j.1365-2672.2007.03396.x
   Liapikou A, 2013, EXPERT OPIN EMERG DR, V18, P291, DOI 10.1517/14728214.2013.813480
   Lima-Mendez G, 2011, RES MICROBIOL, V162, P737, DOI 10.1016/j.resmic.2011.06.006
   Lobocka M, 2012, ADV VIRUS RES, V83, P143, DOI 10.1016/B978-0-12-394438-2.00005-0
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Murray CK, 2009, BURNS, V35, P1112, DOI 10.1016/j.burns.2009.02.013
   NARANG HK, 1981, J CLIN MICROBIOL, V13, P982
   O'Flaherty S, 2005, APPL ENVIRON MICROB, V71, P1836, DOI 10.1128/AEM.71.4.1836-1842.2005
   O'Flaherty S, 2004, J BACTERIOL, V186, P2862, DOI 10.1128/JB.186.9.2862-2871.2004
   Pajunen M, 2000, J BACTERIOL, V182, P5114, DOI 10.1128/JB.182.18.5114-5120.2000
   Percival SL, 2012, WOUND REPAIR REGEN, V20, P647, DOI 10.1111/j.1524-475X.2012.00836.x
   Pickard Derek John Juan, 2009, V502, P3, DOI 10.1007/978-1-60327-565-1_1
   Plata K, 2009, ACTA BIOCHIM POL, V56, P597
   REES PJ, 1981, J GEN VIROL, V53, P293, DOI 10.1099/0022-1317-53-2-293
   Ryan EM, 2012, FEMS IMMUNOL MED MIC, V65, P395, DOI 10.1111/j.1574-695X.2012.00977.x
   Sambrook J, 2001, MOL CLONING LAB MANU, V1
   Sen CK, 2010, WOUND REPAIR REGEN, V17, P763, DOI DOI 10.1111/J.1524-475X.2009.00543.X
   Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-80
   Skurnik M, 2007, BIOTECHNOL LETT, V29, P995, DOI 10.1007/s10529-007-9346-1
   STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292
   Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280
   TUCKER RG, 1961, J GEN MICROBIOL, V26, P313, DOI 10.1099/00221287-26-2-313
   Xia GQ, 2011, J BACTERIOL, V193, P4006, DOI 10.1128/JB.01412-10
   Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4
   Zemb O, 2013, J VIROL METHODS, V189, P283, DOI 10.1016/j.jviromet.2013.02.007
NR 66
TC 34
Z9 36
U1 2
U2 54
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD NOV
PY 2014
VL 80
IS 21
BP 6694
EP 6703
DI 10.1128/AEM.01789-14
PG 10
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA AS3FA
UT WOS:000344160900014
PM 25149517
OA Green Published, Bronze
DA 2019-02-28
ER

PT J
AU Liao, CT
   Du, SC
   Lo, HH
   Hsiao, YM
AF Liao, Chao-Tsai
   Du, Shin-Chiao
   Lo, Hsueh-Hsia
   Hsiao, Yi-Min
TI The galU gene of Xanthomonas campestris pv. campestris is involved in
   bacterial attachment, cell motility, polysaccharide synthesis,
   virulence, and tolerance to various stresses
SO ARCHIVES OF MICROBIOLOGY
LA English
DT Article
DE Motility; Pathogenicity; Polysaccharide; Xanthomonas
ID UDP-GLUCOSE PYROPHOSPHORYLASE; COMPLETE GENOME SEQUENCE; PHAGE PHI-LF;
   GLUCOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; ESCHERICHIA-COLI;
   LIPOPOLYSACCHARIDE BIOSYNTHESIS; TRANSCRIPTION FACTOR; PLANT
   INTERACTIONS; BIOFILM FORMATION; XANTHAN GUM
AB Uridine triphosphate (UTP)-glucose-1-phosphate uridylyltransferase (GalU; EC 2.7.7.9) is an enzyme that catalyzes the formation of uridine diphosphate (UDP)-glucose from UTP and glucose-1-phosphate. GalU is involved in virulence in a number of animal-pathogenic bacteria since its product, UDP-glucose, is indispensable for the biosynthesis of virulence factors such as lipopolysaccharide and exopolysaccharide. However, its function in Xanthomonas campestris pv. campestris, the phytopathogen that causes black rot in cruciferous plants, is unclear. Here, we characterized a galU mutant of X. campestris pv. campestris and showed that the X. campestris pv. campestris galU mutant resulted in a reduction in virulence on the host cabbage. We also demonstrated that galU is involved in bacterial attachment, cell motility, and polysaccharide synthesis. Furthermore, the galU mutant showed increased sensitivity to various stress conditions including copper sulfate, hydrogen peroxide, and sodium dodecyl sulfate. In addition, mutation of galU impairs the expression of the flagellin gene fliC as well as the attachment-related genes xadA, fhaC, and yapH. In conclusion, our results indicate involvement of galU in the virulence factor production and pathogenicity in X. campestris pv. campestris, and a role for galU in stress tolerance of this crucifer pathogen.
C1 [Liao, Chao-Tsai; Du, Shin-Chiao; Lo, Hsueh-Hsia; Hsiao, Yi-Min] Cent Taiwan Univ Sci & Technol, Dept Med Lab Sci & Biotechnol, Taichung 406, Taiwan.
RP Hsiao, YM (reprint author), Cent Taiwan Univ Sci & Technol, Dept Med Lab Sci & Biotechnol, Taichung 406, Taiwan.
EM ymhsiao@ctust.edu.tw
FU National Science Council of Taiwan [NSC 101-2313-B-166-001-MY3]; Central
   Taiwan University of Science and Technology [CTU100-PC-010]
FX This work was supported by the National Science Council of Taiwan Grant
   No. NSC 101-2313-B-166-001-MY3 to Yi-Min Hsiao, and the Central Taiwan
   University of Science and Technology Grant No. CTU100-PC-010 to
   Chao-Tsai Liao.
CR Aragao D, 2007, J BACTERIOL, V189, P4520, DOI 10.1128/JB.00277-07
   Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11
   Bosco MB, 2009, BIOCHIMIE, V91, P204, DOI 10.1016/j.biochi.2008.09.001
   Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x
   Chan JWYF, 1999, BIOTECHNOL ADV, V17, P489, DOI 10.1016/S0734-9750(99)00025-7
   Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024
   da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a
   Darsonval A, 2009, MOL PLANT MICROBE IN, V22, P747, DOI 10.1094/MPMI-22-6-0747
   Das A, 2009, MOL PLANT MICROBE IN, V22, P73, DOI 10.1094/MPMI-22-1-0073
   Deng WL, 2010, MOL PLANT MICROBE IN, V23, P1184, DOI 10.1094/MPMI-23-9-1184
   Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29
   Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100
   DOW JM, 1995, MOL PLANT MICROBE IN, V8, P768
   FU JF, 1990, APPL ENVIRON MICROB, V56, P919
   Genevaux P, 1999, ARCH MICROBIOL, V172, P1, DOI 10.1007/s002030050732
   Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358
   Guo YP, 2010, APPL ENVIRON MICROB, V76, P2234, DOI 10.1128/AEM.02897-09
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Hsiao YM, 2012, ARCH MICROBIOL, V194, P293, DOI 10.1007/s00203-011-0760-3
   Hsiao YM, 2011, MICROBIOL RES, V166, P548, DOI 10.1016/j.micres.2010.11.003
   Hsiao YM, 2005, FEBS LETT, V579, P3525, DOI 10.1016/j.febslet.2005.05.023
   Jalan N, 2011, J BACTERIOL, V193, P6342, DOI 10.1128/JB.05777-11
   Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09
   KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5
   Kim H, 2010, MOL CELLS, V29, P397, DOI 10.1007/s10059-010-0047-6
   KOMEDA Y, 1977, J BACTERIOL, V129, P908
   Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206
   Lee MC, 2003, BIOCHEM BIOPH RES CO, V307, P647, DOI 10.1016/S0006-291X(03)01223-3
   Lee TC, 2001, J MOL MICROB BIOTECH, V3, P471
   LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q
   Liu YF, 2013, FEBS J, V280, P199, DOI 10.1111/febs.12061
   Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]
   MILLER JH, 1972, EXPT MOL GENETICS
   Nesper J, 2000, J BACTERIOL, V182, P5097, DOI 10.1128/JB.182.18.5097-5104.2000
   Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001
   Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616
   Priebe GP, 2004, INFECT IMMUN, V72, P4224, DOI 10.1128/IAI.72.7.4224-4232.2004
   Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705
   Rioux S, 1999, CAN J MICROBIOL, V45, P1017, DOI 10.1139/cjm-45-12-1017
   Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558
   Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204
   Sambrook J., 1989, MOL CLONING LAB MANU
   Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005
   Thoden JB, 2007, PROTEIN SCI, V16, P1379, DOI 10.1110/ps.072864707
   Thoden JB, 2007, PROTEIN SCI, V16, P432, DOI 10.1110/ps.062626007
   Vilches S, 2007, MICROBIOL-SGM, V153, P2393, DOI 10.1099/mic.0.2007/006437-0
   Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013
   Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521
   WANG TW, 1992, LETT APPL MICROBIOL, V14, P65, DOI 10.1111/j.1472-765X.1992.tb00649.x
   Wei CL, 1996, BIOCHEM BIOPH RES CO, V226, P607, DOI 10.1006/bbrc.1996.1403
   Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996
   Williams P. H., 1980, Plant Disease, V64, P736
   YANG BY, 1988, BOT BULL ACAD SINICA, V29, P93
   Yen MR, 2002, APPL ENVIRON MICROB, V68, P2924, DOI 10.1128/AEM.68.6.2924-2933.2002
   Zou Y, 2013, VET MICROBIOL, V162, P278, DOI 10.1016/j.vetmic.2012.08.006
NR 55
TC 12
Z9 12
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-8933
EI 1432-072X
J9 ARCH MICROBIOL
JI Arch. Microbiol.
PD OCT
PY 2014
VL 196
IS 10
BP 729
EP 738
DI 10.1007/s00203-014-1012-0
PG 10
WC Microbiology
SC Microbiology
GA AP9TM
UT WOS:000342422800005
PM 25033927
DA 2019-02-28
ER

PT J
AU Peng, F
   Mi, ZQ
   Huang, Y
   Yuan, X
   Niu, WK
   Wang, YH
   Hua, YH
   Fan, HH
   Bai, CQ
   Tong, YG
AF Peng, Fan
   Mi, Zhiqiang
   Huang, Yong
   Yuan, Xin
   Niu, Wenkai
   Wang, Yahui
   Hua, Yuhui
   Fan, Huahao
   Bai, Changqing
   Tong, Yigang
TI Characterization, sequencing and comparative genomic analysis of
   vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects
   multidrug-resistant Acinetobacter baumannii clinical isolates
SO BMC MICROBIOLOGY
LA English
DT Article
DE Acinetobacter baumannii; Bacteriophage; Characteristics; Genome
ID ESCHERICHIA-COLI; PHAGE THERAPY; HOST-RANGE; PROTEINS; VIRULENT;
   BIOFILM; VIRUSES; ARCHAEA; PDR; AB1
AB Background: With the use of broad-spectrum antibiotics, immunosuppressive drugs, and glucocorticoids, multidrug-resistant Acinetobacter baumannii (MDR-AB) has become a major nosocomial pathogen species. The recent renaissance of bacteriophage therapy may provide new treatment strategies for combatting drug-resistant bacterial infections. In this study, we isolated a lytic bacteriophage vB_AbaM-IME-AB2 has a short latent period and a small burst size, which clear its host's suspension quickly, was selected for characterization and a complete genomic comparative study.
   Results: The isolated bacteriophage vB_AbaM-IME-AB2 has an icosahedral head and displays morphology resembling Myoviridae family. Gel separation assays showed that the phage particle contains at least nine protein bands with molecular weights ranging 15-100 kDa. vB_AbaM-IME-AB2 could adsorb its host cells in 9 min with an adsorption rate more than 99% and showed a short latent period (20 min) and a small burst size (62 pfu/cell). It could form clear plaques in the double-layer assay and clear its host's suspension in just 4 hours. Whole genome of vB_AbaM-IME-AB2 was sequenced and annotated and the results showed that its genome is a double-stranded DNA molecule consisting of 43,665 nucleotides. The genome has a G + C content of 37.5% and 82 putative coding sequences (CDSs). We compared the characteristics and complete genome sequence of all known Acinetobacter baumannii bacteriophages. There are only three that have been sequenced Acinetobacter baumannii phages AB1, AP22, and phiAC-1, which have a relatively high similarity and own a coverage of 65%, 50%, 8% respectively when compared with our phage vB_AbaM-IME-AB2. A nucleotide alignment of the four Acinetobacter baumannii phages showed that some CDSs are similar, with no significant rearrangements observed. Yet some sections of these strains of phage are nonhomologous.
   Conclusion: vB_AbaM-IME-AB2 was a novel and unique A. baumannii bacteriophage. These findings suggest a common ancestry and microbial diversity and evolution. A clear understanding of its characteristics and genes is conducive to the treatment of multidrug-resistant A. baumannii in the future.
C1 [Peng, Fan; Mi, Zhiqiang; Huang, Yong; Wang, Yahui; Hua, Yuhui; Fan, Huahao; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Peng, Fan; Yuan, Xin; Niu, Wenkai; Bai, Changqing] PLA Hosp 307, Dept Resp Med, Beijing 100071, Peoples R China.
   [Peng, Fan] Cent S Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China.
RP Bai, CQ (reprint author), PLA Hosp 307, Dept Resp Med, Beijing 100071, Peoples R China.
EM mlp1604@sina.com; tong62035@gmail.com
OI Tong, Yigang/0000-0002-8503-8045
FU National Natural Science Foundation of China [81072350]; National
   Hi-Tech Research and Development (863) Program of China [2012AA022-003];
   China Mega-Project on Major Drug Development [2011ZX09401-023]; China
   Mega-Project on Infectious Disease Prevention [2013ZX10004-605,
   2011ZX10004-001]; State Key Laboratory of Pathogen and BioSecurity
   Program [SKLPBS1113]; Particular Clinical Applied Research of the
   Capital of China [Z121107001012127]
FX This research was supported by a grant from the National Natural Science
   Foundation of China (No. 81072350), the National Hi-Tech Research and
   Development (863) Program of China (No. 2012AA022-003), the China
   Mega-Project on Major Drug Development (No. 2011ZX09401-023), the China
   Mega-Project on Infectious Disease Prevention (No. 2013ZX10004-605 and
   No. 2011ZX10004-001), the State Key Laboratory of Pathogen and
   BioSecurity Program (No. SKLPBS1113), and the Particular Clinical
   Applied Research of the Capital of China (No. Z121107001012127).
CR ABEDON ST, 1989, MICROB ECOL, V18, P79, DOI 10.1007/BF02030117
   Abedon ST, 2011, BACTERIOPHAGE, V1, P1, DOI DOI 10.4161/BACT.1.1.13980
   Adams M. H., 1950, METHODS STUDY BACTER
   Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2
   Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.femsre.2004.12.008
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   BACHRACH U, 1971, APPL MICROBIOL, V22, P706
   Chang KC, 2011, GENOMICS, V97, P249, DOI 10.1016/j.ygeno.2011.01.002
   Chen XD, 2012, BMC MICROBIOL, V12, P156
   Chen ZH, 2005, NUCLEIC ACIDS RES, V33, P6172, DOI 10.1093/nar/gki915
   Falagas ME, 2008, CLIN INFECT DIS, V46, P1121, DOI 10.1086/528867
   Falagas ME, 2006, J MED MICROBIOL, V55, P1619, DOI 10.1099/jmm.0.46747-0
   GADAGKAR R, 1980, J BIOSCIENCE, V2, P253, DOI DOI 10.1007/BF02703251
   GERMIDA JJ, 1983, APPL ENVIRON MICROB, V45, P1380
   Huang GT, 2013, CURR MICROBIOL, V66, P535, DOI 10.1007/s00284-013-0308-7
   Jane FT, 2012, J MED MICROBIOL, V1, P109
   Jeon J, 2012, J VIROL, V86, P12437, DOI 10.1128/JVI.02132-12
   Jiang XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-194
   Jie Z, 2013, J 3 MILITARY MED U, V15, P008
   Kim JH, 2012, J VIROL, V86, P13131, DOI 10.1128/JVI.02454-12
   Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x
   Lee CN, 2011, APPL ENVIRON MICROB, V77, P6755, DOI 10.1128/AEM.05116-11
   Li GQ, 2004, BRIEF BIOINFORM, V5, P378, DOI 10.1093/bib/5.4.378
   Li PZ, 2012, GENE, V507, P125, DOI 10.1016/j.gene.2012.07.029
   Lin HC, 1999, J MOL BIOL, V289, P249, DOI 10.1006/jmbi.1999.2781
   Lin NT, 2010, RES MICROBIOL, V161, P308, DOI 10.1016/j.resmic.2010.03.007
   LU MJ, 1989, J VIROL, V63, P3472
   Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944
   Mishra CK, 2012, J GEN VIROL, V93, P2310, DOI 10.1099/vir.0.043562-0
   Mulder NJ, 2008, CURRENT PROTOCOLS BI
   Niu YD, 2009, J APPL MICROBIOL, V107, P646, DOI 10.1111/j.1365-2672.2009.04231.x
   Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06
   Pirisi A, 2000, LANCET, V356, P1418, DOI 10.1016/S0140-6736(05)74059-9
   Popova AV, 2012, FEMS MICROBIOL LETT, V332, P40, DOI 10.1111/j.1574-6968.2012.02573.x
   Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200
   Ryan EM, 2011, J PHARM PHARMACOL, V63, P1253, DOI 10.1111/j.2042-7158.2011.01324.x
   Seed KD, 2011, MBIO, V2, DOI 10.1128/mBio.00334-10
   Shen GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046537
   Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001
   Thawal ND, 2012, CURR MICROBIOL, V65, P66, DOI 10.1007/s00284-012-0127-2
   Turner D, 2012, J GEN VIROL, V93, P2046, DOI 10.1099/vir.0.043331-0
   Vasiliy P, 2010, VIROL J, V7, P292
   Weber-Dabrowska B., 2001, Clinical and Applied Immunology Reviews, V1, P131, DOI 10.1016/S1529-1049(01)00015-0
   Yang HJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-131
   Yele AB, 2012, ARCH VIROL, V157, P1441, DOI 10.1007/s00705-012-1320-0
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
   Zhang WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080435
NR 49
TC 18
Z9 19
U1 0
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD JUL 5
PY 2014
VL 14
AR 181
DI 10.1186/1471-2180-14-181
PG 14
WC Microbiology
SC Microbiology
GA AK9YI
UT WOS:000338784100001
PM 24996449
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Cappitelli, F
   Polo, A
   Villa, F
AF Cappitelli, F.
   Polo, A.
   Villa, F.
TI Biofilm Formation in Food Processing Environments is Still Poorly
   Understood and Controlled
SO FOOD ENGINEERING REVIEWS
LA English
DT Review
DE Biofilm; Antibiofilm action; Food safety; Alternative control
ID LISTERIA-MONOCYTOGENES BIOFILM; ESCHERICHIA-COLI O157H7; STAINLESS-STEEL
   SURFACES; SALMONELLA-ENTERICA; CONTACT SURFACES; BENZALKONIUM CHLORIDE;
   FOODBORNE PATHOGENS; BACILLUS-CEREUS; PSEUDOMONAS-AERUGINOSA;
   MULTISPECIES BIOFILM
AB The presence of undesirable biofilms on food processing contact surfaces may lead to: (1) transmission of diseases; (2) food spoilage; (3) shortened time between cleaning events; (4) contamination of product by nonstarter bacteria; (5) metal corrosion in pipelines and tanks; (6) reduced heat transfer efficacy or even obstruction of the heat equipment. Despite the significant problems caused by biofilms in the food industry, biofilm formation in these environments is still poorly understood and effective control of biofilms remains challenging. Although it is understood that cell attachment and biofilm formation are influenced by several factors, including type of strain, chemical-physical properties of the surface, temperature, growth media and the presence of other microorganisms, some conflicting statements can be retrieved from the literature and there are no general trends yet that allow us to easily predict biofilm development. It is likely that still unexplored interaction of factors may be more critical than the effect of a single parameter. New alternative biofilm control strategies, such as biocontrol, use of enzymes and phages and cell-to-cell communication interference, are now available that can reduce the use of chemical agents. In addition, as preventing biofilm formation is a more efficient strategy than controlling mature biofilm, the use of surface-modified materials have been suggested. These strategies may better reveal their beneficial potential when the ecological complexity of biofilms in food environments is addressed.
C1 [Cappitelli, F.; Polo, A.; Villa, F.] Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, I-20133 Milan, Italy.
RP Cappitelli, F (reprint author), Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, Via Celoria 2, I-20133 Milan, Italy.
EM francesca.cappitelli@unimi.it
RI Villa, Federica/B-8787-2017; Cappitelli, Francesca/H-1492-2015;
   Abbracchio, Maria Pia/B-9342-2014
OI Villa, Federica/0000-0003-2930-4684; Abbracchio, Maria
   Pia/0000-0002-7833-3388; Cappitelli, Francesca/0000-0003-1237-1813;
   Polo, Andrea/0000-0002-3001-4927
CR Abee T, 2004, TRENDS BIOTECHNOL, V22, P653, DOI 10.1016/j.tibtech.2004.10.007
   Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515
   Alpkvist E, 2007, B MATH BIOL, V69, P765, DOI 10.1007/s11538-006-9168-7
   Bai AJ, 2011, COMPR REV FOOD SCI F, V10, P184, DOI 10.1111/j.1541-4337.2011.00150.x
   Barish JA, 2013, FOOD BIOPROD PROCESS, V91, P352, DOI 10.1016/j.fbp.2013.01.003
   Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001
   Behnke S, 2011, APPL ENVIRON MICROB, V77, P7176, DOI 10.1128/AEM.05514-11
   Beresford MR, 2001, J APPL MICROBIOL, V90, P1000, DOI 10.1046/j.1365-2672.2001.01330.x
   Boistier-Marquis E, 2000, BIOFOULING, V14, P279, DOI 10.1080/08927010009378420
   Bremer PJ, 2001, J FOOD PROTECT, V64, P1369, DOI 10.4315/0362-028X-64.9.1369
   Brooks JD, 2008, INT J FOOD SCI TECH, V43, P2163, DOI 10.1111/j.1365-2621.2008.01839.x
   Buchovec I, 2010, J PHOTOCH PHOTOBIO B, V99, P9, DOI 10.1016/j.jphotobiol.2010.01.007
   Cappello S, 2006, BRAZ J MICROBIOL, V37, P205, DOI 10.1590/S1517-83822006000300001
   Carpentier B, 2004, INT J FOOD MICROBIOL, V97, P111, DOI 10.1016/j.ijfoodmicro.2004.03.031
   CARPENTIER B, 1993, J APPL BACTERIOL, V75, P499, DOI 10.1111/j.1365-2672.1993.tb01587.x
   Castelijn GAA, 2012, BIOFOULING, V28, P51, DOI 10.1080/08927014.2011.648927
   CHARACKLIS WG, 1981, BIOTECHNOL BIOENG, V23, P1923, DOI 10.1002/bit.260230902
   Chia TWR, 2009, FOOD MICROBIOL, V26, P853, DOI 10.1016/j.fm.2009.05.012
   Chmielewski R. A. N., 2003, Comprehensive Reviews in Food Science and Food Safety, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x
   Tarifa MC, 2013, BIOFOULING, V29, P841, DOI 10.1080/08927014.2013.808628
   Costerton J. William, 2007, V1, P1
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   Critzer FJ, 2007, J FOOD PROTECT, V70, P2290, DOI 10.4315/0362-028X-70.10.2290
   Meira QGD, 2012, FOOD CONTROL, V25, P469, DOI 10.1016/j.foodcont.2011.11.030
   Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08
   Di Bonaventura G, 2008, J APPL MICROBIOL, V104, P1552, DOI 10.1111/j.1365-2672.2007.03688.x
   Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Flint SH, 1997, BIOFOULING, V11, P81, DOI 10.1080/08927019709378321
   Furukawa S, 2010, INT J FOOD MICROBIOL, V138, P176, DOI 10.1016/j.ijfoodmicro.2009.12.026
   Gerstel U, 2001, ENVIRON MICROBIOL, V3, P638, DOI 10.1046/j.1462-2920.2001.00235.x
   Gibson H, 1999, J APPL MICROBIOL, V87, P41, DOI 10.1046/j.1365-2672.1999.00790.x
   Gram L, 2002, INT J FOOD MICROBIOL, V78, P79, DOI 10.1016/S0168-1605(02)00233-7
   Greer GG, 2005, J FOOD PROTECT, V68, P1102, DOI 10.4315/0362-028X-68.5.1102
   Gunduz GT, 2006, ANTON LEEUW INT J G, V89, P329, DOI 10.1007/s10482-005-9035-9
   Habimana O, 2010, APPL ENVIRON MICROB, V76, P4557, DOI 10.1128/AEM.02707-09
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hamanaka D, 2012, FOOD CONTROL, V24, P165, DOI 10.1016/j.foodcont.2011.09.021
   Han JT, 2011, BIOFOULING, V27, P459, DOI 10.1080/08927014.2011.583984
   Hingston PA, 2013, FOOD MICROBIOL, V36, P46, DOI 10.1016/j.fm.2013.04.011
   Hinton AR, 2002, FOOD BIOPROD PROCESS, V80, P299, DOI 10.1205/096030802321154817
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Husmark U, 1999, BIOFOULING, V14, P15, DOI 10.1080/08927019909378393
   Jahid IK, 2012, FOOD SCI BIOTECHNOL, V21, P299, DOI 10.1007/s10068-012-0041-1
   Jun W, 2010, J FOOD ENG, V99, P314, DOI 10.1016/j.jfoodeng.2010.03.005
   Kalmokoff ML, 2001, J APPL MICROBIOL, V91, P725, DOI 10.1046/j.1365-2672.2001.01419.x
   Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403
   Kives J, 2005, J DAIRY SCI, V88, P4165, DOI 10.3168/jds.S0022-0302(05)73102-7
   Klapper I, 2002, BIOTECHNOL BIOENG, V80, P289, DOI 10.1002/bit.10376
   Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88
   Kostaki M, 2012, APPL ENVIRON MICROB, V78, P2586, DOI 10.1128/AEM.07099-11
   Kregiel D., 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/232514, DOI 10.1155/2014/232514]
   Kregiel D, 2013, FOOD TECHNOL BIOTECH, V51, P345
   Lee KWK, 2014, ISME J, V8, P894, DOI 10.1038/ismej.2013.194
   Lee Soon-Ja, 2004, International Journal of Costume and Fashion, V4, P21
   Lee YD, 2013, FOOD CONTROL, V34, P255, DOI 10.1016/j.foodcont.2013.04.043
   Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06
   Lequette Y, 2010, BIOFOULING, V26, P421, DOI 10.1080/08927011003699535
   Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306
   Lindback T, 2011, APPL ENVIRON MICROB, V77, P3478, DOI 10.1128/AEM.02708-10
   Lindsay D, 2006, J FOOD PROTECT, V69, P1168, DOI 10.4315/0362-028X-69.5.1168
   Luksiene Z, 2013, FOOD ENG REV, V5, P185, DOI 10.1007/s12393-013-9070-7
   Luksiene Z, 2010, J PHOTOCH PHOTOBIO B, V101, P326, DOI 10.1016/j.jphotobiol.2010.08.002
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Malek F, 2012, AFR J MICROBIOL RES, V6, P3836, DOI 10.5897/AJMR11.1120
   McLandsborough L, 2006, FOOD BIOPHYS, V1, P94, DOI 10.1007/s11483-005-9004-x
   Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001
   Misra NN, 2011, FOOD ENG REV, V3, P159, DOI 10.1007/s12393-011-9041-9
   Moretro T, 2009, J APPL MICROBIOL, V106, P1005, DOI 10.1111/j.1365-2672.2008.04067.x
   Moretro T, 2003, VET MICROBIOL, V94, P207, DOI 10.1016/S0378-1135(03)00105-6
   Moretro T, 2012, FOOD RES INT, V45, P532, DOI 10.1016/j.foodres.2011.02.002
   Morimatsu K, 2013, J FAC AGR KYUSHU U, V58, P125
   Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x
   Dat NM, 2012, FOOD CONTROL, V23, P215, DOI 10.1016/j.foodcont.2011.07.013
   Niemira BA, 2012, ANNU REV FOOD SCI T, V3, P125, DOI 10.1146/annurev-food-022811-101132
   Nitschke M, 2007, TRENDS FOOD SCI TECH, V18, P252, DOI 10.1016/j.tifs.2007.01.002
   Norwood DE, 2000, J APPL MICROBIOL, V88, P512, DOI 10.1046/j.1365-2672.2000.00990.x
   Olsson IM, 2006, CHEMOMETR INTELL LAB, V83, P66, DOI 10.1016/j.chemolab.2006.01.005
   Orgaz B, 2013, FOOD CONTROL, V32, P484, DOI 10.1016/j.foodcont.2013.01.024
   Ortega ME, 2013, INT J FOOD MICROBIOL, V162, P13
   Oulahal N., 2004, BIOFILMS, V1, P65, DOI DOI 10.1017/S1479050504001140
   Oulahal-Lagsir N, 2000, LETT APPL MICROBIOL, V30, P47, DOI 10.1046/j.1472-765X.2000.00653.x
   Oulahal-Lagsir O, 2003, BIOFOULING, V19, P159, DOI 10.1080/0892701031000064676
   Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4
   Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06
   Percival SL, 2011, SPRINGER SER BIOFILM, V6, P1, DOI 10.1007/978-3-642-21289-5
   Perez I. M., 2014, MEAT SCI, V96, P295
   Pilchova T, 2014, FOOD CONTROL, V35, P366, DOI 10.1016/j.foodcont.2013.07.021
   Potenski CJ, 2003, FEMS MICROBIOL LETT, V220, P181, DOI 10.1016/S0378-1097(03)00099-5
   Preston GM, 1998, CURR OPIN MICROBIOL, V1, P589, DOI 10.1016/S1369-5274(98)80094-5
   Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09
   RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255
   Romanova NA, 2007, J MICROBIOL METH, V71, P231, DOI 10.1016/j.mimet.2007.09.002
   Rorvik LM, 2000, INT J FOOD MICROBIOL, V62, P183, DOI 10.1016/S0168-1605(00)00334-2
   Rudi K, 2002, APPL ENVIRON MICROB, V68, P1146, DOI 10.1128/AEM.68.3.1146-1156.2002
   Salustiano VC, 2009, FOOD CONTROL, V20, P439, DOI 10.1016/j.foodcont.2008.07.004
   SCENIHR, 2009, SCI COMM EM NEWL ID
   Schirmer BCT, 2012, J MICROBIOL METH, V91, P295, DOI 10.1016/j.mimet.2012.08.013
   Schlisselberg DB, 2013, FOOD MICROBIOL, V35, P65, DOI 10.1016/j.fm.2013.02.005
   Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054
   Sillankorva Sanna M, 2012, Int J Microbiol, V2012, P863945, DOI 10.1155/2012/863945
   Silva S, 2008, J FOOD PROTECT, V71, P1379, DOI 10.4315/0362-028X-71.7.1379
   Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008
   Skandamis PN, 2012, APPL ENVIRON MICROB, V78, P5473, DOI 10.1128/AEM.00468-12
   Splendiani A, 2006, BIOTECHNOL BIOENG, V94, P15, DOI 10.1002/bit.20752
   Srey S, 2013, FOOD CONTROL, V31, P572, DOI 10.1016/j.foodcont.2012.12.001
   Stepanovic S, 2003, FOOD MICROBIOL, V20, P339, DOI 10.1016/S0740-0020(02)00123-5
   Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003
   Strathmann M, 2013, BIOFOULING, V29, P573, DOI 10.1080/08927014.2013.791287
   Tang L, 2011, BIOFOULING, V27, P111, DOI 10.1080/08927014.2010.544848
   Taormina PJ, 2002, J APPL MICROBIOL, V92, P71, DOI 10.1046/j.1365-2672.2002.01488.x
   Torlak E, 2013, LETT APPL MICROBIOL, V57, P220, DOI 10.1111/lam.12100
   Toussaint A, 2003, EMBO REP, V4, P820, DOI 10.1038/sj.embor.embor930
   Trachoo N., 2005, Pakistan Journal of Biological Sciences, V8, P599
   Valderrama WB, 2013, CRIT REV FOOD SCI, V53, P801, DOI 10.1080/10408398.2011.561378
   Valeriano C, 2012, FOOD CONTROL, V25, P673, DOI 10.1016/j.foodcont.2011.12.015
   van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029
   Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x
   Verran J, 2002, BIOFOULING, V18, P167, DOI 10.1080/08927010290006736
   Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004
   Villa F, 2013, PHYTOCHEM REV, V12, P245, DOI 10.1007/s11101-013-9286-4
   Villa F, 2009, BIOTECHNOL LETT, V31, P1407, DOI 10.1007/s10529-009-0031-4
   Vinten AJA, 2011, J MICROBIOL METH, V85, P190, DOI 10.1016/j.mimet.2011.03.001
   Wang HH, 2013, FOOD CONTROL, V32, P650, DOI 10.1016/j.foodcont.2013.01.047
   Wang HH, 2013, FOOD CONTROL, V33, P378, DOI 10.1016/j.foodcont.2013.03.030
   WANNER O, 1986, BIOTECHNOL BIOENG, V28, P314, DOI 10.1002/bit.260280304
   Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06
   Willis C, 2006, J APPL MICROBIOL, V101, P711, DOI 10.1111/j.1365-2672.2006.02917.x
   Wong ACL, 1998, J DAIRY SCI, V81, P2765, DOI 10.3168/jds.S0022-0302(98)75834-5
   Wong HS, 2010, BIOFOULING, V26, P859, DOI 10.1080/08927014.2010.527959
   Wu H, 2013, MOD FOOD SCI TECHNOL, V29, P2793
   Xu H, 2011, J FOOD SAFETY, V31, P91, DOI 10.1111/j.1745-4565.2010.00271.x
   Xu H, 2010, J FOOD SCI, V75, pM580, DOI 10.1111/j.1750-3841.2010.01865.x
   Yang HS, 2013, FOOD CONTROL, V33, P232, DOI 10.1016/j.foodcont.2013.03.007
NR 138
TC 43
Z9 43
U1 12
U2 163
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1866-7910
EI 1866-7929
J9 FOOD ENG REV
JI Food Eng. Rev.
PD JUN
PY 2014
VL 6
IS 1-2
BP 29
EP 42
DI 10.1007/s12393-014-9077-8
PG 14
WC Food Science & Technology
SC Food Science & Technology
GA AG9MW
UT WOS:000335744400003
DA 2019-02-28
ER

PT J
AU Landstorfer, R
   Simon, S
   Schober, S
   Keim, D
   Scherer, S
   Neuhaus, K
AF Landstorfer, Richard
   Simon, Svenja
   Schober, Steffen
   Keim, Daniel
   Scherer, Siegfried
   Neuhaus, Klaus
TI Comparison of strand-specific transcriptomes of enterohemorrhagic
   Escherichia coli O157:H7 EDL933 (EHEC) under eleven different
   environmental conditions including radish sprouts and cattle feces
SO BMC GENOMICS
LA English
DT Article
DE EHEC; Radish sprouts; Cattle feces; Environment; Global transcriptome;
   Next Generation Sequencing; SOLiD-Illumina comparison; Background
   transcription; Hypothetical genes
ID HEMOLYTIC-UREMIC SYNDROME; GLOBAL GENE-EXPRESSION; C-DI-GMP; BIOFILM
   FORMATION; STRESS-RESPONSE; LETTUCE LEAVES; III SECRETION; HEAT-SHOCK;
   RNA-SEQ; HYPOTHETICAL GENES
AB Background: Multiple infection sources for enterohemorrhagic Escherichia coli O157:H7 (EHEC) are known, including animal products, fruit and vegetables. The ecology of this pathogen outside its human host is largely unknown and one third of its annotated genes are still hypothetical. To identify genetic determinants expressed under a variety of environmental factors, we applied strand-specific RNA-sequencing, comparing the SOLiD and Illumina systems.
   Results: Transcriptomes of EHEC were sequenced under 11 different biotic and abiotic conditions: LB medium at pH4, pH7, pH9, or at 15 degrees C; LB with nitrite or trimethoprim-sulfamethoxazole; LB-agar surface, M9 minimal medium, spinach leaf juice, surface of living radish sprouts, and cattle feces. Of 5379 annotated genes in strain EDL933 (genome and plasmid), a surprising minority of only 144 had null sequencing reads under all conditions. We therefore developed a statistical method to distinguish weakly transcribed genes from background transcription. We find that 96% of all genes and 91.5% of the hypothetical genes exhibit a significant transcriptional signal under at least one condition. Comparing SOLiD and Illumina systems, we find a high correlation between both approaches for fold-changes of the induced or repressed genes. The pathogenicity island LEE showed highest transcriptional activity in LB medium, minimal medium, and after treatment with antibiotics. Unique sets of genes, including many hypothetical genes, are highly up-regulated on radish sprouts, cattle feces, or in the presence of antibiotics. Furthermore, we observed induction of the shiga-toxin carrying phages by antibiotics and confirmed active biofilm related genes on radish sprouts, in cattle feces, and on agar plates.
   Conclusions: Since only a minority of genes (2.7%) were not active under any condition tested (null reads), we suggest that the assumption of significant genome over-annotations is wrong. Environmental transcriptomics uncovered hitherto unknown gene functions and unique regulatory patterns in EHEC. For instance, the environmental function of azoR had been elusive, but this gene is highly active on radish sprouts. Thus, NGS-transcriptomics is an appropriate technique to propose new roles of hypothetical genes and to guide future research.
C1 [Landstorfer, Richard; Scherer, Siegfried; Neuhaus, Klaus] Tech Univ Munich, Wissensch Zentrum Weihenstephan, Lehrstuhl Mikrobielle Okol, D-85350 Freising Weihenstephan, Germany.
   [Simon, Svenja; Keim, Daniel] Univ Konstanz, Fachbereich Informat & Informat Wissensch, Lehrstuhl Datenanalyse & Visualisierung, D-78457 Constance, Germany.
   [Schober, Steffen] Univ Ulm, Inst Nachrichtentech, D-89081 Ulm, Germany.
RP Neuhaus, K (reprint author), Tech Univ Munich, Wissensch Zentrum Weihenstephan, Lehrstuhl Mikrobielle Okol, Weihenstephaner Berg 3, D-85350 Freising Weihenstephan, Germany.
EM neuhaus@wzw.tum.de
OI Scherer, Siegfried/0000-0002-0394-9890; Neuhaus,
   Klaus/0000-0002-6020-2814
FU Deutsche Forschungsgemeinschaft [BO867/23-1, KE740/13-1, SCHE316/3-1]
FX This work was funded by grants from the Deutsche Forschungsgemeinschaft,
   No. BO867/23-1, KE740/13-1, and SCHE316/3-1 under the direction of the
   SPP-1395 "Informations-und Kommunikationstheorie in der
   Molekularbiologie (InKoMBio)".
CR Aboyoun P, GENOMICRANGES REPRES
   Adams M, 2005, J BIOL CHEM, V280, P28675, DOI 10.1074/jbc.M501034200
   Armalyte J, 2008, RES MICROBIOL, V159, P486, DOI 10.1016/j.resmic.2008.06.003
   Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408
   Augustus AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-558
   Augustus AM, 2009, P NATL ACAD SCI USA, V106, P5065, DOI 10.1073/pnas.0811130106
   Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1016/S0378-1097(99)00076-2
   Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725
   Bender JK, 2012, APPL ENVIRON MICROB, V78, P5083, DOI 10.1128/AEM.00617-12
   Benson DA, 2009, NUCLEIC ACIDS RES, V37, pD26, DOI 10.1093/nar/gkn723
   Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x
   Berger CN, 2012, MBIO, V3, DOI 10.1128/mBio.00317-12
   Bergholz TM, 2009, APPL ENVIRON MICROB, V75, P3542, DOI 10.1128/AEM.02841-08
   Bernal V, 2007, MICROB CELL FACT, V6, P1, DOI 10.1186/1475-2859-6-31
   Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7
   Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89
   Borodovsky M, 2011, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0406S35
   Brombacher E, 2006, J BACTERIOL, V188, P2027, DOI 10.1128/JB.188.6.2027-2037.2006
   Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110
   Callaway TR, 2003, J DAIRY SCI, V86, P852, DOI 10.3168/jds.S0022-0302(03)73668-6
   Carruthers MD, 2009, FEMS MICROBIOL LETT, V295, P96, DOI 10.1111/j.1574-6968.2009.01587.x
   Carver T, 2010, BIOINFORMATICS, V26, P676, DOI 10.1093/bioinformatics/btq010
   Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625
   Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265
   Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x
   Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009
   Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006
   Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104
   Duffitt Ashley D, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/340506
   Elias DA, 2009, NUCLEIC ACIDS RES, V37, P2926, DOI 10.1093/nar/gkp164
   Erickson MC, 2007, J FOOD PROTECT, V70, P2426, DOI 10.4315/0362-028X-70.10.2426
   Feller W.S., 1968, INTRO PROBABILITY TH, V1
   Feng Jinhui, 2012, Front Biosci (Elite Ed), V4, P568
   Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673
   Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09
   Fink RC, 2012, APPL ENVIRON MICROB, V78, P1752, DOI 10.1128/AEM.07454-11
   Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332
   Flockhart AF, 2012, MOL MICROBIOL, V83, P208, DOI 10.1111/j.1365-2958.2011.07927.x
   Gaubig LC, 2011, MICROBIOL-SGM, V157, P66, DOI 10.1099/mic.0.043802-0
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86
   Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734
   Hancock V, 2007, INFECT IMMUN, V75, P966, DOI 10.1128/IAI.01748-06
   Hancock V, 2010, MOL GENET GENOMICS, V284, P437, DOI 10.1007/s00438-010-0578-8
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Herold S, 2005, ANTIMICROB AGENTS CH, V49, P931, DOI 10.1128/AAC.49.3.931-944.2005
   Hou Z, 2013, INT J FOOD MICROBIOL, V162, P260, DOI 10.1016/j.ijfoodmicro.2013.01.027
   Iyoda S, 2006, J BACTERIOL, V188, P5682, DOI 10.1128/JB.00352-06
   Jansohn M, 2007, GENTECHNISCHE METHOD
   Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746
   John M, 2005, INFECT IMMUN, V73, P2665, DOI 10.1128/IAI.73.5.2665-2679.2005
   Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x
   Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x
   Jovanovic G, 2006, J BIOL CHEM, V281, P21147, DOI 10.1074/jbc.M602323200
   Kanack KJ, 2005, INFECT IMMUN, V73, P4327, DOI 10.1128/IAI.73.7.4327-4337.2005
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818
   Kolker E, 2004, NUCLEIC ACIDS RES, V32, P2353, DOI 10.1093/nar/gkh555
   Kudva IT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-103
   Kus JV, 2011, J BACTERIOL, V193, P4509, DOI 10.1128/JB.00200-11
   Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09
   Laegreid WW, 1999, EPIDEMIOL INFECT, V123, P291, DOI 10.1017/S0950268899002757
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lee JH, 2011, CURR MICROBIOL, V62, P1321, DOI 10.1007/s00284-010-9862-4
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007
   Liu GF, 2009, J BACTERIOL, V191, P6394, DOI 10.1128/JB.00552-09
   Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513
   Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526
   Miot M, 2007, PROTEIN SCI, V16, P2445, DOI 10.1110/ps.073047807
   Morgan M, RSAMTOOLS BINARY ALI
   Morrison JM, 2012, ANAEROBE, V18, P229, DOI 10.1016/j.anaerobe.2011.12.006
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x
   Nam SH, 2011, J BACTERIOL, V193, P1014, DOI 10.1128/JB.01027-10
   Neuwirth E, RCOLORBREWER COLORBR
   Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/JMBR.69.3.501-526.2005
   Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x
   Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206
   Olesen I, 2010, INT J FOOD MICROBIOL, V141, P248, DOI 10.1016/j.ijfoodmicro.2010.05.019
   Pages H, IRANGES INFRASTRUCTU
   Patel J, 2011, FOODBORNE PATHOG DIS, V8, P541, DOI 10.1089/fpd.2010.0734
   Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569
   Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842
   R_ Development_ Core_ Team, 2011, R LANG ENV STAT COMP
   Raghavan R, 2012, MBIO, V3, DOI 10.1128/mBio.00156-12
   Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rosner B, 2011, J VERBRAUCH LEBENSM, V2011, P1
   Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Saenz JB, 2010, CELL MICROBIOL, V12, P516, DOI 10.1111/j.1462-5822.2009.01414.x
   Saldana Z, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00119
   Sambrook JS, 2001, MOL CLONING LAB MANU
   Sankar TS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000405
   Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x
   Semenov AM, 2010, MICROB ECOL, V60, P239, DOI 10.1007/s00248-010-9663-0
   Seputiene V, 2003, J BACTERIOL, V185, P2475, DOI 10.1128/JB.185.8.2475-2484.2003
   Shames SR, 2010, CELL MICROBIOL, V12, P1322, DOI 10.1111/j.1462-5822.2010.01470.x
   Simon S, 2011, IEEE S BIOL DATA VIS, V1, P47
   Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001
   Thomas GH, 1999, BIOINFORMATICS, V15, P860, DOI 10.1093/bioinformatics/15.10.860
   Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142
   Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103
   Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104
   van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059
   Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109
   Warnes G.R., GPLOTS VARIOUS R PRO
   Watanabe Y, 1999, EMERG INFECT DIS, V5, P424, DOI 10.3201/eid0503.990313
   Weber MM, 2010, MICROBIOL-SGM, V156, P139, DOI 10.1099/mic.0.031468-0
   Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570
   Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x
   Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027
   Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601
   Zhang XS, 2008, ISME J, V2, P615, DOI 10.1038/ismej.2008.24
   Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06
NR 115
TC 31
Z9 31
U1 0
U2 26
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD MAY 9
PY 2014
VL 15
AR 353
DI 10.1186/1471-2164-15-353
PG 25
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA AI2FR
UT WOS:000336673400001
PM 24885796
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

PT J
AU Altindis, E
   Fu, Y
   Mekalanos, JJ
AF Altindis, Emrah
   Fu, Yang
   Mekalanos, John J.
TI Proteomic analysis of Vibrio cholerae outer membrane vesicles
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE HtrA family; in-solution digestion; biofilm formation; CTX phi phage
ID INTESTINAL EPITHELIAL-CELLS; VIRULENCE GENE-EXPRESSION; HOST-PATHOGEN
   INTERACTION; BIOFILM FORMATION; EL-TOR; PSEUDOMONAS-AERUGINOSA;
   ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; HELICOBACTER-PYLORI;
   STRUCTURAL BASIS
AB Outer membrane vesicles (OMVs) produced by Gram-negative bacteria provide an interesting research material for defining cell-envelope proteins without experimental cell disruption. OMVs are also promising immunogenic platforms and may play important roles in bacterial survival and pathogenesis. We used in-solution trypsin digestion coupled to mass spectrometry to identify 90 proteins present in OMVs of Vibrio cholerae when grown under conditions that activate the TCP pilus virulence regulatory protein (ToxT) virulence regulon. The ToxT expression profile and potential contribution to virulence of these proteins were assessed using ToxT and in vivo RNA-seq, Tn-seq, and cholera stool proteomic and other genome-wide data sets. Thirteen OMV-associated proteins appear to be essential for cell growth, and therefore may represent antibacterial drug targets. Another 12 nonessential OMV proteins, including DegP protease, were required for intestinal colonization in rabbits. Comparative proteomics of a degP mutant revealed the importance of DegP in the incorporation of nine proteins into OMVs, including ones involved in biofilm matrix formation and various substrates of the type II secretion system. Taken together, these results suggest that DegP plays an important role in determining the content of OMVs and also affects phenotypes such as intestinal colonization, proper function of the type II secretion system, and formation of biofilm matrix.
C1 [Altindis, Emrah; Fu, Yang; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
RP Mekalanos, JJ (reprint author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
EM john_mekalanos@hms.harvard.edu
FU National Institute of Allergy and Infectious Diseases [AI-01845]
FX We thank Dr. Ronald Taylor for providing alpha-TcpA monoclonal
   antibodies; Dr. Ewen Cameron for the V. cholera-defined TnFGL3
   transposon library; the J.J.M. group for helpful discussion; Dr. William
   Robins and Dr. Andrew McCluskey for their comments and critical reading
   of this manuscript; and Ross Tomaino (Taplin Mass Spectrometry Facility)
   and Maria Ericsson (Cell Biology Conventional Electron Microscopy
   Facility) for their technical contributions. This work was supported by
   National Institute of Allergy and Infectious Diseases Grant AI-01845 (to
   J.J.M.).
CR Absalon C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002210
   Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09
   Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008
   Anthouard R, 2013, MBIO, V4
   Baud C, 2009, MOL MICROBIOL, V74, P315, DOI 10.1111/j.1365-2958.2009.06860.x
   Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981
   Beyhan S, 2006, INFECT IMMUN, V74, P3633, DOI 10.1128/IAI.01750-05
   Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100
   Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001
   Bishop AL, 2012, J INFECT DIS, V205, P412, DOI 10.1093/infdis/jir756
   Bishop AL, 2010, INFECT IMMUN, V78, P4402, DOI 10.1128/IAI.00398-10
   Biswas S, 2005, INFECT IMMUN, V73, P6923, DOI 10.1128/IAI.73.10.6923-6934.2005
   Blanco LP, 2006, CELL MICROBIOL, V8, P982, DOI 10.1111/j.1462-5822.2006.00681.x
   Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105
   Chao MC, 2013, NUCLEIC ACIDS RES, V41, P9033, DOI 10.1093/nar/gkt654
   Chatterjee D, 2013, J BIOL CHEM, V288, P4299, DOI 10.1074/jbc.M112.408302
   Chatterjee D, 2011, FEBS LETT, V585, P1357, DOI 10.1016/j.febslet.2011.04.017
   Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108
   Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928
   Cinar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011558
   Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065
   Cobaxin M, 2014, MICROB PATHOGENESIS, V66, P5, DOI 10.1016/j.micpath.2013.11.002
   Damron FH, 2012, MOL MICROBIOL, V84, P595, DOI 10.1111/j.1365-2958.2012.08049.x
   Damron FH, 2011, J BACTERIOL, V193, P286, DOI 10.1128/JB.01132-10
   Avila-Calderon ED, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/352493
   Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053
   Debellis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005074
   Duperthuy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003620
   Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999
   Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09
   Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145
   Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103
   Faruque SM, 1998, INFECT IMMUN, V66, P5819
   Faruque SM, 1998, INFECT IMMUN, V66, P3752
   Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301
   Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164
   Fong JCN, 2007, J BACTERIOL, V189, P2319, DOI 10.1128/JB.01569-06
   Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0
   Fu Y, 2013, CELL HOST MICROBE, V14, P652, DOI 10.1016/j.chom.2013.11.001
   GALEN JE, 1992, INFECT IMMUN, V60, P406
   Giglio KM, 2013, J BACTERIOL, V195, P3277, DOI 10.1128/JB.00374-13
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X
   Heilpern AJ, 2000, J BACTERIOL, V182, P1739, DOI 10.1128/JB.182.6.1739-1747.2000
   HENDERSON DP, 1994, J BACTERIOL, V176, P3269, DOI 10.1128/jb.176.11.3269-3277.1994
   Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114
   Hsiao A, 2006, P NATL ACAD SCI USA, V103, P14542, DOI 10.1073/pnas.0604650103
   HUGHES KJ, 1995, GENE, V156, P59, DOI 10.1016/0378-1119(95)00054-A
   Hung DT, 2006, MOL MICROBIOL, V59, P193, DOI 10.1111/j.1365-2958.2005.04846.x
   Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739
   IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x
   Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07
   Jude BA, 2011, J STRUCT BIOL, V175, P1, DOI 10.1016/j.jsb.2011.04.008
   Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996
   Kamp HD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003800
   Kenyon WJ, 2010, ANTON LEEUW INT J G, V98, P51, DOI 10.1007/s10482-010-9428-2
   Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11
   Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004
   Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905
   LaRocque RC, 2008, INFECT IMMUN, V76, P4145, DOI 10.1128/IAI.00585-08
   Leitner DR, 2013, INFECT IMMUN, V81, P2379, DOI 10.1128/IAI.01382-12
   Li ZS, 1998, J BACTERIOL, V180, P5478
   Lombardo MJ, 2007, P NATL ACAD SCI USA, V104, P18229, DOI 10.1073/pnas.0705636104
   Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004
   MacDonald KL, 2002, CAN J MICROBIOL, V48, P810, DOI [10.1139/w02-077, 10.1139/W02-077]
   Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007
   Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07
   McCaig WD, 2013, J BACTERIOL, V195, P1120, DOI 10.1128/JB.02007-12
   Mullaney E, 2009, PROTEOM CLIN APPL, V3, P785, DOI 10.1002/prca.200800192
   Nakasone N, 1998, INFECT IMMUN, V66, P4726
   Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204
   Nielsen AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001102
   OGIERMAN MA, 1992, FEMS MICROBIOL LETT, V97, P179, DOI 10.1016/0378-1097(92)90383-Y
   Park SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017629
   Qiu X, 2011, CURR MED CHEM, V18, P4513, DOI 10.2174/092986711797287566
   Richard AL, 2010, MOL MICROBIOL, V78, P1171, DOI 10.1111/j.1365-2958.2010.07397.x
   Ritchie JM, 2010, MBIO, V18, P1
   Rossiter AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11
   Roy N, 2010, FEMS IMMUNOL MED MIC, V60, P18, DOI 10.1111/j.1574-695X.2010.00692.x
   Scanlan D, 2014, SCIENCE, V343, P143, DOI 10.1126/science.1248566
   Schertzer JW, 2013, J MOL MICROB BIOTECH, V23, P118, DOI 10.1159/000346770
   Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08
   Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08
   Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200
   Sherman DJ, 2013, BIOORGAN MED CHEM, V21, P4846, DOI 10.1016/j.bmc.2013.04.020
   Sikora AE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003126
   Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078
   Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11
   Syngkon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013122
   Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10
   TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833
   Uli L, 2006, PROTEOMICS, V6, P3389, DOI 10.1002/pmic.200500502
   Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910
   Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x
   Yuan L, 2008, MICROBIOL-SGM, V154, P1161, DOI 10.1099/mic.0.2007/015131-0
   Zhang WW, 2008, APPL ENVIRON MICROB, V74, P6254, DOI 10.1128/AEM.00109-08
   Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8
NR 97
TC 51
Z9 53
U1 3
U2 35
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 15
PY 2014
VL 111
IS 15
BP E1548
EP E1556
DI 10.1073/pnas.1403683111
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE8YI
UT WOS:000334288600016
PM 24706774
OA Green Published, Bronze
DA 2019-02-28
ER

PT J
AU Schellhorn, HE
AF Schellhorn, Herb E.
TI Elucidating the function of the RpoS regulon
SO FUTURE MICROBIOLOGY
LA English
DT Review
DE adaptation; evolution; gene regulation; persistence; regulon;
   starvation; stationary phase; stress; viable but not culturable
ID ENTEROHEMORRHAGIC ESCHERICHIA-COLI; GENERAL STRESS-RESPONSE;
   DNA-POLYMERASE-IV; FACTOR KATF RPOS; SIGMA-FACTOR; STATIONARY-PHASE;
   RNA-POLYMERASE; SALMONELLA-TYPHIMURIUM; BIOFILM FORMATION;
   SIGMA(S)-DEPENDENT GENES
AB Bacterial adaptation to suboptimal nutrient environments, including host and/or extreme environments, is subject to complex, coordinated control involving many proteins and RNAs. Among the gamma-proteobacteria, which includes many pathogens, the RpoS regulon has been a key focus for many years. Although the RpoS regulator was first identified as a growth phase-dependent regulator, our current understanding of RpoS is now more nuanced as this central regulator also has roles in exponential phase, biofilm development, bacterial virulence and bacterial persistence, as well as in stress adaptation. Induction of RpoS can also exert substantial metabolic effects by negatively regulating key systems including flagella biosynthesis, cryptic phage gene expression and the tricarboxylic acid cycle. Although core RpoS-controlled metabolic functions are conserved, there are substantial differences in RpoS regulation even among closely related bacteria, indicating that regulatory plasticity may be an important aspect of RpoS regulation, which is important in evolutionary adaptation to specialized environments.
C1 McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada.
RP Schellhorn, HE (reprint author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.
EM schell@mcmaster.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
FX Current funding is provided by the Natural Sciences and Engineering
   Research Council of Canada (NSERC). The author has no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Adams JL, 1999, APPL ENVIRON MICROB, V65, P4285
   Alvarez-Ordonez A, 2013, APPL ENVIRON MICROB, V79, P2099, DOI 10.1128/AEM.03302-12
   Banta AB, 2013, P NATL ACAD SCI USA, V110, P6
   Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946
   Beltrametti F, 1999, J BACTERIOL, V181, P3409
   Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x
   Chang L, 1999, MOL MICROBIOL, V34, P756, DOI 10.1046/j.1365-2958.1999.01637.x
   Chen GZ, 2004, MUTAT RES-FUND MOL M, V554, P193, DOI 10.1016/j.mfrmmm.2004.04.013
   Chiang SM, 2011, APPL ENVIRON MICROB, V77, P7915, DOI 10.1128/AEM.05274-11
   Chiang SM, 2010, J MOL EVOL, V70, P557, DOI 10.1007/s00239-010-9352-0
   Collet A, 2008, J PROTEOME RES, V7, P4659, DOI 10.1021/pr8001723
   Corona-Izquierdo FP, 2002, FEMS MICROBIOL LETT, V211, P105, DOI 10.1016/S0378-1097(02)00672-9
   Coynault C, 1996, MOL MICROBIOL, V22, P149, DOI 10.1111/j.1365-2958.1996.tb02664.x
   Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200
   Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4
   Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x
   Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09
   Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349
   Dong T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-118
   Dudin O, 2013, RES MICROBIOL, V164, P838, DOI 10.1016/j.resmic.2013.07.002
   Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027
   Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000
   Eydallin G., 2013, ENVIRON MICROBIOL, V16, P813
   FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978
   Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003
   Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x
   Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09
   Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340
   Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08
   Frisch RL, 2010, J BACTERIOL, V192, P4694, DOI 10.1128/JB.00570-10
   Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607
   Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014
   HENGGEARONIS R, 1991, J BACTERIOL, V173, P7918, DOI 10.1128/jb.173.24.7918-7924.1991
   Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459
   Ito A, 2009, BIOTECHNOL BIOENG, V103, P975, DOI 10.1002/bit.22305
   Iyoda S, 2005, J BACTERIOL, V187, P4086, DOI 10.1128/JB.187.12.4086-4094.2005
   Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997
   JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995
   King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614.5620.2004
   Krogfelt KA, 2000, INFECT IMMUN, V68, P2518, DOI 10.1128/IAI.68.5.2518-2524.2000
   Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017
   Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004
   LANGE R, 1994, MOL MICROBIOL, V13, P733, DOI 10.1111/j.1365-2958.1994.tb00466.x
   LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600
   LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x
   Layton JC, 2003, MOL MICROBIOL, V50, P549, DOI 10.1046/j.1365-2958.2003.03704.x
   Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129
   Maeda H, 2000, J BACTERIOL, V182, P1181, DOI 10.1128/JB.182.4.1181-1184.2000
   Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108
   Mand TD, 2013, J APPL MICROBIOL, V114, P242, DOI 10.1111/jam.12021
   Mika F, 2012, MOL MICROBIOL, V84, P51, DOI 10.1111/j.1365-2958.2012.08002.x
   MOYED HS, 1983, J BACTERIOL, V155, P768
   Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565
   NOREL F, 1992, FEMS MICROBIOL LETT, V99, P271, DOI 10.1016/0378-1097(92)90039-Q
   Nunez C, 2004, J BACTERIOL, V186, P5543, DOI 10.1128/JB.186.16.5543-5546.2004
   OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x
   ONEAL CR, 1994, J BACTERIOL, V176, P4610
   Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203
   Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2
   Phan K, 2013, ISME J, V7, P2034, DOI 10.1038/ismej.2013.82
   Price SB, 2000, APPL ENVIRON MICROB, V66, P632, DOI 10.1128/AEM.66.2.632-637.2000
   Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001
   Rahman M, 2006, BIOTECHNOL BIOENG, V94, P585, DOI 10.1002/bit.20858
   SAMMARTANO LJ, 1986, J BACTERIOL, V168, P13, DOI 10.1128/jb.168.1.13-21.1986
   Schellhorn HE, 1998, J BACTERIOL, V180, P6283
   Serra D. O., 2013, MBIO, V4
   Sheldon JR, 2012, APPL ENVIRON MICROB, V78, P8331, DOI 10.1128/AEM.02149-12
   SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994
   Snyder E, 2012, G3-GENES GENOM GENET, V2, P1341, DOI 10.1534/g3.112.003855
   Spector MP, 1999, MICROBIOL-SGM, V145, P3035, DOI 10.1099/00221287-145-11-3035
   Spira B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-248
   Storvik KAM, 2010, J BACTERIOL, V192, P3639, DOI 10.1128/JB.00358-10
   Subramanian G, 2000, INFECT IMMUN, V68, P1633, DOI 10.1128/IAI.68.3.1633-1648.2000
   Tomoyasu T, 2005, FEMS MICROBIOL LETT, V253, P59, DOI 10.1016/j.femsle.2005.09.020
   Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997
   Typas A, 2007, MOL MICROBIOL, V63, P1296, DOI 10.1111/j.1365-2958.2007.05601.x
   Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629
   Typas A, 2007, MOL MICROBIOL, V63, P780, DOI 10.1111/j.1365-2958.2006.05560.x
   Uhlich GA, 2013, MICROBIOL-SGM, V159, P1586, DOI 10.1099/mic.0.066118-0
   Weber H, 2005, J BACTERIOL, V187, P1591, DOI [10.1128/JB.187.5.1591-1603.2005, 10.1128/JB.1875.5.1591-1603.2005]
   Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200
   Zhao K, 2007, NUCLEIC ACIDS RES, V35, P4441, DOI 10.1093/nar/gkm417
   Zhao K, 2010, NUCLEIC ACIDS RES, V38, P1273, DOI 10.1093/nar/gkp1123
NR 83
TC 18
Z9 21
U1 5
U2 51
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD APR
PY 2014
VL 9
IS 4
BP 497
EP 507
DI 10.2217/fmb.14.9
PG 11
WC Microbiology
SC Microbiology
GA AH2MD
UT WOS:000335954700014
PM 24810349
DA 2019-02-28
ER

PT J
AU Li, CT
   Liao, CT
   Du, SC
   Hsiao, YP
   Lo, HH
   Hsiao, YM
AF Li, Chien-Te
   Liao, Chao-Tsai
   Du, Shin-Chiao
   Hsiao, Yu-Ping
   Lo, Hsueh-Hsia
   Hsiao, Yi-Min
TI Functional characterization and transcriptional analysis of galE gene
   encoding a UDP-galactose 4-epimerase in Xanthomonas campestris pv.
   campestris
SO MICROBIOLOGICAL RESEARCH
LA English
DT Article
DE Reporter assay; Transcriptional regulation; Xanthomonas
ID EXTRACELLULAR POLYSACCHARIDE PRODUCTION; CELL-CELL COMMUNICATION; PHAGE
   PHI-LF; ESCHERICHIA-COLI; BIOFILM FORMATION; AEROMONAS-HYDROPHILA;
   STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; FULL VIRULENCE; ACTIVE-SITE
AB The Gram-negative plant pathogen Xanthomonas campestris pv. campestris (Xcc) is the causative agent of black rot in crucifers, a disease that causes tremendous agricultural loss. In this study, the Xcc galE gene was characterized. Sequence and mutational analysis demonstrated that the Xcc galE encodes a UDP-galactose 4-epimerase (EC 5.1.3.2), which catalyzes the interconversion of UDP-galactose and UDPglucose. Alanine substitution of the putative catalytic residues (Ser124, Tyr147, and Lys151) of GalE caused loss of epimerase activity. Further study showed that the Xcc galE mutant had reduced biofilm formation ability. Furthermore, reporter assays revealed thatga/E transcription exhibits a distinct expression profile under different culture conditions, is subject to catabolite repression, and is positively regulated by Clp and RpfF. In addition, the galE transcription initiation site was mapped. This is the first time that UDP-galactose 4-epimerase has been characterized in the crucifer pathogen Xcc. (C) 2013 Elsevier GmbH. All rights reserved.
C1 [Li, Chien-Te] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua, Taiwan.
   [Liao, Chao-Tsai; Du, Shin-Chiao; Lo, Hsueh-Hsia; Hsiao, Yi-Min] Cent Taiwan Univ Sci & Technol, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.
   [Hsiao, Yu-Ping] Chung Shan Med Univ Hosp, Dept Dermatol, Taichung, Taiwan.
   [Hsiao, Yu-Ping] Chung Shan Med Univ, Inst Med, Taichung, Taiwan.
RP Hsiao, YM (reprint author), Cent Taiwan Univ Sci & Technol, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.
EM ymhsiao@ctust.edu.tw
FU National Science Council of Taiwan [NSC 101-2313-B-166-001-MY3];
   Changhua Christian Hospital of Taiwan [101CCH-IRP-65]
FX This study was supported by the National Science Council of Taiwan grant
   no. NSC 101-2313-B-166-001-MY3 to Yi-Min Hsiao, and the Changhua
   Christian Hospital of Taiwan grant no. 101CCH-IRP-65 to Chien-Te Li.
   Chao-Tsai Liao and Shin-Chiao Du contributed equally to this study.
CR Agarwal S, 2007, BBA-PROTEINS PROTEOM, V1774, P828, DOI 10.1016/j.bbapap.2007.04.007
   Alphey MS, 2006, ACTA CRYSTALLOGR F, V62, P829, DOI 10.1107/S1744309106028740
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x
   Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11
   Canals R, 2007, J BACTERIOL, V189, P540, DOI 10.1128/JB.01260-06
   Chan JWYF, 1999, BIOTECHNOL ADV, V17, P489, DOI 10.1016/S0734-9750(99)00025-7
   Chang KW, 2001, BIOCHEM BIOPH RES CO, V287, P550, DOI 10.1006/bbrc.2001.5591
   Chang WS, 2008, FEMS MICROBIOL LETT, V280, P242, DOI 10.1111/j.1574-6968.2008.01066.x
   Chung SK, 2012, BIORESOURCE TECHNOL, V110, P423, DOI 10.1016/j.biortech.2012.01.046
   da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a
   DONG QP, 1992, J BACTERIOL, V174, P5457
   Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100
   Dow JM, 1994, MOL CELLULAR MECH BA, V192., P29
   Frey PA, 2013, ACCOUNTS CHEM RES, V46, P1417, DOI 10.1021/ar300246k
   Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000
   FU JF, 1990, APPL ENVIRON MICROB, V56, P919
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x
   He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x
   Hsiao YM, 2008, MICROBIOL-SGM, V154, P705, DOI 10.1099/mic.0.2007/012930-0
   Hsiao YM, 2012, ARCH MICROBIOL, V194, P293, DOI 10.1007/s00203-011-0760-3
   Hsiao YM, 2011, RES MICROBIOL, V162, P270, DOI 10.1016/j.resmic.2010.12.002
   Hsiao YM, 2011, MICROBIOL RES, V166, P548, DOI 10.1016/j.micres.2010.11.003
   Hsiao YM, 2010, J AGR FOOD CHEM, V58, P1653, DOI 10.1021/jf903637s
   Hsiao YM, 2009, J AGR FOOD CHEM, V57, P6207, DOI 10.1021/jf900701n
   Hsiao YM, 2005, FEBS LETT, V579, P3525, DOI 10.1016/j.febslet.2005.05.023
   Hsiao YM, 2002, BIOCHEM BIOPH RES CO, V295, P43, DOI 10.1016/S0006-291X(02)00630-7
   Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328
   Hung CH, 2003, BIOCHEM BIOPH RES CO, V302, P878, DOI 10.1016/S0006-291X(03)00255-9
   Jalan N, 2011, J BACTERIOL, V193, P6342, DOI 10.1128/JB.05777-11
   Katzen F, 1996, J BACTERIOL, V178, P4313, DOI 10.1128/jb.178.14.4313-4318.1996
   Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y
   KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5
   Krispin O, 1998, J BACTERIOL, V180, P2265
   Lee TC, 2001, J MOL MICROB BIOTECH, V3, P471
   Liu YJ, 1997, BIOCHEMISTRY-US, V36, P10675, DOI 10.1021/bi970430a
   Liu YF, 2013, FEBS J, V280, P199, DOI 10.1111/febs.12061
   Lu GT, 2009, MICROBIOL-SGM, V155, P1602, DOI 10.1099/mic.0.023762-0
   Lu GT, 2009, J BACTERIOL, V191, P3639, DOI 10.1128/JB.00009-09
   Mahavihakanont A, 2012, J BACTERIOL, V194, P209, DOI 10.1128/JB.05603-11
   Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]
   METZGER M, 1994, J BACTERIOL, V176, P450
   MILLER JH, 1972, EXPT MOL GENETICS
   Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06
   Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001
   Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705
   Sakuraba H, 2011, ARCH BIOCHEM BIOPHYS, V512, P126, DOI 10.1016/j.abb.2011.05.013
   Sambrook J., 1989, MOL CLONING LAB MANU
   Shaw MP, 2003, MOL BIOCHEM PARASIT, V126, P173, DOI 10.1016/S0166-6851(02)00243-8
   Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x
   Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695
   SWANSON BA, 1993, BIOCHEMISTRY-US, V32, P13231, DOI 10.1021/bi00211a035
   Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005
   Thoden JB, 2005, J BIOL CHEM, V280, P21900, DOI 10.1074/jbc.M502411200
   Thoden JB, 1997, BIOCHEMISTRY-US, V36, P10685, DOI 10.1021/bi9704313
   Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l
   Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6294, DOI 10.1021/bi970025j
   Thoden JB, 1996, PROTEIN SCI, V5, P2149, DOI 10.1002/pro.5560051102
   Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y
   Thoden JB, 2002, J BIOL CHEM, V277, P27528, DOI 10.1074/jbc.M204413200
   Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114
   Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200
   Thoden JB, 1998, BIOCHEMISTRY-US, V37, P11469, DOI 10.1021/bi9808969
   Tseng YH, 1999, J BACTERIOL, V181, P117
   Valiente E, 2008, INFECT IMMUN, V76, P1628, DOI 10.1128/IAI.01393-07
   Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013
   WANG TW, 1992, LETT APPL MICROBIOL, V14, P65, DOI 10.1111/j.1472-765X.1992.tb00649.x
   Williams P. H., 1980, Plant Disease, V64, P736
   YANG BY, 1988, BOT BULL ACAD SINICA, V29, P93
   Yen MR, 2002, APPL ENVIRON MICROB, V68, P2924, DOI 10.1128/AEM.68.6.2924-2933.2002
   Zou Y, 2013, VET MICROBIOL, V162, P278, DOI 10.1016/j.vetmic.2012.08.006
NR 72
TC 8
Z9 8
U1 0
U2 6
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0944-5013
J9 MICROBIOL RES
JI Microbiol. Res.
PY 2014
VL 169
IS 5-6
BP 441
EP 452
DI 10.1016/j.micres.2013.08.005
PG 12
WC Microbiology
SC Microbiology
GA AG0LV
UT WOS:000335107900015
PM 24120348
OA Bronze
DA 2019-02-28
ER

PT J
AU Chen, CY
   Hofmann, CS
   Cottrell, BJ
   Strobaugh, TP
   Paoli, GC
   Nguyen, LH
   Yan, XH
   Uhlich, GA
AF Chen, Chin-Yi
   Hofmann, Christopher S.
   Cottrell, Bryan J.
   Strobaugh, Terence P., Jr.
   Paoli, George C.
   Ly-Huong Nguyen
   Yan, Xianghe
   Uhlich, Gaylen A.
TI Phenotypic and Genotypic Characterization of Biofilm Forming
   Capabilities in Non-O157 Shiga Toxin-Producing Escherichia coli Strains
SO PLOS ONE
LA English
DT Article
ID IN-GROUND BEEF; CSGD PROMOTER; SALMONELLA-TYPHIMURIUM;
   EXTRACELLULAR-MATRIX; UNITED-STATES; FOOD; EXPRESSION; MOTILITY;
   O157-H7; BACTERIOPHAGES
AB The biofilm life style helps bacteria resist oxidative stress, desiccation, antibiotic treatment, and starvation. Biofilm formation involves a complex regulatory gene network controlled by various environmental signals. It was previously shown that prophage insertions in mlrA and heterogeneous mutations in rpoS constituted major obstacles limiting biofilm formation and the expression of extracellular curli fibers in strains of Escherichia coli serotype O157: H7. The purpose of this study was to test strains from other important serotypes of Shiga toxin-producing E. coli (STEC) (O26, O45, O103, O111, O113, O121, and O145) for similar regulatory restrictions. In a small but diverse collection of biofilm-forming and non-forming strains, mlrA prophage insertions were identified in only 4 of the 19 strains (serotypes O103, O113, and O145). Only the STEC O103 and O113 strains could be complemented by a trans-copy of mlrA to restore curli production and Congo red (CR) dye affinity. RpoS mutations were found in 5 strains (4 serotypes), each with low CR affinity, and the defects were moderately restored by a wild-type copy of rpoS in 2 of the 3 strains attempted. Fourteen strains in this study showed no or weak biofilm formation, of which 9 could be explained by prophage insertions or rpoS mutations. However, each of the remaining five biofilm-deficient strains, as well as the two O145 strains that could not be complemented by mlrA, showed complete or nearly complete lack of motility. This study indicates that mlrA prophage insertions and rpoS mutations do limit biofilm and curli expression in the non-serotype O157: H7 STEC but prophage insertions may not be as common as in serotype O157: H7 strains. The results also suggest that lack of motility provides a third major factor limiting biofilm formation in the non-O157: H7 STEC. Understanding biofilm regulatory mechanisms will prove beneficial in reducing pathogen survival and enhancing food safety.
C1 [Chen, Chin-Yi; Hofmann, Christopher S.; Cottrell, Bryan J.; Strobaugh, Terence P., Jr.; Paoli, George C.; Ly-Huong Nguyen; Yan, Xianghe; Uhlich, Gaylen A.] ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA.
RP Chen, CY (reprint author), ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA.
EM chin-yi.chen@ars.usda.gov
FU National Program 108 Food Safety Project of the United States Department
   of Agriculture-Agriculture Research Service (USDA-ARS).
FX This research was funded by the National Program 108 Food Safety Project
   of the United States Department of Agriculture-Agriculture Research
   Service (USDA-ARS). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Beutin L, 2007, APPL ENVIRON MICROB, V73, P4769, DOI 10.1128/AEM.00873-07
   Biscola FT, 2011, APPL ENVIRON MICROB, V77, P2201, DOI 10.1128/AEM.01920-10
   Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0
   Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10
   Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536
   Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x
   Burkart M, 1998, P NATL ACAD SCI USA, V95, P2568, DOI 10.1073/pnas.95.5.2568
   DebRoy C, 2011, FOODBORNE PATHOG DIS, V8, P651, DOI 10.1089/fpd.2010.0769
   Fratamico PM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00152
   Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005
   Gerstel U, 2003, MOL MICROBIOL, V49, P639, DOI 10.1046/j.1365-2958.2003.03594.x
   Gerstel U, 2006, FEMS MICROBIOL LETT, V261, P109, DOI 10.1111/j.1574-6968.2006.00332.x
   Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003
   Medina MB, 2012, J FOOD PROTECT, V75, P819, DOI 10.4315/0362-028X.JFP-11-430
   MILLER JH, 1972, EXPT MOL GENETICS
   Ogasawara H, 2010, FEMS MICROBIOL LETT, V312, P160, DOI 10.1111/j.1574-6968.2010.02112.x
   Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0
   Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720
   Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808
   Pesavento C, 2012, NUCLEIC ACIDS RES, V40, P4783, DOI 10.1093/nar/gks055
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739
   Serra-Moreno R, 2007, J BACTERIOL, V189, P6645, DOI 10.1128/JB.00466-07
   Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003
   Takkinen J, 2011, SHIGA TOXIN VEROTOXI
   Uhlich GA, 2001, APPL ENVIRON MICROB, V67, P2367, DOI 10.1128/AEM.67.5.2367-2370.2001
   Uhlich GA, 2013, MICROBIOL-SGM, V159, P1586, DOI 10.1099/mic.0.066118-0
   van Hoek AHAM, 2013, FEMS MICROBIOL LETT, V338, P18, DOI 10.1111/1574-6968.12024
   Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x
   Wang R, 2012, J FOOD PROTECT, V75, P1418, DOI 10.4315/0362-028X.JFP-11-427
   Wasilenko JL, 2012, J FOOD PROTECT, V75, P1939, DOI 10.4315/0362-028X.JFP-12-087
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x
NR 32
TC 15
Z9 15
U1 3
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 27
PY 2013
VL 8
IS 12
AR e84863
DI 10.1371/journal.pone.0084863
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 281RE
UT WOS:000329117900115
PM 24386426
OA DOAJ Gold, Green Published
DA 2019-02-28
ER

EF